ticker,rpa_date_utc,rpa_time_utc,rp_entity_id,entity_name,relevance,event_sentiment_score,group,sub_type,event_text,news_type,source_name,headline
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: FY 2022 was marked by portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.58,acquisitions-mergers,delayed,"Nanostart AG: In particular, the delay of the acquisition",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,0.0,earnings,,"Nanostart AG: On the other hand, proceeds from disposals fell to EUR2.89 million (previous year",PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-07-14,09:32:23,038650,Nanostart AG,99,-0.67,earnings,down,Nanostart AG: The decline in earnings,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,0.0,assets,,Nanostart AG: H1 2023: Large portfolio,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.49,equity-actions,up,Nanostart AG: Total operating costs of EUR 3.10 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2023-11-20,09:01:22,038650,Nanostart AG,99,-0.65,earnings,negative,Nanostart AG: The book loss of EUR 0.61 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:00:19,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-08,07:01:29,038650,Nanostart AG,100,0.55,acquisitions-mergers,,Coreo acquires manufacturing sites and administrative facilities from German,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo acquires manufacturing sites and administrative facilities from German automotive supplier listed on stock exchange
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:00:24,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,DGAP News,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-14,12:01:19,038650,Nanostart AG,99,0.65,acquisitions-mergers,,Coreo AG acquired by way of a share deal a real estate,PRESS-RELEASE,Dow Jones Newswires,"DGAP-Adhoc: Acquisition of a real estate portfolio with 1,356 units by Coreo AG - MagForce shares as part of the purchase price"
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:29:22,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-07-28,12:30:12,038650,Nanostart AG,100,0.0,investor-relations,,Coreo AG: Change of major shareholder,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Change of major shareholder
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.38,credit,,Nanostart AG: The company received a loan of EUR 23 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-08-23,09:31:08,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: the company also announced the change of the major shareholder,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:00:26,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-09-07,06:01:10,038650,Nanostart AG,99,0.0,investor-relations,,Nanostart AG: our new major shareholder,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo pursues growth course with logistics property
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: 1H 2021: earnings improvement,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.64,earnings,up,Nanostart AG: slight increase in 2021,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.37,labor-issues,increase,Coreo AG increased rental income to EUR1.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG had acquired properties with,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: we now expect EBIT of EUR 2.93 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2021-10-04,07:32:07,038650,Nanostart AG,99,0.0,earnings,unchanged,Nanostart AG: The forecasts for the following years remain unchanged,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,DGAP News,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,-0.57,labor-issues,,Nanostart AG: Mr Marinov will also resign from his management,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-02-15,11:55:23,038650,Nanostart AG,99,0.47,labor-issues,,Nanostart AG: The Supervisory Board has also appointed,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Information and explanations of the issuer regarding this announcement: Changes in the Managing Board of Coreo AG
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-03-30,14:47:08,038650,Nanostart AG,100,0.53,labor-issues,,Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG: Supervisory Board appoints Michael Tegeder as Chief Financial Officer
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.53,labor-issues,,Coreo AG announced the change of the management board,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-04-29,08:01:09,038650,Nanostart AG,99,0.46,equity-actions,,Nanostart AG: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Management Interview
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.61,earnings,up,Nanostart AG: The EBIT rose,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-11,16:00:28,038650,Nanostart AG,99,0.0,earnings,,Nanostart AG: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo AG publishes consolidated figures (IFRS) for 2021
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,DGAP News,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-12,14:06:55,038650,Nanostart AG,100,0.42,equity-actions,completed,Coreo AG successfully completed the capital increase,PRESS-RELEASE,Dow Jones Newswires,DGAP-Adhoc: Coreo AG completes capital increase with success
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-05-30,07:01:10,038650,Nanostart AG,99,0.86,revenues,up,Nanostart AG: The significant increase in total revenues,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): Buy
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,DGAP News,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-07-27,06:00:49,038650,Nanostart AG,99,-0.44,assets,sale,Coreo sells development site at Mannheim,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Coreo sells development site at Mannheim freight station
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,DGAP News,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.55,acquisitions-mergers,,Coreo AG acquired a logistics property in Delmenhorst,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2022-10-26,08:01:14,038650,Nanostart AG,99,0.0,equity-actions,,Nanostart AG: The increase in operating costs to EUR3.04 million,PRESS-RELEASE,Dow Jones Newswires,Original-Research: Coreo AG (von GBC AG): BUY
COR,2024-06-13,05:00:14,45B7C5,Lotus Bakeries N.V.,100,0.49,partnerships,,Mondelez International and Lotus Bakeries Join Forces to,PRESS-RELEASE,GlobeNewswire,Mondelez International and Lotus Bakeries Join Forces to Expand the Biscoff(R) Brand in India and Create Co-Branded Chocolate Innovations in Key Markets
COR,2024-06-13,05:00:14,45B7C5,Lotus Bakeries N.V.,100,0.57,equity-actions,listing,Lotus Bakeries is listed on Euronext Brussels,PRESS-RELEASE,GlobeNewswire,Mondelez International and Lotus Bakeries Join Forces to Expand the Biscoff(R) Brand in India and Create Co-Branded Chocolate Innovations in Key Markets
COR,2024-06-13,08:38:30,45B7C5,Lotus Bakeries N.V.,100,0.55,products-services,gain,Lotus plans to grow market share,FULL-ARTICLE,Dow Jones Newswires,Lotus Bakeries Shares Rise on Mondelez International Partnership for India Expansion
COR,2024-06-13,08:38:30,45B7C5,Lotus Bakeries N.V.,100,0.41,revenues,up,Lotus's revenue in India made up 0.2%,FULL-ARTICLE,Dow Jones Newswires,Lotus Bakeries Shares Rise on Mondelez International Partnership for India Expansion
COR,2024-06-13,08:53:30,45B7C5,Lotus Bakeries N.V.,100,0.55,products-services,gain,Lotus plans to grow market share,FULL-ARTICLE,Dow Jones Newswires,Lotus Bakeries Shares Rise on Mondelez International Partnership for India Expansion
COR,2024-06-13,08:53:30,45B7C5,Lotus Bakeries N.V.,100,0.41,revenues,up,Lotus's revenue in India made up 0.2%,FULL-ARTICLE,Dow Jones Newswires,Lotus Bakeries Shares Rise on Mondelez International Partnership for India Expansion
COR,2024-06-13,05:00:14,45B7C5,Lotus Bakeries N.V.,100,0.49,partnerships,,Mondelez International and Lotus Bakeries Join Forces to,PRESS-RELEASE,GlobeNewswire,Mondelez International and Lotus Bakeries Join Forces to Expand the Biscoff(R) Brand in India and Create Co-Branded Chocolate Innovations in Key Markets
COR,2024-06-13,05:00:14,45B7C5,Lotus Bakeries N.V.,100,0.57,equity-actions,listing,Lotus Bakeries is listed on Euronext Brussels,PRESS-RELEASE,GlobeNewswire,Mondelez International and Lotus Bakeries Join Forces to Expand the Biscoff(R) Brand in India and Create Co-Branded Chocolate Innovations in Key Markets
COR,2024-06-13,08:38:30,45B7C5,Lotus Bakeries N.V.,100,0.55,products-services,gain,Lotus plans to grow market share,FULL-ARTICLE,Dow Jones Newswires,Lotus Bakeries Shares Rise on Mondelez International Partnership for India Expansion
COR,2024-06-13,08:38:30,45B7C5,Lotus Bakeries N.V.,100,0.41,revenues,up,Lotus's revenue in India made up 0.2%,FULL-ARTICLE,Dow Jones Newswires,Lotus Bakeries Shares Rise on Mondelez International Partnership for India Expansion
COR,2024-06-13,08:53:30,45B7C5,Lotus Bakeries N.V.,100,0.55,products-services,gain,Lotus plans to grow market share,FULL-ARTICLE,Dow Jones Newswires,Lotus Bakeries Shares Rise on Mondelez International Partnership for India Expansion
COR,2024-06-13,08:53:30,45B7C5,Lotus Bakeries N.V.,100,0.41,revenues,up,Lotus's revenue in India made up 0.2%,FULL-ARTICLE,Dow Jones Newswires,Lotus Bakeries Shares Rise on Mondelez International Partnership for India Expansion
COR,2024-06-03,10:46:15,4DF24B,Curzon Energy PLC,99,-0.76,bankruptcy,,Curzon Energy PLC: the Company will be put into liquidation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Corporate Update
COR,2024-08-19,15:14:23,4DF24B,Curzon Energy PLC,99,-0.32,equity-actions,,Curzon Energy PLC: the Company to raise capital from,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Curzon Energy PLC Notice of General Meeting, Placing & CVA"
COR,2024-08-19,15:14:23,4DF24B,Curzon Energy PLC,99,0.53,labor-issues,,Curzon Energy PLC: The Directors have appointed,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Curzon Energy PLC Notice of General Meeting, -2-"
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Results for the Year Ended 31 December 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,99,0.0,investor-relations,,Curzon Energy PLC: The Company will be holding its AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,99,0.44,labor-issues,,Curzon Energy PLC: Directors' Remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -4-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,99,0.57,equity-actions,listing,Curzon Energy PLC: the company's listing on the London Stock Exchange,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -6-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,90,-0.62,earnings,negative,Curzon Energy PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -7-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,90,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -7-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,90,-0.65,earnings,negative,Curzon Energy PLC: Loss per share - Basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -7-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,99,0.62,acquisitions-mergers,,Curzon Energy PLC: On the 4th of October 2017 it acquired Coos Bay Energy,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -8-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,92,0.62,dividends,up,"Curzon Energy PLC: Interest, dividends, gains",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -9-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,93,-0.65,earnings,negative,Curzon Energy PLC: Loss for the Year Before,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -10-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,93,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -10-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,94,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -11-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,94,-0.65,earnings,negative,Curzon Energy PLC: The basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -11-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,94,-0.65,earnings,negative,Curzon Energy PLC: Diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -11-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,94,-0.65,earnings,negative,Curzon Energy PLC: Loss) after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -11-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,94,0.0,equity-actions,,Curzon Energy PLC: Cost: At the beginning of the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -11-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,97,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -14-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,98,-0.32,equity-actions,,Curzon Energy PLC: An increase in share capital,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -15-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,98,-0.65,earnings,negative,Curzon Energy PLC: Total comprehensive loss for the year 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -15-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,98,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -15-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,98,0.46,equity-actions,,Curzon Energy PLC: Investments in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -15-
COR,2024-09-09,10:48:31,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,"Curzon Energy PLC: In the year ended 31 December 2023, credit losses",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Annual Financial Report -16-
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC: Unaudited Half-Year Results for the Six Months Ended 30 June 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,"Curzon Energy PLC: The Company incurred a loss of US$510,956",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Basic loss per share of US$ 0.005,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,100,-0.62,earnings,negative,Curzon Energy PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss) per share Basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,98,0.0,equity-actions,,Curzon Energy PLC: Foreign Share-based currency Share Share Consolidation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -2-
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,98,-0.65,earnings,negative,Curzon Energy PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -2-
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,99,-0.32,equity-actions,,Curzon Energy PLC: the Company's called up share capital,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -3-
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -3-
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Loss after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -3-
COR,2024-09-30,06:00:07,4DF24B,Curzon Energy PLC,96,0.28,equity-actions,completed,"Curzon Energy PLC: the Company completed a capital raise of GBP340,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -4-
COR,2024-10-08,12:59:11,4DF24B,Curzon Energy PLC,98,0.0,investor-relations,,Curzon Energy PLC: Results of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Result of AGM
COR,2021-02-03,07:00:07,4DF24B,Curzon Energy PLC,99,0.39,products-services,,"Curzon Energy PLC: The Company further announces the execution of a Letter of Intent (""LOI"") with",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Termination of Discussions -- Execution of LOI
COR,2021-03-25,07:00:15,4DF24B,Curzon Energy PLC,99,0.36,credit,extension,Curzon Energy PLC: Loan Extension,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Loan Extension
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: The Group loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 December 2020
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,investor-relations,,Curzon Energy PLC: The Company will be holding its AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 December 2020
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.48,equity-actions,down,Curzon Energy PLC: Overall administrative expenses fell,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 December 2020
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -2-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -3-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -4-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss per share - Basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -4-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -5-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -6-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.32,equity-actions,,Curzon Energy PLC: the Company's called up share capital,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -6-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -7-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.62,dividends,up,"Curzon Energy PLC: Interest, dividends, gains",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -7-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -8-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss for the Year Before,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -9-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -9-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -9-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -10-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss) after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -10-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,equity-actions,,Curzon Energy PLC: Cost: At the beginning of the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -10-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -11-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -12-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -13-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -13-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.39,products-services,,"Curzon Energy PLC: The Company further announced the execution of a Letter of Intent (""LOI"") with",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -13-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.36,credit,extension,Curzon Energy PLC: Loan Extension,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -13-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -14-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.46,equity-actions,,Curzon Energy PLC: Investments in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -14-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,"Curzon Energy PLC: In the year ended 31 December 2020, credit losses",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -15-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.46,equity-actions,,Curzon Energy PLC: Investment in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -15-
COR,2021-04-30,16:51:16,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -16-
COR,2021-06-09,14:23:09,4DF24B,Curzon Energy PLC,99,0.0,investor-relations,,Curzon Energy PLC: Results of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Result of AGM
COR,2021-09-10,12:20:45,4DF24B,Curzon Energy PLC,99,0.36,credit,extension,Curzon Energy PLC: Loan Extension,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Loan Extension
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,99,0.0,earnings,,Curzon Energy PLC: Unaudited Half-Year Results for the Six Months Ended 30 June 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,"Curzon Energy PLC: The Company incurred a loss of US$411,907",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Basic loss per share of US$ 0.003,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,99,0.39,products-services,,The planned transaction with Curzon,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,99,-0.62,earnings,negative,"Curzon Energy PLC: Loss before taxation (345,886",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Loss) per share Basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,95,0.0,equity-actions,,Curzon Energy PLC: Foreign Share-based currency Share Share Consolidation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results -2-
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,95,-0.65,earnings,negative,Curzon Energy PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results -2-
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,95,-0.65,earnings,negative,Curzon Energy PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results -2-
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,99,-0.32,equity-actions,,Curzon Energy PLC: the Company's called up share capital,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results -3-
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results -3-
COR,2021-09-13,06:00:12,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Loss after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2021 Interim Results -3-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Results for the Year Ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,0.0,investor-relations,,Curzon Energy PLC: The Company will be holding its AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,-0.62,earnings,negative,Curzon Energy PLC: Loss before taxation 4,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -4-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -4-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Loss per share - Basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -4-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Other comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -5-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,92,0.62,dividends,up,"Curzon Energy PLC: Interest, dividends, gains",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -7-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,95,-0.65,earnings,negative,Curzon Energy PLC: Loss for the Year Before,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -8-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,95,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -8-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,95,-0.62,earnings,negative,"Curzon Energy PLC: Loss before tax (860,463",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -9-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,95,-0.65,earnings,negative,Curzon Energy PLC: Diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -9-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,95,-0.65,earnings,negative,Curzon Energy PLC: Loss) after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -9-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,95,0.0,equity-actions,,Curzon Energy PLC: Cost: At the beginning of the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -9-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,97,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -12-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,0.36,credit,extension,Curzon Energy PLC: Loan Extension,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -13-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -13-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Total comprehensive loss for the year 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -13-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,99,0.46,equity-actions,,Curzon Energy PLC: Investments in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -14-
COR,2022-04-29,06:01:21,4DF24B,Curzon Energy PLC,97,-0.65,earnings,negative,"Curzon Energy PLC: In the year ended 31 December 2021, credit losses",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Final Results -15-
COR,2022-05-31,14:42:37,4DF24B,Curzon Energy PLC,98,0.0,investor-relations,,Curzon Energy PLC: Results of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Result of AGM
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,"Curzon Energy PLC: The Company incurred a loss of US$ 180,131",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,99,0.0,earnings,,Curzon Energy PLC: Unaudited Half-Year Results for the Six Months Ended 30 June 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Basic loss per share of US$ 0.004,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,99,-0.62,earnings,negative,"Curzon Energy PLC: Loss before taxation (408,424",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Loss) per share Basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,98,0.0,equity-actions,,Curzon Energy PLC: Foreign Share-based currency Share Share Consolidation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results -2-
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,98,-0.65,earnings,negative,Curzon Energy PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results -2-
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,98,-0.65,earnings,negative,Curzon Energy PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results -2-
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,99,-0.32,equity-actions,,Curzon Energy PLC: the Company's called up share capital,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results -3-
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results -3-
COR,2022-09-27,06:01:54,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Loss after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC 2022 Interim Results -3-
COR,2022-12-01,12:51:38,4DF24B,Curzon Energy PLC,99,0.0,earnings,,Curzon Energy PLC: the Company's Interim Results on 26 September 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Corporate Update
COR,2023-04-19,06:00:13,4DF24B,Curzon Energy PLC,99,-0.43,products-services,terminated,Curzon Energy PLC: Termination of Transaction,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Termination of Transaction Discussions with PET
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: The Group loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 December 2022
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,investor-relations,,Curzon Energy PLC: The Company will be holding its AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 December 2022
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -2-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -3-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -4-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.44,labor-issues,,Curzon Energy PLC: Directors' Remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -4-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -5-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.62,earnings,negative,Curzon Energy PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -5-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss per share - Basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -5-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -6-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -7-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -8-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.62,dividends,up,"Curzon Energy PLC: Interest, dividends, gains",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -8-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss for the Year Before,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -9-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -9-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -10-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -10-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: The basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -10-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -10-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss) after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -10-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,equity-actions,,Curzon Energy PLC: Cost: At the beginning of the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -10-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -11-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -12-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -13-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.62,earnings,negative,Curzon Energy PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -13-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss for the year 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -14-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Total comprehensive loss for the year 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -14-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.46,equity-actions,,Curzon Energy PLC: Investments in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -14-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,"Curzon Energy PLC: In the year ended 31 December 2022, credit losses",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -15-
COR,2023-04-28,11:06:56,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC Results for the Year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Results for the Year Ended 31 -16-
COR,2023-05-31,16:08:54,4DF24B,Curzon Energy PLC,99,0.0,investor-relations,,Curzon Energy PLC: Results of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Result of AGM
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,100,0.0,earnings,,Curzon Energy PLC: Unaudited Half-Year Results for the Six Months Ended 30 June 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,"Curzon Energy PLC: The Company incurred a loss of US$489,101",PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Basic loss per share of US$ 0.004,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,100,-0.62,earnings,negative,Curzon Energy PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,100,-0.65,earnings,negative,Curzon Energy PLC: Loss) per share Basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,99,0.0,equity-actions,,Curzon Energy PLC: Foreign Share-based currency Share Share Consolidation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -2-
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -2-
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,99,-0.32,equity-actions,,Curzon Energy PLC: the Company's called up share capital,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -3-
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -3-
COR,2023-09-28,06:00:24,4DF24B,Curzon Energy PLC,99,-0.65,earnings,negative,Curzon Energy PLC: Loss after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Curzon Energy PLC Unaudited Half-Year Results -3-
COR,2024-03-05,14:00:27,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Latest Version of CorelDRAW,PRESS-RELEASE,GlobeNewswire,"Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:27,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Latest Version of CorelDRAW,PRESS-RELEASE,GlobeNewswire,"Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:27,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Latest Version of CorelDRAW,PRESS-RELEASE,GlobeNewswire,"Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:27,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Latest Version of CorelDRAW,PRESS-RELEASE,GlobeNewswire,"Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:27,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Latest Version of CorelDRAW,PRESS-RELEASE,GlobeNewswire,"Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:27,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Latest Version of CorelDRAW,PRESS-RELEASE,GlobeNewswire,"Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-03-05,14:00:29,761CC5,Corel Corp.,100,0.52,products-services,,Corel Corp.: Press Release: Latest Version of CorelDRAW,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Latest Version of CorelDRAW Graphics Suite Offers 100 Realistic Pixel-Based Brushes, Built on World-Famous Corel Painter Brush Technology"
COR,2024-01-03,10:36:16,7D85A9,Cencora Inc.,100,0.95,analyst-ratings,positive,Cencora Initiated at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Initiated at Overweight by Barclays
COR,2024-01-03,10:36:16,7D85A9,Cencora Inc.,100,0.0,price-targets,set,Cencora Price Target Announced at $242.00/Share by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Announced at $242.00/Share by Barclays
COR,2024-01-04,21:30:01,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
COR,2024-01-04,21:31:40,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 166 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 166 Of Cencora Inc >COR
COR,2024-01-04,22:06:24,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
COR,2024-01-11,12:27:04,7D85A9,Cencora Inc.,100,0.39,products-services,,Cencora Inc.: QSM Diagnostics Signs National Distribution Agreement with MWI Animal Health,PRESS-RELEASE,PR Newswire,QSM Diagnostics Signs National Distribution Agreement with MWI Animal Health
COR,2024-01-16,21:47:06,7D85A9,Cencora Inc.,100,-0.43,labor-issues,,Mcgee To Retire From Cencora Board in March,RNS-SEC8K,Dow Jones Newswires,Henry W. McGee To Retire From Cencora Board in March
COR,2024-01-17,21:06:07,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Dir Greenberg Acquires 1,340 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Acquires 1,340 Of Cencora Inc >COR"
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $72.3 billion for the First Quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.98,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.25 to $13.50,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2024, revenue was $72.3 billion, up 15.0 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.41,assets,open,Cencora Inc.: less-than-wholly-owned subsidiary in Egypt.,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2024 was $187.6 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.01 $ 2.35,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.41,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $ 64,690,297 $ 62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -5-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -5-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -5-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2024, (i) revenue of $72.3 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,1Q EPS $2.98 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q EPS $2.98 >COR
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Adj EPS $3.28,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Adj EPS $3.28 >COR
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Net $601.5M,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Net $601.5M >COR
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 1Q Rev $72.25B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Rev $72.25B >COR
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: First Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $72.3 billion for the First Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.98,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.25 to $13.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2024, revenue was $72.3 billion, up 15.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2024 was $187.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.01 $ 2.35,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $ 64,690,297 $ 62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -5-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -5-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2024, (i) revenue of $72.3 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:32:14,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $13.25,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $13.25-Adj EPS $13.50 >COR
COR,2024-02-05,16:34:23,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+'
COR,2024-02-05,16:34:23,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+'
COR,2024-02-05,16:34:23,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Inc.: we expect solid revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.44,credit,reduction,Cencora reduced its debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.14,credit,,Cencora will refinance debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,18:03:10,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Neutral by Mizuho
COR,2024-02-05,18:03:10,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $224.00/Share From $192.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $224.00/Share From $192.00 by Mizuho
COR,2024-02-05,18:47:56,7D85A9,Cencora Inc.,100,0.0,credit-ratings,set,Moody's Assigns Baa2 Rating To Cencora's New Senior Notes,NEWS-FLASH,Dow Jones Newswires,Moody's Assigns Baa2 Rating To Cencora's New Senior Notes
COR,2024-02-05,23:18:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 5.125% Senior Notes Due 2034,PRESS-RELEASE,Business Wire,Cencora Prices $500 Million 5.125% Senior Notes Due 2034
COR,2024-02-05,23:18:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 5.125% Senior Notes Due 2034,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Prices $500 Million 5.125% Senior Notes Due 2034
COR,2024-02-07,13:00:01,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora also collaborated with a manufacturing partner to launch,PRESS-RELEASE,Business Wire,Cencora Releases 2023 ESG Report
COR,2024-02-07,18:11:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $500 Million Senior Notes Offering,PRESS-RELEASE,Business Wire,Cencora Closes $500 Million Senior Notes Offering
COR,2024-02-07,18:11:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $500 Million Senior Notes Offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Closes $500 Million Senior Notes Offering
COR,2024-02-07,23:16:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
COR,2024-02-07,23:16:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
COR,2024-02-07,23:16:59,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shares of Cencora for $992 Million of Proceeds
COR,2024-02-07,23:26:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:26:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:26:28,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:27:11,7D85A9,Cencora Inc.,100,0.59,equity-actions,approved,Cencora: Agreed to Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora: Agreed to Repurchase About $50 Million of Common Stock >COR
COR,2024-02-07,23:29:40,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:29:40,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:37:24,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Sells Cencora Shares,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots Sells Cencora Shares for $992 Million
COR,2024-02-08,13:00:01,7D85A9,Cencora Inc.,99,0.52,products-services,,Cencora to introduce solutions,PRESS-RELEASE,Business Wire,Cencora's FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products
COR,2024-02-09,12:53:25,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 4,212,395 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 4,212,395 Of Cencora Inc >COR"
COR,2024-02-09,21:07:00,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 212,395 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-02-13,20:42:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 1,100 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 1,100 Of Cencora Inc >COR"
COR,2024-02-14,21:17:47,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 1,100 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 1,100 Of Cencora Inc >COR"
COR,2024-02-21,08:01:50,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2023 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2023 (COR)"
COR,2024-02-26,14:07:08,7D85A9,Cencora Inc.,100,0.95,analyst-ratings,positive,Cencora Initiated at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Initiated at Outperform by Leerink Partners
COR,2024-02-26,14:07:08,7D85A9,Cencora Inc.,100,0.0,price-targets,set,Cencora Price Target Announced at $261.00/Share by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Announced at $261.00/Share by Leerink Partners
COR,2024-03-11,20:43:08,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Battaglia Acquires 674 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 674 Of Cencora Inc >COR
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,0.47,labor-issues,,Cencora Inc.: be appointed as a member of the Company's Board,PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,-0.49,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President",PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora Inc.: Since Steve's appointment as CEO in 2011,PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,unchanged,Cencora is also reaffirming its fiscal 2024 guidance,PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,-0.49,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,0.47,labor-issues,,Cencora Inc.: be appointed as a member of the Company's Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora Inc.: Since Steve's appointment as CEO in 2011,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,0.0,earnings,unchanged,Cencora is also reaffirming its fiscal 2024 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:31:18,7D85A9,Cencora Inc.,100,0.0,earnings,unchanged,Cencora Reaffirms Fiscal Yr 2024 Guidance,NEWS-FLASH,Dow Jones Newswires,Cencora Reaffirms Fiscal Yr 2024 Guidance >COR
COR,2024-03-12,12:31:18,7D85A9,Cencora Inc.,100,0.0,earnings,unchanged,Cencora Reaffirms Fiscal Yr 2024 Guidance,NEWS-FLASH,Dow Jones Newswires,Cencora Reaffirms Fiscal Yr 2024 Guidance >COR
COR,2024-03-12,12:54:58,7D85A9,Cencora Inc.,100,-0.49,labor-issues,,Cencora CEO to Retire,FULL-ARTICLE,Dow Jones Newswires,"Cencora CEO to Retire, Become Executive Chair"
COR,2024-03-12,12:54:58,7D85A9,Cencora Inc.,100,-0.49,labor-issues,,Chief executive of Cencora plans to retire,FULL-ARTICLE,Dow Jones Newswires,"Cencora CEO to Retire, Become Executive Chair"
COR,2024-03-18,18:18:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 6,977 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 6,977 Of Cencora Inc >COR"
COR,2024-03-18,20:12:52,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 9,644 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 9,644 Of Cencora Inc >COR"
COR,2024-03-19,14:24:28,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,755 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,755 Of Cencora Inc >COR"
COR,2024-03-20,20:25:32,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 6,977 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 6,977 Of Cencora Inc >COR"
COR,2024-03-21,20:06:48,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,755 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,755 Of Cencora Inc >COR"
COR,2024-03-27,15:30:03,7D85A9,Cencora Inc.,99,-0.6,labor-issues,,Amerisourcebergen went on strike after months,PRESS-RELEASE,PR Newswire,STRIKING TEAMSTERS AT AMERISOURCEBERGEN TO RALLY FOR FAIR CONTRACT
COR,2024-03-27,15:36:33,7D85A9,Cencora Inc.,99,-0.6,labor-issues,,Amerisourcebergen went on strike after months,PRESS-RELEASE,Dow Jones Newswires,Press Release: STRIKING TEAMSTERS AT AMERISOURCEBERGEN TO RALLY FOR FAIR CONTRACT
COR,2024-03-27,18:41:54,7D85A9,Cencora Inc.,100,0.01,credit-ratings,affirmation,Moody's Affirms Cencora's Baa2 Senior Unsecured Rating,NEWS-FLASH,Dow Jones Newswires,"Moody's Affirms Cencora's Baa2 Senior Unsecured Rating, Outlook Revised To Positive"
COR,2024-03-28,14:14:26,7D85A9,Cencora Inc.,100,-0.6,labor-issues,,Cencora Inc.: TODAY: STRIKING,PRESS-RELEASE,PR Newswire,TODAY: STRIKING TEAMSTERS AT AMERISOURCEBERGEN TO RALLY FOR FAIR CONTRACT
COR,2024-03-28,22:30:03,7D85A9,Cencora Inc.,99,0.44,labor-issues,,Cencora's CEO Steven H. Collis took home $138 million over the past four years,PRESS-RELEASE,PR Newswire,TEAMSTERS AT CENCORA/AMERISOURCEBERGEN RALLY FOR FAIR CONTRACT IN SACRAMENTO
COR,2024-04-03,23:25:10,7D85A9,Cencora Inc.,100,0.39,products-services,,"Cencora/AMERISOURCEBERGEN, SECURE NEW CONTRACT",PRESS-RELEASE,PR Newswire,"TEAMSTERS END STRIKE AT CENCORA/AMERISOURCEBERGEN, SECURE NEW CONTRACT ADDRESSING WORKERS' CONCERNS"
COR,2024-04-03,23:40:14,7D85A9,Cencora Inc.,100,0.39,products-services,,"Cencora/AMERISOURCEBERGEN, SECURE NEW CONTRACT",PRESS-RELEASE,Dow Jones Newswires,"Press Release: TEAMSTERS END STRIKE AT CENCORA/AMERISOURCEBERGEN, SECURE NEW CONTRACT ADDRESSING WORKERS' CONCERNS"
COR,2024-04-05,12:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
COR,2024-04-05,12:33:41,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
COR,2024-04-11,12:30:05,7D85A9,Cencora Inc.,100,-0.52,legal,,"Class Action Lawsuit Against World Courier, Cencora & Amerisourcebergen Alleging",PRESS-RELEASE,PR Newswire,"Labor & Employment Firms Zakay Law Group APLC and JCL Law Firm APC File Class Action Lawsuit Against World Courier, Cencora & Amerisourcebergen Alleging Labor Code Claims"
COR,2024-04-15,20:30:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Coo Mauch Registers 57,564 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"COO Mauch Registers 57,564 Of Cencora Inc >COR"
COR,2024-04-16,14:30:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,754 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,754 Of Cencora Inc >COR"
COR,2024-04-17,20:23:58,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,754 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,754 Of Cencora Inc >COR"
COR,2024-04-17,20:26:35,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Coo Mauch Sells 57,564 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Sells 57,564 Of Cencora Inc >COR"
COR,2024-04-30,14:31:53,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by Citigroup
COR,2024-04-30,14:31:53,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $280.00/Share From $265.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $280.00/Share From $265.00 by Citigroup
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $2.09,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 second quarter ended March 31, 2024, revenue increased 7.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $68.4B $68.4B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2024 was $192.7 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,-0.57,labor-issues,,Cencora Inc.: Steven H. Collis will retire as President and Chief Executive Officer,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: The fiscal year to date EPS,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,approved,Cencora Inc.: the Company's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.11 $ 2.15,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Gross profit 3.71,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -4-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -4-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.52,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $63,868,046 $ 62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -6-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -6-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted net income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2024, (i) revenue of $68.4 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Net $420.8M,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Net $420.8M >COR
COR,2024-05-01,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 2Q Rev $68.41B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev $68.41B >COR
COR,2024-05-01,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,2Q EPS $2.09 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q EPS $2.09 >COR
COR,2024-05-01,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Adj EPS $3.80,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Adj EPS $3.80 >COR
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Second Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $2.09,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 second quarter ended March 31, 2024, revenue increased 7.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $68.4B $68.4B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2024 was $192.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,-0.57,labor-issues,,Cencora Inc.: Steven H. Collis will retire as President and Chief Executive Officer,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: The fiscal year to date EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.59,equity-actions,approved,Cencora Inc.: the Company's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.11 $ 2.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Gross profit 3.71,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -4-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -4-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.52,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $63,868,046 $ 62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -6-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -6-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2024, (i) revenue of $68.4 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:35:59,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises 2024 View To Adj EPS $13.30,NEWS-FLASH,Dow Jones Newswires,Cencora Raises 2024 View To Adj EPS $13.30-Adj EPS $13.50 >COR
COR,2024-05-01,10:37:00,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees 2024 Intl Healthcare Solutions Segment Rev Growth in 4% to 7%,NEWS-FLASH,Dow Jones Newswires,Cencora Sees 2024 Intl Healthcare Solutions Segment Rev Growth in 4% to 7% Range >COR
COR,2024-05-02,10:58:27,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-05-02,10:58:27,7D85A9,Cencora Inc.,100,0.3,price-targets,upgrade,Cencora Price Target Raised to $277.00/Share From $275.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $277.00/Share From $275.00 by Baird
COR,2024-05-08,12:30:00,7D85A9,Cencora Inc.,99,0.46,equity-actions,,Cencora Inc.: we continue to invest in solutions,PRESS-RELEASE,Business Wire,Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit
COR,2024-05-10,20:02:07,7D85A9,Cencora Inc.,100,0.0,insider-trading,,"Dir Greenberg Gifts 2,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Gifts 2,000 Of Cencora Inc >COR"
COR,2024-05-14,13:00:30,7D85A9,Cencora Inc.,99,0.49,partnerships,,Is collaborating with PharMerica to,PRESS-RELEASE,PR Newswire,mcare and PharMerica Team Up to Provide the Comprehensive Last Mile Solution to Tackle Medication Non-Adherence
COR,2024-05-21,07:00:58,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2024 (COR)"
COR,2024-05-21,14:27:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,755 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,755 Of Cencora Inc >COR"
COR,2024-05-22,20:10:14,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,755 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,755 Of Cencora Inc >COR"
COR,2024-05-22,21:38:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds
COR,2024-05-22,21:38:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds
COR,2024-05-22,21:38:31,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shares of Cencora for $400M of Proceeds
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance And Raises Fiscal 2024 Guidance >COR
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora is also raising its fiscal year 2024 adjusted diluted earnings per share guidance,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:03,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora is also raising its fiscal year 2024 adjusted diluted earnings per share guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:45:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $13.35,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $13.35-Adj EPS $13.55 >COR
COR,2024-05-22,22:03:46,7D85A9,Cencora Inc.,96,0.55,acquisitions-mergers,,Cencora has agreed to buy about $400 million in stock back from Walgreens Boots Alliance,FULL-ARTICLE,Dow Jones Newswires,Cencora To Buy $400M In Stock Back From Walgreens Boots
COR,2024-05-22,22:06:08,7D85A9,Cencora Inc.,96,0.55,acquisitions-mergers,,Cencora has agreed to buy about $400 million in stock back from Walgreens Boots Alliance,FULL-ARTICLE,MarketWatch,MW Cencora to buy $400 million in stock back from Walgreens
COR,2024-05-24,20:06:37,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 1,859,390 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-05-24,20:07:25,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 1,859,390 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 1,859,390 Of Cencora Inc >COR"
COR,2024-05-29,14:42:27,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 27,093 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 27,093 Of Cencora Inc >COR"
COR,2024-05-29,20:04:19,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Dir Durcan Buys 500 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,Dir Durcan Buys 500 Of Cencora Inc >COR
COR,2024-05-31,19:06:41,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 1,874 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 1,874 Of Cencora Inc >COR"
COR,2024-05-31,20:02:12,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 36,737 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 36,737 Of Cencora Inc >COR"
COR,2024-06-03,12:41:00,7D85A9,Cencora Inc.,92,0.55,products-services,gain,Cencora Inc.: The major drivers for this market are rising,PRESS-RELEASE,Business Wire,"Deep Frozen Packaging Logistics Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Almac, AmerisourceBergen, B.P.L., and Biocair - ResearchAndMarkets.com"
COR,2024-06-03,20:07:27,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 1,874 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 1,874 Of Cencora Inc >COR"
COR,2024-06-18,14:24:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,754 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,754 Of Cencora Inc >COR"
COR,2024-06-20,20:17:08,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,754 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,754 Of Cencora Inc >COR"
COR,2024-06-27,17:41:49,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Leerink Partners
COR,2024-06-27,17:48:09,7D85A9,Cencora Inc.,99,0.0,equity-actions,,"Amerisourcebergen, changed its company name",FULL-ARTICLE,Dow Jones Newswires,"Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court -- IBD"
COR,2024-07-02,20:11:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Donato Acquires 899 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Acquires 899 Of Cencora Inc >COR
COR,2024-07-05,20:15:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
COR,2024-07-05,21:26:21,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
COR,2024-07-09,11:13:46,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-07-09,11:13:46,7D85A9,Cencora Inc.,100,0.34,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $280.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $280.00 by Baird
COR,2024-07-16,14:15:52,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,755 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,755 Of Cencora Inc >COR"
COR,2024-07-17,20:11:35,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,755 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,755 Of Cencora Inc >COR"
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Net $483.5M,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Net $483.5M >COR
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 3Q Rev $74.24B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Rev $74.24B >COR
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $74.2 billion for the Third Quarter, a 10.9 Percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Third Quarter GAAP Diluted EPS of $2.42,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.55 to $13.65,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 third quarter ended June 30, 2024, revenue increased 10.9 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: our fiscal 2024 guidance,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $74.2B $74.2B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2024 was $179.4 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.44 $ 2.37,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -4-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -4-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -5-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.47,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -5-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -5-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -6-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $66,772,423 $ 62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -6-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -6-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2024, (i) revenue of $74.2 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2024 (i) revenue of $214.9 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -8-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,3Q EPS $2.42 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q EPS $2.42 >COR
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Adj EPS $3.34,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Adj EPS $3.34 >COR
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter Fiscal Year 2024 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 third quarter ended June 30, 2024, revenue increased 10.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: our fiscal 2024 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $74.2B $74.2B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Diluted Earnings Per Share $2.42 $3.34,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2024 was $179.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.44 $ 2.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -4-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -5-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,98,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -5-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $66,772,423 $ 62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -6-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -6-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2024, (i) revenue of $74.2 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -7-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2024 (i) revenue of $214.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -7-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -7-
COR,2024-07-31,10:35:52,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises FY24 View To Adj EPS $13.55,NEWS-FLASH,Dow Jones Newswires,Cencora Raises FY24 View To Adj EPS $13.55-Adj EPS $13.65 >COR
COR,2024-07-31,10:37:02,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees FY24 Rev Growth of About 12 %,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Rev Growth of About 12 % >COR
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Lifts FY Outlook on 3Q Revenue,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora again raised its outlook for its fiscal year,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Amerisourcebergen on Wednesday reported a net profit of $483.5 million,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora now forecasts adjusted earnings per share for the year ending Sept. 30 of $13.55 to $13.65,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-08-01,12:05:02,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-08-01,12:05:02,7D85A9,Cencora Inc.,100,0.3,price-targets,upgrade,Cencora Price Target Raised to $287.00/Share From $285.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $287.00/Share From $285.00 by Baird
COR,2024-08-01,13:53:12,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2024-08-01,13:53:12,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $249.00/Share From $236.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $249.00/Share From $236.00 by Wells Fargo
COR,2024-08-01,22:08:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds
COR,2024-08-01,22:08:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds
COR,2024-08-01,22:08:37,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of Cencora for Approximately $1.1B of Proceeds
COR,2024-08-01,22:14:51,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Reducing Cencora Stake,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Reducing Cencora Stake to About 10% From 12%
COR,2024-08-01,22:17:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance >COR
COR,2024-08-01,22:17:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:17:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:17:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:17:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:18:48,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora: To Buy Back About $250M of Common Stock,NEWS-FLASH,Dow Jones Newswires,Cencora: To Buy Back About $250M of Common Stock From Walgreens Boots Alliance >COR
COR,2024-08-01,22:39:47,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Sells Shares in Cencora,FULL-ARTICLE,Dow Jones Newswires,"Walgreens Sells Shares in Cencora for Third Time This Year, Raises $1.1 Billion"
COR,2024-08-01,23:04:19,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens sells shares in Cencora,FULL-ARTICLE,MarketWatch,"MW Walgreens sells shares in Cencora for third time this year, raises $1.1 billion"
COR,2024-08-02,17:59:49,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens continues to shed stake in Cencora,FULL-ARTICLE,MarketWatch,MW Walgreens continues to shed stake in Cencora as it looks to bolster turnaround
COR,2024-08-05,20:03:04,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 1,039,242 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-08-05,22:46:23,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 4,438,171 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 4,438,171 Of Cencora Inc >COR"
COR,2024-08-06,18:12:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 1,473 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 1,473 Of Cencora Inc >COR"
COR,2024-08-07,20:12:20,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 1,473 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 1,473 Of Cencora Inc >COR"
COR,2024-08-07,20:16:40,7D85A9,Cencora Inc.,100,0.0,insider-trading,,"Dir Greenberg Gifts 5,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Gifts 5,000 Of Cencora Inc >COR"
COR,2024-08-14,13:00:01,7D85A9,Cencora Inc.,99,0.49,partnerships,,"Solutions, announces an industry-transforming partnership with Cencora",PRESS-RELEASE,Business Wire,"Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems"
COR,2024-08-15,11:30:04,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Frank Clyburn to Its Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Cencora Elects Frank Clyburn to Its Bd of Directors
COR,2024-08-15,11:30:00,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Frank Clyburn to Its Board of Directors,PRESS-RELEASE,Business Wire,Cencora Elects Frank Clyburn to Its Board of Directors
COR,2024-08-15,11:30:03,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Frank Clyburn to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Elects Frank Clyburn to Its Board of Directors
COR,2024-08-15,12:31:09,7D85A9,Cencora Inc.,99,0.47,labor-issues,,"Cencora Inc.: the ""Company"") appointed Frank Clyburn to serve on the Board",RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2024-08-16,20:07:07,7D85A9,Cencora Inc.,99,0.0,labor-issues,,Cencora Inc.: the Company's 2022 Omnibus Incentive Plan,RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2024-08-20,07:16:48,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2024 (COR)"
COR,2024-08-20,14:51:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,754 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,754 Of Cencora Inc >COR"
COR,2024-08-21,14:18:17,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by JP Morgan
COR,2024-08-21,14:18:17,7D85A9,Cencora Inc.,100,0.42,price-targets,upgrade,Cencora Price Target Raised to $287.00/Share From $280.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $287.00/Share From $280.00 by JP Morgan
COR,2024-08-21,20:09:24,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,754 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,754 Of Cencora Inc >COR"
COR,2024-09-05,11:33:55,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $13.60,RNS-SEC8K,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $13.60-Adj EPS $13.70 >COR
COR,2024-09-05,11:31:46,7D85A9,Cencora Inc.,99,0.0,marketing,,"Cencora Inc.: the ""Company"") will be presenting at the Morgan Stanley Healthcare Conference today at 4:05 p.m. ET",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Regulation FD >COR
COR,2024-09-05,11:34:51,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY25 Adj EPS at,RNS-SEC8K,Dow Jones Newswires,Cencora Sees FY25 Adj EPS at Bottom End of 8%-12% Growth Target Range >COR
COR,2024-09-05,11:59:34,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises FY24 Outlook,FULL-ARTICLE,Dow Jones Newswires,"Cencora Raises FY24 Outlook, Warns of Covid-19 Hit in FY25 Growth Views"
COR,2024-09-06,11:31:53,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-09-06,11:31:53,7D85A9,Cencora Inc.,100,-0.28,price-targets,downgrade,Cencora Price Target Cut to $283.00/Share From $287.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $283.00/Share From $287.00 by Baird
COR,2024-09-17,13:51:28,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 21,509 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 21,509 Of Cencora Inc >COR"
COR,2024-09-18,10:51:00,7D85A9,Cencora Inc.,100,-0.58,analyst-ratings,negative,Cencora Cut to Neutral From Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Cut to Neutral From Buy by B of A Securities
COR,2024-09-18,10:51:00,7D85A9,Cencora Inc.,100,-0.8,price-targets,downgrade,Cencora Price Target Cut to $245.00/Share From $275.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $245.00/Share From $275.00 by B of A Securities
COR,2024-09-18,20:40:47,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 21,509 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 21,509 Of Cencora Inc >COR"
COR,2024-10-01,11:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
COR,2024-10-01,11:33:13,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
COR,2024-10-07,13:01:42,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Leerink Partners
COR,2024-10-07,13:01:42,7D85A9,Cencora Inc.,100,-0.17,price-targets,downgrade,Cencora Price Target Cut to $275.00/Share From $277.00 by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $275.00/Share From $277.00 by Leerink Partners
COR,2024-10-08,17:17:24,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Evercore ISI Group
COR,2024-10-08,17:17:24,7D85A9,Cencora Inc.,100,-0.7,price-targets,downgrade,Cencora Price Target Cut to $250.00/Share From $270.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $250.00/Share From $270.00 by Evercore ISI Group
COR,2024-10-15,20:02:49,7D85A9,Cencora Inc.,99,0.38,credit,,Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-10-22,14:45:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 21,509 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 21,509 Of Cencora Inc >COR"
COR,2024-10-23,20:07:20,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 21,509 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 21,509 Of Cencora Inc >COR"
COR,2024-11-04,13:30:02,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora Expands Enterprise Leadership Team with Two Senior Appointments,PRESS-RELEASE,Business Wire,Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-04,13:30:02,7D85A9,Cencora Inc.,99,0.53,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced the appointment of Francois Mandeville as Executive Vice President",PRESS-RELEASE,Business Wire,Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-04,13:30:04,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora Expands Enterprise Leadership Team with Two Senior Appointments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-04,13:30:04,7D85A9,Cencora Inc.,99,0.53,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced the appointment of Francois Mandeville as Executive Vice President",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,0.62,acquisitions-mergers,,Cencora will acquire RCA for approximately $4.6 billion in cash,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,0.22,acquisitions-mergers,,Cencora Inc.: our recent investment in OneOncology,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal year 2025 guidance,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through -2-
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,0.62,acquisitions-mergers,,Cencora will acquire RCA for approximately $4.6 billion in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,0.22,acquisitions-mergers,,Cencora Inc.: our recent investment in OneOncology,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal year 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Net $3.38M,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Net $3.38M >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 4Q Rev $79.05B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Rev $79.05B >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,4Q EPS 2c >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q EPS 2c >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Adj EPS $3.34,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Adj EPS $3.34 >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $79.1 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $0.02,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent to $294.0 billion for the fiscal year,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2024 GAAP Diluted EPS of $7.53,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.62,dividends,up,Cencora Inc.: Company increases its quarterly dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, adjusted diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.1,earnings,,Cencora Inc.: Adjusted operating income increased 10.9 percent to $3.6 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the fourth quarter of fiscal 2024 was $153.7 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2024 Summary Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.28,equity-actions,up,Cencora Inc.: Operating expenses increased 16.9 percent,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, GAAP diluted EPS was $7.53",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent from the prior fiscal year to $294.0 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 8.1 percent to $9.7 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, adjusted diluted EPS was $13.76",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora announced the appointment of Francois Mandeville to its executive,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.55,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's preliminary fiscal 2025 guidance,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.59,equity-actions,completed,"On September 5, 2024, Cencora has executed on opportunistic share repurchases",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Capital expenditures to be approximately $600 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal 2025 guidance,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 0.02 $ 1.74,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 7.60 $ 8.62,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -4-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.15,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -4-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.37,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -5-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -5-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -6-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $67,101,667 $62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -6-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -8-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2024, (i) revenue of $79.1 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -8-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2024, (i) revenue of $294.0 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -8-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $79.1 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $0.02,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent to $294.0 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2024 GAAP Diluted EPS of $7.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.62,dividends,up,Cencora Inc.: Company increases its quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.1,earnings,,Cencora Inc.: Adjusted operating income increased 10.9 percent to $3.6 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the fourth quarter of fiscal 2024 was $153.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2024 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.28,equity-actions,up,Cencora Inc.: Operating expenses increased 16.9 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, GAAP diluted EPS was $7.53",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent from the prior fiscal year to $294.0 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 8.1 percent to $9.7 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, adjusted diluted EPS was $13.76",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora announced the appointment of Francois Mandeville to its executive,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's preliminary fiscal 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.59,equity-actions,completed,"On September 5, 2024, Cencora has executed on opportunistic share repurchases",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Capital expenditures to be approximately $600 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 0.02 $ 1.74,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 7.60 $ 8.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -4-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -4-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -5-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -5-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -6-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $67,101,667 $62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -6-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -8-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2024, (i) revenue of $79.1 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -8-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2024, (i) revenue of $294.0 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -8-
COR,2024-11-06,11:37:09,7D85A9,Cencora Inc.,100,0.38,dividends,up,Cencora Raises Dividend to 55c Vs. 51c,NEWS-FLASH,Dow Jones Newswires,Cencora Raises Dividend to 55c Vs. 51c >COR
COR,2024-11-06,11:37:53,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees 2025 Revenue Growth of 7%-9%,NEWS-FLASH,Dow Jones Newswires,Cencora Sees 2025 Revenue Growth of 7%-9% >COR
COR,2024-11-06,11:38:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees 2025 Adj EPS $14.80,NEWS-FLASH,Dow Jones Newswires,Cencora Sees 2025 Adj EPS $14.80-Adj EPS $15.10 >COR
COR,2024-11-06,11:52:56,7D85A9,Cencora Inc.,100,0.55,acquisitions-mergers,,Cencora to Acquire Retina Consultants of America for $4.6B,FULL-ARTICLE,Dow Jones Newswires,Cencora to Acquire Retina Consultants of America for $4.6B
COR,2024-11-06,12:22:49,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora 4Q Sales Climb,FULL-ARTICLE,Dow Jones Newswires,Cencora 4Q Sales Climb While Profit Falls on Higher Costs
COR,2024-11-06,12:22:49,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Amerisourcebergen posted a profit of $3.38 million,FULL-ARTICLE,Dow Jones Newswires,Cencora 4Q Sales Climb While Profit Falls on Higher Costs
COR,2024-11-06,23:21:09,7D85A9,Cencora Inc.,100,0.03,credit-ratings,stable,S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable,NEWS-FLASH,Dow Jones Newswires,S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable
COR,2024-11-06,23:21:09,7D85A9,Cencora Inc.,100,0.03,credit-ratings,stable,S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable
COR,2024-11-06,23:21:09,7D85A9,Cencora Inc.,100,0.62,acquisitions-mergers,,Cencora's acquisition of OneOncology will,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable
COR,2024-11-06,23:21:19,7D85A9,Cencora Inc.,100,0.03,credit-ratings,affirmation,S&PGR Affirms Cencora 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Cencora 'BBB+' -2-
COR,2024-11-07,13:54:23,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Evercore ISI Group
COR,2024-11-07,13:54:23,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $250.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $250.00 by Evercore ISI Group
COR,2024-11-07,14:57:43,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by Barclays
COR,2024-11-07,14:57:43,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $290.00/Share From $263.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $290.00/Share From $263.00 by Barclays
COR,2024-11-07,16:08:23,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by UBS
COR,2024-11-07,16:08:23,7D85A9,Cencora Inc.,100,0.48,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $275.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $275.00 by UBS
COR,2024-11-07,17:52:54,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-11-07,17:52:54,7D85A9,Cencora Inc.,100,0.32,price-targets,upgrade,Cencora Price Target Raised to $292.00/Share From $287.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $292.00/Share From $287.00 by Baird
COR,2024-11-08,12:01:16,7D85A9,Cencora Inc.,99,0.62,acquisitions-mergers,,"Cencora Inc.: the Company entered into an agreement to acquire RCA, a portfolio company of Webster Equity Partners",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Other Events >COR
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.62,acquisitions-mergers,,Cencora recently announced that it plans to acquire Retina Consultants of America (RCA) for approximately $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.14,credit,,Cencora will refinance debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:43,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable -2-
COR,2024-11-08,16:19:53,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable -3-
COR,2024-11-13,21:14:37,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Ceo Mauch Acquires 6,684 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Acquires 6,684 Of Cencora Inc >COR"
COR,2024-11-13,21:18:02,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 2,723 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 2,723 Of Cencora Inc >COR"
COR,2024-11-13,21:19:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 21,664 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 21,664 Of Cencora Inc >COR"
COR,2024-11-13,21:22:21,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 3,351 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 3,351 Of Cencora Inc >COR"
COR,2024-11-13,21:23:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 4,676 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 4,676 Of Cencora Inc >COR"
COR,2024-11-13,21:26:28,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 3,001 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 3,001 Of Cencora Inc >COR"
COR,2024-11-19,15:03:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 21,509 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 21,509 Of Cencora Inc >COR"
COR,2024-11-20,08:16:02,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2024 (COR)"
COR,2024-11-21,21:51:10,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 21,509 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 21,509 Of Cencora Inc >COR"
COR,2024-11-22,21:20:32,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 69,805 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 69,805 Of Cencora Inc >COR"
COR,2024-11-22,21:21:25,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 8,058 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 8,058 Of Cencora Inc >COR"
COR,2024-11-22,21:21:55,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 1,039 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 1,039 Of Cencora Inc >COR"
COR,2024-11-22,21:22:05,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 7,083 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 7,083 Of Cencora Inc >COR"
COR,2024-11-22,21:23:13,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 18,889 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 18,889 Of Cencora Inc >COR"
COR,2024-11-22,21:26:18,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Ceo Mauch Acquires 21,718 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Acquires 21,718 Of Cencora Inc >COR"
COR,2024-11-25,21:10:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 50,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 50,000 Of Cencora Inc >COR"
COR,2024-11-26,21:35:58,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 50,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 50,000 Of Cencora Inc >COR"
COR,2024-12-02,16:02:50,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-12-02,16:02:50,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-12-02,16:02:50,7D85A9,Cencora Inc.,100,0.14,credit,,Cencora will refinance debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-12-02,16:03:00,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-' -2-
COR,2024-12-02,21:02:15,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 11,662 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 11,662 Of Cencora Inc >COR"
COR,2024-12-03,03:49:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 4.625% Senior Notes Due 2027,PRESS-RELEASE,Business Wire,"Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035"
COR,2024-12-03,03:49:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 4.625% Senior Notes Due 2027,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035"
COR,2024-12-03,16:15:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 1,816 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 1,816 Of Cencora Inc >COR"
COR,2024-12-04,21:27:27,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 1,816 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 1,816 Of Cencora Inc >COR"
COR,2024-12-06,13:30:00,7D85A9,Cencora Inc.,100,0.44,products-services,,Cencora Launches Accelerate Pharmacy Solutions to Enhance,PRESS-RELEASE,Business Wire,Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
COR,2024-12-06,13:30:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora partners with hospitals and health systems across,PRESS-RELEASE,Business Wire,Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
COR,2024-12-09,21:15:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $1.8 Billion Senior Notes Offering,PRESS-RELEASE,Business Wire,Cencora Closes $1.8 Billion Senior Notes Offering
COR,2024-12-09,21:15:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $1.8 Billion Senior Notes Offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Closes $1.8 Billion Senior Notes Offering
COR,2024-12-09,21:15:12,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $1.8 B Senior Notes Offering,NEWS-FLASH,Dow Jones Newswires,Cencora Closes $1.8 B Senior Notes Offering
COR,2024-12-10,21:31:21,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: the Company obtained $3.3 billion in bridge financing,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Other Events >COR
COR,2024-12-13,17:40:35,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2024-12-13,17:40:35,7D85A9,Cencora Inc.,100,-0.58,price-targets,downgrade,Cencora Price Target Cut to $237.00/Share From $249.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $237.00/Share From $249.00 by Wells Fargo
COR,2024-12-20,18:51:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 1,678 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 1,678 Of Cencora Inc >COR"
COR,2024-12-20,21:07:49,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Ceo Mauch Acquires 789 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mauch Acquires 789 Of Cencora Inc >COR
COR,2024-12-20,21:10:05,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 108 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 108 Of Cencora Inc >COR
COR,2024-12-20,21:12:42,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Chmn Collis Acquires 395 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,Chmn Collis Acquires 395 Of Cencora Inc >COR
COR,2024-12-20,21:15:16,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Cfo Cleary Jr Acquires 207 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,CFO Cleary Jr Acquires 207 Of Cencora Inc >COR
COR,2024-12-23,20:48:37,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 1,678 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 1,678 Of Cencora Inc >COR"
COR,2024-01-03,10:36:16,7D85A9,Cencora Inc.,100,0.95,analyst-ratings,positive,Cencora Initiated at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Initiated at Overweight by Barclays
COR,2024-01-03,10:36:16,7D85A9,Cencora Inc.,100,0.0,price-targets,set,Cencora Price Target Announced at $242.00/Share by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Announced at $242.00/Share by Barclays
COR,2024-01-04,21:30:01,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
COR,2024-01-04,21:31:40,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 166 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 166 Of Cencora Inc >COR
COR,2024-01-04,22:06:24,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
COR,2024-01-11,12:27:04,7D85A9,Cencora Inc.,100,0.39,products-services,,Cencora Inc.: QSM Diagnostics Signs National Distribution Agreement with MWI Animal Health,PRESS-RELEASE,PR Newswire,QSM Diagnostics Signs National Distribution Agreement with MWI Animal Health
COR,2024-01-16,21:47:06,7D85A9,Cencora Inc.,100,-0.43,labor-issues,,Mcgee To Retire From Cencora Board in March,RNS-SEC8K,Dow Jones Newswires,Henry W. McGee To Retire From Cencora Board in March
COR,2024-01-17,21:06:07,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Dir Greenberg Acquires 1,340 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Acquires 1,340 Of Cencora Inc >COR"
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $72.3 billion for the First Quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.98,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.25 to $13.50,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2024, revenue was $72.3 billion, up 15.0 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.41,assets,open,Cencora Inc.: less-than-wholly-owned subsidiary in Egypt.,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2024 was $187.6 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.01 $ 2.35,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.41,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $ 64,690,297 $ 62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -5-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -5-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -5-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2024, (i) revenue of $72.3 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,1Q EPS $2.98 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q EPS $2.98 >COR
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Adj EPS $3.28,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Adj EPS $3.28 >COR
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Net $601.5M,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Net $601.5M >COR
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 1Q Rev $72.25B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Rev $72.25B >COR
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: First Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $72.3 billion for the First Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.98,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.25 to $13.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2024, revenue was $72.3 billion, up 15.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2024 was $187.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.01 $ 2.35,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $ 64,690,297 $ 62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -5-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -5-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2024, (i) revenue of $72.3 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:32:14,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $13.25,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $13.25-Adj EPS $13.50 >COR
COR,2024-02-05,16:34:23,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+'
COR,2024-02-05,16:34:23,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+'
COR,2024-02-05,16:34:23,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Inc.: we expect solid revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.44,credit,reduction,Cencora reduced its debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.14,credit,,Cencora will refinance debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,18:03:10,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Neutral by Mizuho
COR,2024-02-05,18:03:10,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $224.00/Share From $192.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $224.00/Share From $192.00 by Mizuho
COR,2024-02-05,18:47:56,7D85A9,Cencora Inc.,100,0.0,credit-ratings,set,Moody's Assigns Baa2 Rating To Cencora's New Senior Notes,NEWS-FLASH,Dow Jones Newswires,Moody's Assigns Baa2 Rating To Cencora's New Senior Notes
COR,2024-02-05,23:18:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 5.125% Senior Notes Due 2034,PRESS-RELEASE,Business Wire,Cencora Prices $500 Million 5.125% Senior Notes Due 2034
COR,2024-02-05,23:18:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 5.125% Senior Notes Due 2034,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Prices $500 Million 5.125% Senior Notes Due 2034
COR,2024-02-07,13:00:01,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora also collaborated with a manufacturing partner to launch,PRESS-RELEASE,Business Wire,Cencora Releases 2023 ESG Report
COR,2024-02-07,18:11:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $500 Million Senior Notes Offering,PRESS-RELEASE,Business Wire,Cencora Closes $500 Million Senior Notes Offering
COR,2024-02-07,18:11:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $500 Million Senior Notes Offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Closes $500 Million Senior Notes Offering
COR,2024-02-07,23:16:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
COR,2024-02-07,23:16:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
COR,2024-02-07,23:16:59,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shares of Cencora for $992 Million of Proceeds
COR,2024-02-07,23:26:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:26:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:26:28,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:27:11,7D85A9,Cencora Inc.,100,0.59,equity-actions,approved,Cencora: Agreed to Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora: Agreed to Repurchase About $50 Million of Common Stock >COR
COR,2024-02-07,23:29:40,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:29:40,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:37:24,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Sells Cencora Shares,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots Sells Cencora Shares for $992 Million
COR,2024-02-08,13:00:01,7D85A9,Cencora Inc.,99,0.52,products-services,,Cencora to introduce solutions,PRESS-RELEASE,Business Wire,Cencora's FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products
COR,2024-02-09,12:53:25,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 4,212,395 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 4,212,395 Of Cencora Inc >COR"
COR,2024-02-09,21:07:00,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 212,395 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-02-13,20:42:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 1,100 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 1,100 Of Cencora Inc >COR"
COR,2024-02-14,21:17:47,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 1,100 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 1,100 Of Cencora Inc >COR"
COR,2024-02-21,08:01:50,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2023 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2023 (COR)"
COR,2024-02-26,14:07:08,7D85A9,Cencora Inc.,100,0.95,analyst-ratings,positive,Cencora Initiated at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Initiated at Outperform by Leerink Partners
COR,2024-02-26,14:07:08,7D85A9,Cencora Inc.,100,0.0,price-targets,set,Cencora Price Target Announced at $261.00/Share by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Announced at $261.00/Share by Leerink Partners
COR,2024-03-11,20:43:08,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Battaglia Acquires 674 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 674 Of Cencora Inc >COR
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,0.47,labor-issues,,Cencora Inc.: be appointed as a member of the Company's Board,PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,-0.49,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President",PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora Inc.: Since Steve's appointment as CEO in 2011,PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,unchanged,Cencora is also reaffirming its fiscal 2024 guidance,PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,-0.49,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,0.47,labor-issues,,Cencora Inc.: be appointed as a member of the Company's Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora Inc.: Since Steve's appointment as CEO in 2011,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,0.0,earnings,unchanged,Cencora is also reaffirming its fiscal 2024 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:31:18,7D85A9,Cencora Inc.,100,0.0,earnings,unchanged,Cencora Reaffirms Fiscal Yr 2024 Guidance,NEWS-FLASH,Dow Jones Newswires,Cencora Reaffirms Fiscal Yr 2024 Guidance >COR
COR,2024-03-12,12:31:18,7D85A9,Cencora Inc.,100,0.0,earnings,unchanged,Cencora Reaffirms Fiscal Yr 2024 Guidance,NEWS-FLASH,Dow Jones Newswires,Cencora Reaffirms Fiscal Yr 2024 Guidance >COR
COR,2024-03-12,12:54:58,7D85A9,Cencora Inc.,100,-0.49,labor-issues,,Cencora CEO to Retire,FULL-ARTICLE,Dow Jones Newswires,"Cencora CEO to Retire, Become Executive Chair"
COR,2024-03-12,12:54:58,7D85A9,Cencora Inc.,100,-0.49,labor-issues,,Chief executive of Cencora plans to retire,FULL-ARTICLE,Dow Jones Newswires,"Cencora CEO to Retire, Become Executive Chair"
COR,2024-03-18,18:18:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 6,977 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 6,977 Of Cencora Inc >COR"
COR,2024-03-18,20:12:52,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 9,644 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 9,644 Of Cencora Inc >COR"
COR,2024-03-19,14:24:28,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,755 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,755 Of Cencora Inc >COR"
COR,2024-03-20,20:25:32,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 6,977 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 6,977 Of Cencora Inc >COR"
COR,2024-03-21,20:06:48,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,755 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,755 Of Cencora Inc >COR"
COR,2024-03-27,15:30:03,7D85A9,Cencora Inc.,99,-0.6,labor-issues,,Amerisourcebergen went on strike after months,PRESS-RELEASE,PR Newswire,STRIKING TEAMSTERS AT AMERISOURCEBERGEN TO RALLY FOR FAIR CONTRACT
COR,2024-03-27,15:36:33,7D85A9,Cencora Inc.,99,-0.6,labor-issues,,Amerisourcebergen went on strike after months,PRESS-RELEASE,Dow Jones Newswires,Press Release: STRIKING TEAMSTERS AT AMERISOURCEBERGEN TO RALLY FOR FAIR CONTRACT
COR,2024-03-27,18:41:54,7D85A9,Cencora Inc.,100,0.01,credit-ratings,affirmation,Moody's Affirms Cencora's Baa2 Senior Unsecured Rating,NEWS-FLASH,Dow Jones Newswires,"Moody's Affirms Cencora's Baa2 Senior Unsecured Rating, Outlook Revised To Positive"
COR,2024-03-28,14:14:26,7D85A9,Cencora Inc.,100,-0.6,labor-issues,,Cencora Inc.: TODAY: STRIKING,PRESS-RELEASE,PR Newswire,TODAY: STRIKING TEAMSTERS AT AMERISOURCEBERGEN TO RALLY FOR FAIR CONTRACT
COR,2024-03-28,22:30:03,7D85A9,Cencora Inc.,99,0.44,labor-issues,,Cencora's CEO Steven H. Collis took home $138 million over the past four years,PRESS-RELEASE,PR Newswire,TEAMSTERS AT CENCORA/AMERISOURCEBERGEN RALLY FOR FAIR CONTRACT IN SACRAMENTO
COR,2024-04-03,23:25:10,7D85A9,Cencora Inc.,100,0.39,products-services,,"Cencora/AMERISOURCEBERGEN, SECURE NEW CONTRACT",PRESS-RELEASE,PR Newswire,"TEAMSTERS END STRIKE AT CENCORA/AMERISOURCEBERGEN, SECURE NEW CONTRACT ADDRESSING WORKERS' CONCERNS"
COR,2024-04-03,23:40:14,7D85A9,Cencora Inc.,100,0.39,products-services,,"Cencora/AMERISOURCEBERGEN, SECURE NEW CONTRACT",PRESS-RELEASE,Dow Jones Newswires,"Press Release: TEAMSTERS END STRIKE AT CENCORA/AMERISOURCEBERGEN, SECURE NEW CONTRACT ADDRESSING WORKERS' CONCERNS"
COR,2024-04-05,12:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
COR,2024-04-05,12:33:41,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
COR,2024-04-11,12:30:05,7D85A9,Cencora Inc.,100,-0.52,legal,,"Class Action Lawsuit Against World Courier, Cencora & Amerisourcebergen Alleging",PRESS-RELEASE,PR Newswire,"Labor & Employment Firms Zakay Law Group APLC and JCL Law Firm APC File Class Action Lawsuit Against World Courier, Cencora & Amerisourcebergen Alleging Labor Code Claims"
COR,2024-04-15,20:30:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Coo Mauch Registers 57,564 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"COO Mauch Registers 57,564 Of Cencora Inc >COR"
COR,2024-04-16,14:30:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,754 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,754 Of Cencora Inc >COR"
COR,2024-04-17,20:23:58,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,754 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,754 Of Cencora Inc >COR"
COR,2024-04-17,20:26:35,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Coo Mauch Sells 57,564 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Sells 57,564 Of Cencora Inc >COR"
COR,2024-04-30,14:31:53,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by Citigroup
COR,2024-04-30,14:31:53,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $280.00/Share From $265.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $280.00/Share From $265.00 by Citigroup
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $2.09,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 second quarter ended March 31, 2024, revenue increased 7.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $68.4B $68.4B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2024 was $192.7 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,-0.57,labor-issues,,Cencora Inc.: Steven H. Collis will retire as President and Chief Executive Officer,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: The fiscal year to date EPS,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,approved,Cencora Inc.: the Company's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.11 $ 2.15,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Gross profit 3.71,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -4-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -4-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.52,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $63,868,046 $ 62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -6-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -6-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted net income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2024, (i) revenue of $68.4 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Net $420.8M,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Net $420.8M >COR
COR,2024-05-01,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 2Q Rev $68.41B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev $68.41B >COR
COR,2024-05-01,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,2Q EPS $2.09 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q EPS $2.09 >COR
COR,2024-05-01,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Adj EPS $3.80,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Adj EPS $3.80 >COR
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Second Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $2.09,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 second quarter ended March 31, 2024, revenue increased 7.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $68.4B $68.4B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2024 was $192.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,-0.57,labor-issues,,Cencora Inc.: Steven H. Collis will retire as President and Chief Executive Officer,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: The fiscal year to date EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.59,equity-actions,approved,Cencora Inc.: the Company's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.11 $ 2.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Gross profit 3.71,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -4-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -4-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.52,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $63,868,046 $ 62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -6-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -6-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2024, (i) revenue of $68.4 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:35:59,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises 2024 View To Adj EPS $13.30,NEWS-FLASH,Dow Jones Newswires,Cencora Raises 2024 View To Adj EPS $13.30-Adj EPS $13.50 >COR
COR,2024-05-01,10:37:00,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees 2024 Intl Healthcare Solutions Segment Rev Growth in 4% to 7%,NEWS-FLASH,Dow Jones Newswires,Cencora Sees 2024 Intl Healthcare Solutions Segment Rev Growth in 4% to 7% Range >COR
COR,2024-05-02,10:58:27,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-05-02,10:58:27,7D85A9,Cencora Inc.,100,0.3,price-targets,upgrade,Cencora Price Target Raised to $277.00/Share From $275.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $277.00/Share From $275.00 by Baird
COR,2024-05-08,12:30:00,7D85A9,Cencora Inc.,99,0.46,equity-actions,,Cencora Inc.: we continue to invest in solutions,PRESS-RELEASE,Business Wire,Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit
COR,2024-05-10,20:02:07,7D85A9,Cencora Inc.,100,0.0,insider-trading,,"Dir Greenberg Gifts 2,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Gifts 2,000 Of Cencora Inc >COR"
COR,2024-05-14,13:00:30,7D85A9,Cencora Inc.,99,0.49,partnerships,,Is collaborating with PharMerica to,PRESS-RELEASE,PR Newswire,mcare and PharMerica Team Up to Provide the Comprehensive Last Mile Solution to Tackle Medication Non-Adherence
COR,2024-05-21,07:00:58,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2024 (COR)"
COR,2024-05-21,14:27:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,755 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,755 Of Cencora Inc >COR"
COR,2024-05-22,20:10:14,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,755 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,755 Of Cencora Inc >COR"
COR,2024-05-22,21:38:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds
COR,2024-05-22,21:38:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds
COR,2024-05-22,21:38:31,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shares of Cencora for $400M of Proceeds
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance And Raises Fiscal 2024 Guidance >COR
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora is also raising its fiscal year 2024 adjusted diluted earnings per share guidance,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:03,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora is also raising its fiscal year 2024 adjusted diluted earnings per share guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:45:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $13.35,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $13.35-Adj EPS $13.55 >COR
COR,2024-05-22,22:03:46,7D85A9,Cencora Inc.,96,0.55,acquisitions-mergers,,Cencora has agreed to buy about $400 million in stock back from Walgreens Boots Alliance,FULL-ARTICLE,Dow Jones Newswires,Cencora To Buy $400M In Stock Back From Walgreens Boots
COR,2024-05-22,22:06:08,7D85A9,Cencora Inc.,96,0.55,acquisitions-mergers,,Cencora has agreed to buy about $400 million in stock back from Walgreens Boots Alliance,FULL-ARTICLE,MarketWatch,MW Cencora to buy $400 million in stock back from Walgreens
COR,2024-05-24,20:06:37,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 1,859,390 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-05-24,20:07:25,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 1,859,390 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 1,859,390 Of Cencora Inc >COR"
COR,2024-05-29,14:42:27,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 27,093 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 27,093 Of Cencora Inc >COR"
COR,2024-05-29,20:04:19,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Dir Durcan Buys 500 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,Dir Durcan Buys 500 Of Cencora Inc >COR
COR,2024-05-31,19:06:41,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 1,874 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 1,874 Of Cencora Inc >COR"
COR,2024-05-31,20:02:12,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 36,737 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 36,737 Of Cencora Inc >COR"
COR,2024-06-03,12:41:00,7D85A9,Cencora Inc.,92,0.55,products-services,gain,Cencora Inc.: The major drivers for this market are rising,PRESS-RELEASE,Business Wire,"Deep Frozen Packaging Logistics Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Almac, AmerisourceBergen, B.P.L., and Biocair - ResearchAndMarkets.com"
COR,2024-06-03,20:07:27,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 1,874 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 1,874 Of Cencora Inc >COR"
COR,2024-06-18,14:24:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,754 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,754 Of Cencora Inc >COR"
COR,2024-06-20,20:17:08,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,754 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,754 Of Cencora Inc >COR"
COR,2024-06-27,17:41:49,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Leerink Partners
COR,2024-06-27,17:48:09,7D85A9,Cencora Inc.,99,0.0,equity-actions,,"Amerisourcebergen, changed its company name",FULL-ARTICLE,Dow Jones Newswires,"Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court -- IBD"
COR,2024-07-02,20:11:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Donato Acquires 899 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Acquires 899 Of Cencora Inc >COR
COR,2024-07-05,20:15:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
COR,2024-07-05,21:26:21,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
COR,2024-07-09,11:13:46,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-07-09,11:13:46,7D85A9,Cencora Inc.,100,0.34,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $280.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $280.00 by Baird
COR,2024-07-16,14:15:52,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,755 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,755 Of Cencora Inc >COR"
COR,2024-07-17,20:11:35,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,755 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,755 Of Cencora Inc >COR"
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Net $483.5M,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Net $483.5M >COR
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 3Q Rev $74.24B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Rev $74.24B >COR
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $74.2 billion for the Third Quarter, a 10.9 Percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Third Quarter GAAP Diluted EPS of $2.42,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.55 to $13.65,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 third quarter ended June 30, 2024, revenue increased 10.9 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: our fiscal 2024 guidance,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $74.2B $74.2B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2024 was $179.4 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.44 $ 2.37,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -4-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -4-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -5-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.47,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -5-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -5-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -6-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $66,772,423 $ 62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -6-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -6-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2024, (i) revenue of $74.2 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2024 (i) revenue of $214.9 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -8-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,3Q EPS $2.42 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q EPS $2.42 >COR
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Adj EPS $3.34,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Adj EPS $3.34 >COR
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter Fiscal Year 2024 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 third quarter ended June 30, 2024, revenue increased 10.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: our fiscal 2024 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $74.2B $74.2B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Diluted Earnings Per Share $2.42 $3.34,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2024 was $179.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.44 $ 2.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -4-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -5-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,98,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -5-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $66,772,423 $ 62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -6-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -6-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2024, (i) revenue of $74.2 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -7-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2024 (i) revenue of $214.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -7-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -7-
COR,2024-07-31,10:35:52,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises FY24 View To Adj EPS $13.55,NEWS-FLASH,Dow Jones Newswires,Cencora Raises FY24 View To Adj EPS $13.55-Adj EPS $13.65 >COR
COR,2024-07-31,10:37:02,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees FY24 Rev Growth of About 12 %,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Rev Growth of About 12 % >COR
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Lifts FY Outlook on 3Q Revenue,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora again raised its outlook for its fiscal year,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Amerisourcebergen on Wednesday reported a net profit of $483.5 million,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora now forecasts adjusted earnings per share for the year ending Sept. 30 of $13.55 to $13.65,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-08-01,12:05:02,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-08-01,12:05:02,7D85A9,Cencora Inc.,100,0.3,price-targets,upgrade,Cencora Price Target Raised to $287.00/Share From $285.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $287.00/Share From $285.00 by Baird
COR,2024-08-01,13:53:12,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2024-08-01,13:53:12,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $249.00/Share From $236.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $249.00/Share From $236.00 by Wells Fargo
COR,2024-08-01,22:08:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds
COR,2024-08-01,22:08:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds
COR,2024-08-01,22:08:37,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of Cencora for Approximately $1.1B of Proceeds
COR,2024-08-01,22:14:51,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Reducing Cencora Stake,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Reducing Cencora Stake to About 10% From 12%
COR,2024-08-01,22:17:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance >COR
COR,2024-08-01,22:17:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:17:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:17:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:17:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:18:48,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora: To Buy Back About $250M of Common Stock,NEWS-FLASH,Dow Jones Newswires,Cencora: To Buy Back About $250M of Common Stock From Walgreens Boots Alliance >COR
COR,2024-08-01,22:39:47,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Sells Shares in Cencora,FULL-ARTICLE,Dow Jones Newswires,"Walgreens Sells Shares in Cencora for Third Time This Year, Raises $1.1 Billion"
COR,2024-08-01,23:04:19,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens sells shares in Cencora,FULL-ARTICLE,MarketWatch,"MW Walgreens sells shares in Cencora for third time this year, raises $1.1 billion"
COR,2024-08-02,17:59:49,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens continues to shed stake in Cencora,FULL-ARTICLE,MarketWatch,MW Walgreens continues to shed stake in Cencora as it looks to bolster turnaround
COR,2024-08-05,20:03:04,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 1,039,242 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-08-05,22:46:23,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 4,438,171 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 4,438,171 Of Cencora Inc >COR"
COR,2024-08-06,18:12:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 1,473 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 1,473 Of Cencora Inc >COR"
COR,2024-08-07,20:12:20,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 1,473 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 1,473 Of Cencora Inc >COR"
COR,2024-08-07,20:16:40,7D85A9,Cencora Inc.,100,0.0,insider-trading,,"Dir Greenberg Gifts 5,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Gifts 5,000 Of Cencora Inc >COR"
COR,2024-08-14,13:00:01,7D85A9,Cencora Inc.,99,0.49,partnerships,,"Solutions, announces an industry-transforming partnership with Cencora",PRESS-RELEASE,Business Wire,"Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems"
COR,2024-08-15,11:30:04,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Frank Clyburn to Its Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Cencora Elects Frank Clyburn to Its Bd of Directors
COR,2024-08-15,11:30:00,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Frank Clyburn to Its Board of Directors,PRESS-RELEASE,Business Wire,Cencora Elects Frank Clyburn to Its Board of Directors
COR,2024-08-15,11:30:03,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Frank Clyburn to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Elects Frank Clyburn to Its Board of Directors
COR,2024-08-15,12:31:09,7D85A9,Cencora Inc.,99,0.47,labor-issues,,"Cencora Inc.: the ""Company"") appointed Frank Clyburn to serve on the Board",RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2024-08-16,20:07:07,7D85A9,Cencora Inc.,99,0.0,labor-issues,,Cencora Inc.: the Company's 2022 Omnibus Incentive Plan,RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2024-08-20,07:16:48,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2024 (COR)"
COR,2024-08-20,14:51:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,754 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,754 Of Cencora Inc >COR"
COR,2024-08-21,14:18:17,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by JP Morgan
COR,2024-08-21,14:18:17,7D85A9,Cencora Inc.,100,0.42,price-targets,upgrade,Cencora Price Target Raised to $287.00/Share From $280.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $287.00/Share From $280.00 by JP Morgan
COR,2024-08-21,20:09:24,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,754 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,754 Of Cencora Inc >COR"
COR,2024-09-05,11:33:55,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $13.60,RNS-SEC8K,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $13.60-Adj EPS $13.70 >COR
COR,2024-09-05,11:31:46,7D85A9,Cencora Inc.,99,0.0,marketing,,"Cencora Inc.: the ""Company"") will be presenting at the Morgan Stanley Healthcare Conference today at 4:05 p.m. ET",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Regulation FD >COR
COR,2024-09-05,11:34:51,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY25 Adj EPS at,RNS-SEC8K,Dow Jones Newswires,Cencora Sees FY25 Adj EPS at Bottom End of 8%-12% Growth Target Range >COR
COR,2024-09-05,11:59:34,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises FY24 Outlook,FULL-ARTICLE,Dow Jones Newswires,"Cencora Raises FY24 Outlook, Warns of Covid-19 Hit in FY25 Growth Views"
COR,2024-09-06,11:31:53,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-09-06,11:31:53,7D85A9,Cencora Inc.,100,-0.28,price-targets,downgrade,Cencora Price Target Cut to $283.00/Share From $287.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $283.00/Share From $287.00 by Baird
COR,2024-09-17,13:51:28,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 21,509 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 21,509 Of Cencora Inc >COR"
COR,2024-09-18,10:51:00,7D85A9,Cencora Inc.,100,-0.58,analyst-ratings,negative,Cencora Cut to Neutral From Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Cut to Neutral From Buy by B of A Securities
COR,2024-09-18,10:51:00,7D85A9,Cencora Inc.,100,-0.8,price-targets,downgrade,Cencora Price Target Cut to $245.00/Share From $275.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $245.00/Share From $275.00 by B of A Securities
COR,2024-09-18,20:40:47,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 21,509 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 21,509 Of Cencora Inc >COR"
COR,2024-10-01,11:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
COR,2024-10-01,11:33:13,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
COR,2024-10-07,13:01:42,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Leerink Partners
COR,2024-10-07,13:01:42,7D85A9,Cencora Inc.,100,-0.17,price-targets,downgrade,Cencora Price Target Cut to $275.00/Share From $277.00 by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $275.00/Share From $277.00 by Leerink Partners
COR,2024-10-08,17:17:24,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Evercore ISI Group
COR,2024-10-08,17:17:24,7D85A9,Cencora Inc.,100,-0.7,price-targets,downgrade,Cencora Price Target Cut to $250.00/Share From $270.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $250.00/Share From $270.00 by Evercore ISI Group
COR,2024-10-15,20:02:49,7D85A9,Cencora Inc.,99,0.38,credit,,Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-10-22,14:45:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 21,509 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 21,509 Of Cencora Inc >COR"
COR,2024-10-23,20:07:20,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 21,509 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 21,509 Of Cencora Inc >COR"
COR,2024-11-04,13:30:02,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora Expands Enterprise Leadership Team with Two Senior Appointments,PRESS-RELEASE,Business Wire,Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-04,13:30:02,7D85A9,Cencora Inc.,99,0.53,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced the appointment of Francois Mandeville as Executive Vice President",PRESS-RELEASE,Business Wire,Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-04,13:30:04,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora Expands Enterprise Leadership Team with Two Senior Appointments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-04,13:30:04,7D85A9,Cencora Inc.,99,0.53,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced the appointment of Francois Mandeville as Executive Vice President",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,0.62,acquisitions-mergers,,Cencora will acquire RCA for approximately $4.6 billion in cash,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,0.22,acquisitions-mergers,,Cencora Inc.: our recent investment in OneOncology,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal year 2025 guidance,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through -2-
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,0.62,acquisitions-mergers,,Cencora will acquire RCA for approximately $4.6 billion in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,0.22,acquisitions-mergers,,Cencora Inc.: our recent investment in OneOncology,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal year 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Net $3.38M,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Net $3.38M >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 4Q Rev $79.05B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Rev $79.05B >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,4Q EPS 2c >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q EPS 2c >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Adj EPS $3.34,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Adj EPS $3.34 >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $79.1 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $0.02,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent to $294.0 billion for the fiscal year,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2024 GAAP Diluted EPS of $7.53,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.62,dividends,up,Cencora Inc.: Company increases its quarterly dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, adjusted diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.1,earnings,,Cencora Inc.: Adjusted operating income increased 10.9 percent to $3.6 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the fourth quarter of fiscal 2024 was $153.7 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2024 Summary Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.28,equity-actions,up,Cencora Inc.: Operating expenses increased 16.9 percent,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, GAAP diluted EPS was $7.53",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent from the prior fiscal year to $294.0 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 8.1 percent to $9.7 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, adjusted diluted EPS was $13.76",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora announced the appointment of Francois Mandeville to its executive,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.55,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's preliminary fiscal 2025 guidance,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.59,equity-actions,completed,"On September 5, 2024, Cencora has executed on opportunistic share repurchases",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Capital expenditures to be approximately $600 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal 2025 guidance,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 0.02 $ 1.74,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 7.60 $ 8.62,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -4-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.15,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -4-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.37,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -5-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -5-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -6-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $67,101,667 $62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -6-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -8-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2024, (i) revenue of $79.1 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -8-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2024, (i) revenue of $294.0 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -8-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $79.1 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $0.02,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent to $294.0 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2024 GAAP Diluted EPS of $7.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.62,dividends,up,Cencora Inc.: Company increases its quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.1,earnings,,Cencora Inc.: Adjusted operating income increased 10.9 percent to $3.6 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the fourth quarter of fiscal 2024 was $153.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2024 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.28,equity-actions,up,Cencora Inc.: Operating expenses increased 16.9 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, GAAP diluted EPS was $7.53",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent from the prior fiscal year to $294.0 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 8.1 percent to $9.7 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, adjusted diluted EPS was $13.76",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora announced the appointment of Francois Mandeville to its executive,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's preliminary fiscal 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.59,equity-actions,completed,"On September 5, 2024, Cencora has executed on opportunistic share repurchases",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Capital expenditures to be approximately $600 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 0.02 $ 1.74,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 7.60 $ 8.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -4-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -4-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -5-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -5-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -6-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $67,101,667 $62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -6-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -8-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2024, (i) revenue of $79.1 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -8-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2024, (i) revenue of $294.0 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -8-
COR,2024-11-06,11:37:09,7D85A9,Cencora Inc.,100,0.38,dividends,up,Cencora Raises Dividend to 55c Vs. 51c,NEWS-FLASH,Dow Jones Newswires,Cencora Raises Dividend to 55c Vs. 51c >COR
COR,2024-11-06,11:37:53,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees 2025 Revenue Growth of 7%-9%,NEWS-FLASH,Dow Jones Newswires,Cencora Sees 2025 Revenue Growth of 7%-9% >COR
COR,2024-11-06,11:38:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees 2025 Adj EPS $14.80,NEWS-FLASH,Dow Jones Newswires,Cencora Sees 2025 Adj EPS $14.80-Adj EPS $15.10 >COR
COR,2024-11-06,11:52:56,7D85A9,Cencora Inc.,100,0.55,acquisitions-mergers,,Cencora to Acquire Retina Consultants of America for $4.6B,FULL-ARTICLE,Dow Jones Newswires,Cencora to Acquire Retina Consultants of America for $4.6B
COR,2024-11-06,12:22:49,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora 4Q Sales Climb,FULL-ARTICLE,Dow Jones Newswires,Cencora 4Q Sales Climb While Profit Falls on Higher Costs
COR,2024-11-06,12:22:49,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Amerisourcebergen posted a profit of $3.38 million,FULL-ARTICLE,Dow Jones Newswires,Cencora 4Q Sales Climb While Profit Falls on Higher Costs
COR,2024-11-06,23:21:09,7D85A9,Cencora Inc.,100,0.03,credit-ratings,stable,S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable,NEWS-FLASH,Dow Jones Newswires,S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable
COR,2024-11-06,23:21:09,7D85A9,Cencora Inc.,100,0.03,credit-ratings,stable,S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable
COR,2024-11-06,23:21:09,7D85A9,Cencora Inc.,100,0.62,acquisitions-mergers,,Cencora's acquisition of OneOncology will,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable
COR,2024-11-06,23:21:19,7D85A9,Cencora Inc.,100,0.03,credit-ratings,affirmation,S&PGR Affirms Cencora 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Cencora 'BBB+' -2-
COR,2024-11-07,13:54:23,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Evercore ISI Group
COR,2024-11-07,13:54:23,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $250.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $250.00 by Evercore ISI Group
COR,2024-11-07,14:57:43,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by Barclays
COR,2024-11-07,14:57:43,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $290.00/Share From $263.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $290.00/Share From $263.00 by Barclays
COR,2024-11-07,16:08:23,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by UBS
COR,2024-11-07,16:08:23,7D85A9,Cencora Inc.,100,0.48,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $275.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $275.00 by UBS
COR,2024-11-07,17:52:54,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-11-07,17:52:54,7D85A9,Cencora Inc.,100,0.32,price-targets,upgrade,Cencora Price Target Raised to $292.00/Share From $287.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $292.00/Share From $287.00 by Baird
COR,2024-11-08,12:01:16,7D85A9,Cencora Inc.,99,0.62,acquisitions-mergers,,"Cencora Inc.: the Company entered into an agreement to acquire RCA, a portfolio company of Webster Equity Partners",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Other Events >COR
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.62,acquisitions-mergers,,Cencora recently announced that it plans to acquire Retina Consultants of America (RCA) for approximately $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.14,credit,,Cencora will refinance debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:43,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable -2-
COR,2024-11-08,16:19:53,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable -3-
COR,2024-11-13,21:14:37,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Ceo Mauch Acquires 6,684 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Acquires 6,684 Of Cencora Inc >COR"
COR,2024-11-13,21:18:02,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 2,723 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 2,723 Of Cencora Inc >COR"
COR,2024-11-13,21:19:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 21,664 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 21,664 Of Cencora Inc >COR"
COR,2024-11-13,21:22:21,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 3,351 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 3,351 Of Cencora Inc >COR"
COR,2024-11-13,21:23:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 4,676 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 4,676 Of Cencora Inc >COR"
COR,2024-11-13,21:26:28,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 3,001 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 3,001 Of Cencora Inc >COR"
COR,2024-11-19,15:03:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 21,509 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 21,509 Of Cencora Inc >COR"
COR,2024-11-20,08:16:02,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2024 (COR)"
COR,2024-11-21,21:51:10,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 21,509 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 21,509 Of Cencora Inc >COR"
COR,2024-11-22,21:20:32,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 69,805 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 69,805 Of Cencora Inc >COR"
COR,2024-11-22,21:21:25,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 8,058 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 8,058 Of Cencora Inc >COR"
COR,2024-11-22,21:21:55,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 1,039 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 1,039 Of Cencora Inc >COR"
COR,2024-11-22,21:22:05,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 7,083 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 7,083 Of Cencora Inc >COR"
COR,2024-11-22,21:23:13,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 18,889 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 18,889 Of Cencora Inc >COR"
COR,2024-11-22,21:26:18,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Ceo Mauch Acquires 21,718 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Acquires 21,718 Of Cencora Inc >COR"
COR,2024-11-25,21:10:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 50,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 50,000 Of Cencora Inc >COR"
COR,2024-11-26,21:35:58,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 50,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 50,000 Of Cencora Inc >COR"
COR,2024-12-02,16:02:50,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-12-02,16:02:50,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-12-02,16:02:50,7D85A9,Cencora Inc.,100,0.14,credit,,Cencora will refinance debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-12-02,16:03:00,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-' -2-
COR,2024-12-02,21:02:15,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 11,662 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 11,662 Of Cencora Inc >COR"
COR,2024-12-03,03:49:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 4.625% Senior Notes Due 2027,PRESS-RELEASE,Business Wire,"Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035"
COR,2024-12-03,03:49:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 4.625% Senior Notes Due 2027,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035"
COR,2024-12-03,16:15:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 1,816 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 1,816 Of Cencora Inc >COR"
COR,2024-12-04,21:27:27,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 1,816 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 1,816 Of Cencora Inc >COR"
COR,2024-12-06,13:30:00,7D85A9,Cencora Inc.,100,0.44,products-services,,Cencora Launches Accelerate Pharmacy Solutions to Enhance,PRESS-RELEASE,Business Wire,Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
COR,2024-12-06,13:30:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora partners with hospitals and health systems across,PRESS-RELEASE,Business Wire,Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
COR,2024-12-09,21:15:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $1.8 Billion Senior Notes Offering,PRESS-RELEASE,Business Wire,Cencora Closes $1.8 Billion Senior Notes Offering
COR,2024-12-09,21:15:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $1.8 Billion Senior Notes Offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Closes $1.8 Billion Senior Notes Offering
COR,2024-12-09,21:15:12,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $1.8 B Senior Notes Offering,NEWS-FLASH,Dow Jones Newswires,Cencora Closes $1.8 B Senior Notes Offering
COR,2024-12-10,21:31:21,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: the Company obtained $3.3 billion in bridge financing,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Other Events >COR
COR,2024-12-13,17:40:35,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2024-12-13,17:40:35,7D85A9,Cencora Inc.,100,-0.58,price-targets,downgrade,Cencora Price Target Cut to $237.00/Share From $249.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $237.00/Share From $249.00 by Wells Fargo
COR,2024-12-20,18:51:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 1,678 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 1,678 Of Cencora Inc >COR"
COR,2024-12-20,21:07:49,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Ceo Mauch Acquires 789 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mauch Acquires 789 Of Cencora Inc >COR
COR,2024-12-20,21:10:05,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 108 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 108 Of Cencora Inc >COR
COR,2024-12-20,21:12:42,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Chmn Collis Acquires 395 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,Chmn Collis Acquires 395 Of Cencora Inc >COR
COR,2024-12-20,21:15:16,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Cfo Cleary Jr Acquires 207 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,CFO Cleary Jr Acquires 207 Of Cencora Inc >COR
COR,2024-12-23,20:48:37,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 1,678 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 1,678 Of Cencora Inc >COR"
COR,2024-01-03,10:36:16,7D85A9,Cencora Inc.,100,0.95,analyst-ratings,positive,Cencora Initiated at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Initiated at Overweight by Barclays
COR,2024-01-03,10:36:16,7D85A9,Cencora Inc.,100,0.0,price-targets,set,Cencora Price Target Announced at $242.00/Share by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Announced at $242.00/Share by Barclays
COR,2024-01-04,21:30:01,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
COR,2024-01-04,21:31:40,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 166 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 166 Of Cencora Inc >COR
COR,2024-01-04,22:06:24,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
COR,2024-01-11,12:27:04,7D85A9,Cencora Inc.,100,0.39,products-services,,Cencora Inc.: QSM Diagnostics Signs National Distribution Agreement with MWI Animal Health,PRESS-RELEASE,PR Newswire,QSM Diagnostics Signs National Distribution Agreement with MWI Animal Health
COR,2024-01-16,21:47:06,7D85A9,Cencora Inc.,100,-0.43,labor-issues,,Mcgee To Retire From Cencora Board in March,RNS-SEC8K,Dow Jones Newswires,Henry W. McGee To Retire From Cencora Board in March
COR,2024-01-17,21:06:07,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Dir Greenberg Acquires 1,340 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Acquires 1,340 Of Cencora Inc >COR"
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $72.3 billion for the First Quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.98,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.25 to $13.50,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2024, revenue was $72.3 billion, up 15.0 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.41,assets,open,Cencora Inc.: less-than-wholly-owned subsidiary in Egypt.,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2024 was $187.6 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -2-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.01 $ 2.35,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -3-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.41,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $ 64,690,297 $ 62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -4-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -5-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -5-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -5-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2024, (i) revenue of $72.3 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 First Quarter Results -6-
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,1Q EPS $2.98 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q EPS $2.98 >COR
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Adj EPS $3.28,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Adj EPS $3.28 >COR
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Net $601.5M,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Net $601.5M >COR
COR,2024-01-31,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 1Q Rev $72.25B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Rev $72.25B >COR
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: First Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $72.3 billion for the First Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.98,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.25 to $13.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2024, revenue was $72.3 billion, up 15.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First Quarter Results
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2024 was $187.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -2-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.01 $ 2.35,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -3-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $ 64,690,297 $ 62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -4-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -5-
COR,2024-01-31,11:30:30,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -5-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:30:31,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2024, (i) revenue of $72.3 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 First -6-
COR,2024-01-31,11:32:14,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $13.25,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $13.25-Adj EPS $13.50 >COR
COR,2024-02-05,16:34:23,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+'
COR,2024-02-05,16:34:23,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+'
COR,2024-02-05,16:34:23,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Inc.: we expect solid revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora's Senior Unsecured Notes 'BBB+'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.44,credit,reduction,Cencora reduced its debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,16:57:35,7D85A9,Cencora Inc.,100,0.14,credit,,Cencora will refinance debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-02-05,18:03:10,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Neutral by Mizuho
COR,2024-02-05,18:03:10,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $224.00/Share From $192.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $224.00/Share From $192.00 by Mizuho
COR,2024-02-05,18:47:56,7D85A9,Cencora Inc.,100,0.0,credit-ratings,set,Moody's Assigns Baa2 Rating To Cencora's New Senior Notes,NEWS-FLASH,Dow Jones Newswires,Moody's Assigns Baa2 Rating To Cencora's New Senior Notes
COR,2024-02-05,23:18:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 5.125% Senior Notes Due 2034,PRESS-RELEASE,Business Wire,Cencora Prices $500 Million 5.125% Senior Notes Due 2034
COR,2024-02-05,23:18:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 5.125% Senior Notes Due 2034,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Prices $500 Million 5.125% Senior Notes Due 2034
COR,2024-02-07,13:00:01,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora also collaborated with a manufacturing partner to launch,PRESS-RELEASE,Business Wire,Cencora Releases 2023 ESG Report
COR,2024-02-07,18:11:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $500 Million Senior Notes Offering,PRESS-RELEASE,Business Wire,Cencora Closes $500 Million Senior Notes Offering
COR,2024-02-07,18:11:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $500 Million Senior Notes Offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Closes $500 Million Senior Notes Offering
COR,2024-02-07,23:16:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
COR,2024-02-07,23:16:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
COR,2024-02-07,23:16:59,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shares of Cencora for $992 Million of Proceeds
COR,2024-02-07,23:26:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:26:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:26:28,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:27:11,7D85A9,Cencora Inc.,100,0.59,equity-actions,approved,Cencora: Agreed to Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora: Agreed to Repurchase About $50 Million of Common Stock >COR
COR,2024-02-07,23:29:40,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:29:40,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-02-07,23:37:24,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Sells Cencora Shares,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots Sells Cencora Shares for $992 Million
COR,2024-02-08,13:00:01,7D85A9,Cencora Inc.,99,0.52,products-services,,Cencora to introduce solutions,PRESS-RELEASE,Business Wire,Cencora's FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products
COR,2024-02-09,12:53:25,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 4,212,395 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 4,212,395 Of Cencora Inc >COR"
COR,2024-02-09,21:07:00,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 212,395 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-02-13,20:42:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 1,100 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 1,100 Of Cencora Inc >COR"
COR,2024-02-14,21:17:47,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 1,100 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 1,100 Of Cencora Inc >COR"
COR,2024-02-21,08:01:50,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2023 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2023 (COR)"
COR,2024-02-26,14:07:08,7D85A9,Cencora Inc.,100,0.95,analyst-ratings,positive,Cencora Initiated at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Initiated at Outperform by Leerink Partners
COR,2024-02-26,14:07:08,7D85A9,Cencora Inc.,100,0.0,price-targets,set,Cencora Price Target Announced at $261.00/Share by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Announced at $261.00/Share by Leerink Partners
COR,2024-03-11,20:43:08,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Battaglia Acquires 674 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 674 Of Cencora Inc >COR
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,0.47,labor-issues,,Cencora Inc.: be appointed as a member of the Company's Board,PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,-0.49,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President",PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora Inc.: Since Steve's appointment as CEO in 2011,PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,unchanged,Cencora is also reaffirming its fiscal 2024 guidance,PRESS-RELEASE,Business Wire,Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,-0.49,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,0.47,labor-issues,,Cencora Inc.: be appointed as a member of the Company's Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora Inc.: Since Steve's appointment as CEO in 2011,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:30:10,7D85A9,Cencora Inc.,99,0.0,earnings,unchanged,Cencora is also reaffirming its fiscal 2024 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Leadership Succession Plan
COR,2024-03-12,12:31:18,7D85A9,Cencora Inc.,100,0.0,earnings,unchanged,Cencora Reaffirms Fiscal Yr 2024 Guidance,NEWS-FLASH,Dow Jones Newswires,Cencora Reaffirms Fiscal Yr 2024 Guidance >COR
COR,2024-03-12,12:31:18,7D85A9,Cencora Inc.,100,0.0,earnings,unchanged,Cencora Reaffirms Fiscal Yr 2024 Guidance,NEWS-FLASH,Dow Jones Newswires,Cencora Reaffirms Fiscal Yr 2024 Guidance >COR
COR,2024-03-12,12:54:58,7D85A9,Cencora Inc.,100,-0.49,labor-issues,,Cencora CEO to Retire,FULL-ARTICLE,Dow Jones Newswires,"Cencora CEO to Retire, Become Executive Chair"
COR,2024-03-12,12:54:58,7D85A9,Cencora Inc.,100,-0.49,labor-issues,,Chief executive of Cencora plans to retire,FULL-ARTICLE,Dow Jones Newswires,"Cencora CEO to Retire, Become Executive Chair"
COR,2024-03-18,18:18:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 6,977 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 6,977 Of Cencora Inc >COR"
COR,2024-03-18,20:12:52,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 9,644 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 9,644 Of Cencora Inc >COR"
COR,2024-03-19,14:24:28,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,755 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,755 Of Cencora Inc >COR"
COR,2024-03-20,20:25:32,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 6,977 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 6,977 Of Cencora Inc >COR"
COR,2024-03-21,20:06:48,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,755 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,755 Of Cencora Inc >COR"
COR,2024-03-27,15:30:03,7D85A9,Cencora Inc.,99,-0.6,labor-issues,,Amerisourcebergen went on strike after months,PRESS-RELEASE,PR Newswire,STRIKING TEAMSTERS AT AMERISOURCEBERGEN TO RALLY FOR FAIR CONTRACT
COR,2024-03-27,15:36:33,7D85A9,Cencora Inc.,99,-0.6,labor-issues,,Amerisourcebergen went on strike after months,PRESS-RELEASE,Dow Jones Newswires,Press Release: STRIKING TEAMSTERS AT AMERISOURCEBERGEN TO RALLY FOR FAIR CONTRACT
COR,2024-03-27,18:41:54,7D85A9,Cencora Inc.,100,0.01,credit-ratings,affirmation,Moody's Affirms Cencora's Baa2 Senior Unsecured Rating,NEWS-FLASH,Dow Jones Newswires,"Moody's Affirms Cencora's Baa2 Senior Unsecured Rating, Outlook Revised To Positive"
COR,2024-03-28,14:14:26,7D85A9,Cencora Inc.,100,-0.6,labor-issues,,Cencora Inc.: TODAY: STRIKING,PRESS-RELEASE,PR Newswire,TODAY: STRIKING TEAMSTERS AT AMERISOURCEBERGEN TO RALLY FOR FAIR CONTRACT
COR,2024-03-28,22:30:03,7D85A9,Cencora Inc.,99,0.44,labor-issues,,Cencora's CEO Steven H. Collis took home $138 million over the past four years,PRESS-RELEASE,PR Newswire,TEAMSTERS AT CENCORA/AMERISOURCEBERGEN RALLY FOR FAIR CONTRACT IN SACRAMENTO
COR,2024-04-03,23:25:10,7D85A9,Cencora Inc.,100,0.39,products-services,,"Cencora/AMERISOURCEBERGEN, SECURE NEW CONTRACT",PRESS-RELEASE,PR Newswire,"TEAMSTERS END STRIKE AT CENCORA/AMERISOURCEBERGEN, SECURE NEW CONTRACT ADDRESSING WORKERS' CONCERNS"
COR,2024-04-03,23:40:14,7D85A9,Cencora Inc.,100,0.39,products-services,,"Cencora/AMERISOURCEBERGEN, SECURE NEW CONTRACT",PRESS-RELEASE,Dow Jones Newswires,"Press Release: TEAMSTERS END STRIKE AT CENCORA/AMERISOURCEBERGEN, SECURE NEW CONTRACT ADDRESSING WORKERS' CONCERNS"
COR,2024-04-05,12:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
COR,2024-04-05,12:33:41,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
COR,2024-04-11,12:30:05,7D85A9,Cencora Inc.,100,-0.52,legal,,"Class Action Lawsuit Against World Courier, Cencora & Amerisourcebergen Alleging",PRESS-RELEASE,PR Newswire,"Labor & Employment Firms Zakay Law Group APLC and JCL Law Firm APC File Class Action Lawsuit Against World Courier, Cencora & Amerisourcebergen Alleging Labor Code Claims"
COR,2024-04-15,20:30:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Coo Mauch Registers 57,564 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"COO Mauch Registers 57,564 Of Cencora Inc >COR"
COR,2024-04-16,14:30:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,754 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,754 Of Cencora Inc >COR"
COR,2024-04-17,20:23:58,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,754 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,754 Of Cencora Inc >COR"
COR,2024-04-17,20:26:35,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Coo Mauch Sells 57,564 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Sells 57,564 Of Cencora Inc >COR"
COR,2024-04-30,14:31:53,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by Citigroup
COR,2024-04-30,14:31:53,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $280.00/Share From $265.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $280.00/Share From $265.00 by Citigroup
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $2.09,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 second quarter ended March 31, 2024, revenue increased 7.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $68.4B $68.4B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2024 was $192.7 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,-0.57,labor-issues,,Cencora Inc.: Steven H. Collis will retire as President and Chief Executive Officer,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: The fiscal year to date EPS,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,approved,Cencora Inc.: the Company's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter Results -2-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.11 $ 2.15,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -3-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Gross profit 3.71,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -4-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -4-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.52,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $63,868,046 $ 62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -5-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -6-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -6-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted net income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2024, (i) revenue of $68.4 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Second Quarter -7-
COR,2024-05-01,10:30:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Net $420.8M,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Net $420.8M >COR
COR,2024-05-01,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 2Q Rev $68.41B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev $68.41B >COR
COR,2024-05-01,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,2Q EPS $2.09 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q EPS $2.09 >COR
COR,2024-05-01,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Adj EPS $3.80,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Adj EPS $3.80 >COR
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Second Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $68.4 billion for the Second Quarter, a 7.8 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $2.09,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.30 to $13.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 second quarter ended March 31, 2024, revenue increased 7.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $68.4B $68.4B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2024, revenue was $68.4 billion, up 7.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second Quarter Results
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2024 was $192.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,-0.57,labor-issues,,Cencora Inc.: Steven H. Collis will retire as President and Chief Executive Officer,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: The fiscal year to date EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.59,equity-actions,approved,Cencora Inc.: the Company's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -2-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.11 $ 2.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:03,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -3-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Gross profit 3.71,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -4-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -4-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.52,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $63,868,046 $ 62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -5-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -6-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -6-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2024, (i) revenue of $68.4 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Second -7-
COR,2024-05-01,10:35:59,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises 2024 View To Adj EPS $13.30,NEWS-FLASH,Dow Jones Newswires,Cencora Raises 2024 View To Adj EPS $13.30-Adj EPS $13.50 >COR
COR,2024-05-01,10:37:00,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees 2024 Intl Healthcare Solutions Segment Rev Growth in 4% to 7%,NEWS-FLASH,Dow Jones Newswires,Cencora Sees 2024 Intl Healthcare Solutions Segment Rev Growth in 4% to 7% Range >COR
COR,2024-05-02,10:58:27,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-05-02,10:58:27,7D85A9,Cencora Inc.,100,0.3,price-targets,upgrade,Cencora Price Target Raised to $277.00/Share From $275.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $277.00/Share From $275.00 by Baird
COR,2024-05-08,12:30:00,7D85A9,Cencora Inc.,99,0.46,equity-actions,,Cencora Inc.: we continue to invest in solutions,PRESS-RELEASE,Business Wire,Cencora To Host Inaugural ThinkLive Cell and Gene Therapy Summit
COR,2024-05-10,20:02:07,7D85A9,Cencora Inc.,100,0.0,insider-trading,,"Dir Greenberg Gifts 2,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Gifts 2,000 Of Cencora Inc >COR"
COR,2024-05-14,13:00:30,7D85A9,Cencora Inc.,99,0.49,partnerships,,Is collaborating with PharMerica to,PRESS-RELEASE,PR Newswire,mcare and PharMerica Team Up to Provide the Comprehensive Last Mile Solution to Tackle Medication Non-Adherence
COR,2024-05-21,07:00:58,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2024 (COR)"
COR,2024-05-21,14:27:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,755 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,755 Of Cencora Inc >COR"
COR,2024-05-22,20:10:14,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,755 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,755 Of Cencora Inc >COR"
COR,2024-05-22,21:38:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds
COR,2024-05-22,21:38:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of Cencora for $400 Million of Proceeds
COR,2024-05-22,21:38:31,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shares of Cencora for $400M of Proceeds
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance And Raises Fiscal 2024 Guidance >COR
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora is also raising its fiscal year 2024 adjusted diluted earnings per share guidance,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:03,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora is also raising its fiscal year 2024 adjusted diluted earnings per share guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:44:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
COR,2024-05-22,21:45:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $13.35,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $13.35-Adj EPS $13.55 >COR
COR,2024-05-22,22:03:46,7D85A9,Cencora Inc.,96,0.55,acquisitions-mergers,,Cencora has agreed to buy about $400 million in stock back from Walgreens Boots Alliance,FULL-ARTICLE,Dow Jones Newswires,Cencora To Buy $400M In Stock Back From Walgreens Boots
COR,2024-05-22,22:06:08,7D85A9,Cencora Inc.,96,0.55,acquisitions-mergers,,Cencora has agreed to buy about $400 million in stock back from Walgreens Boots Alliance,FULL-ARTICLE,MarketWatch,MW Cencora to buy $400 million in stock back from Walgreens
COR,2024-05-24,20:06:37,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 1,859,390 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-05-24,20:07:25,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 1,859,390 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 1,859,390 Of Cencora Inc >COR"
COR,2024-05-29,14:42:27,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 27,093 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 27,093 Of Cencora Inc >COR"
COR,2024-05-29,20:04:19,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Dir Durcan Buys 500 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,Dir Durcan Buys 500 Of Cencora Inc >COR
COR,2024-05-31,19:06:41,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 1,874 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 1,874 Of Cencora Inc >COR"
COR,2024-05-31,20:02:12,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 36,737 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 36,737 Of Cencora Inc >COR"
COR,2024-06-03,12:41:00,7D85A9,Cencora Inc.,92,0.55,products-services,gain,Cencora Inc.: The major drivers for this market are rising,PRESS-RELEASE,Business Wire,"Deep Frozen Packaging Logistics Market Report 2024: Global Trends, Forecast and Competitive Analysis to 2030 Featuring Almac, AmerisourceBergen, B.P.L., and Biocair - ResearchAndMarkets.com"
COR,2024-06-03,20:07:27,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 1,874 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 1,874 Of Cencora Inc >COR"
COR,2024-06-18,14:24:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,754 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,754 Of Cencora Inc >COR"
COR,2024-06-20,20:17:08,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,754 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,754 Of Cencora Inc >COR"
COR,2024-06-27,17:41:49,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Leerink Partners
COR,2024-06-27,17:48:09,7D85A9,Cencora Inc.,99,0.0,equity-actions,,"Amerisourcebergen, changed its company name",FULL-ARTICLE,Dow Jones Newswires,"Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court -- IBD"
COR,2024-07-02,20:11:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Donato Acquires 899 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Acquires 899 Of Cencora Inc >COR
COR,2024-07-05,20:15:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
COR,2024-07-05,21:26:21,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Third Quarter Fiscal 2024 Earnings Release
COR,2024-07-09,11:13:46,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-07-09,11:13:46,7D85A9,Cencora Inc.,100,0.34,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $280.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $280.00 by Baird
COR,2024-07-16,14:15:52,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,755 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,755 Of Cencora Inc >COR"
COR,2024-07-17,20:11:35,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,755 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,755 Of Cencora Inc >COR"
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Net $483.5M,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Net $483.5M >COR
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 3Q Rev $74.24B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Rev $74.24B >COR
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $74.2 billion for the Third Quarter, a 10.9 Percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Third Quarter GAAP Diluted EPS of $2.42,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $13.55 to $13.65,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 third quarter ended June 30, 2024, revenue increased 10.9 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: our fiscal 2024 guidance,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $74.2B $74.2B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2024 was $179.4 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -2-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.44 $ 2.37,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -3-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -4-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -4-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -5-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.47,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -5-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -5-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -6-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $66,772,423 $ 62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -6-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -6-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2024, (i) revenue of $74.2 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2024 (i) revenue of $214.9 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -7-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Third Quarter Results -8-
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,3Q EPS $2.42 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q EPS $2.42 >COR
COR,2024-07-31,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Adj EPS $3.34,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Adj EPS $3.34 >COR
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter Fiscal Year 2024 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 third quarter ended June 30, 2024, revenue increased 10.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: our fiscal 2024 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $74.2B $74.2B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Diluted Earnings Per Share $2.42 $3.34,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2024, revenue was $74.2 billion, up 10.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third Quarter Results
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2024 was $179.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -2-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.44 $ 2.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -3-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -4-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -5-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,98,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -5-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $66,772,423 $ 62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -6-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -6-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2024, (i) revenue of $74.2 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -7-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2024 (i) revenue of $214.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -7-
COR,2024-07-31,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Third -7-
COR,2024-07-31,10:35:52,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises FY24 View To Adj EPS $13.55,NEWS-FLASH,Dow Jones Newswires,Cencora Raises FY24 View To Adj EPS $13.55-Adj EPS $13.65 >COR
COR,2024-07-31,10:37:02,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees FY24 Rev Growth of About 12 %,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Rev Growth of About 12 % >COR
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Lifts FY Outlook on 3Q Revenue,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora again raised its outlook for its fiscal year,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Amerisourcebergen on Wednesday reported a net profit of $483.5 million,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-07-31,21:45:25,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora now forecasts adjusted earnings per share for the year ending Sept. 30 of $13.55 to $13.65,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts FY Outlook on 3Q Revenue Growth
COR,2024-08-01,12:05:02,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-08-01,12:05:02,7D85A9,Cencora Inc.,100,0.3,price-targets,upgrade,Cencora Price Target Raised to $287.00/Share From $285.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $287.00/Share From $285.00 by Baird
COR,2024-08-01,13:53:12,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2024-08-01,13:53:12,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $249.00/Share From $236.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $249.00/Share From $236.00 by Wells Fargo
COR,2024-08-01,22:08:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds
COR,2024-08-01,22:08:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of Cencora for Approximately $1.1 Billion of Proceeds
COR,2024-08-01,22:08:37,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of Cencora for Approximately $1.1B of Proceeds
COR,2024-08-01,22:14:51,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Reducing Cencora Stake,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Reducing Cencora Stake to About 10% From 12%
COR,2024-08-01,22:17:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance >COR
COR,2024-08-01,22:17:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:17:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:17:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:17:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2024-08-01,22:18:48,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora: To Buy Back About $250M of Common Stock,NEWS-FLASH,Dow Jones Newswires,Cencora: To Buy Back About $250M of Common Stock From Walgreens Boots Alliance >COR
COR,2024-08-01,22:39:47,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Sells Shares in Cencora,FULL-ARTICLE,Dow Jones Newswires,"Walgreens Sells Shares in Cencora for Third Time This Year, Raises $1.1 Billion"
COR,2024-08-01,23:04:19,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens sells shares in Cencora,FULL-ARTICLE,MarketWatch,"MW Walgreens sells shares in Cencora for third time this year, raises $1.1 billion"
COR,2024-08-02,17:59:49,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens continues to shed stake in Cencora,FULL-ARTICLE,MarketWatch,MW Walgreens continues to shed stake in Cencora as it looks to bolster turnaround
COR,2024-08-05,20:03:04,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 1,039,242 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-08-05,22:46:23,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 4,438,171 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 4,438,171 Of Cencora Inc >COR"
COR,2024-08-06,18:12:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 1,473 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 1,473 Of Cencora Inc >COR"
COR,2024-08-07,20:12:20,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 1,473 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 1,473 Of Cencora Inc >COR"
COR,2024-08-07,20:16:40,7D85A9,Cencora Inc.,100,0.0,insider-trading,,"Dir Greenberg Gifts 5,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Gifts 5,000 Of Cencora Inc >COR"
COR,2024-08-14,13:00:01,7D85A9,Cencora Inc.,99,0.49,partnerships,,"Solutions, announces an industry-transforming partnership with Cencora",PRESS-RELEASE,Business Wire,"Intelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management Systems"
COR,2024-08-15,11:30:04,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Frank Clyburn to Its Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Cencora Elects Frank Clyburn to Its Bd of Directors
COR,2024-08-15,11:30:00,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Frank Clyburn to Its Board of Directors,PRESS-RELEASE,Business Wire,Cencora Elects Frank Clyburn to Its Board of Directors
COR,2024-08-15,11:30:03,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Frank Clyburn to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Elects Frank Clyburn to Its Board of Directors
COR,2024-08-15,12:31:09,7D85A9,Cencora Inc.,99,0.47,labor-issues,,"Cencora Inc.: the ""Company"") appointed Frank Clyburn to serve on the Board",RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2024-08-16,20:07:07,7D85A9,Cencora Inc.,99,0.0,labor-issues,,Cencora Inc.: the Company's 2022 Omnibus Incentive Plan,RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2024-08-20,07:16:48,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2024 (COR)"
COR,2024-08-20,14:51:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,754 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,754 Of Cencora Inc >COR"
COR,2024-08-21,14:18:17,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by JP Morgan
COR,2024-08-21,14:18:17,7D85A9,Cencora Inc.,100,0.42,price-targets,upgrade,Cencora Price Target Raised to $287.00/Share From $280.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $287.00/Share From $280.00 by JP Morgan
COR,2024-08-21,20:09:24,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,754 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,754 Of Cencora Inc >COR"
COR,2024-09-05,11:33:55,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $13.60,RNS-SEC8K,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $13.60-Adj EPS $13.70 >COR
COR,2024-09-05,11:31:46,7D85A9,Cencora Inc.,99,0.0,marketing,,"Cencora Inc.: the ""Company"") will be presenting at the Morgan Stanley Healthcare Conference today at 4:05 p.m. ET",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Regulation FD >COR
COR,2024-09-05,11:34:51,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY25 Adj EPS at,RNS-SEC8K,Dow Jones Newswires,Cencora Sees FY25 Adj EPS at Bottom End of 8%-12% Growth Target Range >COR
COR,2024-09-05,11:59:34,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises FY24 Outlook,FULL-ARTICLE,Dow Jones Newswires,"Cencora Raises FY24 Outlook, Warns of Covid-19 Hit in FY25 Growth Views"
COR,2024-09-06,11:31:53,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-09-06,11:31:53,7D85A9,Cencora Inc.,100,-0.28,price-targets,downgrade,Cencora Price Target Cut to $283.00/Share From $287.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $283.00/Share From $287.00 by Baird
COR,2024-09-17,13:51:28,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 21,509 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 21,509 Of Cencora Inc >COR"
COR,2024-09-18,10:51:00,7D85A9,Cencora Inc.,100,-0.58,analyst-ratings,negative,Cencora Cut to Neutral From Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Cut to Neutral From Buy by B of A Securities
COR,2024-09-18,10:51:00,7D85A9,Cencora Inc.,100,-0.8,price-targets,downgrade,Cencora Price Target Cut to $245.00/Share From $275.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $245.00/Share From $275.00 by B of A Securities
COR,2024-09-18,20:40:47,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 21,509 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 21,509 Of Cencora Inc >COR"
COR,2024-10-01,11:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
COR,2024-10-01,11:33:13,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
COR,2024-10-07,13:01:42,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Leerink Partners
COR,2024-10-07,13:01:42,7D85A9,Cencora Inc.,100,-0.17,price-targets,downgrade,Cencora Price Target Cut to $275.00/Share From $277.00 by Leerink,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $275.00/Share From $277.00 by Leerink Partners
COR,2024-10-08,17:17:24,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Evercore ISI Group
COR,2024-10-08,17:17:24,7D85A9,Cencora Inc.,100,-0.7,price-targets,downgrade,Cencora Price Target Cut to $250.00/Share From $270.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $250.00/Share From $270.00 by Evercore ISI Group
COR,2024-10-15,20:02:49,7D85A9,Cencora Inc.,99,0.38,credit,,Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2024-10-22,14:45:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 21,509 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 21,509 Of Cencora Inc >COR"
COR,2024-10-23,20:07:20,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 21,509 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 21,509 Of Cencora Inc >COR"
COR,2024-11-04,13:30:02,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora Expands Enterprise Leadership Team with Two Senior Appointments,PRESS-RELEASE,Business Wire,Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-04,13:30:02,7D85A9,Cencora Inc.,99,0.53,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced the appointment of Francois Mandeville as Executive Vice President",PRESS-RELEASE,Business Wire,Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-04,13:30:04,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora Expands Enterprise Leadership Team with Two Senior Appointments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-04,13:30:04,7D85A9,Cencora Inc.,99,0.53,labor-issues,,"Cencora, Inc. (NYSE: COR) today announced the appointment of Francois Mandeville as Executive Vice President",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Expands Enterprise Leadership Team with Two Senior Appointments
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,0.62,acquisitions-mergers,,Cencora will acquire RCA for approximately $4.6 billion in cash,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,0.22,acquisitions-mergers,,Cencora Inc.: our recent investment in OneOncology,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal year 2025 guidance,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:02,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Advances Specialty Leadership Through -2-
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,0.62,acquisitions-mergers,,Cencora will acquire RCA for approximately $4.6 billion in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,0.22,acquisitions-mergers,,Cencora Inc.: our recent investment in OneOncology,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal year 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America
COR,2024-11-06,11:30:05,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Advances Specialty -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Net $3.38M,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Net $3.38M >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 4Q Rev $79.05B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Rev $79.05B >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,4Q EPS 2c >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q EPS 2c >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Adj EPS $3.34,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Adj EPS $3.34 >COR
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $79.1 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $0.02,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent to $294.0 billion for the fiscal year,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2024 GAAP Diluted EPS of $7.53,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.62,dividends,up,Cencora Inc.: Company increases its quarterly dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, adjusted diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2024,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.1,earnings,,Cencora Inc.: Adjusted operating income increased 10.9 percent to $3.6 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the fourth quarter of fiscal 2024 was $153.7 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2024 Summary Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.28,equity-actions,up,Cencora Inc.: Operating expenses increased 16.9 percent,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, GAAP diluted EPS was $7.53",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent from the prior fiscal year to $294.0 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 8.1 percent to $9.7 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, adjusted diluted EPS was $13.76",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora announced the appointment of Francois Mandeville to its executive,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.55,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's preliminary fiscal 2025 guidance,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.59,equity-actions,completed,"On September 5, 2024, Cencora has executed on opportunistic share repurchases",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Capital expenditures to be approximately $600 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -2-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal 2025 guidance,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 0.02 $ 1.74,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -3-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 7.60 $ 8.62,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -4-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.15,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -4-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.37,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -5-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -5-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -6-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $67,101,667 $62,558,746",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -6-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -7-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -8-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2024, (i) revenue of $79.1 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -8-
COR,2024-11-06,11:35:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2024, (i) revenue of $294.0 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2024 Fourth Quarter and -8-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $79.1 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $0.02,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent to $294.0 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2024 GAAP Diluted EPS of $7.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.62,dividends,up,Cencora Inc.: Company increases its quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 fourth quarter ended September 30, 2024, revenue increased 14.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2024, diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2024, revenue was $79.1 billion, up 14.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.1,earnings,,Cencora Inc.: Adjusted operating income increased 10.9 percent to $3.6 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the fourth quarter of fiscal 2024 was $153.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2024 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.28,equity-actions,up,Cencora Inc.: Operating expenses increased 16.9 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, GAAP diluted EPS was $7.53",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 12.1 percent from the prior fiscal year to $294.0 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 8.1 percent to $9.7 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2024, adjusted diluted EPS was $13.76",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.53,labor-issues,,Cencora announced the appointment of Francois Mandeville to its executive,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's preliminary fiscal 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.59,equity-actions,completed,"On September 5, 2024, Cencora has executed on opportunistic share repurchases",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Capital expenditures to be approximately $600 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -2-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora's fiscal 2025 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 0.02 $ 1.74,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -3-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 7.60 $ 8.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -4-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -4-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -5-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -5-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -6-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $67,101,667 $62,558,746",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -6-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -7-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -8-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2024, (i) revenue of $79.1 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -8-
COR,2024-11-06,11:35:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2024, (i) revenue of $294.0 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2024 Fourth -8-
COR,2024-11-06,11:37:09,7D85A9,Cencora Inc.,100,0.38,dividends,up,Cencora Raises Dividend to 55c Vs. 51c,NEWS-FLASH,Dow Jones Newswires,Cencora Raises Dividend to 55c Vs. 51c >COR
COR,2024-11-06,11:37:53,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees 2025 Revenue Growth of 7%-9%,NEWS-FLASH,Dow Jones Newswires,Cencora Sees 2025 Revenue Growth of 7%-9% >COR
COR,2024-11-06,11:38:30,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees 2025 Adj EPS $14.80,NEWS-FLASH,Dow Jones Newswires,Cencora Sees 2025 Adj EPS $14.80-Adj EPS $15.10 >COR
COR,2024-11-06,11:52:56,7D85A9,Cencora Inc.,100,0.55,acquisitions-mergers,,Cencora to Acquire Retina Consultants of America for $4.6B,FULL-ARTICLE,Dow Jones Newswires,Cencora to Acquire Retina Consultants of America for $4.6B
COR,2024-11-06,12:22:49,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora 4Q Sales Climb,FULL-ARTICLE,Dow Jones Newswires,Cencora 4Q Sales Climb While Profit Falls on Higher Costs
COR,2024-11-06,12:22:49,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Amerisourcebergen posted a profit of $3.38 million,FULL-ARTICLE,Dow Jones Newswires,Cencora 4Q Sales Climb While Profit Falls on Higher Costs
COR,2024-11-06,23:21:09,7D85A9,Cencora Inc.,100,0.03,credit-ratings,stable,S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable,NEWS-FLASH,Dow Jones Newswires,S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable
COR,2024-11-06,23:21:09,7D85A9,Cencora Inc.,100,0.03,credit-ratings,stable,S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable
COR,2024-11-06,23:21:09,7D85A9,Cencora Inc.,100,0.62,acquisitions-mergers,,Cencora's acquisition of OneOncology will,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Cencora 'BBB+' Rating; Outlook Stable
COR,2024-11-06,23:21:19,7D85A9,Cencora Inc.,100,0.03,credit-ratings,affirmation,S&PGR Affirms Cencora 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Affirms Cencora 'BBB+' -2-
COR,2024-11-07,13:54:23,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Evercore ISI Group
COR,2024-11-07,13:54:23,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $250.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $250.00 by Evercore ISI Group
COR,2024-11-07,14:57:43,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by Barclays
COR,2024-11-07,14:57:43,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $290.00/Share From $263.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $290.00/Share From $263.00 by Barclays
COR,2024-11-07,16:08:23,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by UBS
COR,2024-11-07,16:08:23,7D85A9,Cencora Inc.,100,0.48,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $275.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $275.00 by UBS
COR,2024-11-07,17:52:54,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2024-11-07,17:52:54,7D85A9,Cencora Inc.,100,0.32,price-targets,upgrade,Cencora Price Target Raised to $292.00/Share From $287.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $292.00/Share From $287.00 by Baird
COR,2024-11-08,12:01:16,7D85A9,Cencora Inc.,99,0.62,acquisitions-mergers,,"Cencora Inc.: the Company entered into an agreement to acquire RCA, a portfolio company of Webster Equity Partners",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Other Events >COR
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.62,acquisitions-mergers,,Cencora recently announced that it plans to acquire Retina Consultants of America (RCA) for approximately $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:33,7D85A9,Cencora Inc.,100,0.14,credit,,Cencora will refinance debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable
COR,2024-11-08,16:19:43,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable -2-
COR,2024-11-08,16:19:53,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora at 'A-'/'F1'; Outlook Stable -3-
COR,2024-11-13,21:14:37,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Ceo Mauch Acquires 6,684 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Acquires 6,684 Of Cencora Inc >COR"
COR,2024-11-13,21:18:02,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 2,723 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 2,723 Of Cencora Inc >COR"
COR,2024-11-13,21:19:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 21,664 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 21,664 Of Cencora Inc >COR"
COR,2024-11-13,21:22:21,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 3,351 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 3,351 Of Cencora Inc >COR"
COR,2024-11-13,21:23:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 4,676 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 4,676 Of Cencora Inc >COR"
COR,2024-11-13,21:26:28,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 3,001 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 3,001 Of Cencora Inc >COR"
COR,2024-11-19,15:03:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 21,509 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 21,509 Of Cencora Inc >COR"
COR,2024-11-20,08:16:02,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2024 (COR)"
COR,2024-11-21,21:51:10,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 21,509 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 21,509 Of Cencora Inc >COR"
COR,2024-11-22,21:20:32,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 69,805 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 69,805 Of Cencora Inc >COR"
COR,2024-11-22,21:21:25,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 8,058 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 8,058 Of Cencora Inc >COR"
COR,2024-11-22,21:21:55,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 1,039 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 1,039 Of Cencora Inc >COR"
COR,2024-11-22,21:22:05,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 7,083 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 7,083 Of Cencora Inc >COR"
COR,2024-11-22,21:23:13,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 18,889 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 18,889 Of Cencora Inc >COR"
COR,2024-11-22,21:26:18,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Ceo Mauch Acquires 21,718 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Acquires 21,718 Of Cencora Inc >COR"
COR,2024-11-25,21:10:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 50,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 50,000 Of Cencora Inc >COR"
COR,2024-11-26,21:35:58,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 50,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 50,000 Of Cencora Inc >COR"
COR,2024-12-02,16:02:50,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-12-02,16:02:50,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-12-02,16:02:50,7D85A9,Cencora Inc.,100,0.14,credit,,Cencora will refinance debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2024-12-02,16:03:00,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-' -2-
COR,2024-12-02,21:02:15,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 11,662 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 11,662 Of Cencora Inc >COR"
COR,2024-12-03,03:49:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 4.625% Senior Notes Due 2027,PRESS-RELEASE,Business Wire,"Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035"
COR,2024-12-03,03:49:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Prices $500 Million 4.625% Senior Notes Due 2027,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035"
COR,2024-12-03,16:15:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 1,816 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 1,816 Of Cencora Inc >COR"
COR,2024-12-04,21:27:27,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 1,816 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 1,816 Of Cencora Inc >COR"
COR,2024-12-06,13:30:00,7D85A9,Cencora Inc.,100,0.44,products-services,,Cencora Launches Accelerate Pharmacy Solutions to Enhance,PRESS-RELEASE,Business Wire,Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
COR,2024-12-06,13:30:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora partners with hospitals and health systems across,PRESS-RELEASE,Business Wire,Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
COR,2024-12-09,21:15:00,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $1.8 Billion Senior Notes Offering,PRESS-RELEASE,Business Wire,Cencora Closes $1.8 Billion Senior Notes Offering
COR,2024-12-09,21:15:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $1.8 Billion Senior Notes Offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Closes $1.8 Billion Senior Notes Offering
COR,2024-12-09,21:15:12,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora Closes $1.8 B Senior Notes Offering,NEWS-FLASH,Dow Jones Newswires,Cencora Closes $1.8 B Senior Notes Offering
COR,2024-12-10,21:31:21,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: the Company obtained $3.3 billion in bridge financing,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Other Events >COR
COR,2024-12-13,17:40:35,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2024-12-13,17:40:35,7D85A9,Cencora Inc.,100,-0.58,price-targets,downgrade,Cencora Price Target Cut to $237.00/Share From $249.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Cut to $237.00/Share From $249.00 by Wells Fargo
COR,2024-12-20,18:51:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 1,678 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 1,678 Of Cencora Inc >COR"
COR,2024-12-20,21:07:49,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Ceo Mauch Acquires 789 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,CEO Mauch Acquires 789 Of Cencora Inc >COR
COR,2024-12-20,21:10:05,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 108 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 108 Of Cencora Inc >COR
COR,2024-12-20,21:12:42,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Chmn Collis Acquires 395 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,Chmn Collis Acquires 395 Of Cencora Inc >COR
COR,2024-12-20,21:15:16,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Cfo Cleary Jr Acquires 207 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,CFO Cleary Jr Acquires 207 Of Cencora Inc >COR
COR,2024-12-23,20:48:37,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 1,678 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 1,678 Of Cencora Inc >COR"
COR,2021-02-24,16:01:00,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,GlobeNewswire,"Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-02-24,16:01:58,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Connie Chen as Chief Legal Officer (CLO),PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.0,products-services,,Corel Corp.: we develop new solutions,PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-05-04,13:13:59,761CC5,Corel Corp.,100,0.55,acquisitions-mergers,,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio",PRESS-RELEASE,GlobeNewswire,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio"
COR,2021-06-03,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation announces the appointment of Prashant Ketkar as Chief,PRESS-RELEASE,GlobeNewswire,Corel Announces Prashant Ketkar as Chief Technology and Product Officer
COR,2021-07-20,14:00:02,761CC5,Corel Corp.,100,0.52,products-services,,Corel Launches New Channel Program to,PRESS-RELEASE,GlobeNewswire,Corel Launches New Channel Program to Grow Partner Revenue
COR,2021-08-17,14:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Michelle Chiantera as Chief Marketing Officer,PRESS-RELEASE,GlobeNewswire,Corel Announces Michelle Chiantera as Chief Marketing Officer
COR,2021-08-20,22:51:58,761CC5,Corel Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation
COR,2021-02-24,16:01:00,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,GlobeNewswire,"Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-02-24,16:01:58,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Connie Chen as Chief Legal Officer (CLO),PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.0,products-services,,Corel Corp.: we develop new solutions,PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-05-04,13:13:59,761CC5,Corel Corp.,100,0.55,acquisitions-mergers,,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio",PRESS-RELEASE,GlobeNewswire,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio"
COR,2021-06-03,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation announces the appointment of Prashant Ketkar as Chief,PRESS-RELEASE,GlobeNewswire,Corel Announces Prashant Ketkar as Chief Technology and Product Officer
COR,2021-07-20,14:00:02,761CC5,Corel Corp.,100,0.52,products-services,,Corel Launches New Channel Program to,PRESS-RELEASE,GlobeNewswire,Corel Launches New Channel Program to Grow Partner Revenue
COR,2021-08-17,14:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Michelle Chiantera as Chief Marketing Officer,PRESS-RELEASE,GlobeNewswire,Corel Announces Michelle Chiantera as Chief Marketing Officer
COR,2021-08-20,22:51:58,761CC5,Corel Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation
COR,2021-02-24,16:01:00,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,GlobeNewswire,"Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-02-24,16:01:58,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Connie Chen as Chief Legal Officer (CLO),PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.0,products-services,,Corel Corp.: we develop new solutions,PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-05-04,13:13:59,761CC5,Corel Corp.,100,0.55,acquisitions-mergers,,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio",PRESS-RELEASE,GlobeNewswire,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio"
COR,2021-06-03,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation announces the appointment of Prashant Ketkar as Chief,PRESS-RELEASE,GlobeNewswire,Corel Announces Prashant Ketkar as Chief Technology and Product Officer
COR,2021-07-20,14:00:02,761CC5,Corel Corp.,100,0.52,products-services,,Corel Launches New Channel Program to,PRESS-RELEASE,GlobeNewswire,Corel Launches New Channel Program to Grow Partner Revenue
COR,2021-08-17,14:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Michelle Chiantera as Chief Marketing Officer,PRESS-RELEASE,GlobeNewswire,Corel Announces Michelle Chiantera as Chief Marketing Officer
COR,2021-08-20,22:51:58,761CC5,Corel Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation
COR,2021-02-24,16:01:00,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,GlobeNewswire,"Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-02-24,16:01:58,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Connie Chen as Chief Legal Officer (CLO),PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.0,products-services,,Corel Corp.: we develop new solutions,PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-05-04,13:13:59,761CC5,Corel Corp.,100,0.55,acquisitions-mergers,,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio",PRESS-RELEASE,GlobeNewswire,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio"
COR,2021-06-03,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation announces the appointment of Prashant Ketkar as Chief,PRESS-RELEASE,GlobeNewswire,Corel Announces Prashant Ketkar as Chief Technology and Product Officer
COR,2021-07-20,14:00:02,761CC5,Corel Corp.,100,0.52,products-services,,Corel Launches New Channel Program to,PRESS-RELEASE,GlobeNewswire,Corel Launches New Channel Program to Grow Partner Revenue
COR,2021-08-17,14:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Michelle Chiantera as Chief Marketing Officer,PRESS-RELEASE,GlobeNewswire,Corel Announces Michelle Chiantera as Chief Marketing Officer
COR,2021-08-20,22:51:58,761CC5,Corel Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation
COR,2021-02-24,16:01:00,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,GlobeNewswire,"Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-02-24,16:01:58,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Connie Chen as Chief Legal Officer (CLO),PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.0,products-services,,Corel Corp.: we develop new solutions,PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-05-04,13:13:59,761CC5,Corel Corp.,100,0.55,acquisitions-mergers,,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio",PRESS-RELEASE,GlobeNewswire,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio"
COR,2021-06-03,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation announces the appointment of Prashant Ketkar as Chief,PRESS-RELEASE,GlobeNewswire,Corel Announces Prashant Ketkar as Chief Technology and Product Officer
COR,2021-07-20,14:00:02,761CC5,Corel Corp.,100,0.52,products-services,,Corel Launches New Channel Program to,PRESS-RELEASE,GlobeNewswire,Corel Launches New Channel Program to Grow Partner Revenue
COR,2021-08-17,14:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Michelle Chiantera as Chief Marketing Officer,PRESS-RELEASE,GlobeNewswire,Corel Announces Michelle Chiantera as Chief Marketing Officer
COR,2021-08-20,22:51:58,761CC5,Corel Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation
COR,2021-02-24,16:01:00,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,GlobeNewswire,"Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-02-24,16:01:58,761CC5,Corel Corp.,100,0.53,labor-issues,,Corel Corporation today announces the appointment of Andrea Johnston as Chief Revenue Officer,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Corel Appoints Andrea Johnston, Former COO at OpenTable, as Chief Revenue Officer"
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Connie Chen as Chief Legal Officer (CLO),PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-04-28,15:05:00,761CC5,Corel Corp.,99,0.0,products-services,,Corel Corp.: we develop new solutions,PRESS-RELEASE,GlobeNewswire,Corel Announces Connie Chen as Chief Legal Officer
COR,2021-05-04,13:13:59,761CC5,Corel Corp.,100,0.55,acquisitions-mergers,,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio",PRESS-RELEASE,GlobeNewswire,"Corel Acquires Ad Remover, Expanding its Utility Software Portfolio"
COR,2021-06-03,15:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation announces the appointment of Prashant Ketkar as Chief,PRESS-RELEASE,GlobeNewswire,Corel Announces Prashant Ketkar as Chief Technology and Product Officer
COR,2021-07-20,14:00:02,761CC5,Corel Corp.,100,0.52,products-services,,Corel Launches New Channel Program to,PRESS-RELEASE,GlobeNewswire,Corel Launches New Channel Program to Grow Partner Revenue
COR,2021-08-17,14:05:00,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corporation today announces the appointment of Michelle Chiantera as Chief Marketing Officer,PRESS-RELEASE,GlobeNewswire,Corel Announces Michelle Chiantera as Chief Marketing Officer
COR,2021-08-20,22:51:58,761CC5,Corel Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corel Corporation
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Acquire Alliance Healthcare Businesses from Walgreens Boots Alliance for $6.5 Billion,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: our successful partnership with Walgreens Boots Alliance and welcoming the industry-leading team at Alliance Healthcare,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen will host a conference call today at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,Amerisourcebergen does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance -2-
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Acquire Alliance Healthcare Businesses from Walgreens Boots Alliance for $6.5 Billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: our successful partnership with Walgreens Boots Alliance and welcoming the industry-leading team at Alliance Healthcare,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen will host a conference call today at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,Amerisourcebergen does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens -2-
COR,2021-01-06,12:00:21,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Amerisourcebergen and Walgreens Boots Alliance Announce Strategic Transaction,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:59,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion >ABC
COR,2021-01-06,12:03:38,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to acquire Walgreens Alliance Healthcare businesses for about $6.5 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen to acquire Walgreens Alliance Healthcare businesses for about $6.5 bln in cash and stock
COR,2021-01-06,12:10:14,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted earnings per share",PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:10:14,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:10:14,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:11:26,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY21 Adj EPS $8.25,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY21 Adj EPS $8.25-Adj EPS $8.50 >ABC
COR,2021-01-06,12:12:02,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Previously Forecast Adjusted EPS of $8.20-$8.45,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Previously Forecast Adjusted EPS of $8.20-$8.45 >ABC
COR,2021-01-06,12:13:58,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen Announces Updated Fiscal Year 2021 Financial Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:13:58,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted earnings per share",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:13:58,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:21:29,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion
COR,2021-01-06,12:36:29,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion
COR,2021-01-06,13:03:31,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:03:31,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:03:52,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:03:52,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:23:59,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:23:59,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:38:59,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:38:59,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:40:38,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Raises FY21 Earnings Guidance >ABC,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Raises FY21 Earnings Guidance >ABC
COR,2021-01-06,14:35:08,7D85A9,AmerisourceBergen Corp.,100,0.01,credit-ratings,affirmation,Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating,NEWS-FLASH,Dow Jones Newswires,Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating; Outlook Stable
COR,2021-01-06,15:57:29,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,15:57:29,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,16:08:20,7D85A9,AmerisourceBergen Corp.,100,-0.51,credit-ratings,negative,S&P Puts AmerisourceBergen Corp. On Watch Neg,NEWS-FLASH,Dow Jones Newswires,S&P Puts AmerisourceBergen Corp. On Watch Neg
COR,2021-01-06,17:53:08,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,17:53:08,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday that they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,18:08:09,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,18:08:09,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday that they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,20:03:34,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms AmerisourceBergen at 'A-' Following Announced Plan to Buy Alliance from Walgreens
COR,2021-01-06,20:03:41,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at 'A-' Following Announced Plan to Buy Alliance from Walgreens
COR,2021-01-06,20:03:51,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -2-
COR,2021-01-06,20:04:01,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -3-
COR,2021-01-07,20:35:42,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-07,20:35:42,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-07,21:17:36,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 16,561 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 16,561 Of AmerisourceBergen Corp >ABC"
COR,2021-01-07,22:34:34,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots Alliance Sale of Unit to AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,"Fitch Views Walgreens Boots Alliance Sale of Unit to AmerisourceBergen as Credit-Neutral, Assuming About $2B of Proceeds Used to Repay Debt >WBA.LN"
COR,2021-01-14,21:30:30,7D85A9,AmerisourceBergen Corp.,100,0.0,dividends,,Amerisourcebergen Announces Quarterly Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Quarterly Dividend
COR,2021-01-14,21:30:30,7D85A9,AmerisourceBergen Corp.,100,0.0,dividends,,Amerisourcebergen Announces Quarterly Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Quarterly Dividend
COR,2021-01-22,08:02:13,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2020 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2020 (ABC)"
COR,2021-02-02,14:00:04,7D85A9,AmerisourceBergen Corp.,99,0.0,products-services,,AmerisourceBergen Corp.: from clinical trial to,PRESS-RELEASE,Business Wire,AmerisourceBergen Hosts First-Ever ThinkLive Commercialization Global Conference
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Adj EPS $2.18,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Adj EPS $2.18 >ABC
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 1Q Rev $52.5B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Rev $52.5B >ABC
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $8.40,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $8.40-Adj EPS $8.60 >ABC
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,1Q EPS $1.81 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q EPS $1.81 >ABC
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Net $374.8M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Net $374.8M >ABC
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 First Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $52.5 billion for the First Quarter, a 9.7 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $1.81,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.40 to $8.60,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2021, revenue was $52.5 billion, up 9.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.14,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 first quarter, net interest expense of $33.6 million was up 8.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $50.5 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.58,products-services,,Amerisourcebergen reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC),PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.83 $ 0.91,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.77,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $45,846,768 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $52.5 billion for the First Quarter, a 9.7 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $1.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.40 to $8.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2021, revenue was $52.5 billion, up 9.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.14,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 first quarter, net interest expense of $33.6 million was up 8.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $50.5 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.58,products-services,,Amerisourcebergen reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC),PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.83 $ 0.91,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $45,846,768 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:45,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Had Seen FY21 Adjusted EPS $8.25-$8.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Had Seen FY21 Adjusted EPS $8.25-$8.50 >ABC
COR,2021-02-04,11:31:02,7D85A9,AmerisourceBergen Corp.,100,0.72,revenues,up,Amerisourcebergen Now Sees FY21 Revenue Growth,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Now Sees FY21 Revenue Growth in High-Single Digits >ABC
COR,2021-02-04,11:33:22,7D85A9,AmerisourceBergen Corp.,100,0.82,earnings,up,Amerisourcebergen Q1 EPS $1.81 vs. 90 cents a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 EPS $1.81 vs. 90 cents a year ago
COR,2021-02-04,11:33:38,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q1 adj. EPS $2.18; FactSet consensus $1.95,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 adj. EPS $2.18; FactSet consensus $1.95
COR,2021-02-04,11:34:09,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q1 rev. $52.52 bln vs. $47.86 bln a year ago; FactSet consensus $51.51 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 rev. $52.52 bln vs. $47.86 bln a year ago; FactSet consensus $51.51 bln
COR,2021-02-04,11:35:09,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,Amerisourcebergen Q1 pharmaceutical distribution rev. up 9.7% to $50.5 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 pharmaceutical distribution rev. up 9.7% to $50.5 bln; FactSet consensus $49.0 bln
COR,2021-02-04,11:35:51,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raises 2021 adj. EPS outlook to $8.40-$8.60 from $8.25-$8.50,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raises 2021 adj. EPS outlook to $8.40-$8.60 from $8.25-$8.50
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen Logs Higher 1Q Rev,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.64,earnings,up,Amerisourcebergen Corp.'s first-quarter profit grew year over year,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Net income attributable to the company was $374.8 million,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.72,revenues,up,Amerisourcebergen forecast full-year revenue growth,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: The company had previously forecast a full-year profit of $8.25 a share,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,19:55:41,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q1 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q1 2021 Results -- Earnings Call Transcript >ABC
COR,2021-02-05,15:09:47,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2021-02-05,15:09:47,7D85A9,AmerisourceBergen Corp.,100,0.46,price-targets,upgrade,Amerisourcebergen Price Target Raised to $127.00/Share From $123.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $127.00/Share From $123.00 by Credit Suisse
COR,2021-02-08,13:25:43,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Overweight by Morgan Stanley
COR,2021-02-08,13:25:43,7D85A9,AmerisourceBergen Corp.,100,0.62,price-targets,upgrade,Amerisourcebergen Price Target Raised to $138.00/Share From $130.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $138.00/Share From $130.00 by Morgan Stanley
COR,2021-02-08,17:17:44,7D85A9,AmerisourceBergen Corp.,100,0.2,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Cowen & Co.
COR,2021-02-08,17:17:44,7D85A9,AmerisourceBergen Corp.,100,0.48,price-targets,upgrade,Amerisourcebergen Price Target Raised to $150.00/Share From $145.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $150.00/Share From $145.00 by Cowen & Co.
COR,2021-02-09,16:15:59,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2021-02-09,16:15:59,7D85A9,AmerisourceBergen Corp.,100,0.76,price-targets,upgrade,Amerisourcebergen Price Target Raised to $114.00/Share From $104.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $114.00/Share From $104.00 by Mizuho
COR,2021-02-09,21:09:39,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 84,651 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 84,651 Of AmerisourceBergen Corp >ABC"
COR,2021-02-09,21:11:49,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Dir Hyle Sells 3,085 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Hyle Sells 3,085 Of AmerisourceBergen Corp >ABC"
COR,2021-02-11,21:11:17,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 1,419 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 1,419 Of AmerisourceBergen Corp >ABC"
COR,2021-02-17,21:04:04,7D85A9,AmerisourceBergen Corp.,100,0.0,insider-trading,,"Vp Chou Gifts 2,000 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Gifts 2,000 Of AmerisourceBergen Corp >ABC"
COR,2021-02-25,20:21:00,7D85A9,AmerisourceBergen Corp.,99,0.41,assets,open,AmerisourceBergen Corp.: The new headquarters,PRESS-RELEASE,Business Wire,"PRP Invests in the New Global Headquarters for AmerisourceBergen in Conshohocken, Pa."
COR,2021-03-01,19:47:07,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation
COR,2021-03-09,00:02:41,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Dir McGee III Registers 5,801 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Dir McGee III Registers 5,801 Of AmerisourceBergen Corp >ABC"
COR,2021-03-09,21:05:05,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 16,236 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 16,236 Of AmerisourceBergen Corp >ABC"
COR,2021-03-17,20:11:10,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 33,697 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 33,697 Of AmerisourceBergen Corp >ABC"
COR,2021-03-22,20:06:37,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-03-25,14:32:34,7D85A9,AmerisourceBergen Corp.,100,0.16,credit-ratings,set,Fitch Rates ABC's Unsecured Senior Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates ABC's Unsecured Senior Notes Offering 'A-'; Outlook Stable
COR,2021-03-25,14:33:08,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,set,Moody's Rates Amerisourcebergen's New Unsecured Notes At Baa2,NEWS-FLASH,Dow Jones Newswires,Moody's Rates Amerisourcebergen's New Unsecured Notes At Baa2
COR,2021-03-25,21:44:41,7D85A9,AmerisourceBergen Corp.,100,0.16,credit-ratings,set,S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-,NEWS-FLASH,Dow Jones Newswires,S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-'
COR,2021-03-25,21:44:41,7D85A9,AmerisourceBergen Corp.,100,0.16,credit-ratings,set,S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-'
COR,2021-03-25,22:41:00,7D85A9,AmerisourceBergen Corp.,100,0.0,credit,,Amerisourcebergen Prices $1.525 Billion 0.737% Senior Notes Due 2023,PRESS-RELEASE,Business Wire,AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
COR,2021-03-25,22:41:01,7D85A9,AmerisourceBergen Corp.,100,0.0,credit,,Amerisourcebergen Prices $1.525 Billion 0.737% Senior Notes Due 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
COR,2021-03-25,22:41:22,7D85A9,AmerisourceBergen Corp.,100,0.0,credit,,Amerisourcebergen Prices $1.525B 0.737% Senior Notes Due 2023,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Prices $1.525B 0.737% Senior Notes Due 2023 and $1.0B 2.700% Senior Notes Due 2031
COR,2021-04-01,20:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release
COR,2021-04-01,20:15:41,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release
COR,2021-04-05,20:02:31,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 9,013 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 9,013 Of AmerisourceBergen Corp >ABC"
COR,2021-04-12,12:30:01,7D85A9,AmerisourceBergen Corp.,100,0.26,corporate-responsibility,,"Amerisourcebergen Foundation Donates $700,000 to",PRESS-RELEASE,Business Wire,"AmerisourceBergen Foundation Donates $700,000 to Boys & Girls Clubs of America to Roll Out COVID-19 Vaccine Education Programs Across the U.S."
COR,2021-04-14,20:07:40,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,914 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,914 Of AmerisourceBergen Corp >ABC"
COR,2021-04-21,20:04:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-04-21,21:05:23,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 2,873 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 2,873 Of AmerisourceBergen Corp >ABC"
COR,2021-04-22,07:28:50,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2021 (ABC)"
COR,2021-04-22,20:02:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $2.53,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $2.53 >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 2Q Rev $49.2B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Rev $49.2B >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $8.45,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $8.45-Adj EPS $8.60 >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,2Q EPS $2.10 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q EPS $2.10 >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Net $435.3M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Net $435.3M >ABC
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $47.1 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.12 $ 4.68,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 3.96 $ 5.58,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.93,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -5-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -6-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 18.81,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -6-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $47,003,250 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -6-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -7-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -7-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -8-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -8-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -8-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $49.2 billion for the Second Quarter, a 3.7 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.45 to $8.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.22,acquisitions-mergers,,AmerisourceBergen Corp.: our investments in our,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2021, revenue was $49.2 billion, up 3.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,-0.13,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 second quarter, net interest expense of $34.5 million was up 0.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $47.1 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.12 $ 4.68,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 3.96 $ 5.58,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.93,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 18.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $47,003,250 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-05-05,10:30:23,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $2.53,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $2.53 >ABC
COR,2021-05-05,10:31:59,7D85A9,AmerisourceBergen Corp.,100,-0.64,earnings,down,Amerisourcebergen Q2 EPS $2.10 vs. $4.64 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 EPS $2.10 vs. $4.64 a year ago
COR,2021-05-05,10:32:16,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q2 adj. EPS $2.53; FactSet consensus $2.48,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 adj. EPS $2.53; FactSet consensus $2.48
COR,2021-05-05,10:32:45,7D85A9,AmerisourceBergen Corp.,100,-0.27,revenues,below-expectations,Amerisourcebergen Q2 revenue $49.15 bln vs. $47.42 bln a year ago; FactSet consensus $49.98 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 revenue $49.15 bln vs. $47.42 bln a year ago; FactSet consensus $49.98 bln
COR,2021-05-05,10:33:32,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raised 2021 adj. EPS outlook to $8.45-$8.60 from $8.40-$8.60,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raised 2021 adj. EPS outlook to $8.45-$8.60 from $8.40-$8.60
COR,2021-05-05,10:43:37,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen 2Q Revenue Rises,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen 2Q Revenue Rises
COR,2021-05-05,10:43:37,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen Corp. said its revenue for the fiscal second quarter rose,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen 2Q Revenue Rises
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,0.41,revenues,up,Amerisourcebergen's fiscal 2Q revenue grew 3.7% to $49.2,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,-0.75,revenues,down,Amerisource expects lower Covid-19 treatment sales in the second,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,0.41,revenues,up,Amerisourcebergen's fiscal 2Q revenue grew 3.7% to $49.2,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,-0.75,revenues,down,Amerisource expects lower Covid-19 treatment sales in the second,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,20:09:41,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q2 2021 Results -- Earnings Call Transcript >ABC
COR,2021-05-06,14:32:00,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Barclays
COR,2021-05-06,14:32:00,7D85A9,AmerisourceBergen Corp.,100,0.64,price-targets,upgrade,Amerisourcebergen Price Target Raised to $130.00/Share From $122.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $130.00/Share From $122.00 by Barclays
COR,2021-05-13,20:13:03,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC"
COR,2021-05-14,20:12:17,7D85A9,AmerisourceBergen Corp.,100,0.38,credit,,Amerisourcebergen Amends Revolving Credit,RNS-SEC8K,Dow Jones Newswires,AmerisourceBergen Amends Revolving Credit Amendment
COR,2021-05-19,20:46:23,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-05-20,20:09:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-05-26,15:16:14,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Anivive Announces Collaboration with MWI,PRESS-RELEASE,PR Newswire,Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Newest Lymphoma Treatment for Dogs
COR,2021-06-02,11:00:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition Of Alliance Healthcare Businesses >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Completes Acquisition Of Alliance Healthcare Businesses >ABC
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.5,acquisitions-mergers,completed,AmerisourceBergen Corp.: The acquisition of Alliance Healthcare expands our,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.90 to $9.10,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"Amerisourcebergen, and we look forward to continuing to work together",PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of -2,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of -2-
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.5,acquisitions-mergers,completed,AmerisourceBergen Corp.: The acquisition of Alliance Healthcare expands our,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.90 to $9.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"Amerisourcebergen, and we look forward to continuing to work together",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:02,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen Divesting Alliance Healthcare Businesses
COR,2021-06-02,11:00:02,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen Divesting Alliance Healthcare Businesses
COR,2021-06-02,11:00:25,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Walgreens Boots Alliance Completes Strategic Transaction With AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Completes Strategic Transaction With AmerisourceBergen Divesting Alliance Healthcare Businesses
COR,2021-06-02,11:07:11,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Raises FY21 View To Adj EPS $8.90,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raises FY21 View To Adj EPS $8.90-Adj EPS $9.10 >ABC
COR,2021-06-02,11:08:04,7D85A9,AmerisourceBergen Corp.,100,0.5,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of Alliance Healthcare Businesses for $6.275B,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses for $6.275B in Cash >ABC
COR,2021-06-02,11:08:36,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen Sees FY21 Revenue of at Least $210B,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY21 Revenue of at Least $210B >ABC
COR,2021-06-02,11:36:05,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Boosts FY Earnings Forecast,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts FY Earnings Forecast
COR,2021-06-02,11:36:05,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: The company logged revenue of $189.9 billion in fiscal 2020,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts FY Earnings Forecast
COR,2021-06-02,11:51:05,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Boosts Fiscal Year Earnings Forecast,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Fiscal Year Earnings Forecast
COR,2021-06-02,11:51:05,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: The company logged revenue of $189.9 billion in fiscal 2020,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Fiscal Year Earnings Forecast
COR,2021-06-04,16:29:51,7D85A9,AmerisourceBergen Corp.,100,-0.53,credit-ratings,negative,"S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative",NEWS-FLASH,Dow Jones Newswires,"S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative"
COR,2021-06-04,16:29:51,7D85A9,AmerisourceBergen Corp.,100,-0.53,credit-ratings,negative,"S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative",PRESS-RELEASE,Dow Jones Newswires,"Press Release: S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative"
COR,2021-06-04,16:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.61,credit-ratings,downgrade,S&PGR Downgrades AmerisourceBergen -,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Downgrades AmerisourceBergen -2-
COR,2021-06-04,16:32:36,7D85A9,AmerisourceBergen Corp.,100,-0.54,credit-ratings,downgrade,S&P Cuts AmerisourceBergen Corp. Rtg To BBB+ From A-,NEWS-FLASH,Dow Jones Newswires,S&P Cuts AmerisourceBergen Corp. Rtg To BBB+ From A-; Off Watch; Outlk Neg
COR,2021-06-04,20:15:00,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-06-04,20:15:01,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-06-10,20:21:46,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC"
COR,2021-06-17,20:03:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-06-21,20:18:00,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-06-24,20:15:02,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
COR,2021-06-24,20:15:02,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
COR,2021-07-14,20:11:35,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC"
COR,2021-07-20,20:09:54,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-07-21,20:05:14,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-07-22,07:30:26,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2021 (ABC)"
COR,2021-07-22,21:22:30,7D85A9,AmerisourceBergen Corp.,96,-0.54,credit-ratings,downgrade,Amerisourcebergen Corp. Downgraded To 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: AmerisourceBergen Opioid Settlement As Expected
COR,2021-07-26,13:13:02,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: Aeronics, Inc. Announces Collaboration with MWI",PRESS-RELEASE,PR Newswire,"Aeronics, Inc. Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Pawprint Oxygen Canister System for Companion Animals"
COR,2021-07-26,13:15:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: Press Release: Aeronics, Inc. Announces Collaboration with MWI",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aeronics, Inc. Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Pawprint Oxygen Canister System for Companion Animals"
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Adj EPS $2.16,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Adj EPS $2.16 >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 3Q Rev $53.4B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Rev $53.4B >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $9.15,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $9.15-Adj EPS $9.30 >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,3Q EPS $1.40 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q EPS $1.40 >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Net $292.1M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Net $292.1M >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Third Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $53.4 billion for the Third Quarter, a 17.7 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $9.15 to $9.30,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2021, revenue was $53.4 billion, up 17.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2021,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.42,equity-actions,up,AmerisourceBergen Corp.: expense of $51.3 million was up 36.0 percent versus the prior year quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $49.3 billion in the third quarter of fiscal 2021,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Adjusted operating income to be approximately $2.6 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,Amerisourcebergen announced the completion of its acquisition,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"In June 2021, AmerisourceBergen updated its fiscal year 2021 financial guidance",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted operating expense to be approximately $3.9 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 1.42,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 5.37 $ 7.01,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 2.70,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -5-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.73,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $55,930,936 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $53.4 billion for the Third Quarter, a 17.7 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $9.15 to $9.30,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2021, revenue was $53.4 billion, up 17.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.42,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 third quarter, net interest expense of $51.3 million was up 36.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $49.3 billion in the third quarter of fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Adjusted operating income to be approximately $2.6 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,Amerisourcebergen announced the completion of its acquisition,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"In June 2021, AmerisourceBergen updated its fiscal year 2021 financial guidance",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted operating expense to be approximately $3.9 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 1.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 5.37 $ 7.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 2.70,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.73,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $55,930,936 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-08-04,10:31:56,7D85A9,AmerisourceBergen Corp.,100,-0.23,earnings,down,Amerisourcebergen Q3 EPS $1.40 vs. $1.41 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 EPS $1.40 vs. $1.41 a year ago
COR,2021-08-04,10:32:28,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q3 adj. EPS $2.16; FactSet consensus $2.04,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 adj. EPS $2.16; FactSet consensus $2.04
COR,2021-08-04,10:32:51,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q3 revenue $53.41 bln vs. $45.37 bln a year ago; FactSet consensus $52.16 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 revenue $53.41 bln vs. $45.37 bln a year ago; FactSet consensus $52.16 bln
COR,2021-08-04,10:34:17,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raised FY2021 adj. EPS outlook to $9.15-$9.30 from $8.90-$9.10,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raised FY2021 adj. EPS outlook to $9.15-$9.30 from $8.90-$9.10
COR,2021-08-04,10:45:27,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen 3Q Revenue Rises,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen 3Q Revenue Rises, Led by Pharmaceutical Distribution Services"
COR,2021-08-04,10:45:27,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen Corp. said its revenue for the fiscal third quarter rose,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen 3Q Revenue Rises, Led by Pharmaceutical Distribution Services"
COR,2021-08-04,10:45:35,7D85A9,AmerisourceBergen Corp.,91,0.7,earnings,up,Amerisourcebergen Corp. raised its full-year guidance for,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Raises Fiscal 2021 Adjusted Earnings Guidance
COR,2021-08-05,12:28:45,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen stock price target raised to $136 from $117 at Deutsche Bank,NEWS-FLASH,MarketWatch,MW AmerisourceBergen stock price target raised to $136 from $117 at Deutsche Bank
COR,2021-08-05,12:40:43,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2021-08-05,12:40:43,7D85A9,AmerisourceBergen Corp.,100,0.74,price-targets,upgrade,Amerisourcebergen Price Target Raised to $144.00/Share From $132.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $144.00/Share From $132.00 by Credit Suisse
COR,2021-08-09,20:08:21,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Battaglia Sells 4,655 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 4,655 Of AmerisourceBergen Corp >ABC"
COR,2021-08-12,20:15:29,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC"
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer,PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer,PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,labor-issues,,"AmerisourceBergen Corp.: John Chou, current Executive Vice President and Chief Legal Officer, to retire",PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,labor-issues,,"AmerisourceBergen Corp.: John Chou, current Executive Vice President and Chief Legal Officer, to retire",PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-19,12:00:01,7D85A9,AmerisourceBergen Corp.,99,0.53,labor-issues,,Amerisourcebergen adds FirstView's copay program management,PRESS-RELEASE,Business Wire,AmerisourceBergen Adds FirstView Financial to its Suite of Manufacturer Solutions
COR,2021-08-19,12:05:04,7D85A9,AmerisourceBergen Corp.,99,0.53,labor-issues,,Amerisourcebergen adds FirstView's copay program management,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Adds FirstView Financial to its Suite of Manufacturer Solutions
COR,2021-08-19,20:33:38,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-08-23,20:05:36,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,081 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,081 Of AmerisourceBergen Corp >ABC"
COR,2021-08-31,11:33:39,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Overweight by Morgan Stanley
COR,2021-08-31,11:33:39,7D85A9,AmerisourceBergen Corp.,100,0.4,price-targets,upgrade,Amerisourcebergen Price Target Raised to $141.00/Share From $138.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $141.00/Share From $138.00 by Morgan Stanley
COR,2021-09-02,20:15:01,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-09-02,20:15:01,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-09-03,20:15:16,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 17,673 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 17,673 Of AmerisourceBergen Corp >ABC"
COR,2021-09-22,20:12:10,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC"
COR,2021-09-28,14:59:00,7D85A9,AmerisourceBergen Corp.,100,0.41,assets,open,"Amerisourcebergen Unveils New Global Headquarters in Conshohocken, PA",PRESS-RELEASE,Business Wire,"AmerisourceBergen Unveils New Global Headquarters in Conshohocken, PA & Announces Great Place to Work(R) Recognition"
COR,2021-10-05,20:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2021 Earnings Release
COR,2021-10-05,20:19:42,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2021 Earnings Release
COR,2021-10-06,12:30:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Innomar Strategies, in collaboration with the Government of Canada and FedEx Express Canada",PRESS-RELEASE,Business Wire,AmerisourceBergen Supports Global Distribution of COVID-19 Vaccines
COR,2021-10-06,12:34:04,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Innomar Strategies, in collaboration with the Government of Canada and FedEx Express Canada",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Supports Global Distribution of COVID-19 Vaccines
COR,2021-10-14,20:17:24,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC"
COR,2021-10-21,19:30:00,7D85A9,AmerisourceBergen Corp.,99,0.52,products-services,,Amerisourcebergen also introduced its new President of Manufacturer Services and Commercial Solutions,PRESS-RELEASE,Business Wire,"AmerisourceBergen & Global Pharmaceutical Manufacturers Discuss ""Moving Health Forward"" at Second Annual ThinkLive Trade Virtual Conference"
COR,2021-10-21,19:58:53,7D85A9,AmerisourceBergen Corp.,99,0.52,products-services,,Amerisourcebergen also introduced its new President of Manufacturer Services and Commercial Solutions,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen & Global Pharmaceutical Manufacturers Discuss ""Moving Health Forward"" at Second Annual ThinkLive Trade Virtual Conference"
COR,2021-10-22,07:48:59,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2021 (ABC)"
COR,2021-11-03,20:39:53,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 41,214 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 41,214 Of AmerisourceBergen Corp >ABC"
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.50-Adj EPS $10.80 >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Adj EPS $2.39,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Adj EPS $2.39 >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 4Q Rev $58.9B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Rev $58.9B >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,4Q EPS $2.08 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q EPS $2.08 >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Net $437.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Net $437.7M >ABC
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.65,earnings,negative,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $58.9 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2021 Summary Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $2.08,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent to $214.0 billion for the fiscal year,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2021 GAAP Diluted EPS of $7.39,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE:ABC) today reported that in its fiscal year 2021 fourth quarter ended September 30, 2021, revenue increased 19.6 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 fourth quarter, net interest expense of $54.6 million was up 57.3 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2021, revenue was $58.9 billion, up 19.6 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $51.2 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.82,earnings,up,AmerisourceBergen Corp.: Operating income increased 145.8 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expenses increased 30.2 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, GAAP diluted EPS was $7.39",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent from last fiscal year to $214.0 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.5,earnings,up,AmerisourceBergen Corp.: Gross profit increased 33.7 percent to $6.9 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, adjusted diluted EPS was $9.26",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,assets,open,"Amerisourcebergen opened its new global headquarters in Conshohocken, Pennsylvania.",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.46,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: International Healthcare Solutions revenue of approximately $26 to $27 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Interest expense growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.11 $,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.51,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -5-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.24,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -6-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 12.09,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,337,805 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -8-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.65,earnings,negative,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.65,earnings,negative,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $58.9 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $2.08,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent to $214.0 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2021 GAAP Diluted EPS of $7.39,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE:ABC) today reported that in its fiscal year 2021 fourth quarter ended September 30, 2021, revenue increased 19.6 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 fourth quarter, net interest expense of $54.6 million was up 57.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2021, revenue was $58.9 billion, up 19.6 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $51.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.82,earnings,up,AmerisourceBergen Corp.: Operating income increased 145.8 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2021 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expenses increased 30.2 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, GAAP diluted EPS was $7.39",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent from last fiscal year to $214.0 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.5,earnings,up,AmerisourceBergen Corp.: Gross profit increased 33.7 percent to $6.9 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, adjusted diluted EPS was $9.26",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,assets,open,"Amerisourcebergen opened its new global headquarters in Conshohocken, Pennsylvania.",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: International Healthcare Solutions revenue of approximately $26 to $27 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Interest expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.11 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.24,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 12.09,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,337,805 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.65,earnings,negative,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:32:08,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen Sees FY Revenue Growth,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Revenue Growth in High-Single Digit to Low-Double Digit % Range >ABC
COR,2021-11-04,10:34:48,7D85A9,AmerisourceBergen Corp.,100,0.82,earnings,up,Amerisourcebergen Q4 EPS $2.08 vs. per-share loss $23.74 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 EPS $2.08 vs. per-share loss $23.74 a year ago
COR,2021-11-04,10:35:20,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q4 adj. EPS $2.39; FactSet consensus $2.36,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 adj. EPS $2.39; FactSet consensus $2.36
COR,2021-11-04,10:35:43,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q4 revenue $58.91 bln vs. $49.24 bln a year ago; FactSet consensus $57.17 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 revenue $58.91 bln vs. $49.24 bln a year ago; FactSet consensus $57.17 bln
COR,2021-11-04,10:36:47,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Q4 sees FY2022 adj. EPS $10.50-$10.80,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 sees FY2022 adj. EPS $10.50-$10.80; FactSet consensus $10.61
COR,2021-11-04,10:49:21,7D85A9,AmerisourceBergen Corp.,100,0.64,earnings,up,Amerisourcebergen swings to profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen swings to profit, as it laps the big loss from opioid lawsuit expenses"
COR,2021-11-04,10:49:21,7D85A9,AmerisourceBergen Corp.,100,0.64,earnings,up,Amerisourcebergen Swings To Profit,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Swings To Profit, As It Laps The Big Loss From Opioid Lawsuit Expenses -- MarketWatch"
COR,2021-11-04,13:31:24,7D85A9,AmerisourceBergen Corp.,93,0.0,revenues,,Amerisourcebergen reported fiscal 4Q sales,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Gets Boost from Covid-19 Drug Distribution -- Market Talk
COR,2021-11-04,13:31:24,7D85A9,AmerisourceBergen Corp.,94,0.0,revenues,,Amerisourcebergen reported fiscal 4Q sales,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Gets Boost from Covid-19 Drug Distribution -- Market Talk
COR,2021-11-04,16:05:47,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q4 Fiscal 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q4 Fiscal 2021 Results -- Earnings Call Transcript >ABC
COR,2021-11-05,14:09:47,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Barclays
COR,2021-11-05,14:09:47,7D85A9,AmerisourceBergen Corp.,100,0.48,price-targets,upgrade,Amerisourcebergen Price Target Raised to $135.00/Share From $130.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $135.00/Share From $130.00 by Barclays
COR,2021-11-08,13:26:46,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2021-11-08,13:26:46,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $145.00/Share From $144.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $145.00/Share From $144.00 by Credit Suisse
COR,2021-11-12,13:51:02,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Hold by Deutsche Bank
COR,2021-11-12,13:51:02,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $153.00/Share From $136.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $153.00/Share From $136.00 by Deutsche Bank
COR,2021-11-12,21:25:36,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Mauch Acquires 2,259 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Acquires 2,259 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:31:20,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Chou Acquires 1,643 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Acquires 1,643 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:45:57,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:55:03,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Campbell Acquires 814 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Campbell Acquires 814 Of AmerisourceBergen Corp >ABC
COR,2021-11-12,21:55:14,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Clark Acquires 1,299 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 1,299 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:55:34,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Battaglia Acquires 821 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 821 Of AmerisourceBergen Corp >ABC
COR,2021-11-16,01:30:24,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 16,027 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 16,027 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,01:49:46,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Campbell Acquires 1,429 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 1,429 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,01:51:43,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Chou Acquires 4,689 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Acquires 4,689 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,02:03:17,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Mauch Acquires 4,689 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Acquires 4,689 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,02:15:31,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Cfo Cleary Jr Disposes 5,812 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Disposes 5,812 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,02:28:20,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Krikorian Acquires 580 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 580 Of AmerisourceBergen Corp >ABC
COR,2021-11-16,02:38:18,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Chmn Collis Acquires 17,861 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 17,861 Of AmerisourceBergen Corp >ABC"
COR,2021-11-18,21:03:28,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,664 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,664 Of AmerisourceBergen Corp >ABC"
COR,2021-11-29,21:03:10,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC"
COR,2021-12-15,19:31:42,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2021-12-15,19:31:42,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2021-12-15,19:31:52,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -2-
COR,2021-12-15,19:32:02,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -3-
COR,2021-12-15,21:09:14,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC"
COR,2021-12-16,21:30:43,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC"
COR,2021-12-17,14:04:24,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Overweight by Morgan Stanley
COR,2021-12-17,14:04:24,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $142.00/Share From $141.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $142.00/Share From $141.00 by Morgan Stanley
COR,2021-12-21,21:12:46,7D85A9,AmerisourceBergen Corp.,100,0.0,insider-trading,,"Vp Chou Gifts 3,276 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Gifts 3,276 Of AmerisourceBergen Corp >ABC"
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Acquire Alliance Healthcare Businesses from Walgreens Boots Alliance for $6.5 Billion,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: our successful partnership with Walgreens Boots Alliance and welcoming the industry-leading team at Alliance Healthcare,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen will host a conference call today at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,Amerisourcebergen does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance -2-
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Acquire Alliance Healthcare Businesses from Walgreens Boots Alliance for $6.5 Billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: our successful partnership with Walgreens Boots Alliance and welcoming the industry-leading team at Alliance Healthcare,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen will host a conference call today at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,Amerisourcebergen does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens -2-
COR,2021-01-06,12:00:21,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Amerisourcebergen and Walgreens Boots Alliance Announce Strategic Transaction,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:59,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion >ABC
COR,2021-01-06,12:03:38,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to acquire Walgreens Alliance Healthcare businesses for about $6.5 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen to acquire Walgreens Alliance Healthcare businesses for about $6.5 bln in cash and stock
COR,2021-01-06,12:10:14,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted earnings per share",PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:10:14,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:10:14,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:11:26,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY21 Adj EPS $8.25,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY21 Adj EPS $8.25-Adj EPS $8.50 >ABC
COR,2021-01-06,12:12:02,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Previously Forecast Adjusted EPS of $8.20-$8.45,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Previously Forecast Adjusted EPS of $8.20-$8.45 >ABC
COR,2021-01-06,12:13:58,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen Announces Updated Fiscal Year 2021 Financial Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:13:58,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted earnings per share",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:13:58,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:21:29,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion
COR,2021-01-06,12:36:29,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion
COR,2021-01-06,13:03:31,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:03:31,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:03:52,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:03:52,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:23:59,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:23:59,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:38:59,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:38:59,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:40:38,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Raises FY21 Earnings Guidance >ABC,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Raises FY21 Earnings Guidance >ABC
COR,2021-01-06,14:35:08,7D85A9,AmerisourceBergen Corp.,100,0.01,credit-ratings,affirmation,Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating,NEWS-FLASH,Dow Jones Newswires,Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating; Outlook Stable
COR,2021-01-06,15:57:29,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,15:57:29,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,16:08:20,7D85A9,AmerisourceBergen Corp.,100,-0.51,credit-ratings,negative,S&P Puts AmerisourceBergen Corp. On Watch Neg,NEWS-FLASH,Dow Jones Newswires,S&P Puts AmerisourceBergen Corp. On Watch Neg
COR,2021-01-06,17:53:08,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,17:53:08,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday that they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,18:08:09,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,18:08:09,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday that they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,20:03:34,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms AmerisourceBergen at 'A-' Following Announced Plan to Buy Alliance from Walgreens
COR,2021-01-06,20:03:41,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at 'A-' Following Announced Plan to Buy Alliance from Walgreens
COR,2021-01-06,20:03:51,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -2-
COR,2021-01-06,20:04:01,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -3-
COR,2021-01-07,20:35:42,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-07,20:35:42,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-07,21:17:36,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 16,561 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 16,561 Of AmerisourceBergen Corp >ABC"
COR,2021-01-07,22:34:34,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots Alliance Sale of Unit to AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,"Fitch Views Walgreens Boots Alliance Sale of Unit to AmerisourceBergen as Credit-Neutral, Assuming About $2B of Proceeds Used to Repay Debt >WBA.LN"
COR,2021-01-14,21:30:30,7D85A9,AmerisourceBergen Corp.,100,0.0,dividends,,Amerisourcebergen Announces Quarterly Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Quarterly Dividend
COR,2021-01-14,21:30:30,7D85A9,AmerisourceBergen Corp.,100,0.0,dividends,,Amerisourcebergen Announces Quarterly Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Quarterly Dividend
COR,2021-01-22,08:02:13,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2020 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2020 (ABC)"
COR,2021-02-02,14:00:04,7D85A9,AmerisourceBergen Corp.,99,0.0,products-services,,AmerisourceBergen Corp.: from clinical trial to,PRESS-RELEASE,Business Wire,AmerisourceBergen Hosts First-Ever ThinkLive Commercialization Global Conference
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Adj EPS $2.18,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Adj EPS $2.18 >ABC
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 1Q Rev $52.5B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Rev $52.5B >ABC
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $8.40,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $8.40-Adj EPS $8.60 >ABC
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,1Q EPS $1.81 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q EPS $1.81 >ABC
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Net $374.8M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Net $374.8M >ABC
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 First Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $52.5 billion for the First Quarter, a 9.7 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $1.81,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.40 to $8.60,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2021, revenue was $52.5 billion, up 9.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.14,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 first quarter, net interest expense of $33.6 million was up 8.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $50.5 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.58,products-services,,Amerisourcebergen reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC),PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.83 $ 0.91,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.77,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $45,846,768 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $52.5 billion for the First Quarter, a 9.7 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $1.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.40 to $8.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2021, revenue was $52.5 billion, up 9.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.14,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 first quarter, net interest expense of $33.6 million was up 8.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $50.5 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.58,products-services,,Amerisourcebergen reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC),PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.83 $ 0.91,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $45,846,768 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:45,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Had Seen FY21 Adjusted EPS $8.25-$8.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Had Seen FY21 Adjusted EPS $8.25-$8.50 >ABC
COR,2021-02-04,11:31:02,7D85A9,AmerisourceBergen Corp.,100,0.72,revenues,up,Amerisourcebergen Now Sees FY21 Revenue Growth,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Now Sees FY21 Revenue Growth in High-Single Digits >ABC
COR,2021-02-04,11:33:22,7D85A9,AmerisourceBergen Corp.,100,0.82,earnings,up,Amerisourcebergen Q1 EPS $1.81 vs. 90 cents a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 EPS $1.81 vs. 90 cents a year ago
COR,2021-02-04,11:33:38,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q1 adj. EPS $2.18; FactSet consensus $1.95,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 adj. EPS $2.18; FactSet consensus $1.95
COR,2021-02-04,11:34:09,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q1 rev. $52.52 bln vs. $47.86 bln a year ago; FactSet consensus $51.51 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 rev. $52.52 bln vs. $47.86 bln a year ago; FactSet consensus $51.51 bln
COR,2021-02-04,11:35:09,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,Amerisourcebergen Q1 pharmaceutical distribution rev. up 9.7% to $50.5 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 pharmaceutical distribution rev. up 9.7% to $50.5 bln; FactSet consensus $49.0 bln
COR,2021-02-04,11:35:51,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raises 2021 adj. EPS outlook to $8.40-$8.60 from $8.25-$8.50,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raises 2021 adj. EPS outlook to $8.40-$8.60 from $8.25-$8.50
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen Logs Higher 1Q Rev,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.64,earnings,up,Amerisourcebergen Corp.'s first-quarter profit grew year over year,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Net income attributable to the company was $374.8 million,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.72,revenues,up,Amerisourcebergen forecast full-year revenue growth,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: The company had previously forecast a full-year profit of $8.25 a share,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,19:55:41,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q1 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q1 2021 Results -- Earnings Call Transcript >ABC
COR,2021-02-05,15:09:47,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2021-02-05,15:09:47,7D85A9,AmerisourceBergen Corp.,100,0.46,price-targets,upgrade,Amerisourcebergen Price Target Raised to $127.00/Share From $123.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $127.00/Share From $123.00 by Credit Suisse
COR,2021-02-08,13:25:43,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Overweight by Morgan Stanley
COR,2021-02-08,13:25:43,7D85A9,AmerisourceBergen Corp.,100,0.62,price-targets,upgrade,Amerisourcebergen Price Target Raised to $138.00/Share From $130.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $138.00/Share From $130.00 by Morgan Stanley
COR,2021-02-08,17:17:44,7D85A9,AmerisourceBergen Corp.,100,0.2,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Cowen & Co.
COR,2021-02-08,17:17:44,7D85A9,AmerisourceBergen Corp.,100,0.48,price-targets,upgrade,Amerisourcebergen Price Target Raised to $150.00/Share From $145.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $150.00/Share From $145.00 by Cowen & Co.
COR,2021-02-09,16:15:59,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2021-02-09,16:15:59,7D85A9,AmerisourceBergen Corp.,100,0.76,price-targets,upgrade,Amerisourcebergen Price Target Raised to $114.00/Share From $104.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $114.00/Share From $104.00 by Mizuho
COR,2021-02-09,21:09:39,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 84,651 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 84,651 Of AmerisourceBergen Corp >ABC"
COR,2021-02-09,21:11:49,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Dir Hyle Sells 3,085 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Hyle Sells 3,085 Of AmerisourceBergen Corp >ABC"
COR,2021-02-11,21:11:17,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 1,419 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 1,419 Of AmerisourceBergen Corp >ABC"
COR,2021-02-17,21:04:04,7D85A9,AmerisourceBergen Corp.,100,0.0,insider-trading,,"Vp Chou Gifts 2,000 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Gifts 2,000 Of AmerisourceBergen Corp >ABC"
COR,2021-02-25,20:21:00,7D85A9,AmerisourceBergen Corp.,99,0.41,assets,open,AmerisourceBergen Corp.: The new headquarters,PRESS-RELEASE,Business Wire,"PRP Invests in the New Global Headquarters for AmerisourceBergen in Conshohocken, Pa."
COR,2021-03-01,19:47:07,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation
COR,2021-03-09,00:02:41,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Dir McGee III Registers 5,801 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Dir McGee III Registers 5,801 Of AmerisourceBergen Corp >ABC"
COR,2021-03-09,21:05:05,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 16,236 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 16,236 Of AmerisourceBergen Corp >ABC"
COR,2021-03-17,20:11:10,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 33,697 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 33,697 Of AmerisourceBergen Corp >ABC"
COR,2021-03-22,20:06:37,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-03-25,14:32:34,7D85A9,AmerisourceBergen Corp.,100,0.16,credit-ratings,set,Fitch Rates ABC's Unsecured Senior Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates ABC's Unsecured Senior Notes Offering 'A-'; Outlook Stable
COR,2021-03-25,14:33:08,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,set,Moody's Rates Amerisourcebergen's New Unsecured Notes At Baa2,NEWS-FLASH,Dow Jones Newswires,Moody's Rates Amerisourcebergen's New Unsecured Notes At Baa2
COR,2021-03-25,21:44:41,7D85A9,AmerisourceBergen Corp.,100,0.16,credit-ratings,set,S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-,NEWS-FLASH,Dow Jones Newswires,S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-'
COR,2021-03-25,21:44:41,7D85A9,AmerisourceBergen Corp.,100,0.16,credit-ratings,set,S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-'
COR,2021-03-25,22:41:00,7D85A9,AmerisourceBergen Corp.,100,0.0,credit,,Amerisourcebergen Prices $1.525 Billion 0.737% Senior Notes Due 2023,PRESS-RELEASE,Business Wire,AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
COR,2021-03-25,22:41:01,7D85A9,AmerisourceBergen Corp.,100,0.0,credit,,Amerisourcebergen Prices $1.525 Billion 0.737% Senior Notes Due 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
COR,2021-03-25,22:41:22,7D85A9,AmerisourceBergen Corp.,100,0.0,credit,,Amerisourcebergen Prices $1.525B 0.737% Senior Notes Due 2023,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Prices $1.525B 0.737% Senior Notes Due 2023 and $1.0B 2.700% Senior Notes Due 2031
COR,2021-04-01,20:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release
COR,2021-04-01,20:15:41,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release
COR,2021-04-05,20:02:31,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 9,013 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 9,013 Of AmerisourceBergen Corp >ABC"
COR,2021-04-12,12:30:01,7D85A9,AmerisourceBergen Corp.,100,0.26,corporate-responsibility,,"Amerisourcebergen Foundation Donates $700,000 to",PRESS-RELEASE,Business Wire,"AmerisourceBergen Foundation Donates $700,000 to Boys & Girls Clubs of America to Roll Out COVID-19 Vaccine Education Programs Across the U.S."
COR,2021-04-14,20:07:40,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,914 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,914 Of AmerisourceBergen Corp >ABC"
COR,2021-04-21,20:04:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-04-21,21:05:23,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 2,873 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 2,873 Of AmerisourceBergen Corp >ABC"
COR,2021-04-22,07:28:50,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2021 (ABC)"
COR,2021-04-22,20:02:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $2.53,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $2.53 >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 2Q Rev $49.2B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Rev $49.2B >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $8.45,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $8.45-Adj EPS $8.60 >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,2Q EPS $2.10 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q EPS $2.10 >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Net $435.3M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Net $435.3M >ABC
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $47.1 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.12 $ 4.68,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 3.96 $ 5.58,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.93,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -5-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -6-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 18.81,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -6-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $47,003,250 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -6-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -7-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -7-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -8-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -8-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -8-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $49.2 billion for the Second Quarter, a 3.7 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.45 to $8.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.22,acquisitions-mergers,,AmerisourceBergen Corp.: our investments in our,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2021, revenue was $49.2 billion, up 3.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,-0.13,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 second quarter, net interest expense of $34.5 million was up 0.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $47.1 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.12 $ 4.68,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 3.96 $ 5.58,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.93,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 18.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $47,003,250 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-05-05,10:30:23,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $2.53,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $2.53 >ABC
COR,2021-05-05,10:31:59,7D85A9,AmerisourceBergen Corp.,100,-0.64,earnings,down,Amerisourcebergen Q2 EPS $2.10 vs. $4.64 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 EPS $2.10 vs. $4.64 a year ago
COR,2021-05-05,10:32:16,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q2 adj. EPS $2.53; FactSet consensus $2.48,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 adj. EPS $2.53; FactSet consensus $2.48
COR,2021-05-05,10:32:45,7D85A9,AmerisourceBergen Corp.,100,-0.27,revenues,below-expectations,Amerisourcebergen Q2 revenue $49.15 bln vs. $47.42 bln a year ago; FactSet consensus $49.98 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 revenue $49.15 bln vs. $47.42 bln a year ago; FactSet consensus $49.98 bln
COR,2021-05-05,10:33:32,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raised 2021 adj. EPS outlook to $8.45-$8.60 from $8.40-$8.60,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raised 2021 adj. EPS outlook to $8.45-$8.60 from $8.40-$8.60
COR,2021-05-05,10:43:37,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen 2Q Revenue Rises,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen 2Q Revenue Rises
COR,2021-05-05,10:43:37,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen Corp. said its revenue for the fiscal second quarter rose,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen 2Q Revenue Rises
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,0.41,revenues,up,Amerisourcebergen's fiscal 2Q revenue grew 3.7% to $49.2,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,-0.75,revenues,down,Amerisource expects lower Covid-19 treatment sales in the second,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,0.41,revenues,up,Amerisourcebergen's fiscal 2Q revenue grew 3.7% to $49.2,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,-0.75,revenues,down,Amerisource expects lower Covid-19 treatment sales in the second,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,20:09:41,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q2 2021 Results -- Earnings Call Transcript >ABC
COR,2021-05-06,14:32:00,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Barclays
COR,2021-05-06,14:32:00,7D85A9,AmerisourceBergen Corp.,100,0.64,price-targets,upgrade,Amerisourcebergen Price Target Raised to $130.00/Share From $122.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $130.00/Share From $122.00 by Barclays
COR,2021-05-13,20:13:03,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC"
COR,2021-05-14,20:12:17,7D85A9,AmerisourceBergen Corp.,100,0.38,credit,,Amerisourcebergen Amends Revolving Credit,RNS-SEC8K,Dow Jones Newswires,AmerisourceBergen Amends Revolving Credit Amendment
COR,2021-05-19,20:46:23,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-05-20,20:09:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-05-26,15:16:14,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Anivive Announces Collaboration with MWI,PRESS-RELEASE,PR Newswire,Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Newest Lymphoma Treatment for Dogs
COR,2021-06-02,11:00:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition Of Alliance Healthcare Businesses >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Completes Acquisition Of Alliance Healthcare Businesses >ABC
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.5,acquisitions-mergers,completed,AmerisourceBergen Corp.: The acquisition of Alliance Healthcare expands our,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.90 to $9.10,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"Amerisourcebergen, and we look forward to continuing to work together",PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of -2,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of -2-
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.5,acquisitions-mergers,completed,AmerisourceBergen Corp.: The acquisition of Alliance Healthcare expands our,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.90 to $9.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"Amerisourcebergen, and we look forward to continuing to work together",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:02,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen Divesting Alliance Healthcare Businesses
COR,2021-06-02,11:00:02,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen Divesting Alliance Healthcare Businesses
COR,2021-06-02,11:00:25,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Walgreens Boots Alliance Completes Strategic Transaction With AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Completes Strategic Transaction With AmerisourceBergen Divesting Alliance Healthcare Businesses
COR,2021-06-02,11:07:11,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Raises FY21 View To Adj EPS $8.90,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raises FY21 View To Adj EPS $8.90-Adj EPS $9.10 >ABC
COR,2021-06-02,11:08:04,7D85A9,AmerisourceBergen Corp.,100,0.5,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of Alliance Healthcare Businesses for $6.275B,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses for $6.275B in Cash >ABC
COR,2021-06-02,11:08:36,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen Sees FY21 Revenue of at Least $210B,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY21 Revenue of at Least $210B >ABC
COR,2021-06-02,11:36:05,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Boosts FY Earnings Forecast,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts FY Earnings Forecast
COR,2021-06-02,11:36:05,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: The company logged revenue of $189.9 billion in fiscal 2020,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts FY Earnings Forecast
COR,2021-06-02,11:51:05,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Boosts Fiscal Year Earnings Forecast,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Fiscal Year Earnings Forecast
COR,2021-06-02,11:51:05,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: The company logged revenue of $189.9 billion in fiscal 2020,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Fiscal Year Earnings Forecast
COR,2021-06-04,16:29:51,7D85A9,AmerisourceBergen Corp.,100,-0.53,credit-ratings,negative,"S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative",NEWS-FLASH,Dow Jones Newswires,"S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative"
COR,2021-06-04,16:29:51,7D85A9,AmerisourceBergen Corp.,100,-0.53,credit-ratings,negative,"S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative",PRESS-RELEASE,Dow Jones Newswires,"Press Release: S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative"
COR,2021-06-04,16:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.61,credit-ratings,downgrade,S&PGR Downgrades AmerisourceBergen -,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Downgrades AmerisourceBergen -2-
COR,2021-06-04,16:32:36,7D85A9,AmerisourceBergen Corp.,100,-0.54,credit-ratings,downgrade,S&P Cuts AmerisourceBergen Corp. Rtg To BBB+ From A-,NEWS-FLASH,Dow Jones Newswires,S&P Cuts AmerisourceBergen Corp. Rtg To BBB+ From A-; Off Watch; Outlk Neg
COR,2021-06-04,20:15:00,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-06-04,20:15:01,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-06-10,20:21:46,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC"
COR,2021-06-17,20:03:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-06-21,20:18:00,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-06-24,20:15:02,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
COR,2021-06-24,20:15:02,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
COR,2021-07-14,20:11:35,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC"
COR,2021-07-20,20:09:54,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-07-21,20:05:14,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-07-22,07:30:26,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2021 (ABC)"
COR,2021-07-22,21:22:30,7D85A9,AmerisourceBergen Corp.,96,-0.54,credit-ratings,downgrade,Amerisourcebergen Corp. Downgraded To 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: AmerisourceBergen Opioid Settlement As Expected
COR,2021-07-26,13:13:02,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: Aeronics, Inc. Announces Collaboration with MWI",PRESS-RELEASE,PR Newswire,"Aeronics, Inc. Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Pawprint Oxygen Canister System for Companion Animals"
COR,2021-07-26,13:15:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: Press Release: Aeronics, Inc. Announces Collaboration with MWI",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aeronics, Inc. Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Pawprint Oxygen Canister System for Companion Animals"
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Adj EPS $2.16,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Adj EPS $2.16 >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 3Q Rev $53.4B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Rev $53.4B >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $9.15,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $9.15-Adj EPS $9.30 >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,3Q EPS $1.40 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q EPS $1.40 >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Net $292.1M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Net $292.1M >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Third Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $53.4 billion for the Third Quarter, a 17.7 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $9.15 to $9.30,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2021, revenue was $53.4 billion, up 17.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2021,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.42,equity-actions,up,AmerisourceBergen Corp.: expense of $51.3 million was up 36.0 percent versus the prior year quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $49.3 billion in the third quarter of fiscal 2021,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Adjusted operating income to be approximately $2.6 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,Amerisourcebergen announced the completion of its acquisition,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"In June 2021, AmerisourceBergen updated its fiscal year 2021 financial guidance",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted operating expense to be approximately $3.9 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 1.42,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 5.37 $ 7.01,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 2.70,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -5-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.73,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $55,930,936 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $53.4 billion for the Third Quarter, a 17.7 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $9.15 to $9.30,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2021, revenue was $53.4 billion, up 17.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.42,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 third quarter, net interest expense of $51.3 million was up 36.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $49.3 billion in the third quarter of fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Adjusted operating income to be approximately $2.6 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,Amerisourcebergen announced the completion of its acquisition,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"In June 2021, AmerisourceBergen updated its fiscal year 2021 financial guidance",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted operating expense to be approximately $3.9 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 1.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 5.37 $ 7.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 2.70,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.73,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $55,930,936 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-08-04,10:31:56,7D85A9,AmerisourceBergen Corp.,100,-0.23,earnings,down,Amerisourcebergen Q3 EPS $1.40 vs. $1.41 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 EPS $1.40 vs. $1.41 a year ago
COR,2021-08-04,10:32:28,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q3 adj. EPS $2.16; FactSet consensus $2.04,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 adj. EPS $2.16; FactSet consensus $2.04
COR,2021-08-04,10:32:51,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q3 revenue $53.41 bln vs. $45.37 bln a year ago; FactSet consensus $52.16 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 revenue $53.41 bln vs. $45.37 bln a year ago; FactSet consensus $52.16 bln
COR,2021-08-04,10:34:17,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raised FY2021 adj. EPS outlook to $9.15-$9.30 from $8.90-$9.10,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raised FY2021 adj. EPS outlook to $9.15-$9.30 from $8.90-$9.10
COR,2021-08-04,10:45:27,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen 3Q Revenue Rises,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen 3Q Revenue Rises, Led by Pharmaceutical Distribution Services"
COR,2021-08-04,10:45:27,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen Corp. said its revenue for the fiscal third quarter rose,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen 3Q Revenue Rises, Led by Pharmaceutical Distribution Services"
COR,2021-08-04,10:45:35,7D85A9,AmerisourceBergen Corp.,91,0.7,earnings,up,Amerisourcebergen Corp. raised its full-year guidance for,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Raises Fiscal 2021 Adjusted Earnings Guidance
COR,2021-08-05,12:28:45,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen stock price target raised to $136 from $117 at Deutsche Bank,NEWS-FLASH,MarketWatch,MW AmerisourceBergen stock price target raised to $136 from $117 at Deutsche Bank
COR,2021-08-05,12:40:43,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2021-08-05,12:40:43,7D85A9,AmerisourceBergen Corp.,100,0.74,price-targets,upgrade,Amerisourcebergen Price Target Raised to $144.00/Share From $132.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $144.00/Share From $132.00 by Credit Suisse
COR,2021-08-09,20:08:21,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Battaglia Sells 4,655 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 4,655 Of AmerisourceBergen Corp >ABC"
COR,2021-08-12,20:15:29,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC"
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer,PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer,PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,labor-issues,,"AmerisourceBergen Corp.: John Chou, current Executive Vice President and Chief Legal Officer, to retire",PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,labor-issues,,"AmerisourceBergen Corp.: John Chou, current Executive Vice President and Chief Legal Officer, to retire",PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-19,12:00:01,7D85A9,AmerisourceBergen Corp.,99,0.53,labor-issues,,Amerisourcebergen adds FirstView's copay program management,PRESS-RELEASE,Business Wire,AmerisourceBergen Adds FirstView Financial to its Suite of Manufacturer Solutions
COR,2021-08-19,12:05:04,7D85A9,AmerisourceBergen Corp.,99,0.53,labor-issues,,Amerisourcebergen adds FirstView's copay program management,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Adds FirstView Financial to its Suite of Manufacturer Solutions
COR,2021-08-19,20:33:38,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-08-23,20:05:36,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,081 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,081 Of AmerisourceBergen Corp >ABC"
COR,2021-08-31,11:33:39,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Overweight by Morgan Stanley
COR,2021-08-31,11:33:39,7D85A9,AmerisourceBergen Corp.,100,0.4,price-targets,upgrade,Amerisourcebergen Price Target Raised to $141.00/Share From $138.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $141.00/Share From $138.00 by Morgan Stanley
COR,2021-09-02,20:15:01,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-09-02,20:15:01,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-09-03,20:15:16,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 17,673 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 17,673 Of AmerisourceBergen Corp >ABC"
COR,2021-09-22,20:12:10,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC"
COR,2021-09-28,14:59:00,7D85A9,AmerisourceBergen Corp.,100,0.41,assets,open,"Amerisourcebergen Unveils New Global Headquarters in Conshohocken, PA",PRESS-RELEASE,Business Wire,"AmerisourceBergen Unveils New Global Headquarters in Conshohocken, PA & Announces Great Place to Work(R) Recognition"
COR,2021-10-05,20:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2021 Earnings Release
COR,2021-10-05,20:19:42,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2021 Earnings Release
COR,2021-10-06,12:30:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Innomar Strategies, in collaboration with the Government of Canada and FedEx Express Canada",PRESS-RELEASE,Business Wire,AmerisourceBergen Supports Global Distribution of COVID-19 Vaccines
COR,2021-10-06,12:34:04,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Innomar Strategies, in collaboration with the Government of Canada and FedEx Express Canada",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Supports Global Distribution of COVID-19 Vaccines
COR,2021-10-14,20:17:24,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC"
COR,2021-10-21,19:30:00,7D85A9,AmerisourceBergen Corp.,99,0.52,products-services,,Amerisourcebergen also introduced its new President of Manufacturer Services and Commercial Solutions,PRESS-RELEASE,Business Wire,"AmerisourceBergen & Global Pharmaceutical Manufacturers Discuss ""Moving Health Forward"" at Second Annual ThinkLive Trade Virtual Conference"
COR,2021-10-21,19:58:53,7D85A9,AmerisourceBergen Corp.,99,0.52,products-services,,Amerisourcebergen also introduced its new President of Manufacturer Services and Commercial Solutions,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen & Global Pharmaceutical Manufacturers Discuss ""Moving Health Forward"" at Second Annual ThinkLive Trade Virtual Conference"
COR,2021-10-22,07:48:59,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2021 (ABC)"
COR,2021-11-03,20:39:53,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 41,214 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 41,214 Of AmerisourceBergen Corp >ABC"
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.50-Adj EPS $10.80 >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Adj EPS $2.39,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Adj EPS $2.39 >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 4Q Rev $58.9B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Rev $58.9B >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,4Q EPS $2.08 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q EPS $2.08 >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Net $437.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Net $437.7M >ABC
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.65,earnings,negative,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $58.9 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2021 Summary Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $2.08,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent to $214.0 billion for the fiscal year,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2021 GAAP Diluted EPS of $7.39,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE:ABC) today reported that in its fiscal year 2021 fourth quarter ended September 30, 2021, revenue increased 19.6 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 fourth quarter, net interest expense of $54.6 million was up 57.3 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2021, revenue was $58.9 billion, up 19.6 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $51.2 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.82,earnings,up,AmerisourceBergen Corp.: Operating income increased 145.8 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expenses increased 30.2 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, GAAP diluted EPS was $7.39",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent from last fiscal year to $214.0 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.5,earnings,up,AmerisourceBergen Corp.: Gross profit increased 33.7 percent to $6.9 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, adjusted diluted EPS was $9.26",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,assets,open,"Amerisourcebergen opened its new global headquarters in Conshohocken, Pennsylvania.",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.46,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: International Healthcare Solutions revenue of approximately $26 to $27 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Interest expense growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.11 $,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.51,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -5-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.24,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -6-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 12.09,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,337,805 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -8-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.65,earnings,negative,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.65,earnings,negative,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $58.9 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $2.08,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent to $214.0 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2021 GAAP Diluted EPS of $7.39,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE:ABC) today reported that in its fiscal year 2021 fourth quarter ended September 30, 2021, revenue increased 19.6 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 fourth quarter, net interest expense of $54.6 million was up 57.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2021, revenue was $58.9 billion, up 19.6 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $51.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.82,earnings,up,AmerisourceBergen Corp.: Operating income increased 145.8 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2021 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expenses increased 30.2 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, GAAP diluted EPS was $7.39",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent from last fiscal year to $214.0 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.5,earnings,up,AmerisourceBergen Corp.: Gross profit increased 33.7 percent to $6.9 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, adjusted diluted EPS was $9.26",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,assets,open,"Amerisourcebergen opened its new global headquarters in Conshohocken, Pennsylvania.",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: International Healthcare Solutions revenue of approximately $26 to $27 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Interest expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.11 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.24,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 12.09,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,337,805 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.65,earnings,negative,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:32:08,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen Sees FY Revenue Growth,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Revenue Growth in High-Single Digit to Low-Double Digit % Range >ABC
COR,2021-11-04,10:34:48,7D85A9,AmerisourceBergen Corp.,100,0.82,earnings,up,Amerisourcebergen Q4 EPS $2.08 vs. per-share loss $23.74 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 EPS $2.08 vs. per-share loss $23.74 a year ago
COR,2021-11-04,10:35:20,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q4 adj. EPS $2.39; FactSet consensus $2.36,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 adj. EPS $2.39; FactSet consensus $2.36
COR,2021-11-04,10:35:43,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q4 revenue $58.91 bln vs. $49.24 bln a year ago; FactSet consensus $57.17 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 revenue $58.91 bln vs. $49.24 bln a year ago; FactSet consensus $57.17 bln
COR,2021-11-04,10:36:47,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Q4 sees FY2022 adj. EPS $10.50-$10.80,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 sees FY2022 adj. EPS $10.50-$10.80; FactSet consensus $10.61
COR,2021-11-04,10:49:21,7D85A9,AmerisourceBergen Corp.,100,0.64,earnings,up,Amerisourcebergen swings to profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen swings to profit, as it laps the big loss from opioid lawsuit expenses"
COR,2021-11-04,10:49:21,7D85A9,AmerisourceBergen Corp.,100,0.64,earnings,up,Amerisourcebergen Swings To Profit,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Swings To Profit, As It Laps The Big Loss From Opioid Lawsuit Expenses -- MarketWatch"
COR,2021-11-04,13:31:24,7D85A9,AmerisourceBergen Corp.,93,0.0,revenues,,Amerisourcebergen reported fiscal 4Q sales,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Gets Boost from Covid-19 Drug Distribution -- Market Talk
COR,2021-11-04,13:31:24,7D85A9,AmerisourceBergen Corp.,94,0.0,revenues,,Amerisourcebergen reported fiscal 4Q sales,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Gets Boost from Covid-19 Drug Distribution -- Market Talk
COR,2021-11-04,16:05:47,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q4 Fiscal 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q4 Fiscal 2021 Results -- Earnings Call Transcript >ABC
COR,2021-11-05,14:09:47,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Barclays
COR,2021-11-05,14:09:47,7D85A9,AmerisourceBergen Corp.,100,0.48,price-targets,upgrade,Amerisourcebergen Price Target Raised to $135.00/Share From $130.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $135.00/Share From $130.00 by Barclays
COR,2021-11-08,13:26:46,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2021-11-08,13:26:46,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $145.00/Share From $144.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $145.00/Share From $144.00 by Credit Suisse
COR,2021-11-12,13:51:02,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Hold by Deutsche Bank
COR,2021-11-12,13:51:02,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $153.00/Share From $136.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $153.00/Share From $136.00 by Deutsche Bank
COR,2021-11-12,21:25:36,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Mauch Acquires 2,259 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Acquires 2,259 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:31:20,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Chou Acquires 1,643 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Acquires 1,643 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:45:57,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:55:03,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Campbell Acquires 814 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Campbell Acquires 814 Of AmerisourceBergen Corp >ABC
COR,2021-11-12,21:55:14,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Clark Acquires 1,299 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 1,299 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:55:34,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Battaglia Acquires 821 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 821 Of AmerisourceBergen Corp >ABC
COR,2021-11-16,01:30:24,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 16,027 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 16,027 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,01:49:46,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Campbell Acquires 1,429 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 1,429 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,01:51:43,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Chou Acquires 4,689 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Acquires 4,689 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,02:03:17,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Mauch Acquires 4,689 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Acquires 4,689 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,02:15:31,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Cfo Cleary Jr Disposes 5,812 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Disposes 5,812 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,02:28:20,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Krikorian Acquires 580 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 580 Of AmerisourceBergen Corp >ABC
COR,2021-11-16,02:38:18,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Chmn Collis Acquires 17,861 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 17,861 Of AmerisourceBergen Corp >ABC"
COR,2021-11-18,21:03:28,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,664 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,664 Of AmerisourceBergen Corp >ABC"
COR,2021-11-29,21:03:10,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC"
COR,2021-12-15,19:31:42,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2021-12-15,19:31:42,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2021-12-15,19:31:52,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -2-
COR,2021-12-15,19:32:02,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -3-
COR,2021-12-15,21:09:14,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC"
COR,2021-12-16,21:30:43,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC"
COR,2021-12-17,14:04:24,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Overweight by Morgan Stanley
COR,2021-12-17,14:04:24,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $142.00/Share From $141.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $142.00/Share From $141.00 by Morgan Stanley
COR,2021-12-21,21:12:46,7D85A9,AmerisourceBergen Corp.,100,0.0,insider-trading,,"Vp Chou Gifts 3,276 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Gifts 3,276 Of AmerisourceBergen Corp >ABC"
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Acquire Alliance Healthcare Businesses from Walgreens Boots Alliance for $6.5 Billion,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: our successful partnership with Walgreens Boots Alliance and welcoming the industry-leading team at Alliance Healthcare,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen will host a conference call today at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,Amerisourcebergen does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen and Walgreens Boots Alliance -2-
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Acquire Alliance Healthcare Businesses from Walgreens Boots Alliance for $6.5 Billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: our successful partnership with Walgreens Boots Alliance and welcoming the industry-leading team at Alliance Healthcare,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen will host a conference call today at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:17,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,Amerisourcebergen does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen and Walgreens -2-
COR,2021-01-06,12:00:21,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Amerisourcebergen and Walgreens Boots Alliance Announce Strategic Transaction,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen and Walgreens Boots Alliance Announce Strategic Transaction
COR,2021-01-06,12:00:59,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion >ABC
COR,2021-01-06,12:03:38,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to acquire Walgreens Alliance Healthcare businesses for about $6.5 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen to acquire Walgreens Alliance Healthcare businesses for about $6.5 bln in cash and stock
COR,2021-01-06,12:10:14,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted earnings per share",PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:10:14,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:10:14,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:11:26,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY21 Adj EPS $8.25,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY21 Adj EPS $8.25-Adj EPS $8.50 >ABC
COR,2021-01-06,12:12:02,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Previously Forecast Adjusted EPS of $8.20-$8.45,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Previously Forecast Adjusted EPS of $8.20-$8.45 >ABC
COR,2021-01-06,12:13:58,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen Announces Updated Fiscal Year 2021 Financial Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:13:58,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted earnings per share",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:13:58,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Updated Fiscal Year 2021 Financial Outlook
COR,2021-01-06,12:21:29,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion
COR,2021-01-06,12:36:29,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Amerisourcebergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen to Buy Alliance Healthcare From Walgreens Boots for $6.5 Billion
COR,2021-01-06,13:03:31,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:03:31,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:03:52,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:03:52,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,13:23:59,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:23:59,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:38:59,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:38:59,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen
COR,2021-01-06,13:40:38,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Raises FY21 Earnings Guidance >ABC,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Raises FY21 Earnings Guidance >ABC
COR,2021-01-06,14:35:08,7D85A9,AmerisourceBergen Corp.,100,0.01,credit-ratings,affirmation,Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating,NEWS-FLASH,Dow Jones Newswires,Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating; Outlook Stable
COR,2021-01-06,15:57:29,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,15:57:29,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-06,16:08:20,7D85A9,AmerisourceBergen Corp.,100,-0.51,credit-ratings,negative,S&P Puts AmerisourceBergen Corp. On Watch Neg,NEWS-FLASH,Dow Jones Newswires,S&P Puts AmerisourceBergen Corp. On Watch Neg
COR,2021-01-06,17:53:08,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,17:53:08,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday that they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,18:08:09,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,18:08:09,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Walgreens and AmerisourceBergen also said Wednesday that they extended a distribution agreement,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots to Sell Pharmacy Wholesale Operation to AmerisourceBergen -- Update
COR,2021-01-06,20:03:34,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms AmerisourceBergen at 'A-' Following Announced Plan to Buy Alliance from Walgreens
COR,2021-01-06,20:03:41,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at 'A-' Following Announced Plan to Buy Alliance from Walgreens
COR,2021-01-06,20:03:51,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -2-
COR,2021-01-06,20:04:01,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -3-
COR,2021-01-07,20:35:42,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-07,20:35:42,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Walgreens is AmerisourceBergen's largest stockholder,FULL-ARTICLE,MarketWatch,MW UPDATE: Walgreens sells majority of Alliance Healthcare pharmacy business to AmerisourceBergen in $6.5 billion deal
COR,2021-01-07,21:17:36,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 16,561 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 16,561 Of AmerisourceBergen Corp >ABC"
COR,2021-01-07,22:34:34,7D85A9,AmerisourceBergen Corp.,100,0.55,acquisitions-mergers,,Walgreens Boots Alliance Sale of Unit to AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,"Fitch Views Walgreens Boots Alliance Sale of Unit to AmerisourceBergen as Credit-Neutral, Assuming About $2B of Proceeds Used to Repay Debt >WBA.LN"
COR,2021-01-14,21:30:30,7D85A9,AmerisourceBergen Corp.,100,0.0,dividends,,Amerisourcebergen Announces Quarterly Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Quarterly Dividend
COR,2021-01-14,21:30:30,7D85A9,AmerisourceBergen Corp.,100,0.0,dividends,,Amerisourcebergen Announces Quarterly Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Quarterly Dividend
COR,2021-01-22,08:02:13,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2020 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2020 (ABC)"
COR,2021-02-02,14:00:04,7D85A9,AmerisourceBergen Corp.,99,0.0,products-services,,AmerisourceBergen Corp.: from clinical trial to,PRESS-RELEASE,Business Wire,AmerisourceBergen Hosts First-Ever ThinkLive Commercialization Global Conference
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Adj EPS $2.18,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Adj EPS $2.18 >ABC
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 1Q Rev $52.5B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Rev $52.5B >ABC
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $8.40,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $8.40-Adj EPS $8.60 >ABC
COR,2021-02-04,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,1Q EPS $1.81 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q EPS $1.81 >ABC
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Net $374.8M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Net $374.8M >ABC
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 First Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $52.5 billion for the First Quarter, a 9.7 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $1.81,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.40 to $8.60,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2021, revenue was $52.5 billion, up 9.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.14,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 first quarter, net interest expense of $33.6 million was up 8.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $50.5 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.58,products-services,,Amerisourcebergen reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC),PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.83 $ 0.91,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.77,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $45,846,768 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 First -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $52.5 billion for the First Quarter, a 9.7 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $1.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.40 to $8.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2021, revenue was $52.5 billion, up 9.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.14,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 first quarter, net interest expense of $33.6 million was up 8.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 First Quarter Results
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $50.5 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.58,products-services,,Amerisourcebergen reached an agreement with the U.S. Centers for Disease Control and Prevention (CDC),PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,Amerisourcebergen will acquire the majority of Walgreens Boots Alliance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.83 $ 0.91,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $45,846,768 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-02-04,11:30:45,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Had Seen FY21 Adjusted EPS $8.25-$8.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Had Seen FY21 Adjusted EPS $8.25-$8.50 >ABC
COR,2021-02-04,11:31:02,7D85A9,AmerisourceBergen Corp.,100,0.72,revenues,up,Amerisourcebergen Now Sees FY21 Revenue Growth,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Now Sees FY21 Revenue Growth in High-Single Digits >ABC
COR,2021-02-04,11:33:22,7D85A9,AmerisourceBergen Corp.,100,0.82,earnings,up,Amerisourcebergen Q1 EPS $1.81 vs. 90 cents a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 EPS $1.81 vs. 90 cents a year ago
COR,2021-02-04,11:33:38,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q1 adj. EPS $2.18; FactSet consensus $1.95,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 adj. EPS $2.18; FactSet consensus $1.95
COR,2021-02-04,11:34:09,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q1 rev. $52.52 bln vs. $47.86 bln a year ago; FactSet consensus $51.51 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 rev. $52.52 bln vs. $47.86 bln a year ago; FactSet consensus $51.51 bln
COR,2021-02-04,11:35:09,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,Amerisourcebergen Q1 pharmaceutical distribution rev. up 9.7% to $50.5 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 pharmaceutical distribution rev. up 9.7% to $50.5 bln; FactSet consensus $49.0 bln
COR,2021-02-04,11:35:51,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raises 2021 adj. EPS outlook to $8.40-$8.60 from $8.25-$8.50,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raises 2021 adj. EPS outlook to $8.40-$8.60 from $8.25-$8.50
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen Logs Higher 1Q Rev,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.64,earnings,up,Amerisourcebergen Corp.'s first-quarter profit grew year over year,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Net income attributable to the company was $374.8 million,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.72,revenues,up,Amerisourcebergen forecast full-year revenue growth,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,11:42:44,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: The company had previously forecast a full-year profit of $8.25 a share,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Logs Higher 1Q Rev on Covid-19 Treatments
COR,2021-02-04,19:55:41,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q1 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q1 2021 Results -- Earnings Call Transcript >ABC
COR,2021-02-05,15:09:47,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2021-02-05,15:09:47,7D85A9,AmerisourceBergen Corp.,100,0.46,price-targets,upgrade,Amerisourcebergen Price Target Raised to $127.00/Share From $123.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $127.00/Share From $123.00 by Credit Suisse
COR,2021-02-08,13:25:43,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Overweight by Morgan Stanley
COR,2021-02-08,13:25:43,7D85A9,AmerisourceBergen Corp.,100,0.62,price-targets,upgrade,Amerisourcebergen Price Target Raised to $138.00/Share From $130.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $138.00/Share From $130.00 by Morgan Stanley
COR,2021-02-08,17:17:44,7D85A9,AmerisourceBergen Corp.,100,0.2,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Cowen & Co.
COR,2021-02-08,17:17:44,7D85A9,AmerisourceBergen Corp.,100,0.48,price-targets,upgrade,Amerisourcebergen Price Target Raised to $150.00/Share From $145.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $150.00/Share From $145.00 by Cowen & Co.
COR,2021-02-09,16:15:59,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2021-02-09,16:15:59,7D85A9,AmerisourceBergen Corp.,100,0.76,price-targets,upgrade,Amerisourcebergen Price Target Raised to $114.00/Share From $104.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $114.00/Share From $104.00 by Mizuho
COR,2021-02-09,21:09:39,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 84,651 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 84,651 Of AmerisourceBergen Corp >ABC"
COR,2021-02-09,21:11:49,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Dir Hyle Sells 3,085 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Hyle Sells 3,085 Of AmerisourceBergen Corp >ABC"
COR,2021-02-11,21:11:17,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 1,419 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 1,419 Of AmerisourceBergen Corp >ABC"
COR,2021-02-17,21:04:04,7D85A9,AmerisourceBergen Corp.,100,0.0,insider-trading,,"Vp Chou Gifts 2,000 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Gifts 2,000 Of AmerisourceBergen Corp >ABC"
COR,2021-02-25,20:21:00,7D85A9,AmerisourceBergen Corp.,99,0.41,assets,open,AmerisourceBergen Corp.: The new headquarters,PRESS-RELEASE,Business Wire,"PRP Invests in the New Global Headquarters for AmerisourceBergen in Conshohocken, Pa."
COR,2021-03-01,19:47:07,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation
COR,2021-03-09,00:02:41,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Dir McGee III Registers 5,801 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Dir McGee III Registers 5,801 Of AmerisourceBergen Corp >ABC"
COR,2021-03-09,21:05:05,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 16,236 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 16,236 Of AmerisourceBergen Corp >ABC"
COR,2021-03-17,20:11:10,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 33,697 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 33,697 Of AmerisourceBergen Corp >ABC"
COR,2021-03-22,20:06:37,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-03-25,14:32:34,7D85A9,AmerisourceBergen Corp.,100,0.16,credit-ratings,set,Fitch Rates ABC's Unsecured Senior Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates ABC's Unsecured Senior Notes Offering 'A-'; Outlook Stable
COR,2021-03-25,14:33:08,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,set,Moody's Rates Amerisourcebergen's New Unsecured Notes At Baa2,NEWS-FLASH,Dow Jones Newswires,Moody's Rates Amerisourcebergen's New Unsecured Notes At Baa2
COR,2021-03-25,21:44:41,7D85A9,AmerisourceBergen Corp.,100,0.16,credit-ratings,set,S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-,NEWS-FLASH,Dow Jones Newswires,S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-'
COR,2021-03-25,21:44:41,7D85A9,AmerisourceBergen Corp.,100,0.16,credit-ratings,set,S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rts AmerisourceBergen Corp.'s Senior Unsecured Nts 'A-'
COR,2021-03-25,22:41:00,7D85A9,AmerisourceBergen Corp.,100,0.0,credit,,Amerisourcebergen Prices $1.525 Billion 0.737% Senior Notes Due 2023,PRESS-RELEASE,Business Wire,AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
COR,2021-03-25,22:41:01,7D85A9,AmerisourceBergen Corp.,100,0.0,credit,,Amerisourcebergen Prices $1.525 Billion 0.737% Senior Notes Due 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Prices $1.525 Billion 0.737% Senior Notes Due 2023 and $1.0 Billion 2.700% Senior Notes Due 2031
COR,2021-03-25,22:41:22,7D85A9,AmerisourceBergen Corp.,100,0.0,credit,,Amerisourcebergen Prices $1.525B 0.737% Senior Notes Due 2023,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Prices $1.525B 0.737% Senior Notes Due 2023 and $1.0B 2.700% Senior Notes Due 2031
COR,2021-04-01,20:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release
COR,2021-04-01,20:15:41,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2021 Earnings Release
COR,2021-04-05,20:02:31,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 9,013 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 9,013 Of AmerisourceBergen Corp >ABC"
COR,2021-04-12,12:30:01,7D85A9,AmerisourceBergen Corp.,100,0.26,corporate-responsibility,,"Amerisourcebergen Foundation Donates $700,000 to",PRESS-RELEASE,Business Wire,"AmerisourceBergen Foundation Donates $700,000 to Boys & Girls Clubs of America to Roll Out COVID-19 Vaccine Education Programs Across the U.S."
COR,2021-04-14,20:07:40,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,914 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,914 Of AmerisourceBergen Corp >ABC"
COR,2021-04-21,20:04:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-04-21,21:05:23,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 2,873 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 2,873 Of AmerisourceBergen Corp >ABC"
COR,2021-04-22,07:28:50,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2021 (ABC)"
COR,2021-04-22,20:02:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $2.53,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $2.53 >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 2Q Rev $49.2B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Rev $49.2B >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $8.45,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $8.45-Adj EPS $8.60 >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,2Q EPS $2.10 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q EPS $2.10 >ABC
COR,2021-05-05,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Net $435.3M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Net $435.3M >ABC
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $47.1 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -2-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.12 $ 4.68,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -3-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 3.96 $ 5.58,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -4-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.93,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -5-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -6-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 18.81,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -6-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $47,003,250 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -6-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -7-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -7-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -8-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -8-
COR,2021-05-05,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Second -8-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $49.2 billion for the Second Quarter, a 3.7 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.45 to $8.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.22,acquisitions-mergers,,AmerisourceBergen Corp.: our investments in our,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2021, revenue was $49.2 billion, up 3.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,-0.13,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 second quarter, net interest expense of $34.5 million was up 0.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Second Quarter Results
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $47.1 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.12 $ 4.68,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 3.96 $ 5.58,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.93,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 18.81,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $47,003,250 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-05-05,10:30:03,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-05-05,10:30:23,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $2.53,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $2.53 >ABC
COR,2021-05-05,10:31:59,7D85A9,AmerisourceBergen Corp.,100,-0.64,earnings,down,Amerisourcebergen Q2 EPS $2.10 vs. $4.64 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 EPS $2.10 vs. $4.64 a year ago
COR,2021-05-05,10:32:16,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q2 adj. EPS $2.53; FactSet consensus $2.48,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 adj. EPS $2.53; FactSet consensus $2.48
COR,2021-05-05,10:32:45,7D85A9,AmerisourceBergen Corp.,100,-0.27,revenues,below-expectations,Amerisourcebergen Q2 revenue $49.15 bln vs. $47.42 bln a year ago; FactSet consensus $49.98 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 revenue $49.15 bln vs. $47.42 bln a year ago; FactSet consensus $49.98 bln
COR,2021-05-05,10:33:32,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raised 2021 adj. EPS outlook to $8.45-$8.60 from $8.40-$8.60,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raised 2021 adj. EPS outlook to $8.45-$8.60 from $8.40-$8.60
COR,2021-05-05,10:43:37,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen 2Q Revenue Rises,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen 2Q Revenue Rises
COR,2021-05-05,10:43:37,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen Corp. said its revenue for the fiscal second quarter rose,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen 2Q Revenue Rises
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,0.41,revenues,up,Amerisourcebergen's fiscal 2Q revenue grew 3.7% to $49.2,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,-0.75,revenues,down,Amerisource expects lower Covid-19 treatment sales in the second,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,0.41,revenues,up,Amerisourcebergen's fiscal 2Q revenue grew 3.7% to $49.2,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,13:50:48,7D85A9,AmerisourceBergen Corp.,93,-0.75,revenues,down,Amerisource expects lower Covid-19 treatment sales in the second,FULL-ARTICLE,Dow Jones Newswires,Covid-19 Drugs Boost AmerisourceBergen Sales -- Market Talk
COR,2021-05-05,20:09:41,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q2 2021 Results -- Earnings Call Transcript >ABC
COR,2021-05-06,14:32:00,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Barclays
COR,2021-05-06,14:32:00,7D85A9,AmerisourceBergen Corp.,100,0.64,price-targets,upgrade,Amerisourcebergen Price Target Raised to $130.00/Share From $122.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $130.00/Share From $122.00 by Barclays
COR,2021-05-13,20:13:03,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC"
COR,2021-05-14,20:12:17,7D85A9,AmerisourceBergen Corp.,100,0.38,credit,,Amerisourcebergen Amends Revolving Credit,RNS-SEC8K,Dow Jones Newswires,AmerisourceBergen Amends Revolving Credit Amendment
COR,2021-05-19,20:46:23,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-05-20,20:09:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-05-26,15:16:14,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Anivive Announces Collaboration with MWI,PRESS-RELEASE,PR Newswire,Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Newest Lymphoma Treatment for Dogs
COR,2021-06-02,11:00:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition Of Alliance Healthcare Businesses >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Completes Acquisition Of Alliance Healthcare Businesses >ABC
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.5,acquisitions-mergers,completed,AmerisourceBergen Corp.: The acquisition of Alliance Healthcare expands our,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.90 to $9.10,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"Amerisourcebergen, and we look forward to continuing to work together",PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of -2,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of -2-
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.5,acquisitions-mergers,completed,AmerisourceBergen Corp.: The acquisition of Alliance Healthcare expands our,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $8.90 to $9.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"Amerisourcebergen, and we look forward to continuing to work together",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen has updated its fiscal year 2021 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses
COR,2021-06-02,11:00:02,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen Divesting Alliance Healthcare Businesses
COR,2021-06-02,11:00:02,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Completes Strategic Transaction with AmerisourceBergen Divesting Alliance Healthcare Businesses
COR,2021-06-02,11:00:25,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Walgreens Boots Alliance Completes Strategic Transaction With AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Completes Strategic Transaction With AmerisourceBergen Divesting Alliance Healthcare Businesses
COR,2021-06-02,11:07:11,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Raises FY21 View To Adj EPS $8.90,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raises FY21 View To Adj EPS $8.90-Adj EPS $9.10 >ABC
COR,2021-06-02,11:08:04,7D85A9,AmerisourceBergen Corp.,100,0.5,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of Alliance Healthcare Businesses for $6.275B,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Completes Acquisition of Alliance Healthcare Businesses for $6.275B in Cash >ABC
COR,2021-06-02,11:08:36,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen Sees FY21 Revenue of at Least $210B,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY21 Revenue of at Least $210B >ABC
COR,2021-06-02,11:36:05,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Boosts FY Earnings Forecast,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts FY Earnings Forecast
COR,2021-06-02,11:36:05,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: The company logged revenue of $189.9 billion in fiscal 2020,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts FY Earnings Forecast
COR,2021-06-02,11:51:05,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Boosts Fiscal Year Earnings Forecast,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Fiscal Year Earnings Forecast
COR,2021-06-02,11:51:05,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: The company logged revenue of $189.9 billion in fiscal 2020,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Fiscal Year Earnings Forecast
COR,2021-06-04,16:29:51,7D85A9,AmerisourceBergen Corp.,100,-0.53,credit-ratings,negative,"S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative",NEWS-FLASH,Dow Jones Newswires,"S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative"
COR,2021-06-04,16:29:51,7D85A9,AmerisourceBergen Corp.,100,-0.53,credit-ratings,negative,"S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative",PRESS-RELEASE,Dow Jones Newswires,"Press Release: S&PGR Downgrades AmerisourceBergen To 'BBB+', Outlook Negative"
COR,2021-06-04,16:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.61,credit-ratings,downgrade,S&PGR Downgrades AmerisourceBergen -,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Downgrades AmerisourceBergen -2-
COR,2021-06-04,16:32:36,7D85A9,AmerisourceBergen Corp.,100,-0.54,credit-ratings,downgrade,S&P Cuts AmerisourceBergen Corp. Rtg To BBB+ From A-,NEWS-FLASH,Dow Jones Newswires,S&P Cuts AmerisourceBergen Corp. Rtg To BBB+ From A-; Off Watch; Outlk Neg
COR,2021-06-04,20:15:00,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-06-04,20:15:01,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-06-10,20:21:46,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,913 Of AmerisourceBergen Corp >ABC"
COR,2021-06-17,20:03:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-06-21,20:18:00,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-06-24,20:15:02,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
COR,2021-06-24,20:15:02,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2021 Earnings Release
COR,2021-07-14,20:11:35,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC"
COR,2021-07-20,20:09:54,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,082 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,082 Of AmerisourceBergen Corp >ABC"
COR,2021-07-21,20:05:14,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-07-22,07:30:26,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2021 (ABC)"
COR,2021-07-22,21:22:30,7D85A9,AmerisourceBergen Corp.,96,-0.54,credit-ratings,downgrade,Amerisourcebergen Corp. Downgraded To 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: AmerisourceBergen Opioid Settlement As Expected
COR,2021-07-26,13:13:02,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: Aeronics, Inc. Announces Collaboration with MWI",PRESS-RELEASE,PR Newswire,"Aeronics, Inc. Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Pawprint Oxygen Canister System for Companion Animals"
COR,2021-07-26,13:15:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: Press Release: Aeronics, Inc. Announces Collaboration with MWI",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Aeronics, Inc. Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Pawprint Oxygen Canister System for Companion Animals"
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Adj EPS $2.16,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Adj EPS $2.16 >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 3Q Rev $53.4B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Rev $53.4B >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $9.15,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $9.15-Adj EPS $9.30 >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,3Q EPS $1.40 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q EPS $1.40 >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Net $292.1M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Net $292.1M >ABC
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Third Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $53.4 billion for the Third Quarter, a 17.7 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $9.15 to $9.30,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2021, revenue was $53.4 billion, up 17.7 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2021,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.42,equity-actions,up,AmerisourceBergen Corp.: expense of $51.3 million was up 36.0 percent versus the prior year quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $49.3 billion in the third quarter of fiscal 2021,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Adjusted operating income to be approximately $2.6 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,Amerisourcebergen announced the completion of its acquisition,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"In June 2021, AmerisourceBergen updated its fiscal year 2021 financial guidance",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted operating expense to be approximately $3.9 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 1.42,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 5.37 $ 7.01,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 2.70,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -5-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.73,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $55,930,936 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Third -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $53.4 billion for the Third Quarter, a 17.7 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $9.15 to $9.30,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 third quarter ended June 30, 2021, revenue increased 17.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2021, revenue was $53.4 billion, up 17.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Third Quarter Results
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.42,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 third quarter, net interest expense of $51.3 million was up 36.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $49.3 billion in the third quarter of fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Adjusted operating income to be approximately $2.6 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,Amerisourcebergen announced the completion of its acquisition,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,"In June 2021, AmerisourceBergen updated its fiscal year 2021 financial guidance",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted operating expense to be approximately $3.9 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 1.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 5.37 $ 7.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 2.70,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 2.73,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $55,930,936 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-08-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-08-04,10:31:56,7D85A9,AmerisourceBergen Corp.,100,-0.23,earnings,down,Amerisourcebergen Q3 EPS $1.40 vs. $1.41 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 EPS $1.40 vs. $1.41 a year ago
COR,2021-08-04,10:32:28,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q3 adj. EPS $2.16; FactSet consensus $2.04,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 adj. EPS $2.16; FactSet consensus $2.04
COR,2021-08-04,10:32:51,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q3 revenue $53.41 bln vs. $45.37 bln a year ago; FactSet consensus $52.16 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 revenue $53.41 bln vs. $45.37 bln a year ago; FactSet consensus $52.16 bln
COR,2021-08-04,10:34:17,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raised FY2021 adj. EPS outlook to $9.15-$9.30 from $8.90-$9.10,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raised FY2021 adj. EPS outlook to $9.15-$9.30 from $8.90-$9.10
COR,2021-08-04,10:45:27,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen 3Q Revenue Rises,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen 3Q Revenue Rises, Led by Pharmaceutical Distribution Services"
COR,2021-08-04,10:45:27,7D85A9,AmerisourceBergen Corp.,100,0.65,revenues,up,Amerisourcebergen Corp. said its revenue for the fiscal third quarter rose,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen 3Q Revenue Rises, Led by Pharmaceutical Distribution Services"
COR,2021-08-04,10:45:35,7D85A9,AmerisourceBergen Corp.,91,0.7,earnings,up,Amerisourcebergen Corp. raised its full-year guidance for,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Raises Fiscal 2021 Adjusted Earnings Guidance
COR,2021-08-05,12:28:45,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen stock price target raised to $136 from $117 at Deutsche Bank,NEWS-FLASH,MarketWatch,MW AmerisourceBergen stock price target raised to $136 from $117 at Deutsche Bank
COR,2021-08-05,12:40:43,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2021-08-05,12:40:43,7D85A9,AmerisourceBergen Corp.,100,0.74,price-targets,upgrade,Amerisourcebergen Price Target Raised to $144.00/Share From $132.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $144.00/Share From $132.00 by Credit Suisse
COR,2021-08-09,20:08:21,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Battaglia Sells 4,655 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 4,655 Of AmerisourceBergen Corp >ABC"
COR,2021-08-12,20:15:29,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 20,912 Of AmerisourceBergen Corp >ABC"
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer,PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer,PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,labor-issues,,"AmerisourceBergen Corp.: John Chou, current Executive Vice President and Chief Legal Officer, to retire",PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-18,12:00:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,labor-issues,,"AmerisourceBergen Corp.: John Chou, current Executive Vice President and Chief Legal Officer, to retire",PRESS-RELEASE,Business Wire,AmerisourceBergen Appoints Elizabeth Campbell to Executive Vice President and Chief Legal Officer
COR,2021-08-19,12:00:01,7D85A9,AmerisourceBergen Corp.,99,0.53,labor-issues,,Amerisourcebergen adds FirstView's copay program management,PRESS-RELEASE,Business Wire,AmerisourceBergen Adds FirstView Financial to its Suite of Manufacturer Solutions
COR,2021-08-19,12:05:04,7D85A9,AmerisourceBergen Corp.,99,0.53,labor-issues,,Amerisourcebergen adds FirstView's copay program management,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Adds FirstView Financial to its Suite of Manufacturer Solutions
COR,2021-08-19,20:33:38,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 12,784 Of AmerisourceBergen Corp >ABC"
COR,2021-08-23,20:05:36,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Chou Sells 6,081 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Sells 6,081 Of AmerisourceBergen Corp >ABC"
COR,2021-08-31,11:33:39,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Overweight by Morgan Stanley
COR,2021-08-31,11:33:39,7D85A9,AmerisourceBergen Corp.,100,0.4,price-targets,upgrade,Amerisourcebergen Price Target Raised to $141.00/Share From $138.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $141.00/Share From $138.00 by Morgan Stanley
COR,2021-09-02,20:15:01,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-09-02,20:15:01,7D85A9,AmerisourceBergen Corp.,100,0.0,marketing,,Amerisourcebergen to Participate in Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Participate in Upcoming Investor Conferences
COR,2021-09-03,20:15:16,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 17,673 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 17,673 Of AmerisourceBergen Corp >ABC"
COR,2021-09-22,20:12:10,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC"
COR,2021-09-28,14:59:00,7D85A9,AmerisourceBergen Corp.,100,0.41,assets,open,"Amerisourcebergen Unveils New Global Headquarters in Conshohocken, PA",PRESS-RELEASE,Business Wire,"AmerisourceBergen Unveils New Global Headquarters in Conshohocken, PA & Announces Great Place to Work(R) Recognition"
COR,2021-10-05,20:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2021 Earnings Release
COR,2021-10-05,20:19:42,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2021 Earnings Release
COR,2021-10-06,12:30:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Innomar Strategies, in collaboration with the Government of Canada and FedEx Express Canada",PRESS-RELEASE,Business Wire,AmerisourceBergen Supports Global Distribution of COVID-19 Vaccines
COR,2021-10-06,12:34:04,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Innomar Strategies, in collaboration with the Government of Canada and FedEx Express Canada",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Supports Global Distribution of COVID-19 Vaccines
COR,2021-10-14,20:17:24,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,265 Of AmerisourceBergen Corp >ABC"
COR,2021-10-21,19:30:00,7D85A9,AmerisourceBergen Corp.,99,0.52,products-services,,Amerisourcebergen also introduced its new President of Manufacturer Services and Commercial Solutions,PRESS-RELEASE,Business Wire,"AmerisourceBergen & Global Pharmaceutical Manufacturers Discuss ""Moving Health Forward"" at Second Annual ThinkLive Trade Virtual Conference"
COR,2021-10-21,19:58:53,7D85A9,AmerisourceBergen Corp.,99,0.52,products-services,,Amerisourcebergen also introduced its new President of Manufacturer Services and Commercial Solutions,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen & Global Pharmaceutical Manufacturers Discuss ""Moving Health Forward"" at Second Annual ThinkLive Trade Virtual Conference"
COR,2021-10-22,07:48:59,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2021 (ABC)"
COR,2021-11-03,20:39:53,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 41,214 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 41,214 Of AmerisourceBergen Corp >ABC"
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.50-Adj EPS $10.80 >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Adj EPS $2.39,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Adj EPS $2.39 >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 4Q Rev $58.9B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Rev $58.9B >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,4Q EPS $2.08 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q EPS $2.08 >ABC
COR,2021-11-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Net $437.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Net $437.7M >ABC
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.65,earnings,negative,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $58.9 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2021 Summary Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $2.08,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent to $214.0 billion for the fiscal year,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2021 GAAP Diluted EPS of $7.39,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE:ABC) today reported that in its fiscal year 2021 fourth quarter ended September 30, 2021, revenue increased 19.6 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 fourth quarter, net interest expense of $54.6 million was up 57.3 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2021, revenue was $58.9 billion, up 19.6 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $51.2 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.82,earnings,up,AmerisourceBergen Corp.: Operating income increased 145.8 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expenses increased 30.2 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, GAAP diluted EPS was $7.39",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent from last fiscal year to $214.0 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.5,earnings,up,AmerisourceBergen Corp.: Gross profit increased 33.7 percent to $6.9 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, adjusted diluted EPS was $9.26",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,assets,open,"Amerisourcebergen opened its new global headquarters in Conshohocken, Pennsylvania.",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.46,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: International Healthcare Solutions revenue of approximately $26 to $27 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Interest expense growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.11 $,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.51,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -5-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.24,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -6-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 12.09,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,337,805 $ 44,274,830",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -8-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.65,earnings,negative,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2021 Fourth -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.65,earnings,negative,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2021 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $58.9 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $2.08,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent to $214.0 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2021 GAAP Diluted EPS of $7.39,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE:ABC) today reported that in its fiscal year 2021 fourth quarter ended September 30, 2021, revenue increased 19.6 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2021, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2021 fourth quarter, net interest expense of $54.6 million was up 57.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2021, revenue was $58.9 billion, up 19.6 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2021 Fourth Quarter and Year End Results
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Pharmaceutical Distribution Services revenue was $51.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.82,earnings,up,AmerisourceBergen Corp.: Operating income increased 145.8 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2021 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Adjusted operating expenses increased 30.2 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, GAAP diluted EPS was $7.39",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 12.7 percent from last fiscal year to $214.0 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.5,earnings,up,AmerisourceBergen Corp.: Gross profit increased 33.7 percent to $6.9 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2021, adjusted diluted EPS was $9.26",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,assets,open,"Amerisourcebergen opened its new global headquarters in Conshohocken, Pennsylvania.",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: International Healthcare Solutions revenue of approximately $26 to $27 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.49,equity-actions,up,AmerisourceBergen Corp.: Interest expense growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.11 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.24,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Other Gross profit 12.09,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,337,805 $ 44,274,830",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.65,earnings,negative,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2021-11-04,10:32:08,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen Sees FY Revenue Growth,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Revenue Growth in High-Single Digit to Low-Double Digit % Range >ABC
COR,2021-11-04,10:34:48,7D85A9,AmerisourceBergen Corp.,100,0.82,earnings,up,Amerisourcebergen Q4 EPS $2.08 vs. per-share loss $23.74 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 EPS $2.08 vs. per-share loss $23.74 a year ago
COR,2021-11-04,10:35:20,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q4 adj. EPS $2.39; FactSet consensus $2.36,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 adj. EPS $2.39; FactSet consensus $2.36
COR,2021-11-04,10:35:43,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q4 revenue $58.91 bln vs. $49.24 bln a year ago; FactSet consensus $57.17 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 revenue $58.91 bln vs. $49.24 bln a year ago; FactSet consensus $57.17 bln
COR,2021-11-04,10:36:47,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Q4 sees FY2022 adj. EPS $10.50-$10.80,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 sees FY2022 adj. EPS $10.50-$10.80; FactSet consensus $10.61
COR,2021-11-04,10:49:21,7D85A9,AmerisourceBergen Corp.,100,0.64,earnings,up,Amerisourcebergen swings to profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen swings to profit, as it laps the big loss from opioid lawsuit expenses"
COR,2021-11-04,10:49:21,7D85A9,AmerisourceBergen Corp.,100,0.64,earnings,up,Amerisourcebergen Swings To Profit,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Swings To Profit, As It Laps The Big Loss From Opioid Lawsuit Expenses -- MarketWatch"
COR,2021-11-04,13:31:24,7D85A9,AmerisourceBergen Corp.,93,0.0,revenues,,Amerisourcebergen reported fiscal 4Q sales,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Gets Boost from Covid-19 Drug Distribution -- Market Talk
COR,2021-11-04,13:31:24,7D85A9,AmerisourceBergen Corp.,94,0.0,revenues,,Amerisourcebergen reported fiscal 4Q sales,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Gets Boost from Covid-19 Drug Distribution -- Market Talk
COR,2021-11-04,16:05:47,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q4 Fiscal 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q4 Fiscal 2021 Results -- Earnings Call Transcript >ABC
COR,2021-11-05,14:09:47,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Barclays
COR,2021-11-05,14:09:47,7D85A9,AmerisourceBergen Corp.,100,0.48,price-targets,upgrade,Amerisourcebergen Price Target Raised to $135.00/Share From $130.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $135.00/Share From $130.00 by Barclays
COR,2021-11-08,13:26:46,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2021-11-08,13:26:46,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $145.00/Share From $144.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $145.00/Share From $144.00 by Credit Suisse
COR,2021-11-12,13:51:02,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Hold by Deutsche Bank
COR,2021-11-12,13:51:02,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $153.00/Share From $136.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $153.00/Share From $136.00 by Deutsche Bank
COR,2021-11-12,21:25:36,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Mauch Acquires 2,259 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Acquires 2,259 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:31:20,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Chou Acquires 1,643 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Acquires 1,643 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:45:57,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:55:03,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Campbell Acquires 814 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Campbell Acquires 814 Of AmerisourceBergen Corp >ABC
COR,2021-11-12,21:55:14,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Clark Acquires 1,299 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 1,299 Of AmerisourceBergen Corp >ABC"
COR,2021-11-12,21:55:34,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Battaglia Acquires 821 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 821 Of AmerisourceBergen Corp >ABC
COR,2021-11-16,01:30:24,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 16,027 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 16,027 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,01:49:46,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Campbell Acquires 1,429 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 1,429 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,01:51:43,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Chou Acquires 4,689 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Acquires 4,689 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,02:03:17,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Mauch Acquires 4,689 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Acquires 4,689 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,02:15:31,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Cfo Cleary Jr Disposes 5,812 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Disposes 5,812 Of AmerisourceBergen Corp >ABC"
COR,2021-11-16,02:28:20,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Krikorian Acquires 580 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 580 Of AmerisourceBergen Corp >ABC
COR,2021-11-16,02:38:18,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Chmn Collis Acquires 17,861 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 17,861 Of AmerisourceBergen Corp >ABC"
COR,2021-11-18,21:03:28,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,664 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,664 Of AmerisourceBergen Corp >ABC"
COR,2021-11-29,21:03:10,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC"
COR,2021-12-15,19:31:42,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2021-12-15,19:31:42,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2021-12-15,19:31:52,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -2-
COR,2021-12-15,19:32:02,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -3-
COR,2021-12-15,21:09:14,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC"
COR,2021-12-16,21:30:43,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 17,168 Of AmerisourceBergen Corp >ABC"
COR,2021-12-17,14:04:24,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Overweight by Morgan Stanley
COR,2021-12-17,14:04:24,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $142.00/Share From $141.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $142.00/Share From $141.00 by Morgan Stanley
COR,2021-12-21,21:12:46,7D85A9,AmerisourceBergen Corp.,100,0.0,insider-trading,,"Vp Chou Gifts 3,276 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Chou Gifts 3,276 Of AmerisourceBergen Corp >ABC"
COR,2022-01-06,16:03:59,761CC5,Corel Corp.,99,0.52,products-services,,Corel Corp.: Delivering Windows applications,PRESS-RELEASE,GlobeNewswire,Corel's Creative and Productivity Solutions Earn Top Marks in 22 G2 Winter 2022 Grid Reports
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corp.: Corel Corporation today announced that Scott Day has joined the company as Chief People Officer,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Quarles joined Corel as CEO in Q4 2020,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-06-13,13:05:00,761CC5,Corel Corp.,100,0.62,acquisitions-mergers,,Corel Acquires Awingu to Accelerate,PRESS-RELEASE,GlobeNewswire,Corel Acquires Awingu to Accelerate Its Secure Remote Workspace Offering
COR,2022-01-06,16:03:59,761CC5,Corel Corp.,99,0.52,products-services,,Corel Corp.: Delivering Windows applications,PRESS-RELEASE,GlobeNewswire,Corel's Creative and Productivity Solutions Earn Top Marks in 22 G2 Winter 2022 Grid Reports
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corp.: Corel Corporation today announced that Scott Day has joined the company as Chief People Officer,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Quarles joined Corel as CEO in Q4 2020,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-06-13,13:05:00,761CC5,Corel Corp.,100,0.62,acquisitions-mergers,,Corel Acquires Awingu to Accelerate,PRESS-RELEASE,GlobeNewswire,Corel Acquires Awingu to Accelerate Its Secure Remote Workspace Offering
COR,2022-01-06,16:03:59,761CC5,Corel Corp.,99,0.52,products-services,,Corel Corp.: Delivering Windows applications,PRESS-RELEASE,GlobeNewswire,Corel's Creative and Productivity Solutions Earn Top Marks in 22 G2 Winter 2022 Grid Reports
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corp.: Corel Corporation today announced that Scott Day has joined the company as Chief People Officer,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Quarles joined Corel as CEO in Q4 2020,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-06-13,13:05:00,761CC5,Corel Corp.,100,0.62,acquisitions-mergers,,Corel Acquires Awingu to Accelerate,PRESS-RELEASE,GlobeNewswire,Corel Acquires Awingu to Accelerate Its Secure Remote Workspace Offering
COR,2022-01-06,16:03:59,761CC5,Corel Corp.,99,0.52,products-services,,Corel Corp.: Delivering Windows applications,PRESS-RELEASE,GlobeNewswire,Corel's Creative and Productivity Solutions Earn Top Marks in 22 G2 Winter 2022 Grid Reports
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corp.: Corel Corporation today announced that Scott Day has joined the company as Chief People Officer,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Quarles joined Corel as CEO in Q4 2020,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-06-13,13:05:00,761CC5,Corel Corp.,100,0.62,acquisitions-mergers,,Corel Acquires Awingu to Accelerate,PRESS-RELEASE,GlobeNewswire,Corel Acquires Awingu to Accelerate Its Secure Remote Workspace Offering
COR,2022-01-06,16:03:59,761CC5,Corel Corp.,99,0.52,products-services,,Corel Corp.: Delivering Windows applications,PRESS-RELEASE,GlobeNewswire,Corel's Creative and Productivity Solutions Earn Top Marks in 22 G2 Winter 2022 Grid Reports
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corp.: Corel Corporation today announced that Scott Day has joined the company as Chief People Officer,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Quarles joined Corel as CEO in Q4 2020,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-06-13,13:05:00,761CC5,Corel Corp.,100,0.62,acquisitions-mergers,,Corel Acquires Awingu to Accelerate,PRESS-RELEASE,GlobeNewswire,Corel Acquires Awingu to Accelerate Its Secure Remote Workspace Offering
COR,2022-01-06,16:03:59,761CC5,Corel Corp.,99,0.52,products-services,,Corel Corp.: Delivering Windows applications,PRESS-RELEASE,GlobeNewswire,Corel's Creative and Productivity Solutions Earn Top Marks in 22 G2 Winter 2022 Grid Reports
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Corel Corp.: Corel Corporation today announced that Scott Day has joined the company as Chief People Officer,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-01-27,16:00:17,761CC5,Corel Corp.,99,0.53,labor-issues,,Quarles joined Corel as CEO in Q4 2020,PRESS-RELEASE,GlobeNewswire,"Corel Drives Transformation with New Executive Team: Scott Day, Former PayPal, OpenTable & Airbnb Exec, Joins as Chief People Officer"
COR,2022-06-13,13:05:00,761CC5,Corel Corp.,100,0.62,acquisitions-mergers,,Corel Acquires Awingu to Accelerate,PRESS-RELEASE,GlobeNewswire,Corel Acquires Awingu to Accelerate Its Secure Remote Workspace Offering
COR,2022-01-03,21:16:18,7D85A9,AmerisourceBergen Corp.,100,0.0,insider-trading,,"Chmn Collis Gifts 1,159 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Gifts 1,159 Of AmerisourceBergen Corp >ABC"
COR,2022-01-04,21:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release
COR,2022-01-04,21:28:34,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release
COR,2022-01-11,12:27:19,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Barclays
COR,2022-01-11,12:27:19,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $152.00/Share From $135.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $152.00/Share From $135.00 by Barclays
COR,2022-01-13,21:23:38,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC"
COR,2022-01-22,09:09:39,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2021 (ABC)"
COR,2022-01-25,13:30:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"World Courier, collaborates with multiple orchestration platform providers, including TrakCel, to deliver systems",PRESS-RELEASE,Business Wire,AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies
COR,2022-01-25,14:30:00,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,AmerisourceBergen Corp.: Investing in our,PRESS-RELEASE,Business Wire,"AmerisourceBergen Welcomes New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-25,14:31:39,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Names New SVP and Chief,NEWS-FLASH,Dow Jones Newswires,"AmerisourceBergen Names New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-25,14:31:39,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Names New SVP and Chief,NEWS-FLASH,Dow Jones Newswires,"AmerisourceBergen Names New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-25,14:32:15,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,AmerisourceBergen Corp.: Investing in our,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Welcomes New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-26,19:07:04,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Adj EPS $2.58,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Adj EPS $2.58 >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.60-Adj EPS $10.90 >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,1Q EPS $2.13 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q EPS $2.13 >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 1Q Rev $59.6B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Rev $59.6B >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 First Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenues of $59.6B billion for the First Quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.60 to $10.90,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 first quarter ended December 31, 2021, revenue increased 13.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Our updated fiscal 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2022 first quarter, net interest expense of $53.4 million was up 58.8 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2022, revenue was $59.6 billion, up 13.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Revenue in International Healthcare Solutions was $6.6 billion in the first quarter of fiscal 2022,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2022 was $180.1 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,Amerisourcebergen extended its pharmaceutical supply agreement with Express Scripts,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Interest expense to be in the range of $210 to $215 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 1.83,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,95,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.46,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,577,564 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Net $449.1M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Net $449.1M >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenues of $59.6B billion for the First Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.60 to $10.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 first quarter ended December 31, 2021, revenue increased 13.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Our updated fiscal 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2022 first quarter, net interest expense of $53.4 million was up 58.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2022, revenue was $59.6 billion, up 13.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Revenue in International Healthcare Solutions was $6.6 billion in the first quarter of fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2022 was $180.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,Amerisourcebergen extended its pharmaceutical supply agreement with Express Scripts,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Interest expense to be in the range of $210 to $215 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,577,564 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:35:00,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,Amerisourcebergen Q1 EPS $2.13 vs. $1.81 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 EPS $2.13 vs. $1.81 a year ago
COR,2022-02-02,11:35:19,7D85A9,AmerisourceBergen Corp.,100,0.54,earnings,meet-expectations,"Amerisourcebergen Q1 adj. EPS $2.58, matching",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q1 adj. EPS $2.58, matching FactSet consensus"
COR,2022-02-02,11:35:57,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,Amerisourcebergen Q1 revenue $59.6 bln vs. $52.5 bln a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 revenue $59.6 bln vs. $52.5 bln a year ago; FactSet consensus $59.6 bln
COR,2022-02-02,11:36:53,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees FY22 adj. EPS of $10.60 to $10.90,NEWS-FLASH,MarketWatch,MW AmerisourceBergen now sees FY22 adj. EPS of $10.60 to $10.90 vs. prior guidance of $10.50 to $10.80
COR,2022-02-02,17:37:33,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call Transcript >ABC
COR,2022-02-02,21:41:23,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 44,492 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 44,492 Of AmerisourceBergen Corp >ABC"
COR,2022-02-03,13:29:11,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2022-02-03,13:29:11,7D85A9,AmerisourceBergen Corp.,100,0.66,price-targets,upgrade,Amerisourcebergen Price Target Raised to $139.00/Share From $130.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $139.00/Share From $130.00 by Mizuho
COR,2022-02-04,21:02:38,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 11,653 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 11,653 Of AmerisourceBergen Corp >ABC"
COR,2022-02-04,21:06:27,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Campbell Sells 14,034 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 14,034 Of AmerisourceBergen Corp >ABC"
COR,2022-02-05,09:13:18,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call Transcript >ABC
COR,2022-02-09,21:38:53,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,263 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,263 Of AmerisourceBergen Corp >ABC"
COR,2022-02-24,13:35:37,7D85A9,AmerisourceBergen Corp.,99,0.53,labor-issues,,Amerisourcebergen Adds Freight Management,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Adds Freight Management Capabilities Powered by TRIOSE, Inc. for Hospital & Health System Customers"
COR,2022-03-02,22:24:54,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Battaglia Acquires 6,146 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 6,146 Of AmerisourceBergen Corp >ABC"
COR,2022-03-09,22:40:32,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-03-11,20:43:01,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Battaglia Acquires 674 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 674 Of AmerisourceBergen Corp >ABC
COR,2022-03-15,14:11:30,7D85A9,AmerisourceBergen Corp.,100,0.01,credit-ratings,affirmation,Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating,NEWS-FLASH,Dow Jones Newswires,"Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating, Outlook Remains Stable"
COR,2022-03-16,20:00:53,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Battaglia Sells 6,820 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 6,820 Of AmerisourceBergen Corp >ABC"
COR,2022-03-28,20:40:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day
COR,2022-03-28,20:40:09,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day
COR,2022-03-30,20:02:33,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 43,704 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 43,704 Of AmerisourceBergen Corp >ABC"
COR,2022-04-06,18:00:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Amerisourcebergen partnered with TrakCel, a leading innovator of cellular orchestration solutions",PRESS-RELEASE,Business Wire,AmerisourceBergen Launches $150M Venture Capital Fund
COR,2022-04-12,10:15:16,7D85A9,AmerisourceBergen Corp.,100,-0.58,analyst-ratings,negative,Amerisourcebergen Cut to Equal-Weight From Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Cut to Equal-Weight From Overweight by Morgan Stanley
COR,2022-04-12,10:15:16,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $178.00/Share by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $178.00/Share by Morgan Stanley
COR,2022-04-12,14:53:39,7D85A9,AmerisourceBergen Corp.,100,-0.58,analyst-ratings,negative,Amerisourcebergen downgraded to equal weight from overweight at Morgan Stanley,NEWS-FLASH,MarketWatch,MW AmerisourceBergen downgraded to equal weight from overweight at Morgan Stanley
COR,2022-04-13,20:23:43,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-04-21,12:30:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Amerisourcebergen Partners with Chronicled to,PRESS-RELEASE,Business Wire,AmerisourceBergen Partners with Chronicled to Optimize Pharmaceutical Chargeback Accuracy Using Blockchain-Powered Technology
COR,2022-04-22,08:05:54,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2022 (ABC)"
COR,2022-04-28,12:30:00,7D85A9,AmerisourceBergen Corp.,100,0.52,products-services,,Amerisourcebergen Launches Home Infusion Solution for,PRESS-RELEASE,Business Wire,AmerisourceBergen Launches Home Infusion Solution for Health Systems Nationwide
COR,2022-04-28,12:33:15,7D85A9,AmerisourceBergen Corp.,99,0.52,products-services,,Amerisourcebergen Launches Home Infusion Solution for,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Launches Home Infusion Solution for Health Systems Nationwide
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.80-Adj EPS $11.05 >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $3.22,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $3.22 >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,2Q EPS $2.59 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q EPS $2.59 >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 2Q Rev $57.7B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Rev $57.7B >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Net $548M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Net $548M >ABC
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Second Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $57.7 billion for the Second Quarter, a 17.4 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.59,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.80 to $11.05,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 second quarter ended March 31, 2022, revenue increased 17.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, revenue was $57.7 billion, up 17.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, net interest expense of $52.9 million was up 53.3 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2022 was $187.1 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other national pharmaceutical distributors reached an agreement to,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.62 $ 2.12,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 4.77 $ 3.96,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.12,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,308,153 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -8-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $57.7 billion for the Second Quarter, a 17.4 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.59,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.80 to $11.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 second quarter ended March 31, 2022, revenue increased 17.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, revenue was $57.7 billion, up 17.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, net interest expense of $52.9 million was up 53.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2022 was $187.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other national pharmaceutical distributors reached an agreement to,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.62 $ 2.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 4.77 $ 3.96,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,308,153 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2022-05-04,10:32:21,7D85A9,AmerisourceBergen Corp.,100,0.42,earnings,up,Amerisourcebergen Q2 EPS $2.59 vs. $2.10 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 EPS $2.59 vs. $2.10 a year ago
COR,2022-05-04,10:32:54,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q2 adj. EPS $3.22; FactSet consensus $2.92,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 adj. EPS $3.22; FactSet consensus $2.92
COR,2022-05-04,10:33:40,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,"Amerisourcebergen Q2 revenue $57.7 bln, up 17.4%; FactSet consensus $57.5 bln",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q2 revenue $57.7 bln, up 17.4%; FactSet consensus $57.5 bln"
COR,2022-05-04,10:34:59,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees full-year adj. EPS of $10.80 to $11.05,NEWS-FLASH,MarketWatch,MW AmerisourceBergen now sees full-year adj. EPS of $10.80 to $11.05 vs. prior $10.60 to $10.90
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen beats earnings expectations,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported first-quarter profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Beats Earnings Expectations,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported first-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen beats earnings expectations,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported fiscal second-quarter profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Beats Earnings Expectations,FULL-ARTICLE,Dow Jones Newswires,"Update: AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported fiscal second-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"Update: AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,14:17:35,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q2 2022 Results -- Earnings Call Transcript >ABC
COR,2022-05-05,12:43:10,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2022-05-05,12:43:10,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $162.00/Share From $139.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $162.00/Share From $139.00 by Mizuho
COR,2022-05-05,15:13:31,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Hold by Deutsche Bank
COR,2022-05-05,15:13:31,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $168.00/Share From $153.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $168.00/Share From $153.00 by Deutsche Bank
COR,2022-05-11,21:47:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation
COR,2022-05-11,21:47:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation
COR,2022-05-11,21:49:50,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Six M Shrs of AmerisourceBergen Corp,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Six M Shrs of AmerisourceBergen Corp
COR,2022-05-11,21:52:12,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sold 6M Shrs of AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sold 6M Shrs of AmerisourceBergen at $150/Shr >WBA
COR,2022-05-12,12:01:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: Resuming share repurchases,PRESS-RELEASE,Business Wire,AmerisourceBergen Provides Update on Capital Deployment
COR,2022-05-12,12:01:01,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: Resuming share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Provides Update on Capital Deployment
COR,2022-05-12,15:06:22,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,It sold 6.0 million AmerisourceBergen shares,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares
COR,2022-05-12,15:23:56,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,It sold 6.0 million AmerisourceBergen shares,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares
COR,2022-05-12,20:44:44,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 6,759 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 6,759 Of AmerisourceBergen Corp >ABC"
COR,2022-05-12,20:45:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-05-13,20:06:57,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 4,895 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 4,895 Of AmerisourceBergen Corp >ABC"
COR,2022-05-13,21:02:02,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 6,000,000 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 6,000,000 Of AmerisourceBergen Corp >ABC"
COR,2022-05-23,12:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,products-services,start,Amerisourcebergen Launches Clinical Trial,PRESS-RELEASE,Business Wire,AmerisourceBergen Launches Clinical Trial Navigator to Bolster Equitable and Accessible Community-Based Research Opportunities Nationwide
COR,2022-05-25,12:18:55,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Hold by Deutsche Bank
COR,2022-05-25,12:18:55,7D85A9,AmerisourceBergen Corp.,100,-0.17,price-targets,downgrade,Amerisourcebergen Price Target Cut to $167.00/Share From $168.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $167.00/Share From $168.00 by Deutsche Bank
COR,2022-05-26,11:21:51,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen Raised to Overweight From Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raised to Overweight From Equal-Weight by Barclays
COR,2022-05-26,11:21:51,7D85A9,AmerisourceBergen Corp.,100,0.5,price-targets,upgrade,Amerisourcebergen Price Target Raised to $182.00/Share From $175.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $182.00/Share From $175.00 by Barclays
COR,2022-05-27,11:50:58,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Morgan Stanley
COR,2022-05-27,11:50:58,7D85A9,AmerisourceBergen Corp.,100,-0.32,price-targets,downgrade,Amerisourcebergen Price Target Cut to $175.00/Share From $178.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $175.00/Share From $178.00 by Morgan Stanley
COR,2022-06-01,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,unchanged,AmerisourceBergen Corp.: The company reiterated its fiscal year 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,approved,Amerisourcebergen's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Business Wire,AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,unchanged,AmerisourceBergen Corp.: The company reiterated its fiscal year 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,approved,Amerisourcebergen's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:31,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,approved,Amerisourcebergen Board Authorized New $1B Shr Repurchase Program,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Board Authorized New $1B Shr Repurchase Program >ABC
COR,2022-06-01,10:30:46,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,unchanged,Amerisourcebergen Reiterates Guidance for Fiscal 2022,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Reiterates Guidance for Fiscal 2022 >ABC
COR,2022-06-01,10:31:26,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,unchanged,Amerisourcebergen Backs FY Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Backs FY Adj EPS $10.80-Adj EPS $11.05 >ABC
COR,2022-06-01,10:33:13,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen sets new $1 bln stock repurchase program,NEWS-FLASH,MarketWatch,MW AmerisourceBergen sets new $1 bln stock repurchase program
COR,2022-06-01,10:39:09,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen sets $1 billion stock buyback program,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen sets $1 billion stock buyback program
COR,2022-06-01,10:39:09,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Sets $1 Billion Stock Buyback Program,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Sets $1 Billion Stock Buyback Program -- MarketWatch
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.64,earnings,up,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.64,earnings,up,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:32:58,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,unchanged,Amerisourcebergen Backs FY22 Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Backs FY22 Adj EPS $10.80-Adj EPS $11.05 >ABC
COR,2022-06-07,10:59:06,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen upgraded to buy from hold at Deutsche Bank,NEWS-FLASH,MarketWatch,MW AmerisourceBergen upgraded to buy from hold at Deutsche Bank
COR,2022-06-07,11:34:06,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen Raised to Buy From Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raised to Buy From Hold by Deutsche Bank
COR,2022-06-07,11:34:06,7D85A9,AmerisourceBergen Corp.,100,0.64,price-targets,upgrade,Amerisourcebergen Price Target Raised to $178.00/Share From $167.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $178.00/Share From $167.00 by Deutsche Bank
COR,2022-06-09,13:15:49,7D85A9,AmerisourceBergen Corp.,100,0.2,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Cowen & Co.
COR,2022-06-09,13:15:49,7D85A9,AmerisourceBergen Corp.,100,-0.17,price-targets,downgrade,Amerisourcebergen Price Target Cut to $170.00/Share From $171.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $170.00/Share From $171.00 by Cowen & Co.
COR,2022-06-13,11:37:43,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by UBS
COR,2022-06-13,11:37:43,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $174.00/Share From $144.00 by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $174.00/Share From $144.00 by UBS
COR,2022-06-13,14:16:47,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen stock price target raised to $174 from $144 at UBS,NEWS-FLASH,MarketWatch,MW AmerisourceBergen stock price target raised to $174 from $144 at UBS
COR,2022-06-16,20:21:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-06-22,12:30:13,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,AmerisourceBergen Corp.: Torigen Pharmaceuticals Inks National Distribution Deal with MWI,PRESS-RELEASE,PR Newswire,Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health
COR,2022-06-22,12:30:13,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: The strategic relationship with MWI,PRESS-RELEASE,PR Newswire,Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health
COR,2022-06-22,18:27:05,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-06-29,16:48:00,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,"Petvivo HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI",PRESS-RELEASE,GlobeNewswire,"PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI ANIMAL HEALTH"
COR,2022-06-29,16:48:01,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,"Petvivo HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI",PRESS-RELEASE,Dow Jones Newswires,"Press Release: PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI ANIMAL HEALTH"
COR,2022-06-29,20:15:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release
COR,2022-06-29,22:11:10,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release
COR,2022-07-06,16:23:43,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Chou Registers 12,968 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Chou Registers 12,968 Of AmerisourceBergen Corp >ABC"
COR,2022-07-11,10:36:27,7D85A9,AmerisourceBergen Corp.,100,-0.58,analyst-ratings,negative,Amerisourcebergen Cut to In-Line From Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Cut to In-Line From Outperform by Evercore ISI Group
COR,2022-07-11,10:36:27,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $150.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $150.00/Share by Evercore ISI Group
COR,2022-07-14,20:05:49,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-07-20,13:43:34,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by Argus Research
COR,2022-07-20,13:43:34,7D85A9,AmerisourceBergen Corp.,100,0.62,price-targets,upgrade,Amerisourcebergen Price Target Raised to $170.00/Share From $160.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $170.00/Share From $160.00 by Argus Research
COR,2022-07-20,16:48:07,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-07-22,07:57:39,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2022 (ABC)"
COR,2022-07-22,20:06:23,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Donato Acquires 898 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Acquires 898 Of AmerisourceBergen Corp >ABC
COR,2022-07-27,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.52,products-services,,Amerisourcebergen to Launch Digital Therapeutics Platform to,PRESS-RELEASE,Business Wire,AmerisourceBergen to Launch Digital Therapeutics Platform to Facilitate Access to Innovative Products
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Adj EPS $2.62,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Adj EPS $2.62 >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 3Q Rev $60.1B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Rev $60.1B >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.90,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.90-Adj EPS $11.10 >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,3Q EPS $1.92 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q EPS $1.92 >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Net $407M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Net $407M >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Third Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $60.1 billion for the Third Quarter, a 12.5 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.92,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.90 to $11.10,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 third quarter ended June 30, 2022, revenue increased 12.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, revenue was $60.1 billion, up 12.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2022,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.13,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, net interest expense of $52.9 million was up 3.0 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -7-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2022 was $176.3 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other distributors reached an agreement to,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: Conference Call,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -3-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.95 $ 1.42,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.36,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -5-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.14,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,173,630 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $60.1 billion for the Third Quarter, a 12.5 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.92,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.90 to $11.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 third quarter ended June 30, 2022, revenue increased 12.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, revenue was $60.1 billion, up 12.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.13,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, net interest expense of $52.9 million was up 3.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2022 was $176.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other distributors reached an agreement to,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.95 $ 1.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.36,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,173,630 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-08-03,10:30:54,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Had Seen FY Adjusted EPS $10.80-$11.05,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Had Seen FY Adjusted EPS $10.80-$11.05 >ABC
COR,2022-08-03,10:32:30,7D85A9,AmerisourceBergen Corp.,100,0.52,earnings,up,Amerisourcebergen Q3 EPS $1.92 vs. $1.40 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 EPS $1.92 vs. $1.40 a year ago
COR,2022-08-03,10:32:46,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q3 adj. EPS $2.62; FactSet consensus $2.56,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 adj. EPS $2.62; FactSet consensus $2.56
COR,2022-08-03,10:33:22,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q3 revenue $60.06 bln vs. $53.41 bln a year ago; FactSet consensus $59.08 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 revenue $60.06 bln vs. $53.41 bln a year ago; FactSet consensus $59.08 bln
COR,2022-08-03,10:33:54,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raises FY2022 adj. EPS outlook to $10.90-$11.10 from $10.80-$11.05,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raises FY2022 adj. EPS outlook to $10.90-$11.10 from $10.80-$11.05
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen beats profit and revenue expectations,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats profit and revenue expectations, raises full-year outlook"
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported Wednesday fiscal third-quarter profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats profit and revenue expectations, raises full-year outlook"
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Beats Profit And Revenue Expectations,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Profit And Revenue Expectations, Raises Full-year Outlook -- MarketWatch"
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported Wednesday fiscal third-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Profit And Revenue Expectations, Raises Full-year Outlook -- MarketWatch"
COR,2022-08-03,15:52:45,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corp CEO Steven Collis on Q3 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amerisourcebergen Corp CEO Steven Collis on Q3 2022 Results -- Earnings Call Transcript >ABC
COR,2022-08-04,13:05:59,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2022-08-04,13:05:59,7D85A9,AmerisourceBergen Corp.,100,-0.44,price-targets,downgrade,Amerisourcebergen Price Target Cut to $175.00/Share From $180.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $175.00/Share From $180.00 by Credit Suisse
COR,2022-08-11,20:15:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-08-17,19:08:27,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-08-22,12:08:31,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Morgan Stanley
COR,2022-08-22,12:08:31,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $176.00/Share From $175.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $176.00/Share From $175.00 by Morgan Stanley
COR,2022-08-24,18:20:30,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Chou Registers 17,561 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Chou Registers 17,561 Of AmerisourceBergen Corp >ABC"
COR,2022-09-01,20:08:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,Vp Clark Sells 288 Of AmerisourceBergen Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Clark Sells 288 Of AmerisourceBergen Corp >ABC
COR,2022-09-06,20:51:19,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Donato Acquires 1,867 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 1,867 Of AmerisourceBergen Corp >ABC"
COR,2022-09-07,17:15:18,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,Vp Clark Registers 288 Of AmerisourceBergen Corp >ABC,RNS-SEC144,Dow Jones Newswires,VP Clark Registers 288 Of AmerisourceBergen Corp >ABC
COR,2022-09-07,18:47:46,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Chou Registers 15,264 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Chou Registers 15,264 Of AmerisourceBergen Corp >ABC"
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen To Expand Global Biopharma Services Platform With Acquisition Of PharmaLex >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen To Expand Global Biopharma Services Platform With Acquisition Of PharmaLex >ABC
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: our partnerships with manufacturers, advancing our",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Expand Global -2-
COR,2022-09-12,12:15:01,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex,PRESS-RELEASE,Business Wire,AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: our partnerships with manufacturers, advancing our",PRESS-RELEASE,Business Wire,AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,AmerisourceBergen to Expand Global Biopharma -2-
COR,2022-09-12,12:16:24,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen agrees to acquire PharmaLex for 1.28 bln euros,NEWS-FLASH,MarketWatch,MW AmerisourceBergen agrees to acquire PharmaLex for 1.28 bln euros in cash
COR,2022-09-12,12:16:36,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Acquire PharmaLex From Funds Advised by AUCTUS Capital Partners for EUR1.28B in Cash,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen to Acquire PharmaLex From Funds Advised by AUCTUS Capital Partners for EUR1.28B in Cash >ABC
COR,2022-09-12,12:23:25,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen Agrees To Acquire Germany's PharmaLex For 1.28 Billion Euros,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Agrees To Acquire Germany's PharmaLex For 1.28 Billion Euros In Cash -- MarketWatch
COR,2022-09-12,12:23:25,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen agrees to acquire Germany's PharmaLex for 1.28 billion euros,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen agrees to acquire Germany's PharmaLex for 1.28 billion euros in cash
COR,2022-09-12,12:36:35,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Buy PharmaLex for $1.3 Billion >ABC,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen to Buy PharmaLex for $1.3 Billion >ABC
COR,2022-09-14,19:51:04,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-09-15,20:25:56,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-09-27,11:15:00,7D85A9,AmerisourceBergen Corp.,99,0.47,labor-issues,,Kim joining AmerisourceBergen's Board of Directors,PRESS-RELEASE,Business Wire,"AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors"
COR,2022-09-27,11:15:00,7D85A9,AmerisourceBergen Corp.,99,0.47,labor-issues,,Kim joining AmerisourceBergen's Board of Directors,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors"
COR,2022-09-27,11:16:33,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,Amerisourcebergen Names Lorence H. Kim to Board,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Names Lorence H. Kim to Board
COR,2022-09-27,12:05:00,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,R) and AmerisourceBergen Announce Strategic Commercialization Agreement,PRESS-RELEASE,GlobeNewswire,Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,A relationship with AmerisourceBergen for,PRESS-RELEASE,GlobeNewswire,Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:01,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,R) and AmerisourceBergen Announce Strategic Commercialization Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,A relationship with AmerisourceBergen for,PRESS-RELEASE,Dow Jones Newswires,Press Release: Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:31,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Outlook Therapeutics and AmerisourceBergen Announce Strategic Commercialization Agreement,NEWS-FLASH,Dow Jones Newswires,Outlook Therapeutics and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:07:27,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Outlook Therapeutics Exploring Relationship With AmerisourceBergen to,NEWS-FLASH,Dow Jones Newswires,Outlook Therapeutics Exploring Relationship With AmerisourceBergen to Support Launch of ONS-5010 in Intl Markets >OTLK
COR,2022-09-28,11:15:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release
COR,2022-10-03,11:23:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: our relationship with MWI will provide,PRESS-RELEASE,GlobeNewswire,"PETVIVO HOLDING, INC. ANNOUNCES SPRYNG(TM) NOW AVAILABLE TO VETERNARIANS THROUGH MWI ANIMAL HEALTH"
COR,2022-10-03,11:23:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: our relationship with MWI will provide,PRESS-RELEASE,Dow Jones Newswires,"Press Release: PETVIVO HOLDING, INC. ANNOUNCES SPRYNG(TM) NOW AVAILABLE TO VETERNARIANS THROUGH MWI ANIMAL HEALTH"
COR,2022-10-11,11:38:05,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen Raised to Buy From Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raised to Buy From Neutral by B of A Securities
COR,2022-10-11,11:38:05,7D85A9,AmerisourceBergen Corp.,100,0.6,price-targets,upgrade,Amerisourcebergen Price Target Raised to $169.00/Share From $160.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $169.00/Share From $160.00 by B of A Securities
COR,2022-10-11,13:48:20,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen upgraded to buy from neutral at BofA Securities,NEWS-FLASH,MarketWatch,MW AmerisourceBergen upgraded to buy from neutral at BofA Securities
COR,2022-10-12,20:12:36,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-10-12,20:33:05,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-10-18,14:06:22,7D85A9,AmerisourceBergen Corp.,100,0.2,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Cowen & Co.
COR,2022-10-18,14:06:22,7D85A9,AmerisourceBergen Corp.,100,-0.17,price-targets,downgrade,Amerisourcebergen Price Target Cut to $169.00/Share From $170.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $169.00/Share From $170.00 by Cowen & Co.
COR,2022-10-22,08:05:22,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2022 (ABC)"
COR,2022-10-25,12:00:00,7D85A9,AmerisourceBergen Corp.,99,0.18,acquisitions-mergers,,AmerisourceBergen Corp.: The company received investment from strategic investors Shanda Group and AmerisourceBergen's AB Health,PRESS-RELEASE,Business Wire,WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million
COR,2022-10-25,12:01:04,7D85A9,AmerisourceBergen Corp.,99,0.18,acquisitions-mergers,,AmerisourceBergen Corp.: The company received investment from strategic investors Shanda Group and AmerisourceBergen's AB Health,PRESS-RELEASE,Dow Jones Newswires,Press Release: WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.30,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.30-Adj EPS $11.60 >ABC
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 4Q Rev $61.2B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Rev $61.2B >ABC
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Adj EPS $2.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Adj EPS $2.60 >ABC
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.30,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.30-Adj EPS $11.60 >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,4Q EPS $1.40 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q EPS $1.40 >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $61.2 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent to $238.6 billion for the fiscal year,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2022 GAAP Diluted EPS of $8.04,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 fourth quarter ended September 30, 2022, revenue increased 3.8 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, adjusted diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2022,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2022, revenue was $61.2 billion, up 3.8 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.38,earnings,up,AmerisourceBergen Corp.: Operating income increased 0.5 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2022 Summary Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Operating expenses increased 29.2 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, GAAP diluted EPS was $8.04",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent from last fiscal year to $238.6 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,AmerisourceBergen Corp.: Gross profit increased 19.5 percent to $8.3 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, adjusted diluted EPS was $11.03",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.485,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.68,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue decline,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 2.11,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.25,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -5-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.48,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 56,560,616 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $61.2 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent to $238.6 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2022 GAAP Diluted EPS of $8.04,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 fourth quarter ended September 30, 2022, revenue increased 3.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2022, revenue was $61.2 billion, up 3.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.38,earnings,up,AmerisourceBergen Corp.: Operating income increased 0.5 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2022 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Operating expenses increased 29.2 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, GAAP diluted EPS was $8.04",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent from last fiscal year to $238.6 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,AmerisourceBergen Corp.: Gross profit increased 19.5 percent to $8.3 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, adjusted diluted EPS was $11.03",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.485,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.68,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue decline,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 2.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.25,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 56,560,616 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Adj EPS $2.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Adj EPS $2.60 >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 4Q Rev $61.2B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Rev $61.2B >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Net $294.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Net $294.7M >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,4Q EPS $1.40 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q EPS $1.40 >ABC
COR,2022-11-03,10:30:02,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Net $294.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Net $294.7M >ABC
COR,2022-11-03,10:35:10,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen Sees FY23 Revenue Growth of 5%-7%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Revenue Growth of 5%-7% >ABC
COR,2022-11-03,10:35:34,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen Sees FY23 Constant-Currency Revenue Growth 6%-8%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Constant-Currency Revenue Growth 6%-8% >ABC
COR,2022-11-03,10:36:17,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen Sees FY23 Capital Spending in $500M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Capital Spending in $500M Range >ABC
COR,2022-11-03,10:39:43,7D85A9,AmerisourceBergen Corp.,100,-0.48,earnings,down,Amerisourcebergen Q4 EPS $1.40 vs. $2.08 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 EPS $1.40 vs. $2.08 a year ago
COR,2022-11-03,10:40:07,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q4 adj. EPS $2.60; FactSet consensus $2.57,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 adj. EPS $2.60; FactSet consensus $2.57
COR,2022-11-03,10:40:30,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,"Amerisourcebergen Q4 revenue $61.2 bln, up 3.8%; FactSet consensus $60.5 bln",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q4 revenue $61.2 bln, up 3.8%; FactSet consensus $60.5 bln"
COR,2022-11-03,10:41:29,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen still sees FY23 adj. EPS of $11.30 to $11.60,NEWS-FLASH,MarketWatch,MW AmerisourceBergen still sees FY23 adj. EPS of $11.30 to $11.60
COR,2022-11-03,10:52:26,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen profit falls but tops estimates,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen profit falls but tops estimates for Q4
COR,2022-11-03,10:52:26,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Profit Falls But Tops Estimates,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Profit Falls But Tops Estimates For Q4 -- MarketWatch
COR,2022-11-04,22:20:21,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 21,802 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 21,802 Of AmerisourceBergen Corp >ABC"
COR,2022-11-07,21:21:36,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Mauch Registers 21,802 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Mauch Registers 21,802 Of AmerisourceBergen Corp >ABC"
COR,2022-11-07,22:05:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Secondary Public Offering Of,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Announces Secondary Public Offering Of Common Shares And Common Share Repurchase >ABC
COR,2022-11-07,22:05:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Secondary Public Offering of,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-07,22:05:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10 million shares of common stock of the Company,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-07,22:05:01,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Secondary Public Offering of,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-07,22:05:01,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10 million shares of common stock of the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-08,03:36:01,7D85A9,AmerisourceBergen Corp.,95,0.59,equity-actions,,Offering of 10 million shares of AmerisourceBergen Corporation (NYSE: ABC),PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Announces Offering of 10 Million Shares of AmerisourceBergen Corporation
COR,2022-11-08,03:36:01,7D85A9,AmerisourceBergen Corp.,96,0.59,equity-actions,,Offering of 10 million shares of AmerisourceBergen Corporation (NYSE: ABC),PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Announces Offering of 10 Million Shares of AmerisourceBergen Corporation
COR,2022-11-09,13:02:11,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 13,234,153 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 13,234,153 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:53:15,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Clark Acquires 13,523 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 13,523 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:53:47,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 22,152 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 22,152 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:55:02,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Chmn Collis Acquires 89,323 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 89,323 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:57:01,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Campbell Acquires 4,895 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 4,895 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:57:42,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Donato Acquires 6,322 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 6,322 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:58:37,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Battaglia Acquires 10,231 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 10,231 Of AmerisourceBergen Corp >ABC"
COR,2022-11-15,00:00:16,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Krikorian Acquires 5,928 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 5,928 Of AmerisourceBergen Corp >ABC"
COR,2022-11-15,00:00:43,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Coo Mauch Acquires 23,687 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Acquires 23,687 Of AmerisourceBergen Corp >ABC"
COR,2022-11-16,21:15:01,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,"Amerisourcebergen Elects Redonda Miller, M.D., to its Board of Directors",PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Elects Redonda Miller, M.D., to its Board of Directors"
COR,2022-11-16,21:15:01,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,"Amerisourcebergen Elects Redonda Miller, M.D., to its Board of Directors",PRESS-RELEASE,Business Wire,"AmerisourceBergen Elects Redonda Miller, M.D., to its Board of Directors"
COR,2022-11-16,21:15:05,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,"Amerisourcebergen Elects Redonda Miller, M.D., to Its Bd of Directors",NEWS-FLASH,Dow Jones Newswires,"AmerisourceBergen Elects Redonda Miller, M.D., to Its Bd of Directors"
COR,2022-11-22,13:42:15,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2022-11-22,13:42:15,7D85A9,AmerisourceBergen Corp.,100,0.5,price-targets,upgrade,Amerisourcebergen Price Target Raised to $182.00/Share From $175.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $182.00/Share From $175.00 by Credit Suisse
COR,2022-12-01,18:48:29,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,stable,S&P Sees AmerisourceBergen Corp. Outlk Stable,NEWS-FLASH,Dow Jones Newswires,S&P Sees AmerisourceBergen Corp. Outlk Stable
COR,2022-12-09,01:41:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.0 billion of Proceeds
COR,2022-12-09,01:41:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.0 billion of Proceeds
COR,2022-12-09,01:47:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance >ABC
COR,2022-12-09,01:47:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2022-12-09,01:47:01,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2022-12-09,01:50:58,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen: Agreed to Repurchase Around $200M Common Shares,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen: Agreed to Repurchase Around $200M Common Shares From Walgreens Boots Alliance >ABC
COR,2022-12-09,01:51:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen: Repurchased Shares to,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen: Repurchased Shares to Be Held in Treasury >ABC
COR,2022-12-12,21:22:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Donato Sells 3,014 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,014 Of AmerisourceBergen Corp >ABC"
COR,2022-12-12,21:39:40,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Donato Registers 3,014 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,014 Of AmerisourceBergen Corp >ABC"
COR,2022-12-12,22:28:43,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 5,961,534 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 5,961,534 Of AmerisourceBergen Corp >ABC"
COR,2022-12-13,20:37:07,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 33,000 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 33,000 Of AmerisourceBergen Corp >ABC"
COR,2022-12-13,21:04:03,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,Vp Clark Registers 392 Of AmerisourceBergen Corp >ABC,RNS-SEC144,Dow Jones Newswires,VP Clark Registers 392 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,20:08:05,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 45,920 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 45,920 Of AmerisourceBergen Corp >ABC"
COR,2022-12-14,21:48:16,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Krikorian Acquires 172 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 172 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,21:49:34,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Cfo Cleary Jr Acquires 371 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,CFO Cleary Jr Acquires 371 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,21:52:14,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Coo Mauch Acquires 505 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,COO Mauch Acquires 505 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,21:54:11,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 78,920 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 78,920 Of AmerisourceBergen Corp >ABC"
COR,2022-12-14,22:35:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,Vp Clark Sells 392 Of AmerisourceBergen Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Clark Sells 392 Of AmerisourceBergen Corp >ABC
COR,2022-12-19,16:33:33,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Battaglia Registers 9,852 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 9,852 Of AmerisourceBergen Corp >ABC"
COR,2022-12-20,18:00:09,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2022-12-20,18:00:09,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2022-12-20,18:00:19,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -2-
COR,2022-12-20,18:00:29,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -3-
COR,2022-12-20,21:03:44,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Battaglia Sells 9,852 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 9,852 Of AmerisourceBergen Corp >ABC"
COR,2022-12-22,19:15:33,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Krikorian Registers 2,218 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 2,218 Of AmerisourceBergen Corp >ABC"
COR,2022-12-22,21:06:14,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 2,218 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 2,218 Of AmerisourceBergen Corp >ABC"
COR,2022-12-23,18:42:45,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,Vp Donato Registers 930 Of AmerisourceBergen Corp >ABC,RNS-SEC144,Dow Jones Newswires,VP Donato Registers 930 Of AmerisourceBergen Corp >ABC
COR,2022-12-23,21:05:29,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,Vp Donato Sells 930 Of AmerisourceBergen Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Sells 930 Of AmerisourceBergen Corp >ABC
COR,2022-12-29,16:39:41,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis -- WSJ
COR,2022-12-29,16:40:11,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis
COR,2022-12-29,17:55:38,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis -- Update
COR,2022-12-29,20:22:17,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis -- 2nd Update
COR,2022-01-03,21:16:18,7D85A9,AmerisourceBergen Corp.,100,0.0,insider-trading,,"Chmn Collis Gifts 1,159 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Gifts 1,159 Of AmerisourceBergen Corp >ABC"
COR,2022-01-04,21:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release
COR,2022-01-04,21:28:34,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release
COR,2022-01-11,12:27:19,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Barclays
COR,2022-01-11,12:27:19,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $152.00/Share From $135.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $152.00/Share From $135.00 by Barclays
COR,2022-01-13,21:23:38,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC"
COR,2022-01-22,09:09:39,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2021 (ABC)"
COR,2022-01-25,13:30:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"World Courier, collaborates with multiple orchestration platform providers, including TrakCel, to deliver systems",PRESS-RELEASE,Business Wire,AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies
COR,2022-01-25,14:30:00,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,AmerisourceBergen Corp.: Investing in our,PRESS-RELEASE,Business Wire,"AmerisourceBergen Welcomes New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-25,14:31:39,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Names New SVP and Chief,NEWS-FLASH,Dow Jones Newswires,"AmerisourceBergen Names New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-25,14:31:39,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Names New SVP and Chief,NEWS-FLASH,Dow Jones Newswires,"AmerisourceBergen Names New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-25,14:32:15,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,AmerisourceBergen Corp.: Investing in our,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Welcomes New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-26,19:07:04,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Adj EPS $2.58,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Adj EPS $2.58 >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.60-Adj EPS $10.90 >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,1Q EPS $2.13 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q EPS $2.13 >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 1Q Rev $59.6B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Rev $59.6B >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 First Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenues of $59.6B billion for the First Quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.60 to $10.90,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 first quarter ended December 31, 2021, revenue increased 13.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Our updated fiscal 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2022 first quarter, net interest expense of $53.4 million was up 58.8 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2022, revenue was $59.6 billion, up 13.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Revenue in International Healthcare Solutions was $6.6 billion in the first quarter of fiscal 2022,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2022 was $180.1 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,Amerisourcebergen extended its pharmaceutical supply agreement with Express Scripts,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Interest expense to be in the range of $210 to $215 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 1.83,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,95,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.46,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,577,564 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Net $449.1M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Net $449.1M >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenues of $59.6B billion for the First Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.60 to $10.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 first quarter ended December 31, 2021, revenue increased 13.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Our updated fiscal 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2022 first quarter, net interest expense of $53.4 million was up 58.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2022, revenue was $59.6 billion, up 13.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Revenue in International Healthcare Solutions was $6.6 billion in the first quarter of fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2022 was $180.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,Amerisourcebergen extended its pharmaceutical supply agreement with Express Scripts,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Interest expense to be in the range of $210 to $215 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,577,564 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:35:00,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,Amerisourcebergen Q1 EPS $2.13 vs. $1.81 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 EPS $2.13 vs. $1.81 a year ago
COR,2022-02-02,11:35:19,7D85A9,AmerisourceBergen Corp.,100,0.54,earnings,meet-expectations,"Amerisourcebergen Q1 adj. EPS $2.58, matching",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q1 adj. EPS $2.58, matching FactSet consensus"
COR,2022-02-02,11:35:57,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,Amerisourcebergen Q1 revenue $59.6 bln vs. $52.5 bln a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 revenue $59.6 bln vs. $52.5 bln a year ago; FactSet consensus $59.6 bln
COR,2022-02-02,11:36:53,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees FY22 adj. EPS of $10.60 to $10.90,NEWS-FLASH,MarketWatch,MW AmerisourceBergen now sees FY22 adj. EPS of $10.60 to $10.90 vs. prior guidance of $10.50 to $10.80
COR,2022-02-02,17:37:33,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call Transcript >ABC
COR,2022-02-02,21:41:23,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 44,492 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 44,492 Of AmerisourceBergen Corp >ABC"
COR,2022-02-03,13:29:11,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2022-02-03,13:29:11,7D85A9,AmerisourceBergen Corp.,100,0.66,price-targets,upgrade,Amerisourcebergen Price Target Raised to $139.00/Share From $130.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $139.00/Share From $130.00 by Mizuho
COR,2022-02-04,21:02:38,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 11,653 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 11,653 Of AmerisourceBergen Corp >ABC"
COR,2022-02-04,21:06:27,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Campbell Sells 14,034 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 14,034 Of AmerisourceBergen Corp >ABC"
COR,2022-02-05,09:13:18,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call Transcript >ABC
COR,2022-02-09,21:38:53,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,263 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,263 Of AmerisourceBergen Corp >ABC"
COR,2022-02-24,13:35:37,7D85A9,AmerisourceBergen Corp.,99,0.53,labor-issues,,Amerisourcebergen Adds Freight Management,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Adds Freight Management Capabilities Powered by TRIOSE, Inc. for Hospital & Health System Customers"
COR,2022-03-02,22:24:54,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Battaglia Acquires 6,146 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 6,146 Of AmerisourceBergen Corp >ABC"
COR,2022-03-09,22:40:32,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-03-11,20:43:01,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Battaglia Acquires 674 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 674 Of AmerisourceBergen Corp >ABC
COR,2022-03-15,14:11:30,7D85A9,AmerisourceBergen Corp.,100,0.01,credit-ratings,affirmation,Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating,NEWS-FLASH,Dow Jones Newswires,"Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating, Outlook Remains Stable"
COR,2022-03-16,20:00:53,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Battaglia Sells 6,820 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 6,820 Of AmerisourceBergen Corp >ABC"
COR,2022-03-28,20:40:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day
COR,2022-03-28,20:40:09,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day
COR,2022-03-30,20:02:33,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 43,704 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 43,704 Of AmerisourceBergen Corp >ABC"
COR,2022-04-06,18:00:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Amerisourcebergen partnered with TrakCel, a leading innovator of cellular orchestration solutions",PRESS-RELEASE,Business Wire,AmerisourceBergen Launches $150M Venture Capital Fund
COR,2022-04-12,10:15:16,7D85A9,AmerisourceBergen Corp.,100,-0.58,analyst-ratings,negative,Amerisourcebergen Cut to Equal-Weight From Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Cut to Equal-Weight From Overweight by Morgan Stanley
COR,2022-04-12,10:15:16,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $178.00/Share by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $178.00/Share by Morgan Stanley
COR,2022-04-12,14:53:39,7D85A9,AmerisourceBergen Corp.,100,-0.58,analyst-ratings,negative,Amerisourcebergen downgraded to equal weight from overweight at Morgan Stanley,NEWS-FLASH,MarketWatch,MW AmerisourceBergen downgraded to equal weight from overweight at Morgan Stanley
COR,2022-04-13,20:23:43,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-04-21,12:30:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Amerisourcebergen Partners with Chronicled to,PRESS-RELEASE,Business Wire,AmerisourceBergen Partners with Chronicled to Optimize Pharmaceutical Chargeback Accuracy Using Blockchain-Powered Technology
COR,2022-04-22,08:05:54,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2022 (ABC)"
COR,2022-04-28,12:30:00,7D85A9,AmerisourceBergen Corp.,100,0.52,products-services,,Amerisourcebergen Launches Home Infusion Solution for,PRESS-RELEASE,Business Wire,AmerisourceBergen Launches Home Infusion Solution for Health Systems Nationwide
COR,2022-04-28,12:33:15,7D85A9,AmerisourceBergen Corp.,99,0.52,products-services,,Amerisourcebergen Launches Home Infusion Solution for,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Launches Home Infusion Solution for Health Systems Nationwide
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.80-Adj EPS $11.05 >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $3.22,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $3.22 >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,2Q EPS $2.59 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q EPS $2.59 >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 2Q Rev $57.7B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Rev $57.7B >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Net $548M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Net $548M >ABC
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Second Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $57.7 billion for the Second Quarter, a 17.4 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.59,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.80 to $11.05,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 second quarter ended March 31, 2022, revenue increased 17.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, revenue was $57.7 billion, up 17.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, net interest expense of $52.9 million was up 53.3 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2022 was $187.1 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other national pharmaceutical distributors reached an agreement to,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.62 $ 2.12,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 4.77 $ 3.96,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.12,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,308,153 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -8-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $57.7 billion for the Second Quarter, a 17.4 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.59,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.80 to $11.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 second quarter ended March 31, 2022, revenue increased 17.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, revenue was $57.7 billion, up 17.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, net interest expense of $52.9 million was up 53.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2022 was $187.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other national pharmaceutical distributors reached an agreement to,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.62 $ 2.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 4.77 $ 3.96,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,308,153 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2022-05-04,10:32:21,7D85A9,AmerisourceBergen Corp.,100,0.42,earnings,up,Amerisourcebergen Q2 EPS $2.59 vs. $2.10 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 EPS $2.59 vs. $2.10 a year ago
COR,2022-05-04,10:32:54,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q2 adj. EPS $3.22; FactSet consensus $2.92,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 adj. EPS $3.22; FactSet consensus $2.92
COR,2022-05-04,10:33:40,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,"Amerisourcebergen Q2 revenue $57.7 bln, up 17.4%; FactSet consensus $57.5 bln",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q2 revenue $57.7 bln, up 17.4%; FactSet consensus $57.5 bln"
COR,2022-05-04,10:34:59,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees full-year adj. EPS of $10.80 to $11.05,NEWS-FLASH,MarketWatch,MW AmerisourceBergen now sees full-year adj. EPS of $10.80 to $11.05 vs. prior $10.60 to $10.90
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen beats earnings expectations,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported first-quarter profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Beats Earnings Expectations,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported first-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen beats earnings expectations,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported fiscal second-quarter profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Beats Earnings Expectations,FULL-ARTICLE,Dow Jones Newswires,"Update: AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported fiscal second-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"Update: AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,14:17:35,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q2 2022 Results -- Earnings Call Transcript >ABC
COR,2022-05-05,12:43:10,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2022-05-05,12:43:10,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $162.00/Share From $139.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $162.00/Share From $139.00 by Mizuho
COR,2022-05-05,15:13:31,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Hold by Deutsche Bank
COR,2022-05-05,15:13:31,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $168.00/Share From $153.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $168.00/Share From $153.00 by Deutsche Bank
COR,2022-05-11,21:47:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation
COR,2022-05-11,21:47:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation
COR,2022-05-11,21:49:50,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Six M Shrs of AmerisourceBergen Corp,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Six M Shrs of AmerisourceBergen Corp
COR,2022-05-11,21:52:12,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sold 6M Shrs of AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sold 6M Shrs of AmerisourceBergen at $150/Shr >WBA
COR,2022-05-12,12:01:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: Resuming share repurchases,PRESS-RELEASE,Business Wire,AmerisourceBergen Provides Update on Capital Deployment
COR,2022-05-12,12:01:01,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: Resuming share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Provides Update on Capital Deployment
COR,2022-05-12,15:06:22,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,It sold 6.0 million AmerisourceBergen shares,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares
COR,2022-05-12,15:23:56,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,It sold 6.0 million AmerisourceBergen shares,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares
COR,2022-05-12,20:44:44,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 6,759 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 6,759 Of AmerisourceBergen Corp >ABC"
COR,2022-05-12,20:45:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-05-13,20:06:57,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 4,895 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 4,895 Of AmerisourceBergen Corp >ABC"
COR,2022-05-13,21:02:02,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 6,000,000 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 6,000,000 Of AmerisourceBergen Corp >ABC"
COR,2022-05-23,12:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,products-services,start,Amerisourcebergen Launches Clinical Trial,PRESS-RELEASE,Business Wire,AmerisourceBergen Launches Clinical Trial Navigator to Bolster Equitable and Accessible Community-Based Research Opportunities Nationwide
COR,2022-05-25,12:18:55,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Hold by Deutsche Bank
COR,2022-05-25,12:18:55,7D85A9,AmerisourceBergen Corp.,100,-0.17,price-targets,downgrade,Amerisourcebergen Price Target Cut to $167.00/Share From $168.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $167.00/Share From $168.00 by Deutsche Bank
COR,2022-05-26,11:21:51,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen Raised to Overweight From Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raised to Overweight From Equal-Weight by Barclays
COR,2022-05-26,11:21:51,7D85A9,AmerisourceBergen Corp.,100,0.5,price-targets,upgrade,Amerisourcebergen Price Target Raised to $182.00/Share From $175.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $182.00/Share From $175.00 by Barclays
COR,2022-05-27,11:50:58,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Morgan Stanley
COR,2022-05-27,11:50:58,7D85A9,AmerisourceBergen Corp.,100,-0.32,price-targets,downgrade,Amerisourcebergen Price Target Cut to $175.00/Share From $178.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $175.00/Share From $178.00 by Morgan Stanley
COR,2022-06-01,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,unchanged,AmerisourceBergen Corp.: The company reiterated its fiscal year 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,approved,Amerisourcebergen's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Business Wire,AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,unchanged,AmerisourceBergen Corp.: The company reiterated its fiscal year 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,approved,Amerisourcebergen's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:31,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,approved,Amerisourcebergen Board Authorized New $1B Shr Repurchase Program,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Board Authorized New $1B Shr Repurchase Program >ABC
COR,2022-06-01,10:30:46,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,unchanged,Amerisourcebergen Reiterates Guidance for Fiscal 2022,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Reiterates Guidance for Fiscal 2022 >ABC
COR,2022-06-01,10:31:26,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,unchanged,Amerisourcebergen Backs FY Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Backs FY Adj EPS $10.80-Adj EPS $11.05 >ABC
COR,2022-06-01,10:33:13,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen sets new $1 bln stock repurchase program,NEWS-FLASH,MarketWatch,MW AmerisourceBergen sets new $1 bln stock repurchase program
COR,2022-06-01,10:39:09,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen sets $1 billion stock buyback program,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen sets $1 billion stock buyback program
COR,2022-06-01,10:39:09,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Sets $1 Billion Stock Buyback Program,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Sets $1 Billion Stock Buyback Program -- MarketWatch
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.64,earnings,up,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.64,earnings,up,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:32:58,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,unchanged,Amerisourcebergen Backs FY22 Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Backs FY22 Adj EPS $10.80-Adj EPS $11.05 >ABC
COR,2022-06-07,10:59:06,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen upgraded to buy from hold at Deutsche Bank,NEWS-FLASH,MarketWatch,MW AmerisourceBergen upgraded to buy from hold at Deutsche Bank
COR,2022-06-07,11:34:06,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen Raised to Buy From Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raised to Buy From Hold by Deutsche Bank
COR,2022-06-07,11:34:06,7D85A9,AmerisourceBergen Corp.,100,0.64,price-targets,upgrade,Amerisourcebergen Price Target Raised to $178.00/Share From $167.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $178.00/Share From $167.00 by Deutsche Bank
COR,2022-06-09,13:15:49,7D85A9,AmerisourceBergen Corp.,100,0.2,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Cowen & Co.
COR,2022-06-09,13:15:49,7D85A9,AmerisourceBergen Corp.,100,-0.17,price-targets,downgrade,Amerisourcebergen Price Target Cut to $170.00/Share From $171.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $170.00/Share From $171.00 by Cowen & Co.
COR,2022-06-13,11:37:43,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by UBS
COR,2022-06-13,11:37:43,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $174.00/Share From $144.00 by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $174.00/Share From $144.00 by UBS
COR,2022-06-13,14:16:47,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen stock price target raised to $174 from $144 at UBS,NEWS-FLASH,MarketWatch,MW AmerisourceBergen stock price target raised to $174 from $144 at UBS
COR,2022-06-16,20:21:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-06-22,12:30:13,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,AmerisourceBergen Corp.: Torigen Pharmaceuticals Inks National Distribution Deal with MWI,PRESS-RELEASE,PR Newswire,Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health
COR,2022-06-22,12:30:13,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: The strategic relationship with MWI,PRESS-RELEASE,PR Newswire,Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health
COR,2022-06-22,18:27:05,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-06-29,16:48:00,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,"Petvivo HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI",PRESS-RELEASE,GlobeNewswire,"PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI ANIMAL HEALTH"
COR,2022-06-29,16:48:01,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,"Petvivo HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI",PRESS-RELEASE,Dow Jones Newswires,"Press Release: PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI ANIMAL HEALTH"
COR,2022-06-29,20:15:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release
COR,2022-06-29,22:11:10,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release
COR,2022-07-06,16:23:43,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Chou Registers 12,968 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Chou Registers 12,968 Of AmerisourceBergen Corp >ABC"
COR,2022-07-11,10:36:27,7D85A9,AmerisourceBergen Corp.,100,-0.58,analyst-ratings,negative,Amerisourcebergen Cut to In-Line From Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Cut to In-Line From Outperform by Evercore ISI Group
COR,2022-07-11,10:36:27,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $150.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $150.00/Share by Evercore ISI Group
COR,2022-07-14,20:05:49,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-07-20,13:43:34,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by Argus Research
COR,2022-07-20,13:43:34,7D85A9,AmerisourceBergen Corp.,100,0.62,price-targets,upgrade,Amerisourcebergen Price Target Raised to $170.00/Share From $160.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $170.00/Share From $160.00 by Argus Research
COR,2022-07-20,16:48:07,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-07-22,07:57:39,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2022 (ABC)"
COR,2022-07-22,20:06:23,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Donato Acquires 898 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Acquires 898 Of AmerisourceBergen Corp >ABC
COR,2022-07-27,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.52,products-services,,Amerisourcebergen to Launch Digital Therapeutics Platform to,PRESS-RELEASE,Business Wire,AmerisourceBergen to Launch Digital Therapeutics Platform to Facilitate Access to Innovative Products
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Adj EPS $2.62,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Adj EPS $2.62 >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 3Q Rev $60.1B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Rev $60.1B >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.90,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.90-Adj EPS $11.10 >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,3Q EPS $1.92 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q EPS $1.92 >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Net $407M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Net $407M >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Third Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $60.1 billion for the Third Quarter, a 12.5 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.92,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.90 to $11.10,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 third quarter ended June 30, 2022, revenue increased 12.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, revenue was $60.1 billion, up 12.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2022,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.13,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, net interest expense of $52.9 million was up 3.0 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -7-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2022 was $176.3 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other distributors reached an agreement to,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: Conference Call,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -3-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.95 $ 1.42,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.36,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -5-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.14,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,173,630 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $60.1 billion for the Third Quarter, a 12.5 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.92,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.90 to $11.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 third quarter ended June 30, 2022, revenue increased 12.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, revenue was $60.1 billion, up 12.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.13,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, net interest expense of $52.9 million was up 3.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2022 was $176.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other distributors reached an agreement to,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.95 $ 1.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.36,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,173,630 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-08-03,10:30:54,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Had Seen FY Adjusted EPS $10.80-$11.05,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Had Seen FY Adjusted EPS $10.80-$11.05 >ABC
COR,2022-08-03,10:32:30,7D85A9,AmerisourceBergen Corp.,100,0.52,earnings,up,Amerisourcebergen Q3 EPS $1.92 vs. $1.40 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 EPS $1.92 vs. $1.40 a year ago
COR,2022-08-03,10:32:46,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q3 adj. EPS $2.62; FactSet consensus $2.56,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 adj. EPS $2.62; FactSet consensus $2.56
COR,2022-08-03,10:33:22,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q3 revenue $60.06 bln vs. $53.41 bln a year ago; FactSet consensus $59.08 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 revenue $60.06 bln vs. $53.41 bln a year ago; FactSet consensus $59.08 bln
COR,2022-08-03,10:33:54,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raises FY2022 adj. EPS outlook to $10.90-$11.10 from $10.80-$11.05,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raises FY2022 adj. EPS outlook to $10.90-$11.10 from $10.80-$11.05
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen beats profit and revenue expectations,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats profit and revenue expectations, raises full-year outlook"
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported Wednesday fiscal third-quarter profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats profit and revenue expectations, raises full-year outlook"
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Beats Profit And Revenue Expectations,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Profit And Revenue Expectations, Raises Full-year Outlook -- MarketWatch"
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported Wednesday fiscal third-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Profit And Revenue Expectations, Raises Full-year Outlook -- MarketWatch"
COR,2022-08-03,15:52:45,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corp CEO Steven Collis on Q3 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amerisourcebergen Corp CEO Steven Collis on Q3 2022 Results -- Earnings Call Transcript >ABC
COR,2022-08-04,13:05:59,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2022-08-04,13:05:59,7D85A9,AmerisourceBergen Corp.,100,-0.44,price-targets,downgrade,Amerisourcebergen Price Target Cut to $175.00/Share From $180.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $175.00/Share From $180.00 by Credit Suisse
COR,2022-08-11,20:15:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-08-17,19:08:27,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-08-22,12:08:31,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Morgan Stanley
COR,2022-08-22,12:08:31,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $176.00/Share From $175.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $176.00/Share From $175.00 by Morgan Stanley
COR,2022-08-24,18:20:30,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Chou Registers 17,561 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Chou Registers 17,561 Of AmerisourceBergen Corp >ABC"
COR,2022-09-01,20:08:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,Vp Clark Sells 288 Of AmerisourceBergen Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Clark Sells 288 Of AmerisourceBergen Corp >ABC
COR,2022-09-06,20:51:19,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Donato Acquires 1,867 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 1,867 Of AmerisourceBergen Corp >ABC"
COR,2022-09-07,17:15:18,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,Vp Clark Registers 288 Of AmerisourceBergen Corp >ABC,RNS-SEC144,Dow Jones Newswires,VP Clark Registers 288 Of AmerisourceBergen Corp >ABC
COR,2022-09-07,18:47:46,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Chou Registers 15,264 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Chou Registers 15,264 Of AmerisourceBergen Corp >ABC"
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen To Expand Global Biopharma Services Platform With Acquisition Of PharmaLex >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen To Expand Global Biopharma Services Platform With Acquisition Of PharmaLex >ABC
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: our partnerships with manufacturers, advancing our",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Expand Global -2-
COR,2022-09-12,12:15:01,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex,PRESS-RELEASE,Business Wire,AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: our partnerships with manufacturers, advancing our",PRESS-RELEASE,Business Wire,AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,AmerisourceBergen to Expand Global Biopharma -2-
COR,2022-09-12,12:16:24,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen agrees to acquire PharmaLex for 1.28 bln euros,NEWS-FLASH,MarketWatch,MW AmerisourceBergen agrees to acquire PharmaLex for 1.28 bln euros in cash
COR,2022-09-12,12:16:36,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Acquire PharmaLex From Funds Advised by AUCTUS Capital Partners for EUR1.28B in Cash,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen to Acquire PharmaLex From Funds Advised by AUCTUS Capital Partners for EUR1.28B in Cash >ABC
COR,2022-09-12,12:23:25,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen Agrees To Acquire Germany's PharmaLex For 1.28 Billion Euros,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Agrees To Acquire Germany's PharmaLex For 1.28 Billion Euros In Cash -- MarketWatch
COR,2022-09-12,12:23:25,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen agrees to acquire Germany's PharmaLex for 1.28 billion euros,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen agrees to acquire Germany's PharmaLex for 1.28 billion euros in cash
COR,2022-09-12,12:36:35,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Buy PharmaLex for $1.3 Billion >ABC,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen to Buy PharmaLex for $1.3 Billion >ABC
COR,2022-09-14,19:51:04,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-09-15,20:25:56,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-09-27,11:15:00,7D85A9,AmerisourceBergen Corp.,99,0.47,labor-issues,,Kim joining AmerisourceBergen's Board of Directors,PRESS-RELEASE,Business Wire,"AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors"
COR,2022-09-27,11:15:00,7D85A9,AmerisourceBergen Corp.,99,0.47,labor-issues,,Kim joining AmerisourceBergen's Board of Directors,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors"
COR,2022-09-27,11:16:33,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,Amerisourcebergen Names Lorence H. Kim to Board,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Names Lorence H. Kim to Board
COR,2022-09-27,12:05:00,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,R) and AmerisourceBergen Announce Strategic Commercialization Agreement,PRESS-RELEASE,GlobeNewswire,Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,A relationship with AmerisourceBergen for,PRESS-RELEASE,GlobeNewswire,Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:01,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,R) and AmerisourceBergen Announce Strategic Commercialization Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,A relationship with AmerisourceBergen for,PRESS-RELEASE,Dow Jones Newswires,Press Release: Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:31,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Outlook Therapeutics and AmerisourceBergen Announce Strategic Commercialization Agreement,NEWS-FLASH,Dow Jones Newswires,Outlook Therapeutics and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:07:27,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Outlook Therapeutics Exploring Relationship With AmerisourceBergen to,NEWS-FLASH,Dow Jones Newswires,Outlook Therapeutics Exploring Relationship With AmerisourceBergen to Support Launch of ONS-5010 in Intl Markets >OTLK
COR,2022-09-28,11:15:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release
COR,2022-10-03,11:23:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: our relationship with MWI will provide,PRESS-RELEASE,GlobeNewswire,"PETVIVO HOLDING, INC. ANNOUNCES SPRYNG(TM) NOW AVAILABLE TO VETERNARIANS THROUGH MWI ANIMAL HEALTH"
COR,2022-10-03,11:23:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: our relationship with MWI will provide,PRESS-RELEASE,Dow Jones Newswires,"Press Release: PETVIVO HOLDING, INC. ANNOUNCES SPRYNG(TM) NOW AVAILABLE TO VETERNARIANS THROUGH MWI ANIMAL HEALTH"
COR,2022-10-11,11:38:05,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen Raised to Buy From Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raised to Buy From Neutral by B of A Securities
COR,2022-10-11,11:38:05,7D85A9,AmerisourceBergen Corp.,100,0.6,price-targets,upgrade,Amerisourcebergen Price Target Raised to $169.00/Share From $160.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $169.00/Share From $160.00 by B of A Securities
COR,2022-10-11,13:48:20,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen upgraded to buy from neutral at BofA Securities,NEWS-FLASH,MarketWatch,MW AmerisourceBergen upgraded to buy from neutral at BofA Securities
COR,2022-10-12,20:12:36,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-10-12,20:33:05,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-10-18,14:06:22,7D85A9,AmerisourceBergen Corp.,100,0.2,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Cowen & Co.
COR,2022-10-18,14:06:22,7D85A9,AmerisourceBergen Corp.,100,-0.17,price-targets,downgrade,Amerisourcebergen Price Target Cut to $169.00/Share From $170.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $169.00/Share From $170.00 by Cowen & Co.
COR,2022-10-22,08:05:22,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2022 (ABC)"
COR,2022-10-25,12:00:00,7D85A9,AmerisourceBergen Corp.,99,0.18,acquisitions-mergers,,AmerisourceBergen Corp.: The company received investment from strategic investors Shanda Group and AmerisourceBergen's AB Health,PRESS-RELEASE,Business Wire,WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million
COR,2022-10-25,12:01:04,7D85A9,AmerisourceBergen Corp.,99,0.18,acquisitions-mergers,,AmerisourceBergen Corp.: The company received investment from strategic investors Shanda Group and AmerisourceBergen's AB Health,PRESS-RELEASE,Dow Jones Newswires,Press Release: WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.30,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.30-Adj EPS $11.60 >ABC
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 4Q Rev $61.2B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Rev $61.2B >ABC
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Adj EPS $2.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Adj EPS $2.60 >ABC
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.30,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.30-Adj EPS $11.60 >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,4Q EPS $1.40 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q EPS $1.40 >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $61.2 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent to $238.6 billion for the fiscal year,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2022 GAAP Diluted EPS of $8.04,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 fourth quarter ended September 30, 2022, revenue increased 3.8 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, adjusted diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2022,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2022, revenue was $61.2 billion, up 3.8 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.38,earnings,up,AmerisourceBergen Corp.: Operating income increased 0.5 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2022 Summary Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Operating expenses increased 29.2 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, GAAP diluted EPS was $8.04",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent from last fiscal year to $238.6 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,AmerisourceBergen Corp.: Gross profit increased 19.5 percent to $8.3 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, adjusted diluted EPS was $11.03",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.485,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.68,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue decline,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 2.11,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.25,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -5-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.48,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 56,560,616 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $61.2 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent to $238.6 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2022 GAAP Diluted EPS of $8.04,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 fourth quarter ended September 30, 2022, revenue increased 3.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2022, revenue was $61.2 billion, up 3.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.38,earnings,up,AmerisourceBergen Corp.: Operating income increased 0.5 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2022 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Operating expenses increased 29.2 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, GAAP diluted EPS was $8.04",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent from last fiscal year to $238.6 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,AmerisourceBergen Corp.: Gross profit increased 19.5 percent to $8.3 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, adjusted diluted EPS was $11.03",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.485,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.68,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue decline,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 2.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.25,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 56,560,616 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Adj EPS $2.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Adj EPS $2.60 >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 4Q Rev $61.2B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Rev $61.2B >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Net $294.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Net $294.7M >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,4Q EPS $1.40 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q EPS $1.40 >ABC
COR,2022-11-03,10:30:02,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Net $294.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Net $294.7M >ABC
COR,2022-11-03,10:35:10,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen Sees FY23 Revenue Growth of 5%-7%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Revenue Growth of 5%-7% >ABC
COR,2022-11-03,10:35:34,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen Sees FY23 Constant-Currency Revenue Growth 6%-8%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Constant-Currency Revenue Growth 6%-8% >ABC
COR,2022-11-03,10:36:17,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen Sees FY23 Capital Spending in $500M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Capital Spending in $500M Range >ABC
COR,2022-11-03,10:39:43,7D85A9,AmerisourceBergen Corp.,100,-0.48,earnings,down,Amerisourcebergen Q4 EPS $1.40 vs. $2.08 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 EPS $1.40 vs. $2.08 a year ago
COR,2022-11-03,10:40:07,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q4 adj. EPS $2.60; FactSet consensus $2.57,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 adj. EPS $2.60; FactSet consensus $2.57
COR,2022-11-03,10:40:30,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,"Amerisourcebergen Q4 revenue $61.2 bln, up 3.8%; FactSet consensus $60.5 bln",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q4 revenue $61.2 bln, up 3.8%; FactSet consensus $60.5 bln"
COR,2022-11-03,10:41:29,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen still sees FY23 adj. EPS of $11.30 to $11.60,NEWS-FLASH,MarketWatch,MW AmerisourceBergen still sees FY23 adj. EPS of $11.30 to $11.60
COR,2022-11-03,10:52:26,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen profit falls but tops estimates,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen profit falls but tops estimates for Q4
COR,2022-11-03,10:52:26,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Profit Falls But Tops Estimates,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Profit Falls But Tops Estimates For Q4 -- MarketWatch
COR,2022-11-04,22:20:21,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 21,802 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 21,802 Of AmerisourceBergen Corp >ABC"
COR,2022-11-07,21:21:36,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Mauch Registers 21,802 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Mauch Registers 21,802 Of AmerisourceBergen Corp >ABC"
COR,2022-11-07,22:05:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Secondary Public Offering Of,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Announces Secondary Public Offering Of Common Shares And Common Share Repurchase >ABC
COR,2022-11-07,22:05:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Secondary Public Offering of,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-07,22:05:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10 million shares of common stock of the Company,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-07,22:05:01,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Secondary Public Offering of,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-07,22:05:01,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10 million shares of common stock of the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-08,03:36:01,7D85A9,AmerisourceBergen Corp.,95,0.59,equity-actions,,Offering of 10 million shares of AmerisourceBergen Corporation (NYSE: ABC),PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Announces Offering of 10 Million Shares of AmerisourceBergen Corporation
COR,2022-11-08,03:36:01,7D85A9,AmerisourceBergen Corp.,96,0.59,equity-actions,,Offering of 10 million shares of AmerisourceBergen Corporation (NYSE: ABC),PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Announces Offering of 10 Million Shares of AmerisourceBergen Corporation
COR,2022-11-09,13:02:11,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 13,234,153 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 13,234,153 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:53:15,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Clark Acquires 13,523 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 13,523 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:53:47,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 22,152 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 22,152 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:55:02,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Chmn Collis Acquires 89,323 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 89,323 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:57:01,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Campbell Acquires 4,895 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 4,895 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:57:42,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Donato Acquires 6,322 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 6,322 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:58:37,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Battaglia Acquires 10,231 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 10,231 Of AmerisourceBergen Corp >ABC"
COR,2022-11-15,00:00:16,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Krikorian Acquires 5,928 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 5,928 Of AmerisourceBergen Corp >ABC"
COR,2022-11-15,00:00:43,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Coo Mauch Acquires 23,687 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Acquires 23,687 Of AmerisourceBergen Corp >ABC"
COR,2022-11-16,21:15:01,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,"Amerisourcebergen Elects Redonda Miller, M.D., to its Board of Directors",PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Elects Redonda Miller, M.D., to its Board of Directors"
COR,2022-11-16,21:15:01,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,"Amerisourcebergen Elects Redonda Miller, M.D., to its Board of Directors",PRESS-RELEASE,Business Wire,"AmerisourceBergen Elects Redonda Miller, M.D., to its Board of Directors"
COR,2022-11-16,21:15:05,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,"Amerisourcebergen Elects Redonda Miller, M.D., to Its Bd of Directors",NEWS-FLASH,Dow Jones Newswires,"AmerisourceBergen Elects Redonda Miller, M.D., to Its Bd of Directors"
COR,2022-11-22,13:42:15,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2022-11-22,13:42:15,7D85A9,AmerisourceBergen Corp.,100,0.5,price-targets,upgrade,Amerisourcebergen Price Target Raised to $182.00/Share From $175.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $182.00/Share From $175.00 by Credit Suisse
COR,2022-12-01,18:48:29,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,stable,S&P Sees AmerisourceBergen Corp. Outlk Stable,NEWS-FLASH,Dow Jones Newswires,S&P Sees AmerisourceBergen Corp. Outlk Stable
COR,2022-12-09,01:41:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.0 billion of Proceeds
COR,2022-12-09,01:41:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.0 billion of Proceeds
COR,2022-12-09,01:47:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance >ABC
COR,2022-12-09,01:47:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2022-12-09,01:47:01,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2022-12-09,01:50:58,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen: Agreed to Repurchase Around $200M Common Shares,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen: Agreed to Repurchase Around $200M Common Shares From Walgreens Boots Alliance >ABC
COR,2022-12-09,01:51:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen: Repurchased Shares to,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen: Repurchased Shares to Be Held in Treasury >ABC
COR,2022-12-12,21:22:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Donato Sells 3,014 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,014 Of AmerisourceBergen Corp >ABC"
COR,2022-12-12,21:39:40,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Donato Registers 3,014 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,014 Of AmerisourceBergen Corp >ABC"
COR,2022-12-12,22:28:43,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 5,961,534 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 5,961,534 Of AmerisourceBergen Corp >ABC"
COR,2022-12-13,20:37:07,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 33,000 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 33,000 Of AmerisourceBergen Corp >ABC"
COR,2022-12-13,21:04:03,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,Vp Clark Registers 392 Of AmerisourceBergen Corp >ABC,RNS-SEC144,Dow Jones Newswires,VP Clark Registers 392 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,20:08:05,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 45,920 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 45,920 Of AmerisourceBergen Corp >ABC"
COR,2022-12-14,21:48:16,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Krikorian Acquires 172 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 172 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,21:49:34,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Cfo Cleary Jr Acquires 371 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,CFO Cleary Jr Acquires 371 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,21:52:14,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Coo Mauch Acquires 505 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,COO Mauch Acquires 505 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,21:54:11,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 78,920 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 78,920 Of AmerisourceBergen Corp >ABC"
COR,2022-12-14,22:35:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,Vp Clark Sells 392 Of AmerisourceBergen Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Clark Sells 392 Of AmerisourceBergen Corp >ABC
COR,2022-12-19,16:33:33,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Battaglia Registers 9,852 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 9,852 Of AmerisourceBergen Corp >ABC"
COR,2022-12-20,18:00:09,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2022-12-20,18:00:09,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2022-12-20,18:00:19,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -2-
COR,2022-12-20,18:00:29,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -3-
COR,2022-12-20,21:03:44,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Battaglia Sells 9,852 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 9,852 Of AmerisourceBergen Corp >ABC"
COR,2022-12-22,19:15:33,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Krikorian Registers 2,218 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 2,218 Of AmerisourceBergen Corp >ABC"
COR,2022-12-22,21:06:14,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 2,218 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 2,218 Of AmerisourceBergen Corp >ABC"
COR,2022-12-23,18:42:45,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,Vp Donato Registers 930 Of AmerisourceBergen Corp >ABC,RNS-SEC144,Dow Jones Newswires,VP Donato Registers 930 Of AmerisourceBergen Corp >ABC
COR,2022-12-23,21:05:29,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,Vp Donato Sells 930 Of AmerisourceBergen Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Sells 930 Of AmerisourceBergen Corp >ABC
COR,2022-12-29,16:39:41,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis -- WSJ
COR,2022-12-29,16:40:11,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis
COR,2022-12-29,17:55:38,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis -- Update
COR,2022-12-29,20:22:17,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis -- 2nd Update
COR,2022-01-03,21:16:18,7D85A9,AmerisourceBergen Corp.,100,0.0,insider-trading,,"Chmn Collis Gifts 1,159 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Gifts 1,159 Of AmerisourceBergen Corp >ABC"
COR,2022-01-04,21:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release
COR,2022-01-04,21:28:34,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2022 Earnings Release
COR,2022-01-11,12:27:19,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Barclays
COR,2022-01-11,12:27:19,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $152.00/Share From $135.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $152.00/Share From $135.00 by Barclays
COR,2022-01-13,21:23:38,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,264 Of AmerisourceBergen Corp >ABC"
COR,2022-01-22,09:09:39,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2021 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2021 (ABC)"
COR,2022-01-25,13:30:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"World Courier, collaborates with multiple orchestration platform providers, including TrakCel, to deliver systems",PRESS-RELEASE,Business Wire,AmerisourceBergen and TrakCel Launch Integrated Platform to Support Cell and Gene Therapies
COR,2022-01-25,14:30:00,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,AmerisourceBergen Corp.: Investing in our,PRESS-RELEASE,Business Wire,"AmerisourceBergen Welcomes New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-25,14:31:39,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Names New SVP and Chief,NEWS-FLASH,Dow Jones Newswires,"AmerisourceBergen Names New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-25,14:31:39,7D85A9,AmerisourceBergen Corp.,100,0.53,labor-issues,,Amerisourcebergen Names New SVP and Chief,NEWS-FLASH,Dow Jones Newswires,"AmerisourceBergen Names New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-25,14:32:15,7D85A9,AmerisourceBergen Corp.,99,0.22,acquisitions-mergers,,AmerisourceBergen Corp.: Investing in our,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Welcomes New SVP and Chief Diversity Equity and Inclusion Officer, Ann Anaya"
COR,2022-01-26,19:07:04,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Amerisourcebergen Corporation
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Adj EPS $2.58,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Adj EPS $2.58 >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.60-Adj EPS $10.90 >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,1Q EPS $2.13 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q EPS $2.13 >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 1Q Rev $59.6B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Rev $59.6B >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 First Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenues of $59.6B billion for the First Quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.60 to $10.90,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 first quarter ended December 31, 2021, revenue increased 13.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Our updated fiscal 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2022 first quarter, net interest expense of $53.4 million was up 58.8 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2022, revenue was $59.6 billion, up 13.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Revenue in International Healthcare Solutions was $6.6 billion in the first quarter of fiscal 2022,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2022 was $180.1 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,Amerisourcebergen extended its pharmaceutical supply agreement with Express Scripts,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Interest expense to be in the range of $210 to $215 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 1.83,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,95,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.46,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,577,564 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 First -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Net $449.1M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Net $449.1M >ABC
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenues of $59.6B billion for the First Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.60 to $10.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 first quarter ended December 31, 2021, revenue increased 13.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Our updated fiscal 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.56,equity-actions,up,"AmerisourceBergen Corp.: In the fiscal 2022 first quarter, net interest expense of $53.4 million was up 58.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2022, revenue was $59.6 billion, up 13.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 First Quarter Results
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: Revenue in International Healthcare Solutions was $6.6 billion in the first quarter of fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2022 was $180.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,Amerisourcebergen extended its pharmaceutical supply agreement with Express Scripts,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Interest expense to be in the range of $210 to $215 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,98,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,577,564 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-02-02,11:35:00,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,Amerisourcebergen Q1 EPS $2.13 vs. $1.81 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 EPS $2.13 vs. $1.81 a year ago
COR,2022-02-02,11:35:19,7D85A9,AmerisourceBergen Corp.,100,0.54,earnings,meet-expectations,"Amerisourcebergen Q1 adj. EPS $2.58, matching",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q1 adj. EPS $2.58, matching FactSet consensus"
COR,2022-02-02,11:35:57,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,Amerisourcebergen Q1 revenue $59.6 bln vs. $52.5 bln a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 revenue $59.6 bln vs. $52.5 bln a year ago; FactSet consensus $59.6 bln
COR,2022-02-02,11:36:53,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees FY22 adj. EPS of $10.60 to $10.90,NEWS-FLASH,MarketWatch,MW AmerisourceBergen now sees FY22 adj. EPS of $10.60 to $10.90 vs. prior guidance of $10.50 to $10.80
COR,2022-02-02,17:37:33,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call Transcript >ABC
COR,2022-02-02,21:41:23,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 44,492 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 44,492 Of AmerisourceBergen Corp >ABC"
COR,2022-02-03,13:29:11,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2022-02-03,13:29:11,7D85A9,AmerisourceBergen Corp.,100,0.66,price-targets,upgrade,Amerisourcebergen Price Target Raised to $139.00/Share From $130.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $139.00/Share From $130.00 by Mizuho
COR,2022-02-04,21:02:38,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 11,653 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 11,653 Of AmerisourceBergen Corp >ABC"
COR,2022-02-04,21:06:27,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Campbell Sells 14,034 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 14,034 Of AmerisourceBergen Corp >ABC"
COR,2022-02-05,09:13:18,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen's CEO Steve Collis on Q1 2022 Results -- Earnings Call Transcript >ABC
COR,2022-02-09,21:38:53,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 24,263 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 24,263 Of AmerisourceBergen Corp >ABC"
COR,2022-02-24,13:35:37,7D85A9,AmerisourceBergen Corp.,99,0.53,labor-issues,,Amerisourcebergen Adds Freight Management,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Adds Freight Management Capabilities Powered by TRIOSE, Inc. for Hospital & Health System Customers"
COR,2022-03-02,22:24:54,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Battaglia Acquires 6,146 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 6,146 Of AmerisourceBergen Corp >ABC"
COR,2022-03-09,22:40:32,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-03-11,20:43:01,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Battaglia Acquires 674 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 674 Of AmerisourceBergen Corp >ABC
COR,2022-03-15,14:11:30,7D85A9,AmerisourceBergen Corp.,100,0.01,credit-ratings,affirmation,Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating,NEWS-FLASH,Dow Jones Newswires,"Moody's Affirms Amerisourcebergen's Baa2 Senior Unsecured Rating, Outlook Remains Stable"
COR,2022-03-16,20:00:53,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Battaglia Sells 6,820 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 6,820 Of AmerisourceBergen Corp >ABC"
COR,2022-03-28,20:40:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day
COR,2022-03-28,20:40:09,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day
COR,2022-03-30,20:02:33,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 43,704 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 43,704 Of AmerisourceBergen Corp >ABC"
COR,2022-04-06,18:00:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Amerisourcebergen partnered with TrakCel, a leading innovator of cellular orchestration solutions",PRESS-RELEASE,Business Wire,AmerisourceBergen Launches $150M Venture Capital Fund
COR,2022-04-12,10:15:16,7D85A9,AmerisourceBergen Corp.,100,-0.58,analyst-ratings,negative,Amerisourcebergen Cut to Equal-Weight From Overweight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Cut to Equal-Weight From Overweight by Morgan Stanley
COR,2022-04-12,10:15:16,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $178.00/Share by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $178.00/Share by Morgan Stanley
COR,2022-04-12,14:53:39,7D85A9,AmerisourceBergen Corp.,100,-0.58,analyst-ratings,negative,Amerisourcebergen downgraded to equal weight from overweight at Morgan Stanley,NEWS-FLASH,MarketWatch,MW AmerisourceBergen downgraded to equal weight from overweight at Morgan Stanley
COR,2022-04-13,20:23:43,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-04-21,12:30:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Amerisourcebergen Partners with Chronicled to,PRESS-RELEASE,Business Wire,AmerisourceBergen Partners with Chronicled to Optimize Pharmaceutical Chargeback Accuracy Using Blockchain-Powered Technology
COR,2022-04-22,08:05:54,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2022 (ABC)"
COR,2022-04-28,12:30:00,7D85A9,AmerisourceBergen Corp.,100,0.52,products-services,,Amerisourcebergen Launches Home Infusion Solution for,PRESS-RELEASE,Business Wire,AmerisourceBergen Launches Home Infusion Solution for Health Systems Nationwide
COR,2022-04-28,12:33:15,7D85A9,AmerisourceBergen Corp.,99,0.52,products-services,,Amerisourcebergen Launches Home Infusion Solution for,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Launches Home Infusion Solution for Health Systems Nationwide
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.80-Adj EPS $11.05 >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $3.22,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $3.22 >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,2Q EPS $2.59 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q EPS $2.59 >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 2Q Rev $57.7B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Rev $57.7B >ABC
COR,2022-05-04,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Net $548M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Net $548M >ABC
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Second Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $57.7 billion for the Second Quarter, a 17.4 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.59,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.80 to $11.05,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 second quarter ended March 31, 2022, revenue increased 17.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, revenue was $57.7 billion, up 17.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, net interest expense of $52.9 million was up 53.3 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2022 was $187.1 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other national pharmaceutical distributors reached an agreement to,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.62 $ 2.12,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 4.77 $ 3.96,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.12,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,308,153 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Second -8-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Second Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $57.7 billion for the Second Quarter, a 17.4 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.59,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.80 to $11.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 second quarter ended March 31, 2022, revenue increased 17.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, revenue was $57.7 billion, up 17.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.54,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2022, net interest expense of $52.9 million was up 53.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2022 was $187.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other national pharmaceutical distributors reached an agreement to,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.62 $ 2.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 4.77 $ 3.96,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,308,153 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-05-04,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2022-05-04,10:32:21,7D85A9,AmerisourceBergen Corp.,100,0.42,earnings,up,Amerisourcebergen Q2 EPS $2.59 vs. $2.10 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 EPS $2.59 vs. $2.10 a year ago
COR,2022-05-04,10:32:54,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q2 adj. EPS $3.22; FactSet consensus $2.92,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q2 adj. EPS $3.22; FactSet consensus $2.92
COR,2022-05-04,10:33:40,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,"Amerisourcebergen Q2 revenue $57.7 bln, up 17.4%; FactSet consensus $57.5 bln",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q2 revenue $57.7 bln, up 17.4%; FactSet consensus $57.5 bln"
COR,2022-05-04,10:34:59,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees full-year adj. EPS of $10.80 to $11.05,NEWS-FLASH,MarketWatch,MW AmerisourceBergen now sees full-year adj. EPS of $10.80 to $11.05 vs. prior $10.60 to $10.90
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen beats earnings expectations,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported first-quarter profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Beats Earnings Expectations,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,10:51:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported first-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen beats earnings expectations,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported fiscal second-quarter profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats earnings expectations, and lifts full-year guidance"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Beats Earnings Expectations,FULL-ARTICLE,Dow Jones Newswires,"Update: AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,10:53:31,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported fiscal second-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"Update: AmerisourceBergen Beats Earnings Expectations, And Lifts Full-year Guidance -- MarketWatch"
COR,2022-05-04,14:17:35,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corporation CEO Steve Collis on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corporation CEO Steve Collis on Q2 2022 Results -- Earnings Call Transcript >ABC
COR,2022-05-05,12:43:10,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2022-05-05,12:43:10,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $162.00/Share From $139.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $162.00/Share From $139.00 by Mizuho
COR,2022-05-05,15:13:31,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Hold by Deutsche Bank
COR,2022-05-05,15:13:31,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $168.00/Share From $153.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $168.00/Share From $153.00 by Deutsche Bank
COR,2022-05-11,21:47:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation
COR,2022-05-11,21:47:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation
COR,2022-05-11,21:49:50,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Six M Shrs of AmerisourceBergen Corp,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Six M Shrs of AmerisourceBergen Corp
COR,2022-05-11,21:52:12,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sold 6M Shrs of AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sold 6M Shrs of AmerisourceBergen at $150/Shr >WBA
COR,2022-05-12,12:01:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: Resuming share repurchases,PRESS-RELEASE,Business Wire,AmerisourceBergen Provides Update on Capital Deployment
COR,2022-05-12,12:01:01,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: Resuming share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Provides Update on Capital Deployment
COR,2022-05-12,15:06:22,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,It sold 6.0 million AmerisourceBergen shares,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares
COR,2022-05-12,15:23:56,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,It sold 6.0 million AmerisourceBergen shares,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares
COR,2022-05-12,20:44:44,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 6,759 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 6,759 Of AmerisourceBergen Corp >ABC"
COR,2022-05-12,20:45:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-05-13,20:06:57,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 4,895 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 4,895 Of AmerisourceBergen Corp >ABC"
COR,2022-05-13,21:02:02,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 6,000,000 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 6,000,000 Of AmerisourceBergen Corp >ABC"
COR,2022-05-23,12:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,products-services,start,Amerisourcebergen Launches Clinical Trial,PRESS-RELEASE,Business Wire,AmerisourceBergen Launches Clinical Trial Navigator to Bolster Equitable and Accessible Community-Based Research Opportunities Nationwide
COR,2022-05-25,12:18:55,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Hold by Deutsche Bank
COR,2022-05-25,12:18:55,7D85A9,AmerisourceBergen Corp.,100,-0.17,price-targets,downgrade,Amerisourcebergen Price Target Cut to $167.00/Share From $168.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $167.00/Share From $168.00 by Deutsche Bank
COR,2022-05-26,11:21:51,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen Raised to Overweight From Equal-Weight by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raised to Overweight From Equal-Weight by Barclays
COR,2022-05-26,11:21:51,7D85A9,AmerisourceBergen Corp.,100,0.5,price-targets,upgrade,Amerisourcebergen Price Target Raised to $182.00/Share From $175.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $182.00/Share From $175.00 by Barclays
COR,2022-05-27,11:50:58,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Morgan Stanley
COR,2022-05-27,11:50:58,7D85A9,AmerisourceBergen Corp.,100,-0.32,price-targets,downgrade,Amerisourcebergen Price Target Cut to $175.00/Share From $178.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $175.00/Share From $178.00 by Morgan Stanley
COR,2022-06-01,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,unchanged,AmerisourceBergen Corp.: The company reiterated its fiscal year 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,approved,Amerisourcebergen's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Business Wire,AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,unchanged,AmerisourceBergen Corp.: The company reiterated its fiscal year 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,approved,Amerisourcebergen's Board of Directors authorized a new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook
COR,2022-06-01,10:30:31,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,approved,Amerisourcebergen Board Authorized New $1B Shr Repurchase Program,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Board Authorized New $1B Shr Repurchase Program >ABC
COR,2022-06-01,10:30:46,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,unchanged,Amerisourcebergen Reiterates Guidance for Fiscal 2022,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Reiterates Guidance for Fiscal 2022 >ABC
COR,2022-06-01,10:31:26,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,unchanged,Amerisourcebergen Backs FY Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Backs FY Adj EPS $10.80-Adj EPS $11.05 >ABC
COR,2022-06-01,10:33:13,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen sets new $1 bln stock repurchase program,NEWS-FLASH,MarketWatch,MW AmerisourceBergen sets new $1 bln stock repurchase program
COR,2022-06-01,10:39:09,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen sets $1 billion stock buyback program,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen sets $1 billion stock buyback program
COR,2022-06-01,10:39:09,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Sets $1 Billion Stock Buyback Program,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Sets $1 Billion Stock Buyback Program -- MarketWatch
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.64,earnings,up,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.64,earnings,up,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: The Company's fiscal year 2022 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
COR,2022-06-01,20:32:58,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,unchanged,Amerisourcebergen Backs FY22 Adj EPS $10.80,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Backs FY22 Adj EPS $10.80-Adj EPS $11.05 >ABC
COR,2022-06-07,10:59:06,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen upgraded to buy from hold at Deutsche Bank,NEWS-FLASH,MarketWatch,MW AmerisourceBergen upgraded to buy from hold at Deutsche Bank
COR,2022-06-07,11:34:06,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen Raised to Buy From Hold by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raised to Buy From Hold by Deutsche Bank
COR,2022-06-07,11:34:06,7D85A9,AmerisourceBergen Corp.,100,0.64,price-targets,upgrade,Amerisourcebergen Price Target Raised to $178.00/Share From $167.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $178.00/Share From $167.00 by Deutsche Bank
COR,2022-06-09,13:15:49,7D85A9,AmerisourceBergen Corp.,100,0.2,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Cowen & Co.
COR,2022-06-09,13:15:49,7D85A9,AmerisourceBergen Corp.,100,-0.17,price-targets,downgrade,Amerisourcebergen Price Target Cut to $170.00/Share From $171.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $170.00/Share From $171.00 by Cowen & Co.
COR,2022-06-13,11:37:43,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by UBS
COR,2022-06-13,11:37:43,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $174.00/Share From $144.00 by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $174.00/Share From $144.00 by UBS
COR,2022-06-13,14:16:47,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen stock price target raised to $174 from $144 at UBS,NEWS-FLASH,MarketWatch,MW AmerisourceBergen stock price target raised to $174 from $144 at UBS
COR,2022-06-16,20:21:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-06-22,12:30:13,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,AmerisourceBergen Corp.: Torigen Pharmaceuticals Inks National Distribution Deal with MWI,PRESS-RELEASE,PR Newswire,Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health
COR,2022-06-22,12:30:13,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: The strategic relationship with MWI,PRESS-RELEASE,PR Newswire,Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health
COR,2022-06-22,18:27:05,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-06-29,16:48:00,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,"Petvivo HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI",PRESS-RELEASE,GlobeNewswire,"PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI ANIMAL HEALTH"
COR,2022-06-29,16:48:01,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,"Petvivo HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI",PRESS-RELEASE,Dow Jones Newswires,"Press Release: PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION SERVICES AGREEMENT WITH MWI ANIMAL HEALTH"
COR,2022-06-29,20:15:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release
COR,2022-06-29,22:11:10,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release
COR,2022-07-06,16:23:43,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Chou Registers 12,968 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Chou Registers 12,968 Of AmerisourceBergen Corp >ABC"
COR,2022-07-11,10:36:27,7D85A9,AmerisourceBergen Corp.,100,-0.58,analyst-ratings,negative,Amerisourcebergen Cut to In-Line From Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Cut to In-Line From Outperform by Evercore ISI Group
COR,2022-07-11,10:36:27,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $150.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $150.00/Share by Evercore ISI Group
COR,2022-07-14,20:05:49,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-07-20,13:43:34,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by Argus Research
COR,2022-07-20,13:43:34,7D85A9,AmerisourceBergen Corp.,100,0.62,price-targets,upgrade,Amerisourcebergen Price Target Raised to $170.00/Share From $160.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $170.00/Share From $160.00 by Argus Research
COR,2022-07-20,16:48:07,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-07-22,07:57:39,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2022 (ABC)"
COR,2022-07-22,20:06:23,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Donato Acquires 898 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Acquires 898 Of AmerisourceBergen Corp >ABC
COR,2022-07-27,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.52,products-services,,Amerisourcebergen to Launch Digital Therapeutics Platform to,PRESS-RELEASE,Business Wire,AmerisourceBergen to Launch Digital Therapeutics Platform to Facilitate Access to Innovative Products
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Adj EPS $2.62,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Adj EPS $2.62 >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 3Q Rev $60.1B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Rev $60.1B >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $10.90,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $10.90-Adj EPS $11.10 >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,3Q EPS $1.92 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q EPS $1.92 >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Net $407M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Net $407M >ABC
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Third Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $60.1 billion for the Third Quarter, a 12.5 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.92,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.90 to $11.10,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 third quarter ended June 30, 2022, revenue increased 12.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, revenue was $60.1 billion, up 12.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2022,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.13,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, net interest expense of $52.9 million was up 3.0 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -7-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2022 was $176.3 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other distributors reached an agreement to,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: Conference Call,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -2-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -3-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:00,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.95 $ 1.42,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.36,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -5-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.14,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,173,630 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Third -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Third Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $60.1 billion for the Third Quarter, a 12.5 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $1.92,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $10.90 to $11.10,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 third quarter ended June 30, 2022, revenue increased 12.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, revenue was $60.1 billion, up 12.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the third quarter of fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,equity-actions,up,AmerisourceBergen Corp.: The increase in operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.13,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2022, net interest expense of $52.9 million was up 3.0 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2022 was $176.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2022 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.39,products-services,,AmerisourceBergen Corp.: the Company and the two other distributors reached an agreement to,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,96,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.95 $ 1.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.36,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,assets,,"AmerisourceBergen Corp.: Total assets $57,173,630 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-08-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-08-03,10:30:54,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Had Seen FY Adjusted EPS $10.80-$11.05,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Had Seen FY Adjusted EPS $10.80-$11.05 >ABC
COR,2022-08-03,10:32:30,7D85A9,AmerisourceBergen Corp.,100,0.52,earnings,up,Amerisourcebergen Q3 EPS $1.92 vs. $1.40 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 EPS $1.92 vs. $1.40 a year ago
COR,2022-08-03,10:32:46,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q3 adj. EPS $2.62; FactSet consensus $2.56,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 adj. EPS $2.62; FactSet consensus $2.56
COR,2022-08-03,10:33:22,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q3 revenue $60.06 bln vs. $53.41 bln a year ago; FactSet consensus $59.08 bln,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q3 revenue $60.06 bln vs. $53.41 bln a year ago; FactSet consensus $59.08 bln
COR,2022-08-03,10:33:54,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen raises FY2022 adj. EPS outlook to $10.90-$11.10 from $10.80-$11.05,NEWS-FLASH,MarketWatch,MW AmerisourceBergen raises FY2022 adj. EPS outlook to $10.90-$11.10 from $10.80-$11.05
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen beats profit and revenue expectations,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats profit and revenue expectations, raises full-year outlook"
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported Wednesday fiscal third-quarter profit,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen beats profit and revenue expectations, raises full-year outlook"
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Beats Profit And Revenue Expectations,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Profit And Revenue Expectations, Raises Full-year Outlook -- MarketWatch"
COR,2022-08-03,10:44:38,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen Corp. (ABC) reported Wednesday fiscal third-quarter profit,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Beats Profit And Revenue Expectations, Raises Full-year Outlook -- MarketWatch"
COR,2022-08-03,15:52:45,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,Amerisourcebergen Corp CEO Steven Collis on Q3 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Amerisourcebergen Corp CEO Steven Collis on Q3 2022 Results -- Earnings Call Transcript >ABC
COR,2022-08-04,13:05:59,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2022-08-04,13:05:59,7D85A9,AmerisourceBergen Corp.,100,-0.44,price-targets,downgrade,Amerisourcebergen Price Target Cut to $175.00/Share From $180.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $175.00/Share From $180.00 by Credit Suisse
COR,2022-08-11,20:15:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-08-17,19:08:27,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-08-22,12:08:31,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Morgan Stanley
COR,2022-08-22,12:08:31,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $176.00/Share From $175.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $176.00/Share From $175.00 by Morgan Stanley
COR,2022-08-24,18:20:30,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Chou Registers 17,561 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Chou Registers 17,561 Of AmerisourceBergen Corp >ABC"
COR,2022-09-01,20:08:48,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,Vp Clark Sells 288 Of AmerisourceBergen Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Clark Sells 288 Of AmerisourceBergen Corp >ABC
COR,2022-09-06,20:51:19,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Donato Acquires 1,867 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 1,867 Of AmerisourceBergen Corp >ABC"
COR,2022-09-07,17:15:18,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,Vp Clark Registers 288 Of AmerisourceBergen Corp >ABC,RNS-SEC144,Dow Jones Newswires,VP Clark Registers 288 Of AmerisourceBergen Corp >ABC
COR,2022-09-07,18:47:46,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Chou Registers 15,264 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Chou Registers 15,264 Of AmerisourceBergen Corp >ABC"
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen To Expand Global Biopharma Services Platform With Acquisition Of PharmaLex >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen To Expand Global Biopharma Services Platform With Acquisition Of PharmaLex >ABC
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: our partnerships with manufacturers, advancing our",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen to Expand Global -2-
COR,2022-09-12,12:15:01,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex,PRESS-RELEASE,Business Wire,AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,"AmerisourceBergen Corp.: our partnerships with manufacturers, advancing our",PRESS-RELEASE,Business Wire,AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex
COR,2022-09-12,12:15:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,AmerisourceBergen to Expand Global Biopharma -2-
COR,2022-09-12,12:16:24,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen agrees to acquire PharmaLex for 1.28 bln euros,NEWS-FLASH,MarketWatch,MW AmerisourceBergen agrees to acquire PharmaLex for 1.28 bln euros in cash
COR,2022-09-12,12:16:36,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Acquire PharmaLex From Funds Advised by AUCTUS Capital Partners for EUR1.28B in Cash,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen to Acquire PharmaLex From Funds Advised by AUCTUS Capital Partners for EUR1.28B in Cash >ABC
COR,2022-09-12,12:23:25,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen Agrees To Acquire Germany's PharmaLex For 1.28 Billion Euros,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Agrees To Acquire Germany's PharmaLex For 1.28 Billion Euros In Cash -- MarketWatch
COR,2022-09-12,12:23:25,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen agrees to acquire Germany's PharmaLex for 1.28 billion euros,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen agrees to acquire Germany's PharmaLex for 1.28 billion euros in cash
COR,2022-09-12,12:36:35,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to Buy PharmaLex for $1.3 Billion >ABC,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen to Buy PharmaLex for $1.3 Billion >ABC
COR,2022-09-14,19:51:04,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-09-15,20:25:56,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-09-27,11:15:00,7D85A9,AmerisourceBergen Corp.,99,0.47,labor-issues,,Kim joining AmerisourceBergen's Board of Directors,PRESS-RELEASE,Business Wire,"AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors"
COR,2022-09-27,11:15:00,7D85A9,AmerisourceBergen Corp.,99,0.47,labor-issues,,Kim joining AmerisourceBergen's Board of Directors,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors"
COR,2022-09-27,11:16:33,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,Amerisourcebergen Names Lorence H. Kim to Board,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Names Lorence H. Kim to Board
COR,2022-09-27,12:05:00,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,R) and AmerisourceBergen Announce Strategic Commercialization Agreement,PRESS-RELEASE,GlobeNewswire,Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,A relationship with AmerisourceBergen for,PRESS-RELEASE,GlobeNewswire,Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:01,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,R) and AmerisourceBergen Announce Strategic Commercialization Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:01,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,A relationship with AmerisourceBergen for,PRESS-RELEASE,Dow Jones Newswires,Press Release: Outlook Therapeutics(R) and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:05:31,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Outlook Therapeutics and AmerisourceBergen Announce Strategic Commercialization Agreement,NEWS-FLASH,Dow Jones Newswires,Outlook Therapeutics and AmerisourceBergen Announce Strategic Commercialization Agreement for ONS-5010 for the Treatment of Wet AMD
COR,2022-09-27,12:07:27,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Outlook Therapeutics Exploring Relationship With AmerisourceBergen to,NEWS-FLASH,Dow Jones Newswires,Outlook Therapeutics Exploring Relationship With AmerisourceBergen to Support Launch of ONS-5010 in Intl Markets >OTLK
COR,2022-09-28,11:15:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release
COR,2022-10-03,11:23:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: our relationship with MWI will provide,PRESS-RELEASE,GlobeNewswire,"PETVIVO HOLDING, INC. ANNOUNCES SPRYNG(TM) NOW AVAILABLE TO VETERNARIANS THROUGH MWI ANIMAL HEALTH"
COR,2022-10-03,11:23:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: our relationship with MWI will provide,PRESS-RELEASE,Dow Jones Newswires,"Press Release: PETVIVO HOLDING, INC. ANNOUNCES SPRYNG(TM) NOW AVAILABLE TO VETERNARIANS THROUGH MWI ANIMAL HEALTH"
COR,2022-10-11,11:38:05,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen Raised to Buy From Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Raised to Buy From Neutral by B of A Securities
COR,2022-10-11,11:38:05,7D85A9,AmerisourceBergen Corp.,100,0.6,price-targets,upgrade,Amerisourcebergen Price Target Raised to $169.00/Share From $160.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $169.00/Share From $160.00 by B of A Securities
COR,2022-10-11,13:48:20,7D85A9,AmerisourceBergen Corp.,100,0.94,analyst-ratings,positive,Amerisourcebergen upgraded to buy from neutral at BofA Securities,NEWS-FLASH,MarketWatch,MW AmerisourceBergen upgraded to buy from neutral at BofA Securities
COR,2022-10-12,20:12:36,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-10-12,20:33:05,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 11,480 Of AmerisourceBergen Corp >ABC"
COR,2022-10-18,14:06:22,7D85A9,AmerisourceBergen Corp.,100,0.2,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Cowen & Co.
COR,2022-10-18,14:06:22,7D85A9,AmerisourceBergen Corp.,100,-0.17,price-targets,downgrade,Amerisourcebergen Price Target Cut to $169.00/Share From $170.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Cut to $169.00/Share From $170.00 by Cowen & Co.
COR,2022-10-22,08:05:22,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2022 (ABC)"
COR,2022-10-25,12:00:00,7D85A9,AmerisourceBergen Corp.,99,0.18,acquisitions-mergers,,AmerisourceBergen Corp.: The company received investment from strategic investors Shanda Group and AmerisourceBergen's AB Health,PRESS-RELEASE,Business Wire,WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million
COR,2022-10-25,12:01:04,7D85A9,AmerisourceBergen Corp.,99,0.18,acquisitions-mergers,,AmerisourceBergen Corp.: The company received investment from strategic investors Shanda Group and AmerisourceBergen's AB Health,PRESS-RELEASE,Dow Jones Newswires,Press Release: WhizAI Closes New Round with Investment from Shanda Group and AmerisourceBergen Bringing Total Capital Raised to $21 Million
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.30,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.30-Adj EPS $11.60 >ABC
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 4Q Rev $61.2B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Rev $61.2B >ABC
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Adj EPS $2.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Adj EPS $2.60 >ABC
COR,2022-11-03,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.30,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.30-Adj EPS $11.60 >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,4Q EPS $1.40 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q EPS $1.40 >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $61.2 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent to $238.6 billion for the fiscal year,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2022 GAAP Diluted EPS of $8.04,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 fourth quarter ended September 30, 2022, revenue increased 3.8 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, adjusted diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, diluted EPS",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2022,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2022, revenue was $61.2 billion, up 3.8 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.38,earnings,up,AmerisourceBergen Corp.: Operating income increased 0.5 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2022 Summary Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Operating expenses increased 29.2 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, GAAP diluted EPS was $8.04",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent from last fiscal year to $238.6 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,AmerisourceBergen Corp.: Gross profit increased 19.5 percent to $8.3 billion,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, adjusted diluted EPS was $11.03",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.485,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.68,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue decline,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 2.11,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.25,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -5-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.48,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 56,560,616 $ 57,337,805",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2022 Fourth -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2022 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,AmerisourceBergen Corp.: Revenue of $61.2 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fourth Quarter GAAP Diluted EPS of $1.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent to $238.6 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Fiscal Year 2022 GAAP Diluted EPS of $8.04,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 fourth quarter ended September 30, 2022, revenue increased 3.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,"AmerisourceBergen Corp.: For fiscal year 2022, diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the fourth quarter of fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the fourth quarter of fiscal 2022, revenue was $61.2 billion, up 3.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.38,earnings,up,AmerisourceBergen Corp.: Operating income increased 0.5 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Fiscal Year 2022 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.4,equity-actions,up,AmerisourceBergen Corp.: Operating expenses increased 29.2 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, GAAP diluted EPS was $8.04",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.41,revenues,up,AmerisourceBergen Corp.: Revenue increased 11.5 percent from last fiscal year to $238.6 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,AmerisourceBergen Corp.: Gross profit increased 19.5 percent to $8.3 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,"AmerisourceBergen Corp.: In fiscal year 2022, adjusted diluted EPS was $11.03",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,revenues,up,AmerisourceBergen Corp.: Adjusted operating income margin increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,dividends,,AmerisourceBergen Corp.: The quarterly dividend of $0.485,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.68,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue decline,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 1.42 $ 2.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.25,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,93,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 56,560,616 $ 57,337,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Adj EPS $2.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Adj EPS $2.60 >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 4Q Rev $61.2B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Rev $61.2B >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Net $294.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Net $294.7M >ABC
COR,2022-11-03,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,4Q EPS $1.40 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q EPS $1.40 >ABC
COR,2022-11-03,10:30:02,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 4Q Net $294.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 4Q Net $294.7M >ABC
COR,2022-11-03,10:35:10,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen Sees FY23 Revenue Growth of 5%-7%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Revenue Growth of 5%-7% >ABC
COR,2022-11-03,10:35:34,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen Sees FY23 Constant-Currency Revenue Growth 6%-8%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Constant-Currency Revenue Growth 6%-8% >ABC
COR,2022-11-03,10:36:17,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen Sees FY23 Capital Spending in $500M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Capital Spending in $500M Range >ABC
COR,2022-11-03,10:39:43,7D85A9,AmerisourceBergen Corp.,100,-0.48,earnings,down,Amerisourcebergen Q4 EPS $1.40 vs. $2.08 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 EPS $1.40 vs. $2.08 a year ago
COR,2022-11-03,10:40:07,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q4 adj. EPS $2.60; FactSet consensus $2.57,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q4 adj. EPS $2.60; FactSet consensus $2.57
COR,2022-11-03,10:40:30,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,"Amerisourcebergen Q4 revenue $61.2 bln, up 3.8%; FactSet consensus $60.5 bln",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q4 revenue $61.2 bln, up 3.8%; FactSet consensus $60.5 bln"
COR,2022-11-03,10:41:29,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen still sees FY23 adj. EPS of $11.30 to $11.60,NEWS-FLASH,MarketWatch,MW AmerisourceBergen still sees FY23 adj. EPS of $11.30 to $11.60
COR,2022-11-03,10:52:26,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen profit falls but tops estimates,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen profit falls but tops estimates for Q4
COR,2022-11-03,10:52:26,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,above-expectations,Amerisourcebergen Profit Falls But Tops Estimates,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Profit Falls But Tops Estimates For Q4 -- MarketWatch
COR,2022-11-04,22:20:21,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Mauch Sells 21,802 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Mauch Sells 21,802 Of AmerisourceBergen Corp >ABC"
COR,2022-11-07,21:21:36,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Mauch Registers 21,802 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Mauch Registers 21,802 Of AmerisourceBergen Corp >ABC"
COR,2022-11-07,22:05:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Secondary Public Offering Of,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Announces Secondary Public Offering Of Common Shares And Common Share Repurchase >ABC
COR,2022-11-07,22:05:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Secondary Public Offering of,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-07,22:05:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10 million shares of common stock of the Company,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-07,22:05:01,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Secondary Public Offering of,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-07,22:05:01,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10 million shares of common stock of the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase
COR,2022-11-08,03:36:01,7D85A9,AmerisourceBergen Corp.,95,0.59,equity-actions,,Offering of 10 million shares of AmerisourceBergen Corporation (NYSE: ABC),PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Announces Offering of 10 Million Shares of AmerisourceBergen Corporation
COR,2022-11-08,03:36:01,7D85A9,AmerisourceBergen Corp.,96,0.59,equity-actions,,Offering of 10 million shares of AmerisourceBergen Corporation (NYSE: ABC),PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Announces Offering of 10 Million Shares of AmerisourceBergen Corporation
COR,2022-11-09,13:02:11,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 13,234,153 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 13,234,153 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:53:15,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Clark Acquires 13,523 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 13,523 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:53:47,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 22,152 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 22,152 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:55:02,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Chmn Collis Acquires 89,323 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 89,323 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:57:01,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Campbell Acquires 4,895 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 4,895 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:57:42,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Donato Acquires 6,322 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 6,322 Of AmerisourceBergen Corp >ABC"
COR,2022-11-14,23:58:37,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Battaglia Acquires 10,231 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 10,231 Of AmerisourceBergen Corp >ABC"
COR,2022-11-15,00:00:16,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Krikorian Acquires 5,928 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 5,928 Of AmerisourceBergen Corp >ABC"
COR,2022-11-15,00:00:43,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Coo Mauch Acquires 23,687 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Acquires 23,687 Of AmerisourceBergen Corp >ABC"
COR,2022-11-16,21:15:01,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,"Amerisourcebergen Elects Redonda Miller, M.D., to its Board of Directors",PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen Elects Redonda Miller, M.D., to its Board of Directors"
COR,2022-11-16,21:15:01,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,"Amerisourcebergen Elects Redonda Miller, M.D., to its Board of Directors",PRESS-RELEASE,Business Wire,"AmerisourceBergen Elects Redonda Miller, M.D., to its Board of Directors"
COR,2022-11-16,21:15:05,7D85A9,AmerisourceBergen Corp.,100,0.47,labor-issues,,"Amerisourcebergen Elects Redonda Miller, M.D., to Its Bd of Directors",NEWS-FLASH,Dow Jones Newswires,"AmerisourceBergen Elects Redonda Miller, M.D., to Its Bd of Directors"
COR,2022-11-22,13:42:15,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Credit Suisse
COR,2022-11-22,13:42:15,7D85A9,AmerisourceBergen Corp.,100,0.5,price-targets,upgrade,Amerisourcebergen Price Target Raised to $182.00/Share From $175.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $182.00/Share From $175.00 by Credit Suisse
COR,2022-12-01,18:48:29,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,stable,S&P Sees AmerisourceBergen Corp. Outlk Stable,NEWS-FLASH,Dow Jones Newswires,S&P Sees AmerisourceBergen Corp. Outlk Stable
COR,2022-12-09,01:41:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.0 billion of Proceeds
COR,2022-12-09,01:41:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.0 billion of Proceeds
COR,2022-12-09,01:47:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance >ABC
COR,2022-12-09,01:47:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2022-12-09,01:47:01,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2022-12-09,01:50:58,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen: Agreed to Repurchase Around $200M Common Shares,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen: Agreed to Repurchase Around $200M Common Shares From Walgreens Boots Alliance >ABC
COR,2022-12-09,01:51:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen: Repurchased Shares to,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen: Repurchased Shares to Be Held in Treasury >ABC
COR,2022-12-12,21:22:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Donato Sells 3,014 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,014 Of AmerisourceBergen Corp >ABC"
COR,2022-12-12,21:39:40,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Donato Registers 3,014 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,014 Of AmerisourceBergen Corp >ABC"
COR,2022-12-12,22:28:43,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 5,961,534 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 5,961,534 Of AmerisourceBergen Corp >ABC"
COR,2022-12-13,20:37:07,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 33,000 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 33,000 Of AmerisourceBergen Corp >ABC"
COR,2022-12-13,21:04:03,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,Vp Clark Registers 392 Of AmerisourceBergen Corp >ABC,RNS-SEC144,Dow Jones Newswires,VP Clark Registers 392 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,20:08:05,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 45,920 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 45,920 Of AmerisourceBergen Corp >ABC"
COR,2022-12-14,21:48:16,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Krikorian Acquires 172 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 172 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,21:49:34,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Cfo Cleary Jr Acquires 371 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,CFO Cleary Jr Acquires 371 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,21:52:14,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Coo Mauch Acquires 505 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,COO Mauch Acquires 505 Of AmerisourceBergen Corp >ABC
COR,2022-12-14,21:54:11,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 78,920 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 78,920 Of AmerisourceBergen Corp >ABC"
COR,2022-12-14,22:35:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,Vp Clark Sells 392 Of AmerisourceBergen Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Clark Sells 392 Of AmerisourceBergen Corp >ABC
COR,2022-12-19,16:33:33,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Battaglia Registers 9,852 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 9,852 Of AmerisourceBergen Corp >ABC"
COR,2022-12-20,18:00:09,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2022-12-20,18:00:09,7D85A9,AmerisourceBergen Corp.,100,0.09,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at 'A-'/'F2'; Outlook Stable
COR,2022-12-20,18:00:19,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -2-
COR,2022-12-20,18:00:29,7D85A9,AmerisourceBergen Corp.,100,0.0,credit-ratings,affirmation,Fitch Affirms AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms AmerisourceBergen at -3-
COR,2022-12-20,21:03:44,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Battaglia Sells 9,852 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 9,852 Of AmerisourceBergen Corp >ABC"
COR,2022-12-22,19:15:33,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Krikorian Registers 2,218 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 2,218 Of AmerisourceBergen Corp >ABC"
COR,2022-12-22,21:06:14,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 2,218 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 2,218 Of AmerisourceBergen Corp >ABC"
COR,2022-12-23,18:42:45,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,Vp Donato Registers 930 Of AmerisourceBergen Corp >ABC,RNS-SEC144,Dow Jones Newswires,VP Donato Registers 930 Of AmerisourceBergen Corp >ABC
COR,2022-12-23,21:05:29,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,Vp Donato Sells 930 Of AmerisourceBergen Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Sells 930 Of AmerisourceBergen Corp >ABC
COR,2022-12-29,16:39:41,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis -- WSJ
COR,2022-12-29,16:40:11,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis
COR,2022-12-29,17:55:38,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis -- Update
COR,2022-12-29,20:22:17,7D85A9,AmerisourceBergen Corp.,100,-0.52,legal,,Amerisourcebergen Hit With Federal Lawsuit Over Opioid,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Hit With Federal Lawsuit Over Opioid Crisis -- 2nd Update
COR,2021-01-04,21:30:06,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Fourth Quarter 2020 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Fourth Quarter 2020 Earnings Conference Call
COR,2021-01-04,21:30:50,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Fourth Quarter 2020 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Fourth Quarter 2020 Earnings Conference Call
COR,2021-01-06,11:35:23,9810C0,CoreSite Realty Corp.,100,0.94,analyst-ratings,positive,Coresite Realty Raised to Outperform From Neutral by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Outperform From Neutral by Credit Suisse
COR,2021-01-06,11:35:23,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $161.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $161.00/Share by Credit Suisse
COR,2021-01-20,12:00:02,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,CoreSite Realty Corp.: The 2020 Taxable Ordinary Dividends,PRESS-RELEASE,Business Wire,CoreSite Announces Tax Treatment of 2020 Distributions
COR,2021-01-20,12:00:02,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,CoreSite Realty Corp.: The 2020 Taxable Ordinary Dividends,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Tax Treatment of 2020 Distributions
COR,2021-01-21,09:07:51,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 4Q 2020 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 4Q 2020 (COR)"
COR,2021-02-01,22:05:00,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,CoreSite Realty Corp.: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors,PRESS-RELEASE,Business Wire,Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:00,9810C0,CoreSite Realty Corp.,100,0.68,equity-actions,,CoreSite Realty Corp.: the Company's initial public offering in September 2010,PRESS-RELEASE,Business Wire,Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:01,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,CoreSite Realty Corp.: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:01,9810C0,CoreSite Realty Corp.,100,0.68,equity-actions,,CoreSite Realty Corp.: the Company's initial public offering in September 2010,PRESS-RELEASE,Dow Jones Newswires,Press Release: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:06:34,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,Michael Millegan Joins CoreSite Realty Corporation's Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Michael Millegan Joins CoreSite Realty Corporation's Bd of Directors
COR,2021-02-02,12:29:51,9810C0,CoreSite Realty Corp.,100,0.82,analyst-ratings,positive,Coresite Realty Raised to Outperform From Market Perform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Outperform From Market Perform by Cowen & Co.
COR,2021-02-02,12:29:51,9810C0,CoreSite Realty Corp.,100,0.78,price-targets,upgrade,Coresite Realty Price Target Raised to $152.00/Share From $132.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $152.00/Share From $132.00 by Cowen & Co.
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $22.4 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $606.8 million,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated Funds From Operations (""FFO"") of $5.31 per diluted share",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Financial Outlook,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's guidance for 2021,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,176,273 $ 2,100,999",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -2-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 83,891 $ 82,943 $",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 22,409 $ 24,132 $",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $22.4 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $606.8 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated Funds From Operations (""FFO"") of $5.31 per diluted share",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Financial Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's guidance for 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,176,273 $ 2,100,999",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -2-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 83,891 $ 82,943 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 22,409 $ 24,132 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:25,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 4Q Rev $154.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 4Q Rev $154.9M >COR
COR,2021-02-04,11:30:40,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 4Q EPS 46c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 4Q EPS 46c >COR
COR,2021-02-04,11:32:43,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty Sees 2021 Rev $642M-$652M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees 2021 Rev $642M-$652M >COR
COR,2021-02-04,11:33:12,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,Coresite Realty Sees 2021 EPS $1.81,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees 2021 EPS $1.81-EPS $1.91 >COR
COR,2021-02-04,23:16:09,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q4-2020-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript >COR
COR,2021-02-04,23:16:09,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript >COR
COR,2021-02-05,14:55:47,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-02-05,14:55:47,9810C0,CoreSite Realty Corp.,100,-0.46,price-targets,downgrade,Coresite Realty Price Target Cut to $156.00/Share From $161.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $156.00/Share From $161.00 by Credit Suisse
COR,2021-02-25,12:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,"CoreSite Realty Corp.: 2021 Virtual Citi Global Property CEO Conference on Wednesday, March 10th",PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:02,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:02,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,"CoreSite Realty Corp.: 2021 Virtual Citi Global Property CEO Conference on Wednesday, March 10th",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-26,21:21:25,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-03-04,21:24:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces First-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on April 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces First-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on April 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-06,00:04:22,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 762 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 762 Of CoreSite Realty Corp >COR
COR,2021-03-06,00:04:35,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Cfo Finnin Surrenders 2,709 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Surrenders 2,709 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:07:10,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 129 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 129 Of CoreSite Realty Corp >COR
COR,2021-03-06,00:08:24,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp McCandless Surrenders 1,437 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP McCandless Surrenders 1,437 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:09:25,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Officer Smith Surrenders 2,180 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"Officer Smith Surrenders 2,180 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:16:56,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp Warren Surrenders 1,425 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP Warren Surrenders 1,425 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:40:22,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Surrenders 14,788 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CEO Szurek Surrenders 14,788 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:18:01,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 2,180 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 2,180 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:27:17,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Vp Warren Brian & Anne Jtten Registers 4,131 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"VP Warren Brian & Anne Jtten Registers 4,131 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:35:34,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Vp McCandless Registers 3,131 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"VP McCandless Registers 3,131 Of CoreSite Realty Corp >COR"
COR,2021-03-11,00:27:58,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 234 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 234 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:28:21,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Hatzenbuehler Surrenders 165 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Hatzenbuehler Surrenders 165 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:29:58,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Officer Jones Surrenders 347 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,Officer Jones Surrenders 347 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:33:30,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 350 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 350 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:35:32,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Krusko Surrenders 32 Of CoreSite Realty Corp >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krusko Surrenders 32 Of CoreSite Realty Corp >COR
COR,2021-03-12,11:35:38,9810C0,CoreSite Realty Corp.,100,0.01,analyst-ratings,neutral,Coresite Realty Initiated at In-Line by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Initiated at In-Line by Evercore ISI Group
COR,2021-03-12,11:35:38,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $130.00/Share by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $130.00/Share by Evercore ISI Group
COR,2021-03-12,11:50:50,9810C0,CoreSite Realty Corp.,100,-0.8,price-targets,downgrade,Coresite Realty stock price target cut to $120 from $135 at Mizuho,NEWS-FLASH,MarketWatch,MW CoreSite Realty stock price target cut to $120 from $135 at Mizuho
COR,2021-03-12,14:59:18,9810C0,CoreSite Realty Corp.,100,0.0,analyst-ratings,neutral,Coresite Realty Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Neutral by Mizuho
COR,2021-03-12,14:59:19,9810C0,CoreSite Realty Corp.,100,-0.8,price-targets,downgrade,Coresite Realty Price Target Cut to $120.00/Share From $135.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $120.00/Share From $135.00 by Mizuho
COR,2021-03-17,22:10:27,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 2,918 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 2,918 Of CoreSite Realty Corp >COR"
COR,2021-03-17,22:56:57,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-03-17,22:57:59,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 971 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 971 Of CoreSite Realty Corp >COR
COR,2021-03-17,22:59:26,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Hatzenbuehler Acquires 1,966 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Hatzenbuehler Acquires 1,966 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:03:19,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Officer Jones Surrenders 1,082 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"Officer Jones Surrenders 1,082 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:04:42,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Kaiser Acquires 1,959 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Kaiser Acquires 1,959 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:09:54,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Krusko Acquires 1,398 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krusko Acquires 1,398 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:12:15,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp McCandless Acquires 2,532 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP McCandless Acquires 2,532 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:12:55,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Officer Smith Acquires 4,433 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Smith Acquires 4,433 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:14:02,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Surrenders 7,524 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CEO Szurek Surrenders 7,524 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:14:51,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp Warren Surrenders 1,856 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP Warren Surrenders 1,856 Of CoreSite Realty Corp >COR"
COR,2021-04-05,20:30:00,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces First Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces First Quarter 2021 Earnings Conference Call
COR,2021-04-22,07:17:15,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 1Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 1Q 2021 (COR)"
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.9 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $157.6 million,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $86.1 million,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.40 per diluted share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's 2021 guidance,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,165,213 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 85,207 $ 83,891 $",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,915 $ 22,409 $",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.9 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $157.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $86.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.40 per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's 2021 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,165,213 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 85,207 $ 83,891 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,915 $ 22,409 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:31:13,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 1Q Rev $132.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q Rev $132.9M >COR
COR,2021-04-29,10:31:40,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 1Q EPS 51c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q EPS 51c >COR
COR,2021-04-29,10:32:00,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,Coresite Realty 1Q Adjusted EBITDA $86.1M,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q Adjusted EBITDA $86.1M >COR
COR,2021-04-29,23:10:18,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corp-cor-ceo-paul-szurek-on-q1-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript >COR
COR,2021-04-29,23:10:18,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript >COR
COR,2021-05-05,23:25:04,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-05-05,23:25:13,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,FULL-ARTICLE,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-05-05,23:26:46,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,FULL-ARTICLE,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-05-19,20:29:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Second-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on July 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Second-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on July 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-20,11:00:00,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-05-20,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-05-26,20:45:05,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Font Sells 400 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Font Sells 400 Of CoreSite Realty Corp >COR
COR,2021-06-03,20:22:43,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Vp McCandless Sells 3,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"VP McCandless Sells 3,000 Of CoreSite Realty Corp >COR"
COR,2021-06-14,20:59:56,9810C0,CoreSite Realty Corp.,100,-0.34,equity-actions,decrease,"Holder Carlyle GRP MGMT LLC Sells 1,200,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Carlyle GRP MGMT LLC Sells 1,200,000 Of CoreSite Realty Corp >COR"
COR,2021-07-01,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Second Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Second Quarter 2021 Earnings Conference Call
COR,2021-07-01,11:02:46,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Second Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Second Quarter 2021 Earnings Conference Call
COR,2021-07-22,07:52:10,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 2Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 2Q 2021 (COR)"
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $28.5 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $162.1 million,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $87.4 million,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated FFO, as adjusted, of $1.42 per diluted share",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Updated Guidance,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,157,223 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -2-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: revenue $136,793 $132,976",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 28,475 $24,915",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $28.5 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $162.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $87.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated FFO, as adjusted, of $1.42 per diluted share",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Updated Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,157,223 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -2-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 86,960 $ 85,207 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 28,475 $24,915",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:28,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 2Q EPS 59c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 2Q EPS 59c >COR
COR,2021-07-29,10:30:28,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 2Q Rev $136.8M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 2Q Rev $136.8M >COR
COR,2021-07-29,10:41:30,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 2Q Rev $162.1M >COR,NEWS-FLASH,Dow Jones Newswires,Correct: CoreSite Realty 2Q Rev $162.1M >COR
COR,2021-07-29,10:42:10,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,Coresite Realty Sees FY EPS $1.99,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees FY EPS $1.99-EPS $2.07 >COR
COR,2021-07-29,10:42:10,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty Sees FY Rev $645M-$653M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees FY Rev $645M-$653M >COR
COR,2021-07-29,20:42:06,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 44 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 44 Of CoreSite Realty Corp >COR
COR,2021-07-29,21:54:13,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q2-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript >COR
COR,2021-07-29,21:54:13,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript >COR
COR,2021-07-30,11:43:04,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Wells Fargo
COR,2021-07-30,11:43:05,9810C0,CoreSite Realty Corp.,100,0.72,price-targets,upgrade,Coresite Realty Price Target Raised to $130.00/Share From $120.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $130.00/Share From $120.00 by Wells Fargo
COR,2021-07-30,12:35:45,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Raymond James
COR,2021-07-30,12:35:45,9810C0,CoreSite Realty Corp.,100,0.76,price-targets,upgrade,Coresite Realty Price Target Raised to $149.00/Share From $136.00 by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $149.00/Share From $136.00 by Raymond James
COR,2021-07-30,13:14:15,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-07-30,13:14:15,9810C0,CoreSite Realty Corp.,100,0.42,price-targets,upgrade,Coresite Realty Price Target Raised to $161.00/Share From $157.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $161.00/Share From $157.00 by Credit Suisse
COR,2021-07-30,13:28:25,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Cowen & Co.
COR,2021-07-30,13:28:25,9810C0,CoreSite Realty Corp.,100,0.46,price-targets,upgrade,Coresite Realty Price Target Raised to $158.00/Share From $153.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $158.00/Share From $153.00 by Cowen & Co.
COR,2021-08-02,17:14:59,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 5,435 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 5,435 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:24:24,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Officer Smith Sells 5,435 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Smith Sells 5,435 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:25:04,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:30:20,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-08-04,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at 7(th) Annual Cowen Communications Infrastructure Summit,PRESS-RELEASE,Business Wire,CoreSite to Present at 7(th) Annual Cowen Communications Infrastructure Summit
COR,2021-08-06,20:50:38,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,Vp Warren Brian & Anne Jtten Registers 850 Of CoreSite Realty Corp >COR,RNS-SEC144,Dow Jones Newswires,VP Warren Brian & Anne Jtten Registers 850 Of CoreSite Realty Corp >COR
COR,2021-08-09,20:17:34,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-08-09,20:19:53,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Font Sells 600 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Font Sells 600 Of CoreSite Realty Corp >COR
COR,2021-08-25,12:33:11,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Barclays
COR,2021-08-25,12:33:11,9810C0,CoreSite Realty Corp.,100,0.5,price-targets,upgrade,Coresite Realty Price Target Raised to $123.00/Share From $118.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $123.00/Share From $118.00 by Barclays
COR,2021-09-02,20:25:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Third-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on October 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Third-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on October 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-15,21:44:52,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Krusko Surrenders 27 Of CoreSite Realty Corp >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krusko Surrenders 27 Of CoreSite Realty Corp >COR
COR,2021-10-04,20:30:00,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Third Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Third Quarter 2021 Earnings Conference Call
COR,2021-10-04,21:08:25,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Third Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Third Quarter 2021 Earnings Conference Call
COR,2021-10-22,07:57:46,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 3Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 3Q 2021 (COR)"
COR,2021-10-26,14:34:14,9810C0,CoreSite Realty Corp.,100,0.01,analyst-ratings,neutral,Coresite Realty Initiated at In-Line by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Initiated at In-Line by Evercore ISI Group
COR,2021-10-26,14:34:14,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $154.00/Share by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $154.00/Share by Evercore ISI Group
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.1 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $163.9 million,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $85.7 million,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.39 per diluted share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Updated 2021 Guidance,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,166,995 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 87,596 $ 86,960 $",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,118 $28,475",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.1 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $163.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $85.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.39 per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Updated 2021 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,166,995 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 87,596 $ 86,960 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,118 $28,475",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:33:02,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 3Q EPS 50c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 3Q EPS 50c >COR
COR,2021-10-28,10:33:02,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 3Q Rev $163.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 3Q Rev $163.9M >COR
COR,2021-10-28,10:42:34,9810C0,CoreSite Realty Corp.,100,-0.53,equity-actions,down,Coresite Realty Lowers FY CapEx Guidance to $140M-$150M,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Lowers FY CapEx Guidance to $140M-$150M >COR
COR,2021-10-28,20:48:59,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q3-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript >COR
COR,2021-10-28,20:48:59,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript >COR
COR,2021-10-29,11:42:43,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Barclays
COR,2021-10-29,11:42:43,9810C0,CoreSite Realty Corp.,100,0.4,price-targets,upgrade,Coresite Realty Price Target Raised to $126.00/Share From $123.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $126.00/Share From $123.00 by Barclays
COR,2021-10-29,12:05:33,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-10-29,12:05:33,9810C0,CoreSite Realty Corp.,100,-0.36,price-targets,downgrade,Coresite Realty Price Target Cut to $158.00/Share From $161.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $158.00/Share From $161.00 by Credit Suisse
COR,2021-10-29,12:11:13,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Wells Fargo
COR,2021-10-29,12:11:13,9810C0,CoreSite Realty Corp.,100,0.48,price-targets,upgrade,Coresite Realty Price Target Raised to $135.00/Share From $130.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $135.00/Share From $130.00 by Wells Fargo
COR,2021-10-29,14:12:53,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Raymond James
COR,2021-10-29,14:12:53,9810C0,CoreSite Realty Corp.,100,0.42,price-targets,upgrade,Coresite Realty Price Target Raised to $153.00/Share From $149.00 by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $153.00/Share From $149.00 by Raymond James
COR,2021-11-03,22:22:22,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-11-05,21:45:29,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-11-09,21:46:27,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-11-15,12:00:00,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower To Acquire CoreSite >AMT COR
COR,2021-11-15,12:00:00,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower To Acquire CoreSite >AMT COR
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will acquire CoreSite for $170.00 per share in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Press Release: American Tower to Acquire CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:33,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $170 A Share,NEWS-FLASH,Dow Jones Newswires,American Tower to Buy CoreSite for $170 A Share in Cash >AMT COR
COR,2021-11-15,12:01:59,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower REIT to buy CoreSite Realty in a deal,NEWS-FLASH,MarketWatch,MW American Tower REIT to buy CoreSite Realty in a deal valued at $10.1 bln
COR,2021-11-15,12:03:41,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Coresite to Be Acquired for $170,NEWS-FLASH,Dow Jones Newswires,CoreSite to Be Acquired for $170 A Share; Closed Friday at $166.59 >AMT COR
COR,2021-11-15,12:16:02,9810C0,CoreSite Realty Corp.,95,0.65,acquisitions-mergers,,American Tower will pay $170 for each CoreSite,FULL-ARTICLE,MarketWatch,MW CoreSite's stock rises toward another record after buyout deal with American Tower REIT valued at $10.1 billion
COR,2021-11-15,12:16:02,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will pay $170 for each CoreSite,FULL-ARTICLE,Dow Jones Newswires,CoreSite's Stock Rises Toward Another Record After Buyout Deal With American Tower REIT Valued At $10.1 Billion -- MarketWatch
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will acquire CoreSite for $170.00 per share in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Press Release: American Tower to Acquire CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:29:06,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $10.1 Billion,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy CoreSite for $10.1 Billion
COR,2021-11-15,12:44:06,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $10.1 Billion,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy CoreSite for $10.1 Billion
COR,2021-11-15,12:58:40,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy Data Center Manager CoreSite in $10.1 Billion Deal,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy Data Center Manager CoreSite in $10.1 Billion Deal -- Barrons.com
COR,2021-11-15,17:00:03,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite shareholders will receive only $170.00 per share,PRESS-RELEASE,PR Newswire,Shareholder Alert: Ademi LLP investigates whether CoreSite Realty Corporation has obtained a Fair Price in its going private transaction with American Tower
COR,2021-11-15,17:15:33,9810C0,CoreSite Realty Corp.,92,0.55,acquisitions-mergers,,"Coresite Realty are being acquired in two separate, multibillion deals that highlight that digital-infrastructure",FULL-ARTICLE,Dow Jones Newswires,"CyrusOne, CoreSite Deals Show Data Centers Are in Demand -- Market Insight"
COR,2021-11-15,18:20:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire Data Center Manager CoreSite in $10.1 Billion Deal,FULL-ARTICLE,Dow Jones Newswires,American Tower to Acquire Data Center Manager CoreSite in $10.1 Billion Deal
COR,2021-11-15,19:43:26,9810C0,CoreSite Realty Corp.,100,-0.6,acquisitions-mergers,scrutiny,Announces Investigation of CoreSite Realty Corporation Merger,PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CoreSite Realty Corporation Merger"
COR,2021-11-15,19:43:26,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Coresite's agreement to be acquired by American Tower Corporation (NYSE: AMT).,PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CoreSite Realty Corporation Merger"
COR,2021-11-16,01:13:02,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the Company by American Tower Corporation,PRESS-RELEASE,PR Newswire,SHAREHOLDER ALERT: WeissLaw LLP Investigates CoreSite Realty Corporation
COR,2021-11-16,09:55:37,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Market Perform From Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Market Perform From Outperform by Raymond James
COR,2021-11-16,10:38:57,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Neutral From Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Neutral From Outperform by Credit Suisse
COR,2021-11-16,10:38:57,9810C0,CoreSite Realty Corp.,100,0.68,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $158.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $158.00 by Credit Suisse
COR,2021-11-16,11:21:07,9810C0,CoreSite Realty Corp.,100,0.62,analyst-ratings,positive,Coresite Realty Raised to Equal-Weight From Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Equal-Weight From Underweight by Barclays
COR,2021-11-16,15:30:34,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite Realty Corp.,NEWS-FLASH,Dow Jones Newswires,S&PGRBulletin: American Tower To Acquire CoreSite Realty Corp.
COR,2021-11-16,15:30:50,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite Realty Corp.,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: American Tower To Acquire CoreSite Realty Corp.
COR,2021-11-16,20:31:52,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of CoreSite Realty Corporation with American Tower Corporation"
COR,2021-11-17,15:17:13,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of CONE, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of CONE, COR, RC, and CSPR"
COR,2021-11-17,23:38:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Fourth-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on December 13, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Fourth-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on December 13, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-18,13:00:07,9810C0,CoreSite Realty Corp.,99,0.39,products-services,,Coresite announced entering into a merger agreement with American Tower,PRESS-RELEASE,GlobeNewswire,(COR): Johnson Fistel Investigates Proposed Sale of CoreSite Realty Corporation; Are Shareholders Getting a Fair Deal?
COR,2021-11-18,13:00:07,9810C0,CoreSite Realty Corp.,99,0.61,earnings,positive,Shareholders of CoreSite will receive only $170 per share,PRESS-RELEASE,GlobeNewswire,(COR): Johnson Fistel Investigates Proposed Sale of CoreSite Realty Corporation; Are Shareholders Getting a Fair Deal?
COR,2021-11-18,16:56:50,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of CBTX, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of CBTX, COR, GFED, and VSAT"
COR,2021-11-18,22:15:54,9810C0,CoreSite Realty Corp.,94,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,DJ Global Press Release Wire,"MERGER ALERT - COR, CONE, and DWSN: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
COR,2021-11-20,01:27:02,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,Pc Announces an Investigation of CoreSite Realty Corp.,PRESS-RELEASE,PR Newswire,SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CoreSite Realty Corp. - COR
COR,2021-11-22,15:18:02,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-23,16:19:05,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-23,18:54:03,9810C0,CoreSite Realty Corp.,96,0.0,dividends,,Coresite shareholders will receive $170.00 in cash per share,PRESS-RELEASE,PR Newswire,"Moore Kuehn Encourages CONE, COR, WALD, and ATSPT Investors to Contact Law Firm"
COR,2021-11-23,18:54:03,9810C0,CoreSite Realty Corp.,96,0.0,dividends,,Coresite shareholders will receive $170.00 in cash per share,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Moore Kuehn Encourages CONE, COR, WALD, and ATSPT Investors to Contact Law Firm"
COR,2021-11-24,02:59:02,9810C0,CoreSite Realty Corp.,94,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds COR, CSPR, PNBK, and ZIXI Shareholders About Its Ongoing Investigations"
COR,2021-11-25,14:02:07,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-26,11:57:00,9810C0,CoreSite Realty Corp.,100,0.0,analyst-ratings,neutral,Coresite Realty Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Sector Perform by RBC Capital
COR,2021-11-26,11:57:00,9810C0,CoreSite Realty Corp.,100,0.78,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $136.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $136.00 by RBC Capital
COR,2021-11-29,16:16:09,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-01,17:21:01,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-02,00:44:03,9810C0,CoreSite Realty Corp.,94,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds PNBK, ZIXI, COR, and CSPR Shareholders About Its Ongoing Investigations"
COR,2021-12-06,15:20:34,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-08,00:32:47,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Gifts 13,817 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Szurek Gifts 13,817 Of CoreSite Realty Corp >COR"
COR,2021-12-08,02:30:03,9810C0,CoreSite Realty Corp.,95,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds VG, DRNA, DVD, and COR Shareholders About Its Ongoing Investigations"
COR,2021-12-14,10:23:04,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Neutral From Buy by Citigroup
COR,2021-12-14,10:23:04,9810C0,CoreSite Realty Corp.,100,0.56,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $162.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $162.00 by Citigroup
COR,2021-12-15,14:18:00,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-20,21:21:06,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Cfo Finnin Gifts 3,500 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Gifts 3,500 Of CoreSite Realty Corp >COR"
COR,2021-12-20,21:22:12,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp McCandless Gifts 1,470 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP McCandless Gifts 1,470 Of CoreSite Realty Corp >COR"
COR,2021-12-21,00:55:03,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of CoreSite Realty Corporation with American Tower Corporation"
COR,2021-12-28,13:54:00,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,Promptly complete the acquisition of CoreSite,PRESS-RELEASE,Business Wire,American Tower Announces Expiration of Tender Offer Period for Outstanding Shares of CoreSite Realty Corporation
COR,2021-12-28,13:54:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,Promptly complete the acquisition of CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower Announces Expiration of Tender Offer Period for Outstanding Shares of CoreSite Realty Corporation
COR,2021-12-28,21:30:00,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition Of CoreSite Realty Corporation >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower Completes Acquisition Of CoreSite Realty Corporation >AMT
COR,2021-12-28,21:30:00,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,"American Tower"") announced today that it has closed its acquisition of CoreSite Realty Corporation (NYSE: COR)",PRESS-RELEASE,Business Wire,American Tower Completes Acquisition of CoreSite Realty Corporation
COR,2021-12-28,21:30:01,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,"American Tower"") announced today that it has closed its acquisition of CoreSite Realty Corporation (NYSE: COR)",PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower Completes Acquisition of CoreSite Realty Corporation
COR,2021-01-04,21:30:06,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Fourth Quarter 2020 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Fourth Quarter 2020 Earnings Conference Call
COR,2021-01-04,21:30:50,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Fourth Quarter 2020 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Fourth Quarter 2020 Earnings Conference Call
COR,2021-01-06,11:35:23,9810C0,CoreSite Realty Corp.,100,0.94,analyst-ratings,positive,Coresite Realty Raised to Outperform From Neutral by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Outperform From Neutral by Credit Suisse
COR,2021-01-06,11:35:23,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $161.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $161.00/Share by Credit Suisse
COR,2021-01-20,12:00:02,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,CoreSite Realty Corp.: The 2020 Taxable Ordinary Dividends,PRESS-RELEASE,Business Wire,CoreSite Announces Tax Treatment of 2020 Distributions
COR,2021-01-20,12:00:02,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,CoreSite Realty Corp.: The 2020 Taxable Ordinary Dividends,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Tax Treatment of 2020 Distributions
COR,2021-01-21,09:07:51,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 4Q 2020 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 4Q 2020 (COR)"
COR,2021-02-01,22:05:00,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,CoreSite Realty Corp.: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors,PRESS-RELEASE,Business Wire,Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:00,9810C0,CoreSite Realty Corp.,100,0.68,equity-actions,,CoreSite Realty Corp.: the Company's initial public offering in September 2010,PRESS-RELEASE,Business Wire,Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:01,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,CoreSite Realty Corp.: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:01,9810C0,CoreSite Realty Corp.,100,0.68,equity-actions,,CoreSite Realty Corp.: the Company's initial public offering in September 2010,PRESS-RELEASE,Dow Jones Newswires,Press Release: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:06:34,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,Michael Millegan Joins CoreSite Realty Corporation's Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Michael Millegan Joins CoreSite Realty Corporation's Bd of Directors
COR,2021-02-02,12:29:51,9810C0,CoreSite Realty Corp.,100,0.82,analyst-ratings,positive,Coresite Realty Raised to Outperform From Market Perform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Outperform From Market Perform by Cowen & Co.
COR,2021-02-02,12:29:51,9810C0,CoreSite Realty Corp.,100,0.78,price-targets,upgrade,Coresite Realty Price Target Raised to $152.00/Share From $132.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $152.00/Share From $132.00 by Cowen & Co.
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $22.4 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $606.8 million,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated Funds From Operations (""FFO"") of $5.31 per diluted share",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Financial Outlook,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's guidance for 2021,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,176,273 $ 2,100,999",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -2-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 83,891 $ 82,943 $",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 22,409 $ 24,132 $",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $22.4 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $606.8 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated Funds From Operations (""FFO"") of $5.31 per diluted share",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Financial Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's guidance for 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,176,273 $ 2,100,999",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -2-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 83,891 $ 82,943 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 22,409 $ 24,132 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:25,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 4Q Rev $154.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 4Q Rev $154.9M >COR
COR,2021-02-04,11:30:40,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 4Q EPS 46c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 4Q EPS 46c >COR
COR,2021-02-04,11:32:43,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty Sees 2021 Rev $642M-$652M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees 2021 Rev $642M-$652M >COR
COR,2021-02-04,11:33:12,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,Coresite Realty Sees 2021 EPS $1.81,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees 2021 EPS $1.81-EPS $1.91 >COR
COR,2021-02-04,23:16:09,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q4-2020-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript >COR
COR,2021-02-04,23:16:09,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript >COR
COR,2021-02-05,14:55:47,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-02-05,14:55:47,9810C0,CoreSite Realty Corp.,100,-0.46,price-targets,downgrade,Coresite Realty Price Target Cut to $156.00/Share From $161.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $156.00/Share From $161.00 by Credit Suisse
COR,2021-02-25,12:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,"CoreSite Realty Corp.: 2021 Virtual Citi Global Property CEO Conference on Wednesday, March 10th",PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:02,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:02,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,"CoreSite Realty Corp.: 2021 Virtual Citi Global Property CEO Conference on Wednesday, March 10th",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-26,21:21:25,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-03-04,21:24:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces First-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on April 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces First-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on April 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-06,00:04:22,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 762 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 762 Of CoreSite Realty Corp >COR
COR,2021-03-06,00:04:35,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Cfo Finnin Surrenders 2,709 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Surrenders 2,709 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:07:10,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 129 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 129 Of CoreSite Realty Corp >COR
COR,2021-03-06,00:08:24,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp McCandless Surrenders 1,437 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP McCandless Surrenders 1,437 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:09:25,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Officer Smith Surrenders 2,180 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"Officer Smith Surrenders 2,180 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:16:56,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp Warren Surrenders 1,425 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP Warren Surrenders 1,425 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:40:22,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Surrenders 14,788 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CEO Szurek Surrenders 14,788 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:18:01,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 2,180 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 2,180 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:27:17,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Vp Warren Brian & Anne Jtten Registers 4,131 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"VP Warren Brian & Anne Jtten Registers 4,131 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:35:34,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Vp McCandless Registers 3,131 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"VP McCandless Registers 3,131 Of CoreSite Realty Corp >COR"
COR,2021-03-11,00:27:58,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 234 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 234 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:28:21,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Hatzenbuehler Surrenders 165 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Hatzenbuehler Surrenders 165 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:29:58,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Officer Jones Surrenders 347 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,Officer Jones Surrenders 347 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:33:30,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 350 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 350 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:35:32,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Krusko Surrenders 32 Of CoreSite Realty Corp >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krusko Surrenders 32 Of CoreSite Realty Corp >COR
COR,2021-03-12,11:35:38,9810C0,CoreSite Realty Corp.,100,0.01,analyst-ratings,neutral,Coresite Realty Initiated at In-Line by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Initiated at In-Line by Evercore ISI Group
COR,2021-03-12,11:35:38,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $130.00/Share by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $130.00/Share by Evercore ISI Group
COR,2021-03-12,11:50:50,9810C0,CoreSite Realty Corp.,100,-0.8,price-targets,downgrade,Coresite Realty stock price target cut to $120 from $135 at Mizuho,NEWS-FLASH,MarketWatch,MW CoreSite Realty stock price target cut to $120 from $135 at Mizuho
COR,2021-03-12,14:59:18,9810C0,CoreSite Realty Corp.,100,0.0,analyst-ratings,neutral,Coresite Realty Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Neutral by Mizuho
COR,2021-03-12,14:59:19,9810C0,CoreSite Realty Corp.,100,-0.8,price-targets,downgrade,Coresite Realty Price Target Cut to $120.00/Share From $135.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $120.00/Share From $135.00 by Mizuho
COR,2021-03-17,22:10:27,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 2,918 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 2,918 Of CoreSite Realty Corp >COR"
COR,2021-03-17,22:56:57,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-03-17,22:57:59,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 971 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 971 Of CoreSite Realty Corp >COR
COR,2021-03-17,22:59:26,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Hatzenbuehler Acquires 1,966 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Hatzenbuehler Acquires 1,966 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:03:19,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Officer Jones Surrenders 1,082 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"Officer Jones Surrenders 1,082 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:04:42,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Kaiser Acquires 1,959 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Kaiser Acquires 1,959 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:09:54,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Krusko Acquires 1,398 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krusko Acquires 1,398 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:12:15,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp McCandless Acquires 2,532 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP McCandless Acquires 2,532 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:12:55,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Officer Smith Acquires 4,433 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Smith Acquires 4,433 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:14:02,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Surrenders 7,524 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CEO Szurek Surrenders 7,524 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:14:51,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp Warren Surrenders 1,856 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP Warren Surrenders 1,856 Of CoreSite Realty Corp >COR"
COR,2021-04-05,20:30:00,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces First Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces First Quarter 2021 Earnings Conference Call
COR,2021-04-22,07:17:15,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 1Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 1Q 2021 (COR)"
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.9 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $157.6 million,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $86.1 million,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.40 per diluted share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's 2021 guidance,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,165,213 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 85,207 $ 83,891 $",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,915 $ 22,409 $",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.9 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $157.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $86.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.40 per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's 2021 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,165,213 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 85,207 $ 83,891 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,915 $ 22,409 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:31:13,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 1Q Rev $132.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q Rev $132.9M >COR
COR,2021-04-29,10:31:40,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 1Q EPS 51c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q EPS 51c >COR
COR,2021-04-29,10:32:00,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,Coresite Realty 1Q Adjusted EBITDA $86.1M,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q Adjusted EBITDA $86.1M >COR
COR,2021-04-29,23:10:18,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corp-cor-ceo-paul-szurek-on-q1-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript >COR
COR,2021-04-29,23:10:18,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript >COR
COR,2021-05-05,23:25:04,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-05-05,23:25:13,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,FULL-ARTICLE,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-05-05,23:26:46,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,FULL-ARTICLE,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-05-19,20:29:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Second-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on July 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Second-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on July 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-20,11:00:00,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-05-20,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-05-26,20:45:05,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Font Sells 400 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Font Sells 400 Of CoreSite Realty Corp >COR
COR,2021-06-03,20:22:43,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Vp McCandless Sells 3,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"VP McCandless Sells 3,000 Of CoreSite Realty Corp >COR"
COR,2021-06-14,20:59:56,9810C0,CoreSite Realty Corp.,100,-0.34,equity-actions,decrease,"Holder Carlyle GRP MGMT LLC Sells 1,200,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Carlyle GRP MGMT LLC Sells 1,200,000 Of CoreSite Realty Corp >COR"
COR,2021-07-01,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Second Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Second Quarter 2021 Earnings Conference Call
COR,2021-07-01,11:02:46,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Second Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Second Quarter 2021 Earnings Conference Call
COR,2021-07-22,07:52:10,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 2Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 2Q 2021 (COR)"
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $28.5 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $162.1 million,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $87.4 million,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated FFO, as adjusted, of $1.42 per diluted share",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Updated Guidance,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,157,223 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -2-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: revenue $136,793 $132,976",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 28,475 $24,915",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $28.5 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $162.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $87.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated FFO, as adjusted, of $1.42 per diluted share",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Updated Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,157,223 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -2-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 86,960 $ 85,207 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 28,475 $24,915",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:28,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 2Q EPS 59c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 2Q EPS 59c >COR
COR,2021-07-29,10:30:28,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 2Q Rev $136.8M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 2Q Rev $136.8M >COR
COR,2021-07-29,10:41:30,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 2Q Rev $162.1M >COR,NEWS-FLASH,Dow Jones Newswires,Correct: CoreSite Realty 2Q Rev $162.1M >COR
COR,2021-07-29,10:42:10,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,Coresite Realty Sees FY EPS $1.99,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees FY EPS $1.99-EPS $2.07 >COR
COR,2021-07-29,10:42:10,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty Sees FY Rev $645M-$653M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees FY Rev $645M-$653M >COR
COR,2021-07-29,20:42:06,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 44 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 44 Of CoreSite Realty Corp >COR
COR,2021-07-29,21:54:13,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q2-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript >COR
COR,2021-07-29,21:54:13,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript >COR
COR,2021-07-30,11:43:04,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Wells Fargo
COR,2021-07-30,11:43:05,9810C0,CoreSite Realty Corp.,100,0.72,price-targets,upgrade,Coresite Realty Price Target Raised to $130.00/Share From $120.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $130.00/Share From $120.00 by Wells Fargo
COR,2021-07-30,12:35:45,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Raymond James
COR,2021-07-30,12:35:45,9810C0,CoreSite Realty Corp.,100,0.76,price-targets,upgrade,Coresite Realty Price Target Raised to $149.00/Share From $136.00 by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $149.00/Share From $136.00 by Raymond James
COR,2021-07-30,13:14:15,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-07-30,13:14:15,9810C0,CoreSite Realty Corp.,100,0.42,price-targets,upgrade,Coresite Realty Price Target Raised to $161.00/Share From $157.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $161.00/Share From $157.00 by Credit Suisse
COR,2021-07-30,13:28:25,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Cowen & Co.
COR,2021-07-30,13:28:25,9810C0,CoreSite Realty Corp.,100,0.46,price-targets,upgrade,Coresite Realty Price Target Raised to $158.00/Share From $153.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $158.00/Share From $153.00 by Cowen & Co.
COR,2021-08-02,17:14:59,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 5,435 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 5,435 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:24:24,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Officer Smith Sells 5,435 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Smith Sells 5,435 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:25:04,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:30:20,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-08-04,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at 7(th) Annual Cowen Communications Infrastructure Summit,PRESS-RELEASE,Business Wire,CoreSite to Present at 7(th) Annual Cowen Communications Infrastructure Summit
COR,2021-08-06,20:50:38,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,Vp Warren Brian & Anne Jtten Registers 850 Of CoreSite Realty Corp >COR,RNS-SEC144,Dow Jones Newswires,VP Warren Brian & Anne Jtten Registers 850 Of CoreSite Realty Corp >COR
COR,2021-08-09,20:17:34,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-08-09,20:19:53,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Font Sells 600 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Font Sells 600 Of CoreSite Realty Corp >COR
COR,2021-08-25,12:33:11,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Barclays
COR,2021-08-25,12:33:11,9810C0,CoreSite Realty Corp.,100,0.5,price-targets,upgrade,Coresite Realty Price Target Raised to $123.00/Share From $118.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $123.00/Share From $118.00 by Barclays
COR,2021-09-02,20:25:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Third-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on October 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Third-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on October 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-15,21:44:52,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Krusko Surrenders 27 Of CoreSite Realty Corp >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krusko Surrenders 27 Of CoreSite Realty Corp >COR
COR,2021-10-04,20:30:00,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Third Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Third Quarter 2021 Earnings Conference Call
COR,2021-10-04,21:08:25,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Third Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Third Quarter 2021 Earnings Conference Call
COR,2021-10-22,07:57:46,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 3Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 3Q 2021 (COR)"
COR,2021-10-26,14:34:14,9810C0,CoreSite Realty Corp.,100,0.01,analyst-ratings,neutral,Coresite Realty Initiated at In-Line by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Initiated at In-Line by Evercore ISI Group
COR,2021-10-26,14:34:14,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $154.00/Share by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $154.00/Share by Evercore ISI Group
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.1 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $163.9 million,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $85.7 million,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.39 per diluted share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Updated 2021 Guidance,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,166,995 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 87,596 $ 86,960 $",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,118 $28,475",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.1 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $163.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $85.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.39 per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Updated 2021 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,166,995 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 87,596 $ 86,960 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,118 $28,475",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:33:02,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 3Q EPS 50c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 3Q EPS 50c >COR
COR,2021-10-28,10:33:02,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 3Q Rev $163.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 3Q Rev $163.9M >COR
COR,2021-10-28,10:42:34,9810C0,CoreSite Realty Corp.,100,-0.53,equity-actions,down,Coresite Realty Lowers FY CapEx Guidance to $140M-$150M,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Lowers FY CapEx Guidance to $140M-$150M >COR
COR,2021-10-28,20:48:59,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q3-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript >COR
COR,2021-10-28,20:48:59,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript >COR
COR,2021-10-29,11:42:43,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Barclays
COR,2021-10-29,11:42:43,9810C0,CoreSite Realty Corp.,100,0.4,price-targets,upgrade,Coresite Realty Price Target Raised to $126.00/Share From $123.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $126.00/Share From $123.00 by Barclays
COR,2021-10-29,12:05:33,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-10-29,12:05:33,9810C0,CoreSite Realty Corp.,100,-0.36,price-targets,downgrade,Coresite Realty Price Target Cut to $158.00/Share From $161.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $158.00/Share From $161.00 by Credit Suisse
COR,2021-10-29,12:11:13,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Wells Fargo
COR,2021-10-29,12:11:13,9810C0,CoreSite Realty Corp.,100,0.48,price-targets,upgrade,Coresite Realty Price Target Raised to $135.00/Share From $130.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $135.00/Share From $130.00 by Wells Fargo
COR,2021-10-29,14:12:53,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Raymond James
COR,2021-10-29,14:12:53,9810C0,CoreSite Realty Corp.,100,0.42,price-targets,upgrade,Coresite Realty Price Target Raised to $153.00/Share From $149.00 by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $153.00/Share From $149.00 by Raymond James
COR,2021-11-03,22:22:22,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-11-05,21:45:29,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-11-09,21:46:27,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-11-15,12:00:00,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower To Acquire CoreSite >AMT COR
COR,2021-11-15,12:00:00,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower To Acquire CoreSite >AMT COR
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will acquire CoreSite for $170.00 per share in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Press Release: American Tower to Acquire CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:33,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $170 A Share,NEWS-FLASH,Dow Jones Newswires,American Tower to Buy CoreSite for $170 A Share in Cash >AMT COR
COR,2021-11-15,12:01:59,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower REIT to buy CoreSite Realty in a deal,NEWS-FLASH,MarketWatch,MW American Tower REIT to buy CoreSite Realty in a deal valued at $10.1 bln
COR,2021-11-15,12:03:41,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Coresite to Be Acquired for $170,NEWS-FLASH,Dow Jones Newswires,CoreSite to Be Acquired for $170 A Share; Closed Friday at $166.59 >AMT COR
COR,2021-11-15,12:16:02,9810C0,CoreSite Realty Corp.,95,0.65,acquisitions-mergers,,American Tower will pay $170 for each CoreSite,FULL-ARTICLE,MarketWatch,MW CoreSite's stock rises toward another record after buyout deal with American Tower REIT valued at $10.1 billion
COR,2021-11-15,12:16:02,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will pay $170 for each CoreSite,FULL-ARTICLE,Dow Jones Newswires,CoreSite's Stock Rises Toward Another Record After Buyout Deal With American Tower REIT Valued At $10.1 Billion -- MarketWatch
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will acquire CoreSite for $170.00 per share in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Press Release: American Tower to Acquire CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:29:06,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $10.1 Billion,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy CoreSite for $10.1 Billion
COR,2021-11-15,12:44:06,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $10.1 Billion,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy CoreSite for $10.1 Billion
COR,2021-11-15,12:58:40,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy Data Center Manager CoreSite in $10.1 Billion Deal,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy Data Center Manager CoreSite in $10.1 Billion Deal -- Barrons.com
COR,2021-11-15,17:00:03,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite shareholders will receive only $170.00 per share,PRESS-RELEASE,PR Newswire,Shareholder Alert: Ademi LLP investigates whether CoreSite Realty Corporation has obtained a Fair Price in its going private transaction with American Tower
COR,2021-11-15,17:15:33,9810C0,CoreSite Realty Corp.,92,0.55,acquisitions-mergers,,"Coresite Realty are being acquired in two separate, multibillion deals that highlight that digital-infrastructure",FULL-ARTICLE,Dow Jones Newswires,"CyrusOne, CoreSite Deals Show Data Centers Are in Demand -- Market Insight"
COR,2021-11-15,18:20:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire Data Center Manager CoreSite in $10.1 Billion Deal,FULL-ARTICLE,Dow Jones Newswires,American Tower to Acquire Data Center Manager CoreSite in $10.1 Billion Deal
COR,2021-11-15,19:43:26,9810C0,CoreSite Realty Corp.,100,-0.6,acquisitions-mergers,scrutiny,Announces Investigation of CoreSite Realty Corporation Merger,PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CoreSite Realty Corporation Merger"
COR,2021-11-15,19:43:26,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Coresite's agreement to be acquired by American Tower Corporation (NYSE: AMT).,PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CoreSite Realty Corporation Merger"
COR,2021-11-16,01:13:02,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the Company by American Tower Corporation,PRESS-RELEASE,PR Newswire,SHAREHOLDER ALERT: WeissLaw LLP Investigates CoreSite Realty Corporation
COR,2021-11-16,09:55:37,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Market Perform From Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Market Perform From Outperform by Raymond James
COR,2021-11-16,10:38:57,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Neutral From Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Neutral From Outperform by Credit Suisse
COR,2021-11-16,10:38:57,9810C0,CoreSite Realty Corp.,100,0.68,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $158.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $158.00 by Credit Suisse
COR,2021-11-16,11:21:07,9810C0,CoreSite Realty Corp.,100,0.62,analyst-ratings,positive,Coresite Realty Raised to Equal-Weight From Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Equal-Weight From Underweight by Barclays
COR,2021-11-16,15:30:34,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite Realty Corp.,NEWS-FLASH,Dow Jones Newswires,S&PGRBulletin: American Tower To Acquire CoreSite Realty Corp.
COR,2021-11-16,15:30:50,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite Realty Corp.,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: American Tower To Acquire CoreSite Realty Corp.
COR,2021-11-16,20:31:52,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of CoreSite Realty Corporation with American Tower Corporation"
COR,2021-11-17,15:17:13,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of CONE, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of CONE, COR, RC, and CSPR"
COR,2021-11-17,23:38:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Fourth-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on December 13, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Fourth-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on December 13, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-18,13:00:07,9810C0,CoreSite Realty Corp.,99,0.39,products-services,,Coresite announced entering into a merger agreement with American Tower,PRESS-RELEASE,GlobeNewswire,(COR): Johnson Fistel Investigates Proposed Sale of CoreSite Realty Corporation; Are Shareholders Getting a Fair Deal?
COR,2021-11-18,13:00:07,9810C0,CoreSite Realty Corp.,99,0.61,earnings,positive,Shareholders of CoreSite will receive only $170 per share,PRESS-RELEASE,GlobeNewswire,(COR): Johnson Fistel Investigates Proposed Sale of CoreSite Realty Corporation; Are Shareholders Getting a Fair Deal?
COR,2021-11-18,16:56:50,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of CBTX, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of CBTX, COR, GFED, and VSAT"
COR,2021-11-18,22:15:54,9810C0,CoreSite Realty Corp.,94,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,DJ Global Press Release Wire,"MERGER ALERT - COR, CONE, and DWSN: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
COR,2021-11-20,01:27:02,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,Pc Announces an Investigation of CoreSite Realty Corp.,PRESS-RELEASE,PR Newswire,SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CoreSite Realty Corp. - COR
COR,2021-11-22,15:18:02,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-23,16:19:05,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-23,18:54:03,9810C0,CoreSite Realty Corp.,96,0.0,dividends,,Coresite shareholders will receive $170.00 in cash per share,PRESS-RELEASE,PR Newswire,"Moore Kuehn Encourages CONE, COR, WALD, and ATSPT Investors to Contact Law Firm"
COR,2021-11-23,18:54:03,9810C0,CoreSite Realty Corp.,96,0.0,dividends,,Coresite shareholders will receive $170.00 in cash per share,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Moore Kuehn Encourages CONE, COR, WALD, and ATSPT Investors to Contact Law Firm"
COR,2021-11-24,02:59:02,9810C0,CoreSite Realty Corp.,94,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds COR, CSPR, PNBK, and ZIXI Shareholders About Its Ongoing Investigations"
COR,2021-11-25,14:02:07,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-26,11:57:00,9810C0,CoreSite Realty Corp.,100,0.0,analyst-ratings,neutral,Coresite Realty Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Sector Perform by RBC Capital
COR,2021-11-26,11:57:00,9810C0,CoreSite Realty Corp.,100,0.78,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $136.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $136.00 by RBC Capital
COR,2021-11-29,16:16:09,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-01,17:21:01,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-02,00:44:03,9810C0,CoreSite Realty Corp.,94,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds PNBK, ZIXI, COR, and CSPR Shareholders About Its Ongoing Investigations"
COR,2021-12-06,15:20:34,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-08,00:32:47,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Gifts 13,817 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Szurek Gifts 13,817 Of CoreSite Realty Corp >COR"
COR,2021-12-08,02:30:03,9810C0,CoreSite Realty Corp.,95,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds VG, DRNA, DVD, and COR Shareholders About Its Ongoing Investigations"
COR,2021-12-14,10:23:04,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Neutral From Buy by Citigroup
COR,2021-12-14,10:23:04,9810C0,CoreSite Realty Corp.,100,0.56,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $162.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $162.00 by Citigroup
COR,2021-12-15,14:18:00,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-20,21:21:06,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Cfo Finnin Gifts 3,500 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Gifts 3,500 Of CoreSite Realty Corp >COR"
COR,2021-12-20,21:22:12,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp McCandless Gifts 1,470 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP McCandless Gifts 1,470 Of CoreSite Realty Corp >COR"
COR,2021-12-21,00:55:03,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of CoreSite Realty Corporation with American Tower Corporation"
COR,2021-12-28,13:54:00,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,Promptly complete the acquisition of CoreSite,PRESS-RELEASE,Business Wire,American Tower Announces Expiration of Tender Offer Period for Outstanding Shares of CoreSite Realty Corporation
COR,2021-12-28,13:54:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,Promptly complete the acquisition of CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower Announces Expiration of Tender Offer Period for Outstanding Shares of CoreSite Realty Corporation
COR,2021-12-28,21:30:00,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition Of CoreSite Realty Corporation >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower Completes Acquisition Of CoreSite Realty Corporation >AMT
COR,2021-12-28,21:30:00,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,"American Tower"") announced today that it has closed its acquisition of CoreSite Realty Corporation (NYSE: COR)",PRESS-RELEASE,Business Wire,American Tower Completes Acquisition of CoreSite Realty Corporation
COR,2021-12-28,21:30:01,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,"American Tower"") announced today that it has closed its acquisition of CoreSite Realty Corporation (NYSE: COR)",PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower Completes Acquisition of CoreSite Realty Corporation
COR,2021-01-04,21:30:06,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Fourth Quarter 2020 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Fourth Quarter 2020 Earnings Conference Call
COR,2021-01-04,21:30:50,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Fourth Quarter 2020 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Fourth Quarter 2020 Earnings Conference Call
COR,2021-01-06,11:35:23,9810C0,CoreSite Realty Corp.,100,0.94,analyst-ratings,positive,Coresite Realty Raised to Outperform From Neutral by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Outperform From Neutral by Credit Suisse
COR,2021-01-06,11:35:23,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $161.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $161.00/Share by Credit Suisse
COR,2021-01-20,12:00:02,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,CoreSite Realty Corp.: The 2020 Taxable Ordinary Dividends,PRESS-RELEASE,Business Wire,CoreSite Announces Tax Treatment of 2020 Distributions
COR,2021-01-20,12:00:02,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,CoreSite Realty Corp.: The 2020 Taxable Ordinary Dividends,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Tax Treatment of 2020 Distributions
COR,2021-01-21,09:07:51,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 4Q 2020 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 4Q 2020 (COR)"
COR,2021-02-01,22:05:00,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,CoreSite Realty Corp.: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors,PRESS-RELEASE,Business Wire,Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:00,9810C0,CoreSite Realty Corp.,100,0.68,equity-actions,,CoreSite Realty Corp.: the Company's initial public offering in September 2010,PRESS-RELEASE,Business Wire,Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:01,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,CoreSite Realty Corp.: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:01,9810C0,CoreSite Realty Corp.,100,0.68,equity-actions,,CoreSite Realty Corp.: the Company's initial public offering in September 2010,PRESS-RELEASE,Dow Jones Newswires,Press Release: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:06:34,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,Michael Millegan Joins CoreSite Realty Corporation's Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Michael Millegan Joins CoreSite Realty Corporation's Bd of Directors
COR,2021-02-02,12:29:51,9810C0,CoreSite Realty Corp.,100,0.82,analyst-ratings,positive,Coresite Realty Raised to Outperform From Market Perform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Outperform From Market Perform by Cowen & Co.
COR,2021-02-02,12:29:51,9810C0,CoreSite Realty Corp.,100,0.78,price-targets,upgrade,Coresite Realty Price Target Raised to $152.00/Share From $132.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $152.00/Share From $132.00 by Cowen & Co.
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $22.4 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $606.8 million,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated Funds From Operations (""FFO"") of $5.31 per diluted share",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Financial Outlook,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's guidance for 2021,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,176,273 $ 2,100,999",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -2-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 83,891 $ 82,943 $",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 22,409 $ 24,132 $",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $22.4 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $606.8 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated Funds From Operations (""FFO"") of $5.31 per diluted share",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Financial Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's guidance for 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,176,273 $ 2,100,999",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -2-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 83,891 $ 82,943 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 22,409 $ 24,132 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:25,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 4Q Rev $154.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 4Q Rev $154.9M >COR
COR,2021-02-04,11:30:40,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 4Q EPS 46c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 4Q EPS 46c >COR
COR,2021-02-04,11:32:43,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty Sees 2021 Rev $642M-$652M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees 2021 Rev $642M-$652M >COR
COR,2021-02-04,11:33:12,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,Coresite Realty Sees 2021 EPS $1.81,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees 2021 EPS $1.81-EPS $1.91 >COR
COR,2021-02-04,23:16:09,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q4-2020-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript >COR
COR,2021-02-04,23:16:09,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript >COR
COR,2021-02-05,14:55:47,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-02-05,14:55:47,9810C0,CoreSite Realty Corp.,100,-0.46,price-targets,downgrade,Coresite Realty Price Target Cut to $156.00/Share From $161.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $156.00/Share From $161.00 by Credit Suisse
COR,2021-02-25,12:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,"CoreSite Realty Corp.: 2021 Virtual Citi Global Property CEO Conference on Wednesday, March 10th",PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:02,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:02,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,"CoreSite Realty Corp.: 2021 Virtual Citi Global Property CEO Conference on Wednesday, March 10th",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-26,21:21:25,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-03-04,21:24:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces First-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on April 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces First-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on April 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-06,00:04:22,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 762 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 762 Of CoreSite Realty Corp >COR
COR,2021-03-06,00:04:35,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Cfo Finnin Surrenders 2,709 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Surrenders 2,709 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:07:10,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 129 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 129 Of CoreSite Realty Corp >COR
COR,2021-03-06,00:08:24,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp McCandless Surrenders 1,437 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP McCandless Surrenders 1,437 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:09:25,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Officer Smith Surrenders 2,180 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"Officer Smith Surrenders 2,180 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:16:56,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp Warren Surrenders 1,425 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP Warren Surrenders 1,425 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:40:22,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Surrenders 14,788 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CEO Szurek Surrenders 14,788 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:18:01,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 2,180 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 2,180 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:27:17,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Vp Warren Brian & Anne Jtten Registers 4,131 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"VP Warren Brian & Anne Jtten Registers 4,131 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:35:34,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Vp McCandless Registers 3,131 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"VP McCandless Registers 3,131 Of CoreSite Realty Corp >COR"
COR,2021-03-11,00:27:58,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 234 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 234 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:28:21,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Hatzenbuehler Surrenders 165 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Hatzenbuehler Surrenders 165 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:29:58,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Officer Jones Surrenders 347 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,Officer Jones Surrenders 347 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:33:30,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 350 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 350 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:35:32,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Krusko Surrenders 32 Of CoreSite Realty Corp >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krusko Surrenders 32 Of CoreSite Realty Corp >COR
COR,2021-03-12,11:35:38,9810C0,CoreSite Realty Corp.,100,0.01,analyst-ratings,neutral,Coresite Realty Initiated at In-Line by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Initiated at In-Line by Evercore ISI Group
COR,2021-03-12,11:35:38,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $130.00/Share by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $130.00/Share by Evercore ISI Group
COR,2021-03-12,11:50:50,9810C0,CoreSite Realty Corp.,100,-0.8,price-targets,downgrade,Coresite Realty stock price target cut to $120 from $135 at Mizuho,NEWS-FLASH,MarketWatch,MW CoreSite Realty stock price target cut to $120 from $135 at Mizuho
COR,2021-03-12,14:59:18,9810C0,CoreSite Realty Corp.,100,0.0,analyst-ratings,neutral,Coresite Realty Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Neutral by Mizuho
COR,2021-03-12,14:59:19,9810C0,CoreSite Realty Corp.,100,-0.8,price-targets,downgrade,Coresite Realty Price Target Cut to $120.00/Share From $135.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $120.00/Share From $135.00 by Mizuho
COR,2021-03-17,22:10:27,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 2,918 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 2,918 Of CoreSite Realty Corp >COR"
COR,2021-03-17,22:56:57,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-03-17,22:57:59,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 971 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 971 Of CoreSite Realty Corp >COR
COR,2021-03-17,22:59:26,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Hatzenbuehler Acquires 1,966 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Hatzenbuehler Acquires 1,966 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:03:19,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Officer Jones Surrenders 1,082 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"Officer Jones Surrenders 1,082 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:04:42,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Kaiser Acquires 1,959 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Kaiser Acquires 1,959 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:09:54,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Krusko Acquires 1,398 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krusko Acquires 1,398 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:12:15,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp McCandless Acquires 2,532 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP McCandless Acquires 2,532 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:12:55,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Officer Smith Acquires 4,433 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Smith Acquires 4,433 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:14:02,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Surrenders 7,524 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CEO Szurek Surrenders 7,524 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:14:51,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp Warren Surrenders 1,856 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP Warren Surrenders 1,856 Of CoreSite Realty Corp >COR"
COR,2021-04-05,20:30:00,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces First Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces First Quarter 2021 Earnings Conference Call
COR,2021-04-22,07:17:15,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 1Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 1Q 2021 (COR)"
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.9 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $157.6 million,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $86.1 million,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.40 per diluted share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's 2021 guidance,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,165,213 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 85,207 $ 83,891 $",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,915 $ 22,409 $",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.9 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $157.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $86.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.40 per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's 2021 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,165,213 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 85,207 $ 83,891 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,915 $ 22,409 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:31:13,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 1Q Rev $132.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q Rev $132.9M >COR
COR,2021-04-29,10:31:40,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 1Q EPS 51c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q EPS 51c >COR
COR,2021-04-29,10:32:00,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,Coresite Realty 1Q Adjusted EBITDA $86.1M,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q Adjusted EBITDA $86.1M >COR
COR,2021-04-29,23:10:18,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corp-cor-ceo-paul-szurek-on-q1-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript >COR
COR,2021-04-29,23:10:18,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript >COR
COR,2021-05-05,23:25:04,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-05-05,23:25:13,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,FULL-ARTICLE,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-05-05,23:26:46,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,FULL-ARTICLE,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-05-19,20:29:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Second-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on July 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Second-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on July 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-20,11:00:00,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-05-20,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-05-26,20:45:05,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Font Sells 400 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Font Sells 400 Of CoreSite Realty Corp >COR
COR,2021-06-03,20:22:43,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Vp McCandless Sells 3,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"VP McCandless Sells 3,000 Of CoreSite Realty Corp >COR"
COR,2021-06-14,20:59:56,9810C0,CoreSite Realty Corp.,100,-0.34,equity-actions,decrease,"Holder Carlyle GRP MGMT LLC Sells 1,200,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Carlyle GRP MGMT LLC Sells 1,200,000 Of CoreSite Realty Corp >COR"
COR,2021-07-01,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Second Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Second Quarter 2021 Earnings Conference Call
COR,2021-07-01,11:02:46,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Second Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Second Quarter 2021 Earnings Conference Call
COR,2021-07-22,07:52:10,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 2Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 2Q 2021 (COR)"
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $28.5 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $162.1 million,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $87.4 million,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated FFO, as adjusted, of $1.42 per diluted share",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Updated Guidance,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,157,223 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -2-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: revenue $136,793 $132,976",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 28,475 $24,915",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $28.5 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $162.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $87.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated FFO, as adjusted, of $1.42 per diluted share",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Updated Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,157,223 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -2-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 86,960 $ 85,207 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 28,475 $24,915",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:28,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 2Q EPS 59c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 2Q EPS 59c >COR
COR,2021-07-29,10:30:28,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 2Q Rev $136.8M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 2Q Rev $136.8M >COR
COR,2021-07-29,10:41:30,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 2Q Rev $162.1M >COR,NEWS-FLASH,Dow Jones Newswires,Correct: CoreSite Realty 2Q Rev $162.1M >COR
COR,2021-07-29,10:42:10,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,Coresite Realty Sees FY EPS $1.99,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees FY EPS $1.99-EPS $2.07 >COR
COR,2021-07-29,10:42:10,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty Sees FY Rev $645M-$653M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees FY Rev $645M-$653M >COR
COR,2021-07-29,20:42:06,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 44 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 44 Of CoreSite Realty Corp >COR
COR,2021-07-29,21:54:13,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q2-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript >COR
COR,2021-07-29,21:54:13,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript >COR
COR,2021-07-30,11:43:04,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Wells Fargo
COR,2021-07-30,11:43:05,9810C0,CoreSite Realty Corp.,100,0.72,price-targets,upgrade,Coresite Realty Price Target Raised to $130.00/Share From $120.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $130.00/Share From $120.00 by Wells Fargo
COR,2021-07-30,12:35:45,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Raymond James
COR,2021-07-30,12:35:45,9810C0,CoreSite Realty Corp.,100,0.76,price-targets,upgrade,Coresite Realty Price Target Raised to $149.00/Share From $136.00 by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $149.00/Share From $136.00 by Raymond James
COR,2021-07-30,13:14:15,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-07-30,13:14:15,9810C0,CoreSite Realty Corp.,100,0.42,price-targets,upgrade,Coresite Realty Price Target Raised to $161.00/Share From $157.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $161.00/Share From $157.00 by Credit Suisse
COR,2021-07-30,13:28:25,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Cowen & Co.
COR,2021-07-30,13:28:25,9810C0,CoreSite Realty Corp.,100,0.46,price-targets,upgrade,Coresite Realty Price Target Raised to $158.00/Share From $153.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $158.00/Share From $153.00 by Cowen & Co.
COR,2021-08-02,17:14:59,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 5,435 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 5,435 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:24:24,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Officer Smith Sells 5,435 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Smith Sells 5,435 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:25:04,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:30:20,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-08-04,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at 7(th) Annual Cowen Communications Infrastructure Summit,PRESS-RELEASE,Business Wire,CoreSite to Present at 7(th) Annual Cowen Communications Infrastructure Summit
COR,2021-08-06,20:50:38,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,Vp Warren Brian & Anne Jtten Registers 850 Of CoreSite Realty Corp >COR,RNS-SEC144,Dow Jones Newswires,VP Warren Brian & Anne Jtten Registers 850 Of CoreSite Realty Corp >COR
COR,2021-08-09,20:17:34,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-08-09,20:19:53,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Font Sells 600 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Font Sells 600 Of CoreSite Realty Corp >COR
COR,2021-08-25,12:33:11,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Barclays
COR,2021-08-25,12:33:11,9810C0,CoreSite Realty Corp.,100,0.5,price-targets,upgrade,Coresite Realty Price Target Raised to $123.00/Share From $118.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $123.00/Share From $118.00 by Barclays
COR,2021-09-02,20:25:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Third-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on October 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Third-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on October 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-15,21:44:52,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Krusko Surrenders 27 Of CoreSite Realty Corp >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krusko Surrenders 27 Of CoreSite Realty Corp >COR
COR,2021-10-04,20:30:00,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Third Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Third Quarter 2021 Earnings Conference Call
COR,2021-10-04,21:08:25,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Third Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Third Quarter 2021 Earnings Conference Call
COR,2021-10-22,07:57:46,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 3Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 3Q 2021 (COR)"
COR,2021-10-26,14:34:14,9810C0,CoreSite Realty Corp.,100,0.01,analyst-ratings,neutral,Coresite Realty Initiated at In-Line by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Initiated at In-Line by Evercore ISI Group
COR,2021-10-26,14:34:14,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $154.00/Share by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $154.00/Share by Evercore ISI Group
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.1 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $163.9 million,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $85.7 million,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.39 per diluted share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Updated 2021 Guidance,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,166,995 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 87,596 $ 86,960 $",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,118 $28,475",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.1 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $163.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $85.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.39 per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Updated 2021 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,166,995 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 87,596 $ 86,960 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,118 $28,475",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:33:02,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 3Q EPS 50c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 3Q EPS 50c >COR
COR,2021-10-28,10:33:02,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 3Q Rev $163.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 3Q Rev $163.9M >COR
COR,2021-10-28,10:42:34,9810C0,CoreSite Realty Corp.,100,-0.53,equity-actions,down,Coresite Realty Lowers FY CapEx Guidance to $140M-$150M,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Lowers FY CapEx Guidance to $140M-$150M >COR
COR,2021-10-28,20:48:59,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q3-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript >COR
COR,2021-10-28,20:48:59,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript >COR
COR,2021-10-29,11:42:43,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Barclays
COR,2021-10-29,11:42:43,9810C0,CoreSite Realty Corp.,100,0.4,price-targets,upgrade,Coresite Realty Price Target Raised to $126.00/Share From $123.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $126.00/Share From $123.00 by Barclays
COR,2021-10-29,12:05:33,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-10-29,12:05:33,9810C0,CoreSite Realty Corp.,100,-0.36,price-targets,downgrade,Coresite Realty Price Target Cut to $158.00/Share From $161.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $158.00/Share From $161.00 by Credit Suisse
COR,2021-10-29,12:11:13,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Wells Fargo
COR,2021-10-29,12:11:13,9810C0,CoreSite Realty Corp.,100,0.48,price-targets,upgrade,Coresite Realty Price Target Raised to $135.00/Share From $130.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $135.00/Share From $130.00 by Wells Fargo
COR,2021-10-29,14:12:53,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Raymond James
COR,2021-10-29,14:12:53,9810C0,CoreSite Realty Corp.,100,0.42,price-targets,upgrade,Coresite Realty Price Target Raised to $153.00/Share From $149.00 by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $153.00/Share From $149.00 by Raymond James
COR,2021-11-03,22:22:22,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-11-05,21:45:29,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-11-09,21:46:27,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-11-15,12:00:00,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower To Acquire CoreSite >AMT COR
COR,2021-11-15,12:00:00,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower To Acquire CoreSite >AMT COR
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will acquire CoreSite for $170.00 per share in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Press Release: American Tower to Acquire CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:33,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $170 A Share,NEWS-FLASH,Dow Jones Newswires,American Tower to Buy CoreSite for $170 A Share in Cash >AMT COR
COR,2021-11-15,12:01:59,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower REIT to buy CoreSite Realty in a deal,NEWS-FLASH,MarketWatch,MW American Tower REIT to buy CoreSite Realty in a deal valued at $10.1 bln
COR,2021-11-15,12:03:41,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Coresite to Be Acquired for $170,NEWS-FLASH,Dow Jones Newswires,CoreSite to Be Acquired for $170 A Share; Closed Friday at $166.59 >AMT COR
COR,2021-11-15,12:16:02,9810C0,CoreSite Realty Corp.,95,0.65,acquisitions-mergers,,American Tower will pay $170 for each CoreSite,FULL-ARTICLE,MarketWatch,MW CoreSite's stock rises toward another record after buyout deal with American Tower REIT valued at $10.1 billion
COR,2021-11-15,12:16:02,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will pay $170 for each CoreSite,FULL-ARTICLE,Dow Jones Newswires,CoreSite's Stock Rises Toward Another Record After Buyout Deal With American Tower REIT Valued At $10.1 Billion -- MarketWatch
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will acquire CoreSite for $170.00 per share in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Press Release: American Tower to Acquire CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:29:06,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $10.1 Billion,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy CoreSite for $10.1 Billion
COR,2021-11-15,12:44:06,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $10.1 Billion,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy CoreSite for $10.1 Billion
COR,2021-11-15,12:58:40,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy Data Center Manager CoreSite in $10.1 Billion Deal,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy Data Center Manager CoreSite in $10.1 Billion Deal -- Barrons.com
COR,2021-11-15,17:00:03,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite shareholders will receive only $170.00 per share,PRESS-RELEASE,PR Newswire,Shareholder Alert: Ademi LLP investigates whether CoreSite Realty Corporation has obtained a Fair Price in its going private transaction with American Tower
COR,2021-11-15,17:15:33,9810C0,CoreSite Realty Corp.,92,0.55,acquisitions-mergers,,"Coresite Realty are being acquired in two separate, multibillion deals that highlight that digital-infrastructure",FULL-ARTICLE,Dow Jones Newswires,"CyrusOne, CoreSite Deals Show Data Centers Are in Demand -- Market Insight"
COR,2021-11-15,18:20:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire Data Center Manager CoreSite in $10.1 Billion Deal,FULL-ARTICLE,Dow Jones Newswires,American Tower to Acquire Data Center Manager CoreSite in $10.1 Billion Deal
COR,2021-11-15,19:43:26,9810C0,CoreSite Realty Corp.,100,-0.6,acquisitions-mergers,scrutiny,Announces Investigation of CoreSite Realty Corporation Merger,PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CoreSite Realty Corporation Merger"
COR,2021-11-15,19:43:26,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Coresite's agreement to be acquired by American Tower Corporation (NYSE: AMT).,PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CoreSite Realty Corporation Merger"
COR,2021-11-16,01:13:02,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the Company by American Tower Corporation,PRESS-RELEASE,PR Newswire,SHAREHOLDER ALERT: WeissLaw LLP Investigates CoreSite Realty Corporation
COR,2021-11-16,09:55:37,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Market Perform From Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Market Perform From Outperform by Raymond James
COR,2021-11-16,10:38:57,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Neutral From Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Neutral From Outperform by Credit Suisse
COR,2021-11-16,10:38:57,9810C0,CoreSite Realty Corp.,100,0.68,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $158.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $158.00 by Credit Suisse
COR,2021-11-16,11:21:07,9810C0,CoreSite Realty Corp.,100,0.62,analyst-ratings,positive,Coresite Realty Raised to Equal-Weight From Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Equal-Weight From Underweight by Barclays
COR,2021-11-16,15:30:34,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite Realty Corp.,NEWS-FLASH,Dow Jones Newswires,S&PGRBulletin: American Tower To Acquire CoreSite Realty Corp.
COR,2021-11-16,15:30:50,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite Realty Corp.,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: American Tower To Acquire CoreSite Realty Corp.
COR,2021-11-16,20:31:52,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of CoreSite Realty Corporation with American Tower Corporation"
COR,2021-11-17,15:17:13,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of CONE, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of CONE, COR, RC, and CSPR"
COR,2021-11-17,23:38:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Fourth-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on December 13, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Fourth-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on December 13, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-18,13:00:07,9810C0,CoreSite Realty Corp.,99,0.39,products-services,,Coresite announced entering into a merger agreement with American Tower,PRESS-RELEASE,GlobeNewswire,(COR): Johnson Fistel Investigates Proposed Sale of CoreSite Realty Corporation; Are Shareholders Getting a Fair Deal?
COR,2021-11-18,13:00:07,9810C0,CoreSite Realty Corp.,99,0.61,earnings,positive,Shareholders of CoreSite will receive only $170 per share,PRESS-RELEASE,GlobeNewswire,(COR): Johnson Fistel Investigates Proposed Sale of CoreSite Realty Corporation; Are Shareholders Getting a Fair Deal?
COR,2021-11-18,16:56:50,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of CBTX, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of CBTX, COR, GFED, and VSAT"
COR,2021-11-18,22:15:54,9810C0,CoreSite Realty Corp.,94,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,DJ Global Press Release Wire,"MERGER ALERT - COR, CONE, and DWSN: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
COR,2021-11-20,01:27:02,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,Pc Announces an Investigation of CoreSite Realty Corp.,PRESS-RELEASE,PR Newswire,SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CoreSite Realty Corp. - COR
COR,2021-11-22,15:18:02,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-23,16:19:05,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-23,18:54:03,9810C0,CoreSite Realty Corp.,96,0.0,dividends,,Coresite shareholders will receive $170.00 in cash per share,PRESS-RELEASE,PR Newswire,"Moore Kuehn Encourages CONE, COR, WALD, and ATSPT Investors to Contact Law Firm"
COR,2021-11-23,18:54:03,9810C0,CoreSite Realty Corp.,96,0.0,dividends,,Coresite shareholders will receive $170.00 in cash per share,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Moore Kuehn Encourages CONE, COR, WALD, and ATSPT Investors to Contact Law Firm"
COR,2021-11-24,02:59:02,9810C0,CoreSite Realty Corp.,94,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds COR, CSPR, PNBK, and ZIXI Shareholders About Its Ongoing Investigations"
COR,2021-11-25,14:02:07,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-26,11:57:00,9810C0,CoreSite Realty Corp.,100,0.0,analyst-ratings,neutral,Coresite Realty Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Sector Perform by RBC Capital
COR,2021-11-26,11:57:00,9810C0,CoreSite Realty Corp.,100,0.78,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $136.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $136.00 by RBC Capital
COR,2021-11-29,16:16:09,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-01,17:21:01,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-02,00:44:03,9810C0,CoreSite Realty Corp.,94,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds PNBK, ZIXI, COR, and CSPR Shareholders About Its Ongoing Investigations"
COR,2021-12-06,15:20:34,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-08,00:32:47,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Gifts 13,817 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Szurek Gifts 13,817 Of CoreSite Realty Corp >COR"
COR,2021-12-08,02:30:03,9810C0,CoreSite Realty Corp.,95,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds VG, DRNA, DVD, and COR Shareholders About Its Ongoing Investigations"
COR,2021-12-14,10:23:04,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Neutral From Buy by Citigroup
COR,2021-12-14,10:23:04,9810C0,CoreSite Realty Corp.,100,0.56,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $162.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $162.00 by Citigroup
COR,2021-12-15,14:18:00,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-20,21:21:06,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Cfo Finnin Gifts 3,500 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Gifts 3,500 Of CoreSite Realty Corp >COR"
COR,2021-12-20,21:22:12,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp McCandless Gifts 1,470 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP McCandless Gifts 1,470 Of CoreSite Realty Corp >COR"
COR,2021-12-21,00:55:03,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of CoreSite Realty Corporation with American Tower Corporation"
COR,2021-12-28,13:54:00,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,Promptly complete the acquisition of CoreSite,PRESS-RELEASE,Business Wire,American Tower Announces Expiration of Tender Offer Period for Outstanding Shares of CoreSite Realty Corporation
COR,2021-12-28,13:54:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,Promptly complete the acquisition of CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower Announces Expiration of Tender Offer Period for Outstanding Shares of CoreSite Realty Corporation
COR,2021-12-28,21:30:00,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition Of CoreSite Realty Corporation >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower Completes Acquisition Of CoreSite Realty Corporation >AMT
COR,2021-12-28,21:30:00,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,"American Tower"") announced today that it has closed its acquisition of CoreSite Realty Corporation (NYSE: COR)",PRESS-RELEASE,Business Wire,American Tower Completes Acquisition of CoreSite Realty Corporation
COR,2021-12-28,21:30:01,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,"American Tower"") announced today that it has closed its acquisition of CoreSite Realty Corporation (NYSE: COR)",PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower Completes Acquisition of CoreSite Realty Corporation
COR,2021-01-04,21:30:06,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Fourth Quarter 2020 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Fourth Quarter 2020 Earnings Conference Call
COR,2021-01-04,21:30:50,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Fourth Quarter 2020 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Fourth Quarter 2020 Earnings Conference Call
COR,2021-01-06,11:35:23,9810C0,CoreSite Realty Corp.,100,0.94,analyst-ratings,positive,Coresite Realty Raised to Outperform From Neutral by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Outperform From Neutral by Credit Suisse
COR,2021-01-06,11:35:23,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $161.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $161.00/Share by Credit Suisse
COR,2021-01-20,12:00:02,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,CoreSite Realty Corp.: The 2020 Taxable Ordinary Dividends,PRESS-RELEASE,Business Wire,CoreSite Announces Tax Treatment of 2020 Distributions
COR,2021-01-20,12:00:02,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,CoreSite Realty Corp.: The 2020 Taxable Ordinary Dividends,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Tax Treatment of 2020 Distributions
COR,2021-01-21,09:07:51,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 4Q 2020 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 4Q 2020 (COR)"
COR,2021-02-01,22:05:00,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,CoreSite Realty Corp.: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors,PRESS-RELEASE,Business Wire,Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:00,9810C0,CoreSite Realty Corp.,100,0.68,equity-actions,,CoreSite Realty Corp.: the Company's initial public offering in September 2010,PRESS-RELEASE,Business Wire,Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:01,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,CoreSite Realty Corp.: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:05:01,9810C0,CoreSite Realty Corp.,100,0.68,equity-actions,,CoreSite Realty Corp.: the Company's initial public offering in September 2010,PRESS-RELEASE,Dow Jones Newswires,Press Release: Michael Millegan Joins CoreSite Realty Corporation's Board of Directors
COR,2021-02-01,22:06:34,9810C0,CoreSite Realty Corp.,100,0.47,labor-issues,,Michael Millegan Joins CoreSite Realty Corporation's Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Michael Millegan Joins CoreSite Realty Corporation's Bd of Directors
COR,2021-02-02,12:29:51,9810C0,CoreSite Realty Corp.,100,0.82,analyst-ratings,positive,Coresite Realty Raised to Outperform From Market Perform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Outperform From Market Perform by Cowen & Co.
COR,2021-02-02,12:29:51,9810C0,CoreSite Realty Corp.,100,0.78,price-targets,upgrade,Coresite Realty Price Target Raised to $152.00/Share From $132.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $152.00/Share From $132.00 by Cowen & Co.
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $22.4 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $606.8 million,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated Funds From Operations (""FFO"") of $5.31 per diluted share",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Financial Outlook,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's guidance for 2021,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,176,273 $ 2,100,999",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -2-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 83,891 $ 82,943 $",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,94,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 22,409 $ 24,132 $",PRESS-RELEASE,Business Wire,CoreSite Reports Fourth Quarter 2020 Financial -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $22.4 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $606.8 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated Funds From Operations (""FFO"") of $5.31 per diluted share",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Financial Outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's guidance for 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter 2020 Financial Results
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,176,273 $ 2,100,999",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -2-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 83,891 $ 82,943 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 22,409 $ 24,132 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Fourth Quarter -3-
COR,2021-02-04,11:30:25,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 4Q Rev $154.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 4Q Rev $154.9M >COR
COR,2021-02-04,11:30:40,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 4Q EPS 46c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 4Q EPS 46c >COR
COR,2021-02-04,11:32:43,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty Sees 2021 Rev $642M-$652M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees 2021 Rev $642M-$652M >COR
COR,2021-02-04,11:33:12,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,Coresite Realty Sees 2021 EPS $1.81,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees 2021 EPS $1.81-EPS $1.91 >COR
COR,2021-02-04,23:16:09,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q4-2020-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript >COR
COR,2021-02-04,23:16:09,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q4 2020 Results -- Earnings Call Transcript >COR
COR,2021-02-05,14:55:47,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-02-05,14:55:47,9810C0,CoreSite Realty Corp.,100,-0.46,price-targets,downgrade,Coresite Realty Price Target Cut to $156.00/Share From $161.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $156.00/Share From $161.00 by Credit Suisse
COR,2021-02-25,12:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,"CoreSite Realty Corp.: 2021 Virtual Citi Global Property CEO Conference on Wednesday, March 10th",PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:02,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-25,12:00:02,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,"CoreSite Realty Corp.: 2021 Virtual Citi Global Property CEO Conference on Wednesday, March 10th",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-02-26,21:21:25,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-03-04,21:24:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces First-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on April 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces First-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-04,21:24:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on April 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces First-Quarter 2021 Dividend on Common Stock
COR,2021-03-06,00:04:22,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 762 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 762 Of CoreSite Realty Corp >COR
COR,2021-03-06,00:04:35,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Cfo Finnin Surrenders 2,709 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Surrenders 2,709 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:07:10,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 129 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 129 Of CoreSite Realty Corp >COR
COR,2021-03-06,00:08:24,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp McCandless Surrenders 1,437 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP McCandless Surrenders 1,437 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:09:25,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Officer Smith Surrenders 2,180 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"Officer Smith Surrenders 2,180 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:16:56,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp Warren Surrenders 1,425 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP Warren Surrenders 1,425 Of CoreSite Realty Corp >COR"
COR,2021-03-06,00:40:22,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Surrenders 14,788 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CEO Szurek Surrenders 14,788 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:18:01,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 2,180 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 2,180 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:27:17,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Vp Warren Brian & Anne Jtten Registers 4,131 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"VP Warren Brian & Anne Jtten Registers 4,131 Of CoreSite Realty Corp >COR"
COR,2021-03-09,00:35:34,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Vp McCandless Registers 3,131 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"VP McCandless Registers 3,131 Of CoreSite Realty Corp >COR"
COR,2021-03-11,00:27:58,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 234 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 234 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:28:21,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Hatzenbuehler Surrenders 165 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Hatzenbuehler Surrenders 165 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:29:58,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Officer Jones Surrenders 347 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,Officer Jones Surrenders 347 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:33:30,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 350 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 350 Of CoreSite Realty Corp >COR
COR,2021-03-11,00:35:32,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Krusko Surrenders 32 Of CoreSite Realty Corp >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krusko Surrenders 32 Of CoreSite Realty Corp >COR
COR,2021-03-12,11:35:38,9810C0,CoreSite Realty Corp.,100,0.01,analyst-ratings,neutral,Coresite Realty Initiated at In-Line by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Initiated at In-Line by Evercore ISI Group
COR,2021-03-12,11:35:38,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $130.00/Share by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $130.00/Share by Evercore ISI Group
COR,2021-03-12,11:50:50,9810C0,CoreSite Realty Corp.,100,-0.8,price-targets,downgrade,Coresite Realty stock price target cut to $120 from $135 at Mizuho,NEWS-FLASH,MarketWatch,MW CoreSite Realty stock price target cut to $120 from $135 at Mizuho
COR,2021-03-12,14:59:18,9810C0,CoreSite Realty Corp.,100,0.0,analyst-ratings,neutral,Coresite Realty Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Neutral by Mizuho
COR,2021-03-12,14:59:19,9810C0,CoreSite Realty Corp.,100,-0.8,price-targets,downgrade,Coresite Realty Price Target Cut to $120.00/Share From $135.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $120.00/Share From $135.00 by Mizuho
COR,2021-03-17,22:10:27,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 2,918 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 2,918 Of CoreSite Realty Corp >COR"
COR,2021-03-17,22:56:57,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-03-17,22:57:59,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Font Surrenders 971 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Font Surrenders 971 Of CoreSite Realty Corp >COR
COR,2021-03-17,22:59:26,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Hatzenbuehler Acquires 1,966 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Hatzenbuehler Acquires 1,966 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:03:19,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Officer Jones Surrenders 1,082 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"Officer Jones Surrenders 1,082 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:04:42,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Kaiser Acquires 1,959 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Kaiser Acquires 1,959 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:09:54,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp Krusko Acquires 1,398 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krusko Acquires 1,398 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:12:15,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Vp McCandless Acquires 2,532 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP McCandless Acquires 2,532 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:12:55,9810C0,CoreSite Realty Corp.,100,0.52,insider-trading,,"Officer Smith Acquires 4,433 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Smith Acquires 4,433 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:14:02,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Surrenders 7,524 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"CEO Szurek Surrenders 7,524 Of CoreSite Realty Corp >COR"
COR,2021-03-17,23:14:51,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp Warren Surrenders 1,856 Of CoreSite Realty Corp >COR",FULL-ARTICLE,Dow Jones Newswires,"VP Warren Surrenders 1,856 Of CoreSite Realty Corp >COR"
COR,2021-04-05,20:30:00,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces First Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces First Quarter 2021 Earnings Conference Call
COR,2021-04-22,07:17:15,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 1Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 1Q 2021 (COR)"
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.9 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $157.6 million,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $86.1 million,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.40 per diluted share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's 2021 guidance,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,165,213 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 85,207 $ 83,891 $",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,915 $ 22,409 $",PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports First Quarter 2021 Financial -3-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.9 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $157.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $86.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.40 per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.23 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: The Company's 2021 guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter 2021 Financial Results
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,165,213 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -2-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 85,207 $ 83,891 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,915 $ 22,409 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:30:02,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports First Quarter -3-
COR,2021-04-29,10:31:13,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 1Q Rev $132.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q Rev $132.9M >COR
COR,2021-04-29,10:31:40,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 1Q EPS 51c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q EPS 51c >COR
COR,2021-04-29,10:32:00,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,Coresite Realty 1Q Adjusted EBITDA $86.1M,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 1Q Adjusted EBITDA $86.1M >COR
COR,2021-04-29,23:10:18,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corp-cor-ceo-paul-szurek-on-q1-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript >COR
COR,2021-04-29,23:10:18,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corp CEO Paul Szurek on Q1 2021 Results -- Earnings Call Transcript >COR
COR,2021-05-05,23:25:04,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-05-05,23:25:13,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,FULL-ARTICLE,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-05-05,23:26:46,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,FULL-ARTICLE,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-05-19,20:29:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Second-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on July 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Second-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-19,20:29:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on July 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Second-Quarter 2021 Dividend on Common Stock
COR,2021-05-20,11:00:00,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Business Wire,CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-05-20,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at Two Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite to Present at Two Upcoming Investor Conferences
COR,2021-05-26,20:45:05,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Font Sells 400 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Font Sells 400 Of CoreSite Realty Corp >COR
COR,2021-06-03,20:22:43,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Vp McCandless Sells 3,000 Of CoreSite Realty Corp",FULL-ARTICLE,Dow Jones Newswires,"VP McCandless Sells 3,000 Of CoreSite Realty Corp >COR"
COR,2021-06-14,20:59:56,9810C0,CoreSite Realty Corp.,100,-0.34,equity-actions,decrease,"Holder Carlyle GRP MGMT LLC Sells 1,200,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Carlyle GRP MGMT LLC Sells 1,200,000 Of CoreSite Realty Corp >COR"
COR,2021-07-01,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Second Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Second Quarter 2021 Earnings Conference Call
COR,2021-07-01,11:02:46,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Second Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Second Quarter 2021 Earnings Conference Call
COR,2021-07-22,07:52:10,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 2Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 2Q 2021 (COR)"
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $28.5 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $162.1 million,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $87.4 million,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated FFO, as adjusted, of $1.42 per diluted share",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Updated Guidance,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,157,223 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -2-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: revenue $136,793 $132,976",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 28,475 $24,915",PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Second Quarter 2021 Financial -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $28.5 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $162.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $87.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,"CoreSite Realty Corp.: Generated FFO, as adjusted, of $1.42 per diluted share",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: 2021 Updated Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter 2021 Financial Results
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $2,157,223 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -2-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 86,960 $ 85,207 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 28,475 $24,915",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Second Quarter -3-
COR,2021-07-29,10:30:28,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 2Q EPS 59c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 2Q EPS 59c >COR
COR,2021-07-29,10:30:28,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 2Q Rev $136.8M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 2Q Rev $136.8M >COR
COR,2021-07-29,10:41:30,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 2Q Rev $162.1M >COR,NEWS-FLASH,Dow Jones Newswires,Correct: CoreSite Realty 2Q Rev $162.1M >COR
COR,2021-07-29,10:42:10,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,Coresite Realty Sees FY EPS $1.99,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees FY EPS $1.99-EPS $2.07 >COR
COR,2021-07-29,10:42:10,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty Sees FY Rev $645M-$653M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Sees FY Rev $645M-$653M >COR
COR,2021-07-29,20:42:06,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Kaiser Surrenders 44 Of CoreSite Realty Corp >COR,FULL-ARTICLE,Dow Jones Newswires,VP Kaiser Surrenders 44 Of CoreSite Realty Corp >COR
COR,2021-07-29,21:54:13,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q2-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript >COR
COR,2021-07-29,21:54:13,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q2 2021 Results -- Earnings Call Transcript >COR
COR,2021-07-30,11:43:04,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Wells Fargo
COR,2021-07-30,11:43:05,9810C0,CoreSite Realty Corp.,100,0.72,price-targets,upgrade,Coresite Realty Price Target Raised to $130.00/Share From $120.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $130.00/Share From $120.00 by Wells Fargo
COR,2021-07-30,12:35:45,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Raymond James
COR,2021-07-30,12:35:45,9810C0,CoreSite Realty Corp.,100,0.76,price-targets,upgrade,Coresite Realty Price Target Raised to $149.00/Share From $136.00 by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $149.00/Share From $136.00 by Raymond James
COR,2021-07-30,13:14:15,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-07-30,13:14:15,9810C0,CoreSite Realty Corp.,100,0.42,price-targets,upgrade,Coresite Realty Price Target Raised to $161.00/Share From $157.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $161.00/Share From $157.00 by Credit Suisse
COR,2021-07-30,13:28:25,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Cowen & Co.
COR,2021-07-30,13:28:25,9810C0,CoreSite Realty Corp.,100,0.46,price-targets,upgrade,Coresite Realty Price Target Raised to $158.00/Share From $153.00 by Cowen & Co.,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $158.00/Share From $153.00 by Cowen & Co.
COR,2021-08-02,17:14:59,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,"Officer Smith Registers 5,435 Of CoreSite Realty Corp >COR",RNS-SEC144,Dow Jones Newswires,"Officer Smith Registers 5,435 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:24:24,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Officer Smith Sells 5,435 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Smith Sells 5,435 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:25:04,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-08-03,21:30:20,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-08-04,11:00:01,9810C0,CoreSite Realty Corp.,100,0.0,marketing,,Coresite to Present at 7(th) Annual Cowen Communications Infrastructure Summit,PRESS-RELEASE,Business Wire,CoreSite to Present at 7(th) Annual Cowen Communications Infrastructure Summit
COR,2021-08-06,20:50:38,9810C0,CoreSite Realty Corp.,100,-0.48,insider-trading,,Vp Warren Brian & Anne Jtten Registers 850 Of CoreSite Realty Corp >COR,RNS-SEC144,Dow Jones Newswires,VP Warren Brian & Anne Jtten Registers 850 Of CoreSite Realty Corp >COR
COR,2021-08-09,20:17:34,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-08-09,20:19:53,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Font Sells 600 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Font Sells 600 Of CoreSite Realty Corp >COR
COR,2021-08-25,12:33:11,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Barclays
COR,2021-08-25,12:33:11,9810C0,CoreSite Realty Corp.,100,0.5,price-targets,upgrade,Coresite Realty Price Target Raised to $123.00/Share From $118.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $123.00/Share From $118.00 by Barclays
COR,2021-09-02,20:25:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Third-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on October 15, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Third-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-02,20:25:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on October 15, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Third-Quarter 2021 Dividend on Common Stock
COR,2021-09-15,21:44:52,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,Vp Krusko Surrenders 27 Of CoreSite Realty Corp >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krusko Surrenders 27 Of CoreSite Realty Corp >COR
COR,2021-10-04,20:30:00,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Third Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Business Wire,CoreSite Announces Third Quarter 2021 Earnings Conference Call
COR,2021-10-04,21:08:25,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Announces Third Quarter 2021 Earnings Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces Third Quarter 2021 Earnings Conference Call
COR,2021-10-22,07:57:46,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,"Coresite Realty Corporation, Inst Holders, 3Q 2021 (COR)",RNS-SEC13F,Dow Jones Newswires,"CoreSite Realty Corporation, Inst Holders, 3Q 2021 (COR)"
COR,2021-10-26,14:34:14,9810C0,CoreSite Realty Corp.,100,0.01,analyst-ratings,neutral,Coresite Realty Initiated at In-Line by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Initiated at In-Line by Evercore ISI Group
COR,2021-10-26,14:34:14,9810C0,CoreSite Realty Corp.,100,0.0,price-targets,set,Coresite Realty Price Target Announced at $154.00/Share by Evercore ISI,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Announced at $154.00/Share by Evercore ISI Group
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.1 million for the quarter,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $163.9 million,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $85.7 million,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.39 per diluted share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Updated 2021 Guidance,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,166,995 $ 2,176,273",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 87,596 $ 86,960 $",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,118 $28,475",PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,93,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Business Wire,CoreSite Reports Third Quarter 2021 Financial -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Net income was $24.1 million for the quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,CoreSite Realty Corp.: Grew operating revenues to $163.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.58,earnings,positive,CoreSite Realty Corp.: Grew adjusted EBITDA to $85.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,CoreSite Realty Corp.: Generated FFO of $1.39 per diluted share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,CoreSite Realty Corp.: Paid a dividend of $1.27 per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.39,products-services,,CoreSite Realty Corp.: Leasing Activity,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,earnings,,CoreSite Realty Corp.: Updated 2021 Guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,CoreSite Realty Corp.: The quarterly conference call,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter 2021 Financial Results
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,assets,,"CoreSite Realty Corp.: Total assets $ 2,166,995 $ 2,176,273",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,revenues,,CoreSite Realty Corp.: Total data center revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,99,0.0,equity-actions,,CoreSite Realty Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -2-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Net income per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,revenues,,"CoreSite Realty Corp.: Rental revenue $ 87,596 $ 86,960 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.61,earnings,positive,"CoreSite Realty Corp.: Net income $ 24,118 $28,475",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:30:01,9810C0,CoreSite Realty Corp.,92,0.0,earnings,,CoreSite Realty Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Reports Third Quarter -3-
COR,2021-10-28,10:33:02,9810C0,CoreSite Realty Corp.,100,0.61,earnings,positive,Coresite Realty 3Q EPS 50c,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 3Q EPS 50c >COR
COR,2021-10-28,10:33:02,9810C0,CoreSite Realty Corp.,100,0.0,revenues,,Coresite Realty 3Q Rev $163.9M >COR,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty 3Q Rev $163.9M >COR
COR,2021-10-28,10:42:34,9810C0,CoreSite Realty Corp.,100,-0.53,equity-actions,down,Coresite Realty Lowers FY CapEx Guidance to $140M-$150M,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Lowers FY CapEx Guidance to $140M-$150M >COR
COR,2021-10-28,20:48:59,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite-realty-corporation-cor-ceo-paul-szurek-on-q3-2021-results-earnings-call,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript >COR
COR,2021-10-28,20:48:59,9810C0,CoreSite Realty Corp.,100,0.0,investor-relations,,Coresite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Corporation CEO Paul Szurek on Q3 2021 Results -- Earnings Call Transcript >COR
COR,2021-10-29,11:42:43,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Barclays
COR,2021-10-29,11:42:43,9810C0,CoreSite Realty Corp.,100,0.4,price-targets,upgrade,Coresite Realty Price Target Raised to $126.00/Share From $123.00 by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $126.00/Share From $123.00 by Barclays
COR,2021-10-29,12:05:33,9810C0,CoreSite Realty Corp.,100,0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Credit Suisse
COR,2021-10-29,12:05:33,9810C0,CoreSite Realty Corp.,100,-0.36,price-targets,downgrade,Coresite Realty Price Target Cut to $158.00/Share From $161.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Cut to $158.00/Share From $161.00 by Credit Suisse
COR,2021-10-29,12:11:13,9810C0,CoreSite Realty Corp.,100,-0.34,analyst-ratings,neutral,Coresite Realty Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Underweight by Wells Fargo
COR,2021-10-29,12:11:13,9810C0,CoreSite Realty Corp.,100,0.48,price-targets,upgrade,Coresite Realty Price Target Raised to $135.00/Share From $130.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $135.00/Share From $130.00 by Wells Fargo
COR,2021-10-29,14:12:53,9810C0,CoreSite Realty Corp.,100,0.2,analyst-ratings,neutral,Coresite Realty Is Maintained at Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Outperform by Raymond James
COR,2021-10-29,14:12:53,9810C0,CoreSite Realty Corp.,100,0.42,price-targets,upgrade,Coresite Realty Price Target Raised to $153.00/Share From $149.00 by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $153.00/Share From $149.00 by Raymond James
COR,2021-11-03,22:22:22,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,"Cfo Finnin Sells 4,000 Of CoreSite Realty Corp",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Sells 4,000 Of CoreSite Realty Corp >COR"
COR,2021-11-05,21:45:29,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Officer Jones Sells 750 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Jones Sells 750 Of CoreSite Realty Corp >COR
COR,2021-11-09,21:46:27,9810C0,CoreSite Realty Corp.,100,-0.49,insider-trading,,Vp Warren Sells 850 Of CoreSite Realty Corp,TABULAR-MATERIAL,Dow Jones Newswires,VP Warren Sells 850 Of CoreSite Realty Corp >COR
COR,2021-11-15,12:00:00,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower To Acquire CoreSite >AMT COR
COR,2021-11-15,12:00:00,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower To Acquire CoreSite >AMT COR
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite
COR,2021-11-15,12:00:03,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire CoreSite,PRESS-RELEASE,Business Wire,American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will acquire CoreSite for $170.00 per share in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:00:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Press Release: American Tower to Acquire CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:00:33,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $170 A Share,NEWS-FLASH,Dow Jones Newswires,American Tower to Buy CoreSite for $170 A Share in Cash >AMT COR
COR,2021-11-15,12:01:59,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower REIT to buy CoreSite Realty in a deal,NEWS-FLASH,MarketWatch,MW American Tower REIT to buy CoreSite Realty in a deal valued at $10.1 bln
COR,2021-11-15,12:03:41,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Coresite to Be Acquired for $170,NEWS-FLASH,Dow Jones Newswires,CoreSite to Be Acquired for $170 A Share; Closed Friday at $166.59 >AMT COR
COR,2021-11-15,12:16:02,9810C0,CoreSite Realty Corp.,95,0.65,acquisitions-mergers,,American Tower will pay $170 for each CoreSite,FULL-ARTICLE,MarketWatch,MW CoreSite's stock rises toward another record after buyout deal with American Tower REIT valued at $10.1 billion
COR,2021-11-15,12:16:02,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will pay $170 for each CoreSite,FULL-ARTICLE,Dow Jones Newswires,CoreSite's Stock Rises Toward Another Record After Buyout Deal With American Tower REIT Valued At $10.1 Billion -- MarketWatch
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower will acquire CoreSite for $170.00 per share in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,CoreSite Realty Corp.: We are excited to partner with American Tower to,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite
COR,2021-11-15,12:23:07,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Press Release: American Tower to Acquire CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower to Acquire CoreSite -2-
COR,2021-11-15,12:29:06,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $10.1 Billion,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy CoreSite for $10.1 Billion
COR,2021-11-15,12:44:06,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy CoreSite for $10.1 Billion,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy CoreSite for $10.1 Billion
COR,2021-11-15,12:58:40,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Buy Data Center Manager CoreSite in $10.1 Billion Deal,FULL-ARTICLE,Dow Jones Newswires,American Tower to Buy Data Center Manager CoreSite in $10.1 Billion Deal -- Barrons.com
COR,2021-11-15,17:00:03,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite shareholders will receive only $170.00 per share,PRESS-RELEASE,PR Newswire,Shareholder Alert: Ademi LLP investigates whether CoreSite Realty Corporation has obtained a Fair Price in its going private transaction with American Tower
COR,2021-11-15,17:15:33,9810C0,CoreSite Realty Corp.,92,0.55,acquisitions-mergers,,"Coresite Realty are being acquired in two separate, multibillion deals that highlight that digital-infrastructure",FULL-ARTICLE,Dow Jones Newswires,"CyrusOne, CoreSite Deals Show Data Centers Are in Demand -- Market Insight"
COR,2021-11-15,18:20:04,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower to Acquire Data Center Manager CoreSite in $10.1 Billion Deal,FULL-ARTICLE,Dow Jones Newswires,American Tower to Acquire Data Center Manager CoreSite in $10.1 Billion Deal
COR,2021-11-15,19:43:26,9810C0,CoreSite Realty Corp.,100,-0.6,acquisitions-mergers,scrutiny,Announces Investigation of CoreSite Realty Corporation Merger,PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CoreSite Realty Corporation Merger"
COR,2021-11-15,19:43:26,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,Coresite's agreement to be acquired by American Tower Corporation (NYSE: AMT).,PRESS-RELEASE,GlobeNewswire,"SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of CoreSite Realty Corporation Merger"
COR,2021-11-16,01:13:02,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the Company by American Tower Corporation,PRESS-RELEASE,PR Newswire,SHAREHOLDER ALERT: WeissLaw LLP Investigates CoreSite Realty Corporation
COR,2021-11-16,09:55:37,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Market Perform From Outperform by Raymond James,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Market Perform From Outperform by Raymond James
COR,2021-11-16,10:38:57,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Neutral From Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Neutral From Outperform by Credit Suisse
COR,2021-11-16,10:38:57,9810C0,CoreSite Realty Corp.,100,0.68,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $158.00 by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $158.00 by Credit Suisse
COR,2021-11-16,11:21:07,9810C0,CoreSite Realty Corp.,100,0.62,analyst-ratings,positive,Coresite Realty Raised to Equal-Weight From Underweight by Barclays,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Raised to Equal-Weight From Underweight by Barclays
COR,2021-11-16,15:30:34,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite Realty Corp.,NEWS-FLASH,Dow Jones Newswires,S&PGRBulletin: American Tower To Acquire CoreSite Realty Corp.
COR,2021-11-16,15:30:50,9810C0,CoreSite Realty Corp.,100,0.65,acquisitions-mergers,,American Tower To Acquire CoreSite Realty Corp.,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: American Tower To Acquire CoreSite Realty Corp.
COR,2021-11-16,20:31:52,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,DJ Global Press Release Wire,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of CoreSite Realty Corporation with American Tower Corporation"
COR,2021-11-17,15:17:13,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of CONE, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of CONE, COR, RC, and CSPR"
COR,2021-11-17,23:38:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Fourth-Quarter 2021 Dividend,PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:00,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on December 13, 2021",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,Coresite Realty Corporation Announces Fourth-Quarter 2021 Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-17,23:38:01,9810C0,CoreSite Realty Corp.,100,0.0,dividends,,"CoreSite Realty Corp.: The dividend will be paid on December 13, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Fourth-Quarter 2021 Dividend on Common Stock
COR,2021-11-18,13:00:07,9810C0,CoreSite Realty Corp.,99,0.39,products-services,,Coresite announced entering into a merger agreement with American Tower,PRESS-RELEASE,GlobeNewswire,(COR): Johnson Fistel Investigates Proposed Sale of CoreSite Realty Corporation; Are Shareholders Getting a Fair Deal?
COR,2021-11-18,13:00:07,9810C0,CoreSite Realty Corp.,99,0.61,earnings,positive,Shareholders of CoreSite will receive only $170 per share,PRESS-RELEASE,GlobeNewswire,(COR): Johnson Fistel Investigates Proposed Sale of CoreSite Realty Corporation; Are Shareholders Getting a Fair Deal?
COR,2021-11-18,16:56:50,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of CBTX, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of CBTX, COR, GFED, and VSAT"
COR,2021-11-18,22:15:54,9810C0,CoreSite Realty Corp.,94,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,DJ Global Press Release Wire,"MERGER ALERT - COR, CONE, and DWSN: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
COR,2021-11-20,01:27:02,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,Pc Announces an Investigation of CoreSite Realty Corp.,PRESS-RELEASE,PR Newswire,SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of CoreSite Realty Corp. - COR
COR,2021-11-22,15:18:02,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-23,16:19:05,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-23,18:54:03,9810C0,CoreSite Realty Corp.,96,0.0,dividends,,Coresite shareholders will receive $170.00 in cash per share,PRESS-RELEASE,PR Newswire,"Moore Kuehn Encourages CONE, COR, WALD, and ATSPT Investors to Contact Law Firm"
COR,2021-11-23,18:54:03,9810C0,CoreSite Realty Corp.,96,0.0,dividends,,Coresite shareholders will receive $170.00 in cash per share,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Moore Kuehn Encourages CONE, COR, WALD, and ATSPT Investors to Contact Law Firm"
COR,2021-11-24,02:59:02,9810C0,CoreSite Realty Corp.,94,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds COR, CSPR, PNBK, and ZIXI Shareholders About Its Ongoing Investigations"
COR,2021-11-25,14:02:07,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-11-26,11:57:00,9810C0,CoreSite Realty Corp.,100,0.0,analyst-ratings,neutral,Coresite Realty Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Is Maintained at Sector Perform by RBC Capital
COR,2021-11-26,11:57:00,9810C0,CoreSite Realty Corp.,100,0.78,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $136.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $136.00 by RBC Capital
COR,2021-11-29,16:16:09,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,DJ Global Press Release Wire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-01,17:21:01,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-02,00:44:03,9810C0,CoreSite Realty Corp.,94,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds PNBK, ZIXI, COR, and CSPR Shareholders About Its Ongoing Investigations"
COR,2021-12-06,15:20:34,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-08,00:32:47,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Ceo Szurek Gifts 13,817 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Szurek Gifts 13,817 Of CoreSite Realty Corp >COR"
COR,2021-12-08,02:30:03,9810C0,CoreSite Realty Corp.,95,0.57,acquisitions-mergers,interest,CoreSite Realty Corp.: proposed acquisition of the company by American Tower Corporation,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: WeissLaw LLP Reminds VG, DRNA, DVD, and COR Shareholders About Its Ongoing Investigations"
COR,2021-12-14,10:23:04,9810C0,CoreSite Realty Corp.,100,-0.58,analyst-ratings,negative,Coresite Realty Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Cut to Neutral From Buy by Citigroup
COR,2021-12-14,10:23:04,9810C0,CoreSite Realty Corp.,100,0.56,price-targets,upgrade,Coresite Realty Price Target Raised to $170.00/Share From $162.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,CoreSite Realty Price Target Raised to $170.00/Share From $162.00 by Citigroup
COR,2021-12-15,14:18:00,9810C0,CoreSite Realty Corp.,100,-0.52,legal,,"C. Announces Investigation of ADTN, COR",PRESS-RELEASE,GlobeNewswire,"Lifshitz Law Firm, P.C. Announces Investigation of ADTN, COR, GFED, and IHC"
COR,2021-12-20,21:21:06,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Cfo Finnin Gifts 3,500 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Finnin Gifts 3,500 Of CoreSite Realty Corp >COR"
COR,2021-12-20,21:22:12,9810C0,CoreSite Realty Corp.,100,0.0,insider-trading,,"Vp McCandless Gifts 1,470 Of CoreSite Realty Corp >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP McCandless Gifts 1,470 Of CoreSite Realty Corp >COR"
COR,2021-12-21,00:55:03,9810C0,CoreSite Realty Corp.,99,0.0,dividends,,Coresite stockholders will receive $170.00 per share,PRESS-RELEASE,PR Newswire,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Merger of CoreSite Realty Corporation with American Tower Corporation"
COR,2021-12-28,13:54:00,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,Promptly complete the acquisition of CoreSite,PRESS-RELEASE,Business Wire,American Tower Announces Expiration of Tender Offer Period for Outstanding Shares of CoreSite Realty Corporation
COR,2021-12-28,13:54:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,Promptly complete the acquisition of CoreSite,PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower Announces Expiration of Tender Offer Period for Outstanding Shares of CoreSite Realty Corporation
COR,2021-12-28,21:30:00,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition Of CoreSite Realty Corporation >AMT,NEWS-FLASH,Dow Jones Newswires,American Tower Completes Acquisition Of CoreSite Realty Corporation >AMT
COR,2021-12-28,21:30:00,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,"American Tower"") announced today that it has closed its acquisition of CoreSite Realty Corporation (NYSE: COR)",PRESS-RELEASE,Business Wire,American Tower Completes Acquisition of CoreSite Realty Corporation
COR,2021-12-28,21:30:01,9810C0,CoreSite Realty Corp.,100,0.57,acquisitions-mergers,completed,"American Tower"") announced today that it has closed its acquisition of CoreSite Realty Corporation (NYSE: COR)",PRESS-RELEASE,Dow Jones Newswires,Press Release: American Tower Completes Acquisition of CoreSite Realty Corporation
COR,2023-01-03,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition Of PharmaLex >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Completes Acquisition Of PharmaLex >ABC
COR,2023-01-03,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of PharmaLex,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of PharmaLex
COR,2023-01-03,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of PharmaLex,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of PharmaLex
COR,2023-01-03,21:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release
COR,2023-01-03,22:19:19,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release
COR,2023-01-05,17:50:47,7D85A9,AmerisourceBergen Corp.,96,0.49,partnerships,,"Wearable, announces exclusive animal health partnership with MWI",PRESS-RELEASE,PR Newswire,"Link, the Smart Pet Wearable, announces exclusive animal health partnership with MWI/Amerisource Bergen"
COR,2023-01-05,21:24:22,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Krikorian Acquires 166 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 166 Of AmerisourceBergen Corp >ABC
COR,2023-01-10,13:30:02,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Amerisourcebergen, in partnership with the AmerisourceBergen",PRESS-RELEASE,Business Wire,The AmerisourceBergen Foundation & Good Neighbor Pharmacy Launch Scholarship Program to Support Aspiring Black and African American Pharmacists
COR,2023-01-11,14:50:21,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Baird
COR,2023-01-11,14:50:21,7D85A9,AmerisourceBergen Corp.,100,0.38,price-targets,upgrade,Amerisourcebergen Price Target Raised to $199.00/Share From $195.00 by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $199.00/Share From $195.00 by Baird
COR,2023-01-12,14:44:07,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by Argus Research
COR,2023-01-12,14:44:07,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $190.00/Share From $170.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $190.00/Share From $170.00 by Argus Research
COR,2023-01-18,20:09:31,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-01-19,21:07:36,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-01-22,08:18:25,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2022 (ABC)"
COR,2023-01-24,10:00:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen to Change Name to,FULL-ARTICLE,Dow Jones Newswires,Drug Distributor AmerisourceBergen to Change Name to Cencora -- WSJ
COR,2023-01-24,14:15:13,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen To Change Name To,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen To Change Name To Cencora Later This Year -- MarketWatch
COR,2023-01-24,14:15:13,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen to change name to,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen to change name to Cencora later this year
COR,2023-01-27,13:18:44,7D85A9,AmerisourceBergen Corp.,100,0.44,labor-issues,,Amerisourcebergen Corp. CEO Steven Collis 2022 Total Pay $16.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corp. CEO Steven Collis 2022 Total Pay $16.7M >ABC
COR,2023-01-27,13:45:17,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Amerisourcebergen, in partnership with the AmerisourceBergen",PRESS-RELEASE,DJ Global Press Release Wire,The AmerisourceBergen Foundation & Good Neighbor Pharmacy Launch Scholarship Program To Support Aspiring Black and African American Pharmacists
COR,2023-01-31,12:22:57,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $185.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $185.00/Share by Evercore ISI Group
COR,2023-01-31,13:44:48,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by UBS
COR,2023-01-31,13:44:48,7D85A9,AmerisourceBergen Corp.,100,0.46,price-targets,upgrade,Amerisourcebergen Price Target Raised to $190.00/Share From $184.00 by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $190.00/Share From $184.00 by UBS
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.50-Adj EPS $11.75 >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 1Q Rev $62.8B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Rev $62.8B >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,1Q EPS $2.33 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q EPS $2.33 >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Adj EPS $2.71,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Adj EPS $2.71 >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Net $479.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Net $479.7M >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 First Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $62.8 billion for the First Quarter, a 5.4 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.33,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.50 to $11.75,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 first quarter ended December 31, 2022, revenue increased 5.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2023, revenue was $62.8 billion, up 5.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the first quarter of fiscal 2023,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2023 was $161.3 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,AmerisourceBergen Corp.: Announced the completion of the acquisition of PharmaLex Holding GmbH,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2023 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -3-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -3-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -3-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.41,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -4-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.35 $ 2.15,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -4-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -5-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,906,893 $ 56,560,616",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -5-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,98,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -7-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $62.8 billion for the First Quarter, a 5.4 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.33,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.50 to $11.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 first quarter ended December 31, 2022, revenue increased 5.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2023, revenue was $62.8 billion, up 5.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the first quarter of fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2023 was $161.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,AmerisourceBergen Corp.: Announced the completion of the acquisition of PharmaLex Holding GmbH,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2023 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.35 $ 2.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,906,893 $ 56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,97,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-02-01,11:31:21,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Had Seen FY23 Adjusted EPS $11.30-$11.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Had Seen FY23 Adjusted EPS $11.30-$11.60 >ABC
COR,2023-02-01,11:33:46,7D85A9,AmerisourceBergen Corp.,100,-0.28,earnings,down,Amerisourcebergen Q1 EPS $2.33 vs. $2.71 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 EPS $2.33 vs. $2.71 a year ago
COR,2023-02-01,11:34:46,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q1 adj. EPS $2.71; FactSet consensus $2.64,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 adj. EPS $2.71; FactSet consensus $2.64
COR,2023-02-01,11:35:46,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,Amerisourcebergen Q1 EPS $2.33 vs. $2.13 a year ago,NEWS-FLASH,MarketWatch,MW CORRECTED: AmerisourceBergen Q1 EPS $2.33 vs. $2.13 a year ago
COR,2023-02-01,11:35:46,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Q1 revenue $62.8 bln, up 5.4%",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q1 revenue $62.8 bln, up 5.4% vs. year -ago; FactSet consensus $62.8 bln"
COR,2023-02-01,11:36:46,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees full-year adj. EPS of $11.50 to $11.75,NEWS-FLASH,MarketWatch,MW AmerisourceBergen now sees full-year adj. EPS of $11.50 to $11.75 vs. prior $11.30 to $11.60
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,"AmerisourceBergen Corp.: The company posted net income of $479.8 million, or $2.33 a share, up from $449.1 million",FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance"
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisource Bergen now sees full-year adjusted EPS of $11.50 to $11.75,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance"
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,"AmerisourceBergen Corp.: The company posted net income of $479.8 million, or $2.33 a share, up from $449.1 million",FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Corp. Stock Rises On Q1 Top Line Beat, Raised Guidance -- MarketWatch"
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisource Bergen now sees full-year adjusted EPS of $11.50 to $11.75,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Corp. Stock Rises On Q1 Top Line Beat, Raised Guidance -- MarketWatch"
COR,2023-02-01,14:55:03,7D85A9,AmerisourceBergen Corp.,94,0.0,investor-relations,,Steve Collis on fiscal 1Q earnings call,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Doesn't See Tailwind from Humira Biosimilars -- Market Talk
COR,2023-02-01,14:55:03,7D85A9,AmerisourceBergen Corp.,94,0.0,investor-relations,,Steve Collis on fiscal 1Q earnings call,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Doesn't See Tailwind from Humira Biosimilars -- Market Talk
COR,2023-02-01,14:57:51,7D85A9,AmerisourceBergen Corp.,94,0.59,equity-actions,,Amerisourcebergen repurchased $1B of its own shares,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:51,7D85A9,AmerisourceBergen Corp.,94,0.46,earnings,above-expectations,"Amerisource reported adjusted earnings per share of $2.71, beating analysts' forecast of $2.64",FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:52,7D85A9,AmerisourceBergen Corp.,98,0.59,equity-actions,,Amerisourcebergen repurchased $1B of its own shares,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:52,7D85A9,AmerisourceBergen Corp.,98,0.46,earnings,above-expectations,"Amerisource reported adjusted earnings per share of $2.71, beating analysts' forecast of $2.64",FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:52,7D85A9,AmerisourceBergen Corp.,98,0.0,investor-relations,,Steve Collis on fiscal 1Q earnings call,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-02,12:39:49,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Baird
COR,2023-02-02,12:39:49,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $201.00/Share From $199.00 by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $201.00/Share From $199.00 by Baird
COR,2023-02-02,13:00:49,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2023-02-02,13:00:49,7D85A9,AmerisourceBergen Corp.,100,0.56,price-targets,upgrade,Amerisourcebergen Price Target Raised to $170.00/Share From $162.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $170.00/Share From $162.00 by Mizuho
COR,2023-02-07,21:08:12,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Campbell Acquires 3,182 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 3,182 Of AmerisourceBergen Corp >ABC"
COR,2023-02-07,21:19:32,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Krikorian Acquires 4,152 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 4,152 Of AmerisourceBergen Corp >ABC"
COR,2023-02-08,22:03:48,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Krikorian Registers 5,711 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 5,711 Of AmerisourceBergen Corp >ABC"
COR,2023-02-09,21:07:42,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 5,711 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 5,711 Of AmerisourceBergen Corp >ABC"
COR,2023-02-15,21:00:44,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-02-16,21:08:54,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-03-02,21:51:41,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Clark Registers 1,924 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 1,924 Of AmerisourceBergen Corp >ABC"
COR,2023-03-03,21:14:43,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 1,924 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 1,924 Of AmerisourceBergen Corp >ABC"
COR,2023-03-13,20:16:22,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Battaglia Acquires 852 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 852 Of AmerisourceBergen Corp >ABC
COR,2023-03-15,20:07:12,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-03-15,20:09:51,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-03-29,11:01:03,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: SamaCare Partners with AmerisourceBergen to,PRESS-RELEASE,PR Newswire,SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices
COR,2023-03-29,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release
COR,2023-03-29,21:10:51,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release
COR,2023-03-31,12:45:53,7D85A9,AmerisourceBergen Corp.,100,0.95,analyst-ratings,positive,Amerisourcebergen Initiated at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Initiated at Buy by Citigroup
COR,2023-03-31,12:45:53,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $185.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $185.00/Share by Citigroup
COR,2023-04-11,14:09:27,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-04-13,20:11:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-04-20,12:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,acquisitions-mergers,,Amerisourcebergen will purchase its minority interest in the joint venture for approximately $685 million in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic
COR,2023-04-20,12:30:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen to -2-
COR,2023-04-20,12:30:02,7D85A9,AmerisourceBergen Corp.,99,0.62,acquisitions-mergers,,Amerisourcebergen will purchase its minority interest in the joint venture for approximately $685 million in cash,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic
COR,2023-04-20,12:30:02,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen to Acquire Leading -2-
COR,2023-04-20,12:34:08,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to buy OneOncology from General Atlantic in a deal valued at $2.1 billion,FULL-ARTICLE,MarketWatch,"MW TPG, AmerisourceBergen to buy OneOncology from General Atlantic in a deal valued at $2.1 billion."
COR,2023-04-20,12:53:10,7D85A9,AmerisourceBergen Corp.,95,0.39,products-services,,Tpg and AmerisourceBergen said the deal,FULL-ARTICLE,Dow Jones Newswires,"TPG, AmerisourceBergen to Buy OneOncology From General Atlantic"
COR,2023-04-20,16:06:38,7D85A9,AmerisourceBergen Corp.,97,0.39,products-services,,AmerisourceBergen Corp.: We expect the transaction will close by the end of September,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: AmerisourceBergen Rtgs Same On OneOncology Acq
COR,2023-04-22,07:15:18,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2023 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2023 (ABC)"
COR,2023-04-24,19:47:01,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,Amerisourcebergen reported 5% EPS growth,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Stock Joins Elite Group Of Top Performers -- IBD
COR,2023-04-24,19:48:13,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,Amerisourcebergen reported 5% EPS growth,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Stock Joins Elite Group Of Top Performers -- IBD
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.70,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.70-Adj EPS $11.90 >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $3.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $3.50 >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 2Q Rev $63.5B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Rev $63.5B >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,2Q EPS $2.13 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q EPS $2.13 >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 Second Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $63.5 billion for the Second Quarter, a 9.9 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.70 to $11.90,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 second quarter ended March 31, 2023, revenue increased 9.9 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: our full year financial outlook,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,-0.24,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue declined 0.2 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the second quarter of fiscal 2023,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.34,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, net interest expense of $64.1 million increased 21.2 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2023 was $176.0 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 2.62,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.87,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Net $435.4M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Net $435.4M >ABC
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,assets,,"AmerisourceBergen Corp.: Total assets $58,766,183 $ 56,560,616",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Second Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $63.5 billion for the Second Quarter, a 9.9 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.70 to $11.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 second quarter ended March 31, 2023, revenue increased 9.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: our full year financial outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.24,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue declined 0.2 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the second quarter of fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.34,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, net interest expense of $64.1 million increased 21.2 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2023 was $176.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 2.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.87,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,assets,,"AmerisourceBergen Corp.: Total assets $58,766,183 $ 56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-05-02,10:30:53,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen Sees FY23 Adjusted EPS Up 8%-10%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Adjusted EPS Up 8%-10% Constant Currency >ABC
COR,2023-05-02,10:31:24,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen Now Sees FY23 Revenue Growth 6%-8%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Now Sees FY23 Revenue Growth 6%-8%; Had Seen 5%-7% >ABC
COR,2023-05-02,10:34:00,7D85A9,AmerisourceBergen Corp.,100,-0.36,earnings,down,Amerisourcebergen Q2 EPS $2.13 vs. $2.59 a year ago,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen Q2 EPS $2.13 vs. $2.59 a year ago
COR,2023-05-02,10:35:01,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q2 adj. EPS $3.50; FactSet consensus $3.30,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen Q2 adj. EPS $3.50; FactSet consensus $3.30
COR,2023-05-02,10:35:01,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q2 revenue $63.457 bln vs. $57.719 bln a year ago; FactSet consensus $60.458 bln,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen Q2 revenue $63.457 bln vs. $57.719 bln a year ago; FactSet consensus $60.458 bln
COR,2023-05-02,10:36:01,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen now sees FY23 revenue up 6% to 8%,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen now sees FY23 revenue up 6% to 8% vs. prior guidance of up 5% to 7%
COR,2023-05-02,10:37:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees FY23 adj. EPS of $11.70 to $11.90,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen now sees FY23 adj. EPS of $11.70 to $11.90 vs. prior range of $11.50 to $11.75
COR,2023-05-02,10:56:21,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Boosts Earnings Outlook for 2023,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Earnings Outlook for 2023
COR,2023-05-02,10:56:21,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,Amerisourcebergen said it also expects revenue to grow 6% to 8%,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Earnings Outlook for 2023
COR,2023-05-03,11:13:03,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2023-05-03,11:13:03,7D85A9,AmerisourceBergen Corp.,100,0.4,price-targets,upgrade,Amerisourcebergen Price Target Raised to $174.00/Share From $170.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $174.00/Share From $170.00 by Mizuho
COR,2023-05-03,14:32:04,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by TD,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by TD Cowen
COR,2023-05-03,14:32:04,7D85A9,AmerisourceBergen Corp.,100,0.68,price-targets,upgrade,Amerisourcebergen Price Target Raised to $187.00/Share From $174.00 by TD,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $187.00/Share From $174.00 by TD Cowen
COR,2023-05-03,18:27:05,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by Citigroup
COR,2023-05-03,18:27:05,7D85A9,AmerisourceBergen Corp.,100,0.6,price-targets,upgrade,Amerisourcebergen Price Target Raised to $195.00/Share From $185.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $195.00/Share From $185.00 by Citigroup
COR,2023-05-09,15:18:34,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-05-10,20:04:15,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-05-11,13:04:02,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Discovery Partners with AmerisourceBergen for,PRESS-RELEASE,PR Newswire,Patient Discovery Partners with AmerisourceBergen for Cancer Care Equity
COR,2023-05-12,02:13:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds
COR,2023-05-12,02:13:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds
COR,2023-05-12,02:16:07,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen for $694M in Initial Proceeds >WBA
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance >ABC
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-15,21:11:36,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Llc Reports 16.5% Stake in AmerisourceBergen Corp.,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Holdings LLC Reports 16.5% Stake in AmerisourceBergen Corp.
COR,2023-05-15,21:19:51,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 292,792 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 292,792 Of AmerisourceBergen Corp >ABC"
COR,2023-05-17,16:00:32,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Campbell Registers 7,500 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 7,500 Of AmerisourceBergen Corp >ABC"
COR,2023-05-19,20:03:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Campbell Sells 7,500 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 7,500 Of AmerisourceBergen Corp >ABC"
COR,2023-05-19,20:12:40,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 12,545 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 12,545 Of AmerisourceBergen Corp >ABC"
COR,2023-05-26,12:16:46,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by UBS
COR,2023-05-26,12:16:46,7D85A9,AmerisourceBergen Corp.,100,0.7,price-targets,upgrade,Amerisourcebergen Price Target Raised to $184.00/Share From $170.00 by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $184.00/Share From $170.00 by UBS
COR,2023-06-07,15:18:58,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by B of A Securities
COR,2023-06-07,15:18:58,7D85A9,AmerisourceBergen Corp.,100,0.42,price-targets,upgrade,Amerisourcebergen Price Target Raised to $200.00/Share From $195.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $200.00/Share From $195.00 by B of A Securities
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Announce Completion Of Acquisition Of OneOncology >ABC,NEWS-FLASH,Dow Jones Newswires,TPG And AmerisourceBergen Announce Completion Of Acquisition Of OneOncology >ABC
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Announce Completion of Acquisition of OneOncology,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Announce Completion of Acquisition of OneOncology,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-13,14:12:33,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-06-14,20:15:18,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-06-20,11:52:56,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 275,984 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 275,984 Of AmerisourceBergen Corp >ABC"
COR,2023-06-22,18:45:26,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Clark Registers 27,542 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 27,542 Of AmerisourceBergen Corp >ABC"
COR,2023-06-23,20:08:30,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 27,542 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 27,542 Of AmerisourceBergen Corp >ABC"
COR,2023-06-29,20:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release
COR,2023-06-29,20:34:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release
COR,2023-07-03,20:08:22,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Donato Acquires 898 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Acquires 898 Of AmerisourceBergen Corp >ABC
COR,2023-07-11,11:48:55,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2023-07-11,11:48:55,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $192.00/Share From $174.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $192.00/Share From $174.00 by Mizuho
COR,2023-07-11,14:12:30,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-07-12,20:16:41,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.85,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.85-Adj EPS $11.95 >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Adj EPS $2.92,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Adj EPS $2.92 >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,3Q EPS $2.35 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q EPS $2.35 >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 3Q Rev $66.9B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Rev $66.9B >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Net $479.6M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Net $479.6M >ABC
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Third Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $66.9 billion for the Third Quarter, an 11.5 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $2.35,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,Amerisourcebergen will change its name to,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.85 to $11.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 third quarter ended June 30, 2023, revenue increased 11.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,unchanged,AmerisourceBergen Corp.: Revenue $66.9B $66.9B,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.16,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, net interest expense of $57.9 million increased 9.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2023 was $187.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.44,products-services,cut,AmerisourceBergen Corp.: to reduce prices for our products and services;,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.37 $ 1.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.38,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,assets,,"AmerisourceBergen Corp.: Total assets $61,177,196 $ 56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,revenues,,"AmerisourceBergen Corp.: For the third quarter of fiscal 2023, (i) revenue of $66.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,97,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 Third Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $66.9 billion for the Third Quarter, an 11.5 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $2.35,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.85 to $11.95,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 third quarter ended June 30, 2023, revenue increased 11.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,unchanged,AmerisourceBergen Corp.: Revenue $66.9B $66.9B,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.16,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, net interest expense of $57.9 million increased 9.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2023 was $187.1 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,Amerisourcebergen will change its name to,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.44,products-services,cut,AmerisourceBergen Corp.: to reduce prices for our products and services;,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -3-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.37 $ 1.95,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.38,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.47,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -7-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,assets,,"AmerisourceBergen Corp.: Total assets $61,177,196 $ 56,560,616",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -7-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,98,0.0,revenues,,"AmerisourceBergen Corp.: For the third quarter of fiscal 2023, (i) revenue of $66.9 billion",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -9-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,98,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -9-
COR,2023-08-02,10:32:45,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen Now Sees FY23 Revenue Up at Least 8,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Now Sees FY23 Revenue Up at Least 8%; Had Seen Up 6%-8% >ABC
COR,2023-08-03,13:43:31,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Morgan Stanley
COR,2023-08-03,13:43:31,7D85A9,AmerisourceBergen Corp.,100,0.7,price-targets,upgrade,Amerisourcebergen Price Target Raised to $190.00/Share From $176.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $190.00/Share From $176.00 by Morgan Stanley
COR,2023-08-03,20:33:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10.5 million shares of common stock of the Company,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase
COR,2023-08-03,20:33:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10.5 million shares of common stock of the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase
COR,2023-08-03,22:48:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds
COR,2023-08-03,22:48:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds
COR,2023-08-03,22:48:47,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen Corp,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen Corp for $1.85B of Initial Proceeds
COR,2023-08-03,22:57:37,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells About $1.6B of AmerisourceBergen Shares,NEWS-FLASH,Dow Jones Newswires,"Walgreens Boots Alliance Sells About $1.6B of AmerisourceBergen Shares Through a Registered Public Offering, Also Enters a Concurrent Shr Repurchase Agreement for About $250M"
COR,2023-08-03,23:17:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance sells shares of AmerisourceBergen,FULL-ARTICLE,MarketWatch,MW Walgreens Boots Alliance sells shares of AmerisourceBergen for $1.85 billion
COR,2023-08-03,23:17:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares Of AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots Alliance Sells Shares Of AmerisourceBergen For $1.85 Billion -- MarketWatch
COR,2023-08-07,15:10:46,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by TD Cowen,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by TD Cowen
COR,2023-08-07,15:10:46,7D85A9,AmerisourceBergen Corp.,100,0.56,price-targets,upgrade,Amerisourcebergen Price Target Raised to $215.00/Share From $205.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $215.00/Share From $205.00 by TD Cowen
COR,2023-08-07,21:50:05,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 1,320,858 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 1,320,858 Of AmerisourceBergen Corp >ABC"
COR,2023-08-08,18:57:32,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-08-09,20:09:27,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-08-19,07:13:37,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2023 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2023 (ABC)"
COR,2023-08-28,13:00:01,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Signs Agreement with AmerisourceBergen,PRESS-RELEASE,Business Wire,Tivic Health Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers
COR,2023-08-28,13:00:29,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Signs Agreement With AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Tivic Health Signs Agreement With AmerisourceBergen for Retail Pharmacy Customers
COR,2023-08-28,13:00:40,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Signs Agreement with AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Tivic Health Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers
COR,2023-08-28,13:16:47,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Systems Signs Marketplace Agreement With AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Tivic Health Systems Signs Marketplace Agreement With AmerisourceBergen
COR,2023-08-30,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen becomes Cencora, in alignment with the company's growing global footprint and central role in pharmaceutical access and care"
COR,2023-08-30,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,"AmerisourceBergen becomes Cencora, in alignment with the company's growing global footprint and central role in pharmaceutical access and care"
COR,2023-08-30,11:58:11,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen Changes Name to,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Changes Name to Cencora
COR,2023-09-21,16:12:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Donato Registers 3,386 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,386 Of Cencora Inc >COR"
COR,2023-09-22,20:04:32,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Donato Sells 3,386 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,386 Of Cencora Inc >COR"
COR,2023-09-25,15:39:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Coo Mauch Registers 20,197 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"COO Mauch Registers 20,197 Of Cencora Inc >COR"
COR,2023-09-25,16:09:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 20,971 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 20,971 Of Cencora Inc >COR"
COR,2023-09-27,20:08:05,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 20,971 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 20,971 Of Cencora Inc >COR"
COR,2023-09-27,20:10:11,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Coo Mauch Sells 20,197 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Sells 20,197 Of Cencora Inc >COR"
COR,2023-10-02,20:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,"Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release"
COR,2023-10-02,20:41:33,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release"
COR,2023-10-10,14:45:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 25,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 25,000 Of Cencora Inc >COR"
COR,2023-10-10,17:06:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 10,695 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 10,695 Of Cencora Inc >COR"
COR,2023-10-11,20:20:19,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 10,695 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 10,695 Of Cencora Inc >COR"
COR,2023-10-11,20:21:46,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 25,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 25,000 Of Cencora Inc >COR"
COR,2023-10-17,12:03:10,7D85A9,Cencora Inc.,100,0.49,partnerships,,Mirakl Partners with Cencora to Power,PRESS-RELEASE,DJ Global Press Release Wire,Mirakl Partners with Cencora to Power New Marketplace Solution
COR,2023-10-25,23:52:27,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,DJ Global Press Release Wire,Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
COR,2023-10-25,23:52:27,7D85A9,Cencora Inc.,100,0.39,products-services,,"Epigenetics, announced today it has entered into an agreement with Cencora",PRESS-RELEASE,DJ Global Press Release Wire,Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Net $350.6M,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Net $350.6M >COR
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 4Q Rev $68.92B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Rev $68.92B >COR
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,4Q EPS $1.72 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q EPS $1.72 >COR
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Adj EPS $2.86,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Adj EPS $2.86 >COR
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $68.9 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $1.72,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent to $262.2 billion for the fiscal year,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2023 GAAP Diluted EPS of $8.53,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today reported that in its fiscal year 2023 fourth quarter ended September 30, 2023, revenue increased 12.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, adjusted diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,-0.3,equity-actions,up,"Cencora Inc.: In the fiscal 2023 fourth quarter, net interest expense of $60.9 million increased 18.3 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.02,earnings,,Cencora Inc.: Adjusted operating income increased 4.0 percent to $3.3 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2023 Summary Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.2,equity-actions,up,Cencora Inc.: Operating expenses increased 11.6 percent,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, GAAP diluted EPS was $8.53",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent from last fiscal year to $262.2 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 7.3 percent to $9.0 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, adjusted diluted EPS was $11.99",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.51,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 1.74 $ 1.42,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit 3.27,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 8.62 $ 8.15,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,94,0.0,earnings,,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -5-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,94,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -5-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.48,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -6-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -6-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $62,558,746 $56,560,616",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -6-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -7-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -7-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2023, (i) revenue of $68.9 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -8-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2023, (i) revenue of $262.2 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -8-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -8-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $68.9 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $1.72,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent to $262.2 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2023 GAAP Diluted EPS of $8.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today reported that in its fiscal year 2023 fourth quarter ended September 30, 2023, revenue increased 12.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,-0.3,equity-actions,up,"Cencora Inc.: In the fiscal 2023 fourth quarter, net interest expense of $60.9 million increased 18.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.02,earnings,,Cencora Inc.: Adjusted operating income increased 4.0 percent to $3.3 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2023 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.2,equity-actions,up,Cencora Inc.: Operating expenses increased 11.6 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, GAAP diluted EPS was $8.53",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent from last fiscal year to $262.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 7.3 percent to $9.0 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, adjusted diluted EPS was $11.99",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 1.74 $ 1.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit 3.27,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 8.62 $ 8.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,94,0.0,earnings,,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -5-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,94,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -5-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -6-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -6-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $62,558,746 $56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -6-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -7-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -7-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2023, (i) revenue of $68.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -8-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2023, (i) revenue of $262.2 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -8-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -8-
COR,2023-11-02,10:34:09,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees FY24 Revenue Growth of 7% to 10 %,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Revenue Growth of 7% to 10 % >COR
COR,2023-11-02,10:34:36,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $12.70,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $12.70-Adj EPS $13 >COR
COR,2023-11-03,14:39:41,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora's fiscal fourth-quarter adjusted EPS rose 10% to $2.86,FULL-ARTICLE,Dow Jones Newswires,"Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand -- IBD"
COR,2023-11-03,14:39:41,7D85A9,Cencora Inc.,99,0.48,revenues,up,Cencora sees revenue up 7% to 10%,FULL-ARTICLE,Dow Jones Newswires,"Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand -- IBD"
COR,2023-11-09,23:49:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Walgreens Boots Alliance Sells Shares of Cencora, Inc.",PRESS-RELEASE,Business Wire,"Walgreens Boots Alliance Sells Shares of Cencora, Inc. for $674 Million of Initial Proceeds"
COR,2023-11-09,23:49:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Walgreens Boots Alliance Sells Shares of Cencora, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Walgreens Boots Alliance Sells Shares of Cencora, Inc. for $674 Million of Initial Proceeds"
COR,2023-11-09,23:50:26,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of Cencora for $674M of Initial Proceeds
COR,2023-11-09,23:58:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-09,23:58:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-09,23:58:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance >COR
COR,2023-11-09,23:58:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-09,23:58:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-10,00:24:22,7D85A9,Cencora Inc.,96,0.49,partnerships,,"Cencora,"" a partner with Walgreens since",FULL-ARTICLE,Dow Jones Newswires,Walgreens Sells Shares Of Drug Distributor Cencora -- MarketWatch
COR,2023-11-10,00:24:22,7D85A9,Cencora Inc.,96,0.49,partnerships,,"Cencora,"" a partner with Walgreens since",FULL-ARTICLE,MarketWatch,MW Walgreens sells shares of drug distributor Cencora
COR,2023-11-13,20:12:37,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Donato Registers 3,387 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,387 Of Cencora Inc >COR"
COR,2023-11-13,21:38:15,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 7,582 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 7,582 Of Cencora Inc >COR"
COR,2023-11-13,21:39:02,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 1,889 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 1,889 Of Cencora Inc >COR"
COR,2023-11-13,21:41:28,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Clark Acquires 8,033 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 8,033 Of Cencora Inc >COR"
COR,2023-11-13,21:42:32,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 16,183 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 16,183 Of Cencora Inc >COR"
COR,2023-11-13,21:45:24,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 59,675 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 59,675 Of Cencora Inc >COR"
COR,2023-11-13,21:48:48,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Donato Acquires 5,325 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 5,325 Of Cencora Inc >COR"
COR,2023-11-13,21:48:57,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 1,751 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 1,751 Of Cencora Inc >COR"
COR,2023-11-13,21:50:01,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Coo Mauch Acquires 20,055 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Acquires 20,055 Of Cencora Inc >COR"
COR,2023-11-14,12:52:20,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 1,279,590 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 1,279,590 Of Cencora Inc >COR"
COR,2023-11-14,16:54:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 25,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 25,000 Of Cencora Inc >COR"
COR,2023-11-14,21:59:11,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Donato Acquires 1,244 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 1,244 Of Cencora Inc >COR"
COR,2023-11-14,22:11:24,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 3,778 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 3,778 Of Cencora Inc >COR"
COR,2023-11-14,22:22:25,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Clark Acquires 1,831 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 1,831 Of Cencora Inc >COR"
COR,2023-11-14,22:25:32,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 1,322 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 1,322 Of Cencora Inc >COR"
COR,2023-11-14,23:38:40,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 2,499 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 2,499 Of Cencora Inc >COR"
COR,2023-11-15,01:44:25,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Coo Mauch Acquires 4,357 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Acquires 4,357 Of Cencora Inc >COR"
COR,2023-11-15,02:01:01,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 13,931 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 13,931 Of Cencora Inc >COR"
COR,2023-11-15,02:04:13,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 1,393 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 1,393 Of Cencora Inc >COR"
COR,2023-11-15,23:11:42,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Donato Sells 3,387 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,387 Of Cencora Inc >COR"
COR,2023-11-15,23:14:47,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 12,440 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 12,440 Of Cencora Inc >COR"
COR,2023-11-15,23:15:19,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 25,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 25,000 Of Cencora Inc >COR"
COR,2023-11-16,16:18:35,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 14,747 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 14,747 Of Cencora Inc >COR"
COR,2023-11-17,21:25:12,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 14,747 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 14,747 Of Cencora Inc >COR"
COR,2023-11-19,08:37:27,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2023 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2023 (COR)"
COR,2023-11-22,14:00:07,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corporation, Enter into Distribution Agreement",PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:07,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We are honored to partner with Cencora to,PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:23,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corporation, Enter into Distribution Agreement",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:23,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We are honored to partner with Cencora to,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:30,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corp, Enter Into Distribution Agreement",NEWS-FLASH,Dow Jones Newswires,"Sapphiros and Cencora, Formerly AmerisourceBergen Corp, Enter Into Distribution Agreement"
COR,2023-11-22,14:01:11,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corporation, Enter into Distribution Agreement",PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:01:11,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We are honored to partner with Cencora to,PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-12-01,17:12:43,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 2,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 2,000 Of Cencora Inc >COR"
COR,2023-12-04,21:07:36,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 2,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 2,000 Of Cencora Inc >COR"
COR,2023-12-12,15:12:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 25,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 25,000 Of Cencora Inc >COR"
COR,2023-12-13,21:11:41,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 25,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 25,000 Of Cencora Inc >COR"
COR,2023-12-13,21:15:42,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 42,885 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 42,885 Of Cencora Inc >COR"
COR,2023-12-13,21:25:08,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 5,162 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 5,162 Of Cencora Inc >COR"
COR,2023-12-14,12:51:50,7D85A9,Cencora Inc.,100,0.01,analyst-ratings,neutral,Cencora Initiated at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Initiated at Equal-Weight by Wells Fargo
COR,2023-12-14,12:51:51,7D85A9,Cencora Inc.,100,0.0,price-targets,set,Cencora Price Target Announced at $213.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Announced at $213.00/Share by Wells Fargo
COR,2023-12-14,22:22:11,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora's Long-Term IDR at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms Cencora's Long-Term IDR at 'A-'; Upgrades Short-Term IDR to 'F1'; Outlook Stable
COR,2023-12-14,22:22:11,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora's Long-Term IDR at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term IDR at 'A-'; Upgrades Short-Term IDR to 'F1'; Outlook Stable
COR,2023-12-14,22:22:11,7D85A9,Cencora Inc.,100,0.44,credit,reduction,Cencora reduced its debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term IDR at 'A-'; Upgrades Short-Term IDR to 'F1'; Outlook Stable
COR,2023-12-14,22:22:21,7D85A9,Cencora Inc.,100,0.0,credit-ratings,affirmation,Fitch Affirms Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term -2-
COR,2023-12-14,22:22:31,7D85A9,Cencora Inc.,100,0.0,credit-ratings,affirmation,Fitch Affirms Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term -3-
COR,2023-12-15,21:25:11,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 5,162 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 5,162 Of Cencora Inc >COR"
COR,2023-12-15,21:25:37,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 42,885 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 42,885 Of Cencora Inc >COR"
COR,2023-12-15,22:16:18,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 168 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 168 Of Cencora Inc >COR
COR,2023-12-15,22:18:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Coo Mauch Acquires 487 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,COO Mauch Acquires 487 Of Cencora Inc >COR
COR,2023-12-15,22:21:02,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Clark Acquires 137 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Clark Acquires 137 Of Cencora Inc >COR
COR,2023-12-15,22:23:15,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Cfo Cleary Jr Acquires 307 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,CFO Cleary Jr Acquires 307 Of Cencora Inc >COR
COR,2023-12-18,21:11:24,7D85A9,Cencora Inc.,100,0.0,insider-trading,,"Chmn Collis Gifts 3,600 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Gifts 3,600 Of Cencora Inc >COR"
COR,2023-12-19,13:30:01,7D85A9,Cencora Inc.,100,0.44,products-services,,World Courier to Expand Storage Capacity,PRESS-RELEASE,Business Wire,World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
COR,2023-12-19,13:30:01,7D85A9,Cencora Inc.,100,0.36,assets,upgrade,Cencora Inc.: will expand World Courier's capacity to store,PRESS-RELEASE,Business Wire,World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
COR,2023-12-19,13:30:01,7D85A9,Cencora Inc.,100,0.52,products-services,,World Courier recently launched a Container,PRESS-RELEASE,Business Wire,World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
COR,2023-12-21,18:18:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Donato Registers 3,400 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,400 Of Cencora Inc >COR"
COR,2023-12-26,21:01:13,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Donato Sells 3,400 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,400 Of Cencora Inc >COR"
COR,2023-01-03,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition Of PharmaLex >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Completes Acquisition Of PharmaLex >ABC
COR,2023-01-03,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of PharmaLex,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of PharmaLex
COR,2023-01-03,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of PharmaLex,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of PharmaLex
COR,2023-01-03,21:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release
COR,2023-01-03,22:19:19,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release
COR,2023-01-05,17:50:47,7D85A9,AmerisourceBergen Corp.,96,0.49,partnerships,,"Wearable, announces exclusive animal health partnership with MWI",PRESS-RELEASE,PR Newswire,"Link, the Smart Pet Wearable, announces exclusive animal health partnership with MWI/Amerisource Bergen"
COR,2023-01-05,21:24:22,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Krikorian Acquires 166 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 166 Of AmerisourceBergen Corp >ABC
COR,2023-01-10,13:30:02,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Amerisourcebergen, in partnership with the AmerisourceBergen",PRESS-RELEASE,Business Wire,The AmerisourceBergen Foundation & Good Neighbor Pharmacy Launch Scholarship Program to Support Aspiring Black and African American Pharmacists
COR,2023-01-11,14:50:21,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Baird
COR,2023-01-11,14:50:21,7D85A9,AmerisourceBergen Corp.,100,0.38,price-targets,upgrade,Amerisourcebergen Price Target Raised to $199.00/Share From $195.00 by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $199.00/Share From $195.00 by Baird
COR,2023-01-12,14:44:07,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by Argus Research
COR,2023-01-12,14:44:07,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $190.00/Share From $170.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $190.00/Share From $170.00 by Argus Research
COR,2023-01-18,20:09:31,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-01-19,21:07:36,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-01-22,08:18:25,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2022 (ABC)"
COR,2023-01-24,10:00:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen to Change Name to,FULL-ARTICLE,Dow Jones Newswires,Drug Distributor AmerisourceBergen to Change Name to Cencora -- WSJ
COR,2023-01-24,14:15:13,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen To Change Name To,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen To Change Name To Cencora Later This Year -- MarketWatch
COR,2023-01-24,14:15:13,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen to change name to,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen to change name to Cencora later this year
COR,2023-01-27,13:18:44,7D85A9,AmerisourceBergen Corp.,100,0.44,labor-issues,,Amerisourcebergen Corp. CEO Steven Collis 2022 Total Pay $16.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corp. CEO Steven Collis 2022 Total Pay $16.7M >ABC
COR,2023-01-27,13:45:17,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Amerisourcebergen, in partnership with the AmerisourceBergen",PRESS-RELEASE,DJ Global Press Release Wire,The AmerisourceBergen Foundation & Good Neighbor Pharmacy Launch Scholarship Program To Support Aspiring Black and African American Pharmacists
COR,2023-01-31,12:22:57,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $185.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $185.00/Share by Evercore ISI Group
COR,2023-01-31,13:44:48,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by UBS
COR,2023-01-31,13:44:48,7D85A9,AmerisourceBergen Corp.,100,0.46,price-targets,upgrade,Amerisourcebergen Price Target Raised to $190.00/Share From $184.00 by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $190.00/Share From $184.00 by UBS
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.50-Adj EPS $11.75 >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 1Q Rev $62.8B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Rev $62.8B >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,1Q EPS $2.33 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q EPS $2.33 >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Adj EPS $2.71,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Adj EPS $2.71 >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Net $479.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Net $479.7M >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 First Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $62.8 billion for the First Quarter, a 5.4 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.33,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.50 to $11.75,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 first quarter ended December 31, 2022, revenue increased 5.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2023, revenue was $62.8 billion, up 5.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the first quarter of fiscal 2023,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2023 was $161.3 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,AmerisourceBergen Corp.: Announced the completion of the acquisition of PharmaLex Holding GmbH,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2023 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -3-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -3-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -3-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.41,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -4-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.35 $ 2.15,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -4-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -5-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,906,893 $ 56,560,616",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -5-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,98,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -7-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $62.8 billion for the First Quarter, a 5.4 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.33,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.50 to $11.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 first quarter ended December 31, 2022, revenue increased 5.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2023, revenue was $62.8 billion, up 5.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the first quarter of fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2023 was $161.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,AmerisourceBergen Corp.: Announced the completion of the acquisition of PharmaLex Holding GmbH,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2023 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.35 $ 2.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,906,893 $ 56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,97,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-02-01,11:31:21,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Had Seen FY23 Adjusted EPS $11.30-$11.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Had Seen FY23 Adjusted EPS $11.30-$11.60 >ABC
COR,2023-02-01,11:33:46,7D85A9,AmerisourceBergen Corp.,100,-0.28,earnings,down,Amerisourcebergen Q1 EPS $2.33 vs. $2.71 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 EPS $2.33 vs. $2.71 a year ago
COR,2023-02-01,11:34:46,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q1 adj. EPS $2.71; FactSet consensus $2.64,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 adj. EPS $2.71; FactSet consensus $2.64
COR,2023-02-01,11:35:46,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,Amerisourcebergen Q1 EPS $2.33 vs. $2.13 a year ago,NEWS-FLASH,MarketWatch,MW CORRECTED: AmerisourceBergen Q1 EPS $2.33 vs. $2.13 a year ago
COR,2023-02-01,11:35:46,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Q1 revenue $62.8 bln, up 5.4%",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q1 revenue $62.8 bln, up 5.4% vs. year -ago; FactSet consensus $62.8 bln"
COR,2023-02-01,11:36:46,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees full-year adj. EPS of $11.50 to $11.75,NEWS-FLASH,MarketWatch,MW AmerisourceBergen now sees full-year adj. EPS of $11.50 to $11.75 vs. prior $11.30 to $11.60
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,"AmerisourceBergen Corp.: The company posted net income of $479.8 million, or $2.33 a share, up from $449.1 million",FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance"
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisource Bergen now sees full-year adjusted EPS of $11.50 to $11.75,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance"
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,"AmerisourceBergen Corp.: The company posted net income of $479.8 million, or $2.33 a share, up from $449.1 million",FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Corp. Stock Rises On Q1 Top Line Beat, Raised Guidance -- MarketWatch"
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisource Bergen now sees full-year adjusted EPS of $11.50 to $11.75,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Corp. Stock Rises On Q1 Top Line Beat, Raised Guidance -- MarketWatch"
COR,2023-02-01,14:55:03,7D85A9,AmerisourceBergen Corp.,94,0.0,investor-relations,,Steve Collis on fiscal 1Q earnings call,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Doesn't See Tailwind from Humira Biosimilars -- Market Talk
COR,2023-02-01,14:55:03,7D85A9,AmerisourceBergen Corp.,94,0.0,investor-relations,,Steve Collis on fiscal 1Q earnings call,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Doesn't See Tailwind from Humira Biosimilars -- Market Talk
COR,2023-02-01,14:57:51,7D85A9,AmerisourceBergen Corp.,94,0.59,equity-actions,,Amerisourcebergen repurchased $1B of its own shares,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:51,7D85A9,AmerisourceBergen Corp.,94,0.46,earnings,above-expectations,"Amerisource reported adjusted earnings per share of $2.71, beating analysts' forecast of $2.64",FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:52,7D85A9,AmerisourceBergen Corp.,98,0.59,equity-actions,,Amerisourcebergen repurchased $1B of its own shares,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:52,7D85A9,AmerisourceBergen Corp.,98,0.46,earnings,above-expectations,"Amerisource reported adjusted earnings per share of $2.71, beating analysts' forecast of $2.64",FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:52,7D85A9,AmerisourceBergen Corp.,98,0.0,investor-relations,,Steve Collis on fiscal 1Q earnings call,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-02,12:39:49,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Baird
COR,2023-02-02,12:39:49,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $201.00/Share From $199.00 by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $201.00/Share From $199.00 by Baird
COR,2023-02-02,13:00:49,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2023-02-02,13:00:49,7D85A9,AmerisourceBergen Corp.,100,0.56,price-targets,upgrade,Amerisourcebergen Price Target Raised to $170.00/Share From $162.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $170.00/Share From $162.00 by Mizuho
COR,2023-02-07,21:08:12,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Campbell Acquires 3,182 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 3,182 Of AmerisourceBergen Corp >ABC"
COR,2023-02-07,21:19:32,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Krikorian Acquires 4,152 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 4,152 Of AmerisourceBergen Corp >ABC"
COR,2023-02-08,22:03:48,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Krikorian Registers 5,711 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 5,711 Of AmerisourceBergen Corp >ABC"
COR,2023-02-09,21:07:42,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 5,711 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 5,711 Of AmerisourceBergen Corp >ABC"
COR,2023-02-15,21:00:44,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-02-16,21:08:54,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-03-02,21:51:41,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Clark Registers 1,924 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 1,924 Of AmerisourceBergen Corp >ABC"
COR,2023-03-03,21:14:43,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 1,924 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 1,924 Of AmerisourceBergen Corp >ABC"
COR,2023-03-13,20:16:22,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Battaglia Acquires 852 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 852 Of AmerisourceBergen Corp >ABC
COR,2023-03-15,20:07:12,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-03-15,20:09:51,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-03-29,11:01:03,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: SamaCare Partners with AmerisourceBergen to,PRESS-RELEASE,PR Newswire,SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices
COR,2023-03-29,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release
COR,2023-03-29,21:10:51,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release
COR,2023-03-31,12:45:53,7D85A9,AmerisourceBergen Corp.,100,0.95,analyst-ratings,positive,Amerisourcebergen Initiated at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Initiated at Buy by Citigroup
COR,2023-03-31,12:45:53,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $185.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $185.00/Share by Citigroup
COR,2023-04-11,14:09:27,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-04-13,20:11:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-04-20,12:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,acquisitions-mergers,,Amerisourcebergen will purchase its minority interest in the joint venture for approximately $685 million in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic
COR,2023-04-20,12:30:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen to -2-
COR,2023-04-20,12:30:02,7D85A9,AmerisourceBergen Corp.,99,0.62,acquisitions-mergers,,Amerisourcebergen will purchase its minority interest in the joint venture for approximately $685 million in cash,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic
COR,2023-04-20,12:30:02,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen to Acquire Leading -2-
COR,2023-04-20,12:34:08,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to buy OneOncology from General Atlantic in a deal valued at $2.1 billion,FULL-ARTICLE,MarketWatch,"MW TPG, AmerisourceBergen to buy OneOncology from General Atlantic in a deal valued at $2.1 billion."
COR,2023-04-20,12:53:10,7D85A9,AmerisourceBergen Corp.,95,0.39,products-services,,Tpg and AmerisourceBergen said the deal,FULL-ARTICLE,Dow Jones Newswires,"TPG, AmerisourceBergen to Buy OneOncology From General Atlantic"
COR,2023-04-20,16:06:38,7D85A9,AmerisourceBergen Corp.,97,0.39,products-services,,AmerisourceBergen Corp.: We expect the transaction will close by the end of September,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: AmerisourceBergen Rtgs Same On OneOncology Acq
COR,2023-04-22,07:15:18,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2023 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2023 (ABC)"
COR,2023-04-24,19:47:01,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,Amerisourcebergen reported 5% EPS growth,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Stock Joins Elite Group Of Top Performers -- IBD
COR,2023-04-24,19:48:13,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,Amerisourcebergen reported 5% EPS growth,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Stock Joins Elite Group Of Top Performers -- IBD
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.70,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.70-Adj EPS $11.90 >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $3.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $3.50 >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 2Q Rev $63.5B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Rev $63.5B >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,2Q EPS $2.13 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q EPS $2.13 >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 Second Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $63.5 billion for the Second Quarter, a 9.9 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.70 to $11.90,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 second quarter ended March 31, 2023, revenue increased 9.9 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: our full year financial outlook,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,-0.24,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue declined 0.2 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the second quarter of fiscal 2023,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.34,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, net interest expense of $64.1 million increased 21.2 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2023 was $176.0 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 2.62,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.87,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Net $435.4M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Net $435.4M >ABC
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,assets,,"AmerisourceBergen Corp.: Total assets $58,766,183 $ 56,560,616",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Second Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $63.5 billion for the Second Quarter, a 9.9 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.70 to $11.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 second quarter ended March 31, 2023, revenue increased 9.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: our full year financial outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.24,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue declined 0.2 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the second quarter of fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.34,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, net interest expense of $64.1 million increased 21.2 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2023 was $176.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 2.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.87,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,assets,,"AmerisourceBergen Corp.: Total assets $58,766,183 $ 56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-05-02,10:30:53,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen Sees FY23 Adjusted EPS Up 8%-10%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Adjusted EPS Up 8%-10% Constant Currency >ABC
COR,2023-05-02,10:31:24,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen Now Sees FY23 Revenue Growth 6%-8%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Now Sees FY23 Revenue Growth 6%-8%; Had Seen 5%-7% >ABC
COR,2023-05-02,10:34:00,7D85A9,AmerisourceBergen Corp.,100,-0.36,earnings,down,Amerisourcebergen Q2 EPS $2.13 vs. $2.59 a year ago,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen Q2 EPS $2.13 vs. $2.59 a year ago
COR,2023-05-02,10:35:01,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q2 adj. EPS $3.50; FactSet consensus $3.30,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen Q2 adj. EPS $3.50; FactSet consensus $3.30
COR,2023-05-02,10:35:01,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q2 revenue $63.457 bln vs. $57.719 bln a year ago; FactSet consensus $60.458 bln,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen Q2 revenue $63.457 bln vs. $57.719 bln a year ago; FactSet consensus $60.458 bln
COR,2023-05-02,10:36:01,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen now sees FY23 revenue up 6% to 8%,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen now sees FY23 revenue up 6% to 8% vs. prior guidance of up 5% to 7%
COR,2023-05-02,10:37:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees FY23 adj. EPS of $11.70 to $11.90,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen now sees FY23 adj. EPS of $11.70 to $11.90 vs. prior range of $11.50 to $11.75
COR,2023-05-02,10:56:21,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Boosts Earnings Outlook for 2023,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Earnings Outlook for 2023
COR,2023-05-02,10:56:21,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,Amerisourcebergen said it also expects revenue to grow 6% to 8%,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Earnings Outlook for 2023
COR,2023-05-03,11:13:03,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2023-05-03,11:13:03,7D85A9,AmerisourceBergen Corp.,100,0.4,price-targets,upgrade,Amerisourcebergen Price Target Raised to $174.00/Share From $170.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $174.00/Share From $170.00 by Mizuho
COR,2023-05-03,14:32:04,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by TD,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by TD Cowen
COR,2023-05-03,14:32:04,7D85A9,AmerisourceBergen Corp.,100,0.68,price-targets,upgrade,Amerisourcebergen Price Target Raised to $187.00/Share From $174.00 by TD,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $187.00/Share From $174.00 by TD Cowen
COR,2023-05-03,18:27:05,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by Citigroup
COR,2023-05-03,18:27:05,7D85A9,AmerisourceBergen Corp.,100,0.6,price-targets,upgrade,Amerisourcebergen Price Target Raised to $195.00/Share From $185.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $195.00/Share From $185.00 by Citigroup
COR,2023-05-09,15:18:34,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-05-10,20:04:15,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-05-11,13:04:02,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Discovery Partners with AmerisourceBergen for,PRESS-RELEASE,PR Newswire,Patient Discovery Partners with AmerisourceBergen for Cancer Care Equity
COR,2023-05-12,02:13:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds
COR,2023-05-12,02:13:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds
COR,2023-05-12,02:16:07,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen for $694M in Initial Proceeds >WBA
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance >ABC
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-15,21:11:36,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Llc Reports 16.5% Stake in AmerisourceBergen Corp.,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Holdings LLC Reports 16.5% Stake in AmerisourceBergen Corp.
COR,2023-05-15,21:19:51,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 292,792 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 292,792 Of AmerisourceBergen Corp >ABC"
COR,2023-05-17,16:00:32,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Campbell Registers 7,500 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 7,500 Of AmerisourceBergen Corp >ABC"
COR,2023-05-19,20:03:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Campbell Sells 7,500 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 7,500 Of AmerisourceBergen Corp >ABC"
COR,2023-05-19,20:12:40,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 12,545 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 12,545 Of AmerisourceBergen Corp >ABC"
COR,2023-05-26,12:16:46,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by UBS
COR,2023-05-26,12:16:46,7D85A9,AmerisourceBergen Corp.,100,0.7,price-targets,upgrade,Amerisourcebergen Price Target Raised to $184.00/Share From $170.00 by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $184.00/Share From $170.00 by UBS
COR,2023-06-07,15:18:58,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by B of A Securities
COR,2023-06-07,15:18:58,7D85A9,AmerisourceBergen Corp.,100,0.42,price-targets,upgrade,Amerisourcebergen Price Target Raised to $200.00/Share From $195.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $200.00/Share From $195.00 by B of A Securities
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Announce Completion Of Acquisition Of OneOncology >ABC,NEWS-FLASH,Dow Jones Newswires,TPG And AmerisourceBergen Announce Completion Of Acquisition Of OneOncology >ABC
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Announce Completion of Acquisition of OneOncology,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Announce Completion of Acquisition of OneOncology,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-13,14:12:33,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-06-14,20:15:18,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-06-20,11:52:56,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 275,984 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 275,984 Of AmerisourceBergen Corp >ABC"
COR,2023-06-22,18:45:26,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Clark Registers 27,542 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 27,542 Of AmerisourceBergen Corp >ABC"
COR,2023-06-23,20:08:30,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 27,542 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 27,542 Of AmerisourceBergen Corp >ABC"
COR,2023-06-29,20:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release
COR,2023-06-29,20:34:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release
COR,2023-07-03,20:08:22,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Donato Acquires 898 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Acquires 898 Of AmerisourceBergen Corp >ABC
COR,2023-07-11,11:48:55,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2023-07-11,11:48:55,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $192.00/Share From $174.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $192.00/Share From $174.00 by Mizuho
COR,2023-07-11,14:12:30,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-07-12,20:16:41,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.85,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.85-Adj EPS $11.95 >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Adj EPS $2.92,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Adj EPS $2.92 >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,3Q EPS $2.35 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q EPS $2.35 >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 3Q Rev $66.9B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Rev $66.9B >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Net $479.6M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Net $479.6M >ABC
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Third Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $66.9 billion for the Third Quarter, an 11.5 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $2.35,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,Amerisourcebergen will change its name to,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.85 to $11.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 third quarter ended June 30, 2023, revenue increased 11.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,unchanged,AmerisourceBergen Corp.: Revenue $66.9B $66.9B,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.16,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, net interest expense of $57.9 million increased 9.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2023 was $187.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.44,products-services,cut,AmerisourceBergen Corp.: to reduce prices for our products and services;,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.37 $ 1.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.38,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,assets,,"AmerisourceBergen Corp.: Total assets $61,177,196 $ 56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,revenues,,"AmerisourceBergen Corp.: For the third quarter of fiscal 2023, (i) revenue of $66.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,97,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 Third Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $66.9 billion for the Third Quarter, an 11.5 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $2.35,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.85 to $11.95,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 third quarter ended June 30, 2023, revenue increased 11.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,unchanged,AmerisourceBergen Corp.: Revenue $66.9B $66.9B,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.16,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, net interest expense of $57.9 million increased 9.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2023 was $187.1 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,Amerisourcebergen will change its name to,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.44,products-services,cut,AmerisourceBergen Corp.: to reduce prices for our products and services;,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -3-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.37 $ 1.95,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.38,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.47,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -7-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,assets,,"AmerisourceBergen Corp.: Total assets $61,177,196 $ 56,560,616",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -7-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,98,0.0,revenues,,"AmerisourceBergen Corp.: For the third quarter of fiscal 2023, (i) revenue of $66.9 billion",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -9-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,98,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -9-
COR,2023-08-02,10:32:45,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen Now Sees FY23 Revenue Up at Least 8,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Now Sees FY23 Revenue Up at Least 8%; Had Seen Up 6%-8% >ABC
COR,2023-08-03,13:43:31,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Morgan Stanley
COR,2023-08-03,13:43:31,7D85A9,AmerisourceBergen Corp.,100,0.7,price-targets,upgrade,Amerisourcebergen Price Target Raised to $190.00/Share From $176.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $190.00/Share From $176.00 by Morgan Stanley
COR,2023-08-03,20:33:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10.5 million shares of common stock of the Company,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase
COR,2023-08-03,20:33:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10.5 million shares of common stock of the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase
COR,2023-08-03,22:48:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds
COR,2023-08-03,22:48:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds
COR,2023-08-03,22:48:47,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen Corp,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen Corp for $1.85B of Initial Proceeds
COR,2023-08-03,22:57:37,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells About $1.6B of AmerisourceBergen Shares,NEWS-FLASH,Dow Jones Newswires,"Walgreens Boots Alliance Sells About $1.6B of AmerisourceBergen Shares Through a Registered Public Offering, Also Enters a Concurrent Shr Repurchase Agreement for About $250M"
COR,2023-08-03,23:17:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance sells shares of AmerisourceBergen,FULL-ARTICLE,MarketWatch,MW Walgreens Boots Alliance sells shares of AmerisourceBergen for $1.85 billion
COR,2023-08-03,23:17:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares Of AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots Alliance Sells Shares Of AmerisourceBergen For $1.85 Billion -- MarketWatch
COR,2023-08-07,15:10:46,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by TD Cowen,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by TD Cowen
COR,2023-08-07,15:10:46,7D85A9,AmerisourceBergen Corp.,100,0.56,price-targets,upgrade,Amerisourcebergen Price Target Raised to $215.00/Share From $205.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $215.00/Share From $205.00 by TD Cowen
COR,2023-08-07,21:50:05,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 1,320,858 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 1,320,858 Of AmerisourceBergen Corp >ABC"
COR,2023-08-08,18:57:32,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-08-09,20:09:27,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-08-19,07:13:37,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2023 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2023 (ABC)"
COR,2023-08-28,13:00:01,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Signs Agreement with AmerisourceBergen,PRESS-RELEASE,Business Wire,Tivic Health Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers
COR,2023-08-28,13:00:29,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Signs Agreement With AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Tivic Health Signs Agreement With AmerisourceBergen for Retail Pharmacy Customers
COR,2023-08-28,13:00:40,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Signs Agreement with AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Tivic Health Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers
COR,2023-08-28,13:16:47,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Systems Signs Marketplace Agreement With AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Tivic Health Systems Signs Marketplace Agreement With AmerisourceBergen
COR,2023-08-30,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen becomes Cencora, in alignment with the company's growing global footprint and central role in pharmaceutical access and care"
COR,2023-08-30,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,"AmerisourceBergen becomes Cencora, in alignment with the company's growing global footprint and central role in pharmaceutical access and care"
COR,2023-08-30,11:58:11,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen Changes Name to,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Changes Name to Cencora
COR,2023-09-21,16:12:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Donato Registers 3,386 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,386 Of Cencora Inc >COR"
COR,2023-09-22,20:04:32,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Donato Sells 3,386 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,386 Of Cencora Inc >COR"
COR,2023-09-25,15:39:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Coo Mauch Registers 20,197 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"COO Mauch Registers 20,197 Of Cencora Inc >COR"
COR,2023-09-25,16:09:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 20,971 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 20,971 Of Cencora Inc >COR"
COR,2023-09-27,20:08:05,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 20,971 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 20,971 Of Cencora Inc >COR"
COR,2023-09-27,20:10:11,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Coo Mauch Sells 20,197 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Sells 20,197 Of Cencora Inc >COR"
COR,2023-10-02,20:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,"Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release"
COR,2023-10-02,20:41:33,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release"
COR,2023-10-10,14:45:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 25,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 25,000 Of Cencora Inc >COR"
COR,2023-10-10,17:06:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 10,695 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 10,695 Of Cencora Inc >COR"
COR,2023-10-11,20:20:19,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 10,695 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 10,695 Of Cencora Inc >COR"
COR,2023-10-11,20:21:46,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 25,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 25,000 Of Cencora Inc >COR"
COR,2023-10-17,12:03:10,7D85A9,Cencora Inc.,100,0.49,partnerships,,Mirakl Partners with Cencora to Power,PRESS-RELEASE,DJ Global Press Release Wire,Mirakl Partners with Cencora to Power New Marketplace Solution
COR,2023-10-25,23:52:27,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,DJ Global Press Release Wire,Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
COR,2023-10-25,23:52:27,7D85A9,Cencora Inc.,100,0.39,products-services,,"Epigenetics, announced today it has entered into an agreement with Cencora",PRESS-RELEASE,DJ Global Press Release Wire,Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Net $350.6M,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Net $350.6M >COR
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 4Q Rev $68.92B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Rev $68.92B >COR
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,4Q EPS $1.72 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q EPS $1.72 >COR
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Adj EPS $2.86,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Adj EPS $2.86 >COR
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $68.9 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $1.72,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent to $262.2 billion for the fiscal year,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2023 GAAP Diluted EPS of $8.53,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today reported that in its fiscal year 2023 fourth quarter ended September 30, 2023, revenue increased 12.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, adjusted diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,-0.3,equity-actions,up,"Cencora Inc.: In the fiscal 2023 fourth quarter, net interest expense of $60.9 million increased 18.3 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.02,earnings,,Cencora Inc.: Adjusted operating income increased 4.0 percent to $3.3 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2023 Summary Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.2,equity-actions,up,Cencora Inc.: Operating expenses increased 11.6 percent,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, GAAP diluted EPS was $8.53",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent from last fiscal year to $262.2 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 7.3 percent to $9.0 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, adjusted diluted EPS was $11.99",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.51,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 1.74 $ 1.42,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit 3.27,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 8.62 $ 8.15,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,94,0.0,earnings,,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -5-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,94,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -5-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.48,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -6-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -6-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $62,558,746 $56,560,616",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -6-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -7-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -7-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2023, (i) revenue of $68.9 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -8-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2023, (i) revenue of $262.2 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -8-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -8-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $68.9 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $1.72,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent to $262.2 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2023 GAAP Diluted EPS of $8.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today reported that in its fiscal year 2023 fourth quarter ended September 30, 2023, revenue increased 12.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,-0.3,equity-actions,up,"Cencora Inc.: In the fiscal 2023 fourth quarter, net interest expense of $60.9 million increased 18.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.02,earnings,,Cencora Inc.: Adjusted operating income increased 4.0 percent to $3.3 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2023 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.2,equity-actions,up,Cencora Inc.: Operating expenses increased 11.6 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, GAAP diluted EPS was $8.53",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent from last fiscal year to $262.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 7.3 percent to $9.0 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, adjusted diluted EPS was $11.99",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 1.74 $ 1.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit 3.27,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 8.62 $ 8.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,94,0.0,earnings,,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -5-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,94,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -5-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -6-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -6-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $62,558,746 $56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -6-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -7-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -7-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2023, (i) revenue of $68.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -8-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2023, (i) revenue of $262.2 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -8-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -8-
COR,2023-11-02,10:34:09,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees FY24 Revenue Growth of 7% to 10 %,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Revenue Growth of 7% to 10 % >COR
COR,2023-11-02,10:34:36,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $12.70,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $12.70-Adj EPS $13 >COR
COR,2023-11-03,14:39:41,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora's fiscal fourth-quarter adjusted EPS rose 10% to $2.86,FULL-ARTICLE,Dow Jones Newswires,"Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand -- IBD"
COR,2023-11-03,14:39:41,7D85A9,Cencora Inc.,99,0.48,revenues,up,Cencora sees revenue up 7% to 10%,FULL-ARTICLE,Dow Jones Newswires,"Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand -- IBD"
COR,2023-11-09,23:49:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Walgreens Boots Alliance Sells Shares of Cencora, Inc.",PRESS-RELEASE,Business Wire,"Walgreens Boots Alliance Sells Shares of Cencora, Inc. for $674 Million of Initial Proceeds"
COR,2023-11-09,23:49:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Walgreens Boots Alliance Sells Shares of Cencora, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Walgreens Boots Alliance Sells Shares of Cencora, Inc. for $674 Million of Initial Proceeds"
COR,2023-11-09,23:50:26,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of Cencora for $674M of Initial Proceeds
COR,2023-11-09,23:58:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-09,23:58:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-09,23:58:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance >COR
COR,2023-11-09,23:58:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-09,23:58:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-10,00:24:22,7D85A9,Cencora Inc.,96,0.49,partnerships,,"Cencora,"" a partner with Walgreens since",FULL-ARTICLE,Dow Jones Newswires,Walgreens Sells Shares Of Drug Distributor Cencora -- MarketWatch
COR,2023-11-10,00:24:22,7D85A9,Cencora Inc.,96,0.49,partnerships,,"Cencora,"" a partner with Walgreens since",FULL-ARTICLE,MarketWatch,MW Walgreens sells shares of drug distributor Cencora
COR,2023-11-13,20:12:37,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Donato Registers 3,387 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,387 Of Cencora Inc >COR"
COR,2023-11-13,21:38:15,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 7,582 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 7,582 Of Cencora Inc >COR"
COR,2023-11-13,21:39:02,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 1,889 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 1,889 Of Cencora Inc >COR"
COR,2023-11-13,21:41:28,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Clark Acquires 8,033 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 8,033 Of Cencora Inc >COR"
COR,2023-11-13,21:42:32,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 16,183 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 16,183 Of Cencora Inc >COR"
COR,2023-11-13,21:45:24,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 59,675 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 59,675 Of Cencora Inc >COR"
COR,2023-11-13,21:48:48,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Donato Acquires 5,325 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 5,325 Of Cencora Inc >COR"
COR,2023-11-13,21:48:57,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 1,751 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 1,751 Of Cencora Inc >COR"
COR,2023-11-13,21:50:01,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Coo Mauch Acquires 20,055 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Acquires 20,055 Of Cencora Inc >COR"
COR,2023-11-14,12:52:20,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 1,279,590 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 1,279,590 Of Cencora Inc >COR"
COR,2023-11-14,16:54:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 25,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 25,000 Of Cencora Inc >COR"
COR,2023-11-14,21:59:11,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Donato Acquires 1,244 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 1,244 Of Cencora Inc >COR"
COR,2023-11-14,22:11:24,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 3,778 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 3,778 Of Cencora Inc >COR"
COR,2023-11-14,22:22:25,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Clark Acquires 1,831 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 1,831 Of Cencora Inc >COR"
COR,2023-11-14,22:25:32,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 1,322 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 1,322 Of Cencora Inc >COR"
COR,2023-11-14,23:38:40,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 2,499 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 2,499 Of Cencora Inc >COR"
COR,2023-11-15,01:44:25,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Coo Mauch Acquires 4,357 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Acquires 4,357 Of Cencora Inc >COR"
COR,2023-11-15,02:01:01,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 13,931 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 13,931 Of Cencora Inc >COR"
COR,2023-11-15,02:04:13,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 1,393 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 1,393 Of Cencora Inc >COR"
COR,2023-11-15,23:11:42,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Donato Sells 3,387 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,387 Of Cencora Inc >COR"
COR,2023-11-15,23:14:47,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 12,440 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 12,440 Of Cencora Inc >COR"
COR,2023-11-15,23:15:19,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 25,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 25,000 Of Cencora Inc >COR"
COR,2023-11-16,16:18:35,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 14,747 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 14,747 Of Cencora Inc >COR"
COR,2023-11-17,21:25:12,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 14,747 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 14,747 Of Cencora Inc >COR"
COR,2023-11-19,08:37:27,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2023 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2023 (COR)"
COR,2023-11-22,14:00:07,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corporation, Enter into Distribution Agreement",PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:07,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We are honored to partner with Cencora to,PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:23,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corporation, Enter into Distribution Agreement",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:23,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We are honored to partner with Cencora to,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:30,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corp, Enter Into Distribution Agreement",NEWS-FLASH,Dow Jones Newswires,"Sapphiros and Cencora, Formerly AmerisourceBergen Corp, Enter Into Distribution Agreement"
COR,2023-11-22,14:01:11,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corporation, Enter into Distribution Agreement",PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:01:11,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We are honored to partner with Cencora to,PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-12-01,17:12:43,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 2,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 2,000 Of Cencora Inc >COR"
COR,2023-12-04,21:07:36,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 2,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 2,000 Of Cencora Inc >COR"
COR,2023-12-12,15:12:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 25,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 25,000 Of Cencora Inc >COR"
COR,2023-12-13,21:11:41,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 25,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 25,000 Of Cencora Inc >COR"
COR,2023-12-13,21:15:42,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 42,885 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 42,885 Of Cencora Inc >COR"
COR,2023-12-13,21:25:08,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 5,162 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 5,162 Of Cencora Inc >COR"
COR,2023-12-14,12:51:50,7D85A9,Cencora Inc.,100,0.01,analyst-ratings,neutral,Cencora Initiated at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Initiated at Equal-Weight by Wells Fargo
COR,2023-12-14,12:51:51,7D85A9,Cencora Inc.,100,0.0,price-targets,set,Cencora Price Target Announced at $213.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Announced at $213.00/Share by Wells Fargo
COR,2023-12-14,22:22:11,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora's Long-Term IDR at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms Cencora's Long-Term IDR at 'A-'; Upgrades Short-Term IDR to 'F1'; Outlook Stable
COR,2023-12-14,22:22:11,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora's Long-Term IDR at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term IDR at 'A-'; Upgrades Short-Term IDR to 'F1'; Outlook Stable
COR,2023-12-14,22:22:11,7D85A9,Cencora Inc.,100,0.44,credit,reduction,Cencora reduced its debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term IDR at 'A-'; Upgrades Short-Term IDR to 'F1'; Outlook Stable
COR,2023-12-14,22:22:21,7D85A9,Cencora Inc.,100,0.0,credit-ratings,affirmation,Fitch Affirms Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term -2-
COR,2023-12-14,22:22:31,7D85A9,Cencora Inc.,100,0.0,credit-ratings,affirmation,Fitch Affirms Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term -3-
COR,2023-12-15,21:25:11,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 5,162 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 5,162 Of Cencora Inc >COR"
COR,2023-12-15,21:25:37,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 42,885 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 42,885 Of Cencora Inc >COR"
COR,2023-12-15,22:16:18,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 168 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 168 Of Cencora Inc >COR
COR,2023-12-15,22:18:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Coo Mauch Acquires 487 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,COO Mauch Acquires 487 Of Cencora Inc >COR
COR,2023-12-15,22:21:02,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Clark Acquires 137 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Clark Acquires 137 Of Cencora Inc >COR
COR,2023-12-15,22:23:15,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Cfo Cleary Jr Acquires 307 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,CFO Cleary Jr Acquires 307 Of Cencora Inc >COR
COR,2023-12-18,21:11:24,7D85A9,Cencora Inc.,100,0.0,insider-trading,,"Chmn Collis Gifts 3,600 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Gifts 3,600 Of Cencora Inc >COR"
COR,2023-12-19,13:30:01,7D85A9,Cencora Inc.,100,0.44,products-services,,World Courier to Expand Storage Capacity,PRESS-RELEASE,Business Wire,World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
COR,2023-12-19,13:30:01,7D85A9,Cencora Inc.,100,0.36,assets,upgrade,Cencora Inc.: will expand World Courier's capacity to store,PRESS-RELEASE,Business Wire,World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
COR,2023-12-19,13:30:01,7D85A9,Cencora Inc.,100,0.52,products-services,,World Courier recently launched a Container,PRESS-RELEASE,Business Wire,World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
COR,2023-12-21,18:18:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Donato Registers 3,400 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,400 Of Cencora Inc >COR"
COR,2023-12-26,21:01:13,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Donato Sells 3,400 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,400 Of Cencora Inc >COR"
COR,2023-01-03,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition Of PharmaLex >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Completes Acquisition Of PharmaLex >ABC
COR,2023-01-03,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of PharmaLex,PRESS-RELEASE,Business Wire,AmerisourceBergen Completes Acquisition of PharmaLex
COR,2023-01-03,12:00:01,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Completes Acquisition of PharmaLex,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Completes Acquisition of PharmaLex
COR,2023-01-03,21:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release
COR,2023-01-03,22:19:19,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release
COR,2023-01-05,17:50:47,7D85A9,AmerisourceBergen Corp.,96,0.49,partnerships,,"Wearable, announces exclusive animal health partnership with MWI",PRESS-RELEASE,PR Newswire,"Link, the Smart Pet Wearable, announces exclusive animal health partnership with MWI/Amerisource Bergen"
COR,2023-01-05,21:24:22,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Krikorian Acquires 166 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 166 Of AmerisourceBergen Corp >ABC
COR,2023-01-10,13:30:02,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Amerisourcebergen, in partnership with the AmerisourceBergen",PRESS-RELEASE,Business Wire,The AmerisourceBergen Foundation & Good Neighbor Pharmacy Launch Scholarship Program to Support Aspiring Black and African American Pharmacists
COR,2023-01-11,14:50:21,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Baird
COR,2023-01-11,14:50:21,7D85A9,AmerisourceBergen Corp.,100,0.38,price-targets,upgrade,Amerisourcebergen Price Target Raised to $199.00/Share From $195.00 by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $199.00/Share From $195.00 by Baird
COR,2023-01-12,14:44:07,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by Argus Research
COR,2023-01-12,14:44:07,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $190.00/Share From $170.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $190.00/Share From $170.00 by Argus Research
COR,2023-01-18,20:09:31,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-01-19,21:07:36,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-01-22,08:18:25,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2022 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2022 (ABC)"
COR,2023-01-24,10:00:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen to Change Name to,FULL-ARTICLE,Dow Jones Newswires,Drug Distributor AmerisourceBergen to Change Name to Cencora -- WSJ
COR,2023-01-24,14:15:13,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen To Change Name To,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen To Change Name To Cencora Later This Year -- MarketWatch
COR,2023-01-24,14:15:13,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen to change name to,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen to change name to Cencora later this year
COR,2023-01-27,13:18:44,7D85A9,AmerisourceBergen Corp.,100,0.44,labor-issues,,Amerisourcebergen Corp. CEO Steven Collis 2022 Total Pay $16.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Corp. CEO Steven Collis 2022 Total Pay $16.7M >ABC
COR,2023-01-27,13:45:17,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,"Amerisourcebergen, in partnership with the AmerisourceBergen",PRESS-RELEASE,DJ Global Press Release Wire,The AmerisourceBergen Foundation & Good Neighbor Pharmacy Launch Scholarship Program To Support Aspiring Black and African American Pharmacists
COR,2023-01-31,12:22:57,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $185.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $185.00/Share by Evercore ISI Group
COR,2023-01-31,13:44:48,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by UBS
COR,2023-01-31,13:44:48,7D85A9,AmerisourceBergen Corp.,100,0.46,price-targets,upgrade,Amerisourcebergen Price Target Raised to $190.00/Share From $184.00 by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $190.00/Share From $184.00 by UBS
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.50-Adj EPS $11.75 >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 1Q Rev $62.8B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Rev $62.8B >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,1Q EPS $2.33 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q EPS $2.33 >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Adj EPS $2.71,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Adj EPS $2.71 >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 1Q Net $479.7M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 1Q Net $479.7M >ABC
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 First Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $62.8 billion for the First Quarter, a 5.4 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.33,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.50 to $11.75,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 first quarter ended December 31, 2022, revenue increased 5.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2023, revenue was $62.8 billion, up 5.4 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the first quarter of fiscal 2023,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2023 was $161.3 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,AmerisourceBergen Corp.: Announced the completion of the acquisition of PharmaLex Holding GmbH,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2023 financial guidance,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -2-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -3-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -3-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -3-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.41,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -4-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.35 $ 2.15,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -4-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -5-
COR,2023-02-01,11:30:00,7D85A9,AmerisourceBergen Corp.,94,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,906,893 $ 56,560,616",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -5-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,98,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 First -7-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 First Quarter Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenues of $62.8 billion for the First Quarter, a 5.4 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: First Quarter GAAP Diluted EPS of $2.33,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.50 to $11.75,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 first quarter ended December 31, 2022, revenue increased 5.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the first quarter of fiscal 2023, revenue was $62.8 billion, up 5.4 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the first quarter of fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Operating Income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 First Quarter Results
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the first quarter of fiscal 2023 was $161.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.57,acquisitions-mergers,completed,AmerisourceBergen Corp.: Announced the completion of the acquisition of PharmaLex Holding GmbH,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's fiscal year 2023 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.35 $ 2.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,94,0.0,assets,,"AmerisourceBergen Corp.: Total assets $ 57,906,893 $ 56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-02-01,11:30:01,7D85A9,AmerisourceBergen Corp.,97,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-02-01,11:31:21,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Had Seen FY23 Adjusted EPS $11.30-$11.60,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Had Seen FY23 Adjusted EPS $11.30-$11.60 >ABC
COR,2023-02-01,11:33:46,7D85A9,AmerisourceBergen Corp.,100,-0.28,earnings,down,Amerisourcebergen Q1 EPS $2.33 vs. $2.71 a year ago,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 EPS $2.33 vs. $2.71 a year ago
COR,2023-02-01,11:34:46,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q1 adj. EPS $2.71; FactSet consensus $2.64,NEWS-FLASH,MarketWatch,MW AmerisourceBergen Q1 adj. EPS $2.71; FactSet consensus $2.64
COR,2023-02-01,11:35:46,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,Amerisourcebergen Q1 EPS $2.33 vs. $2.13 a year ago,NEWS-FLASH,MarketWatch,MW CORRECTED: AmerisourceBergen Q1 EPS $2.33 vs. $2.13 a year ago
COR,2023-02-01,11:35:46,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Q1 revenue $62.8 bln, up 5.4%",NEWS-FLASH,MarketWatch,"MW AmerisourceBergen Q1 revenue $62.8 bln, up 5.4% vs. year -ago; FactSet consensus $62.8 bln"
COR,2023-02-01,11:36:46,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees full-year adj. EPS of $11.50 to $11.75,NEWS-FLASH,MarketWatch,MW AmerisourceBergen now sees full-year adj. EPS of $11.50 to $11.75 vs. prior $11.30 to $11.60
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,"AmerisourceBergen Corp.: The company posted net income of $479.8 million, or $2.33 a share, up from $449.1 million",FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance"
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisource Bergen now sees full-year adjusted EPS of $11.50 to $11.75,FULL-ARTICLE,MarketWatch,"MW AmerisourceBergen Corp. stock rises on Q1 top line beat, raised guidance"
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.4,earnings,up,"AmerisourceBergen Corp.: The company posted net income of $479.8 million, or $2.33 a share, up from $449.1 million",FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Corp. Stock Rises On Q1 Top Line Beat, Raised Guidance -- MarketWatch"
COR,2023-02-01,11:59:47,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisource Bergen now sees full-year adjusted EPS of $11.50 to $11.75,FULL-ARTICLE,Dow Jones Newswires,"AmerisourceBergen Corp. Stock Rises On Q1 Top Line Beat, Raised Guidance -- MarketWatch"
COR,2023-02-01,14:55:03,7D85A9,AmerisourceBergen Corp.,94,0.0,investor-relations,,Steve Collis on fiscal 1Q earnings call,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Doesn't See Tailwind from Humira Biosimilars -- Market Talk
COR,2023-02-01,14:55:03,7D85A9,AmerisourceBergen Corp.,94,0.0,investor-relations,,Steve Collis on fiscal 1Q earnings call,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Doesn't See Tailwind from Humira Biosimilars -- Market Talk
COR,2023-02-01,14:57:51,7D85A9,AmerisourceBergen Corp.,94,0.59,equity-actions,,Amerisourcebergen repurchased $1B of its own shares,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:51,7D85A9,AmerisourceBergen Corp.,94,0.46,earnings,above-expectations,"Amerisource reported adjusted earnings per share of $2.71, beating analysts' forecast of $2.64",FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:52,7D85A9,AmerisourceBergen Corp.,98,0.59,equity-actions,,Amerisourcebergen repurchased $1B of its own shares,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:52,7D85A9,AmerisourceBergen Corp.,98,0.46,earnings,above-expectations,"Amerisource reported adjusted earnings per share of $2.71, beating analysts' forecast of $2.64",FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-01,14:57:52,7D85A9,AmerisourceBergen Corp.,98,0.0,investor-relations,,Steve Collis on fiscal 1Q earnings call,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Remains a Buyer If Walgreens Sells Mores Shares -- Market Talk
COR,2023-02-02,12:39:49,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by Baird
COR,2023-02-02,12:39:49,7D85A9,AmerisourceBergen Corp.,100,0.3,price-targets,upgrade,Amerisourcebergen Price Target Raised to $201.00/Share From $199.00 by Baird,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $201.00/Share From $199.00 by Baird
COR,2023-02-02,13:00:49,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2023-02-02,13:00:49,7D85A9,AmerisourceBergen Corp.,100,0.56,price-targets,upgrade,Amerisourcebergen Price Target Raised to $170.00/Share From $162.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $170.00/Share From $162.00 by Mizuho
COR,2023-02-07,21:08:12,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Campbell Acquires 3,182 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 3,182 Of AmerisourceBergen Corp >ABC"
COR,2023-02-07,21:19:32,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Vp Krikorian Acquires 4,152 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 4,152 Of AmerisourceBergen Corp >ABC"
COR,2023-02-08,22:03:48,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Krikorian Registers 5,711 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 5,711 Of AmerisourceBergen Corp >ABC"
COR,2023-02-09,21:07:42,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Krikorian Sells 5,711 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 5,711 Of AmerisourceBergen Corp >ABC"
COR,2023-02-15,21:00:44,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-02-16,21:08:54,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-03-02,21:51:41,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Clark Registers 1,924 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 1,924 Of AmerisourceBergen Corp >ABC"
COR,2023-03-03,21:14:43,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 1,924 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 1,924 Of AmerisourceBergen Corp >ABC"
COR,2023-03-13,20:16:22,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Battaglia Acquires 852 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Battaglia Acquires 852 Of AmerisourceBergen Corp >ABC
COR,2023-03-15,20:07:12,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-03-15,20:09:51,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-03-29,11:01:03,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: SamaCare Partners with AmerisourceBergen to,PRESS-RELEASE,PR Newswire,SamaCare Partners with AmerisourceBergen to Offer Prior Authorization Platform to Specialty Practices
COR,2023-03-29,20:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release
COR,2023-03-29,21:10:51,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release
COR,2023-03-31,12:45:53,7D85A9,AmerisourceBergen Corp.,100,0.95,analyst-ratings,positive,Amerisourcebergen Initiated at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Initiated at Buy by Citigroup
COR,2023-03-31,12:45:53,7D85A9,AmerisourceBergen Corp.,100,0.0,price-targets,set,Amerisourcebergen Price Target Announced at $185.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Announced at $185.00/Share by Citigroup
COR,2023-04-11,14:09:27,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-04-13,20:11:01,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-04-20,12:30:01,7D85A9,AmerisourceBergen Corp.,99,0.62,acquisitions-mergers,,Amerisourcebergen will purchase its minority interest in the joint venture for approximately $685 million in cash,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic
COR,2023-04-20,12:30:01,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen to -2-
COR,2023-04-20,12:30:02,7D85A9,AmerisourceBergen Corp.,99,0.62,acquisitions-mergers,,Amerisourcebergen will purchase its minority interest in the joint venture for approximately $685 million in cash,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic
COR,2023-04-20,12:30:02,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen to Acquire Leading -2-
COR,2023-04-20,12:34:08,7D85A9,AmerisourceBergen Corp.,100,0.62,acquisitions-mergers,,Amerisourcebergen to buy OneOncology from General Atlantic in a deal valued at $2.1 billion,FULL-ARTICLE,MarketWatch,"MW TPG, AmerisourceBergen to buy OneOncology from General Atlantic in a deal valued at $2.1 billion."
COR,2023-04-20,12:53:10,7D85A9,AmerisourceBergen Corp.,95,0.39,products-services,,Tpg and AmerisourceBergen said the deal,FULL-ARTICLE,Dow Jones Newswires,"TPG, AmerisourceBergen to Buy OneOncology From General Atlantic"
COR,2023-04-20,16:06:38,7D85A9,AmerisourceBergen Corp.,97,0.39,products-services,,AmerisourceBergen Corp.: We expect the transaction will close by the end of September,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGRBulletin: AmerisourceBergen Rtgs Same On OneOncology Acq
COR,2023-04-22,07:15:18,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2023 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2023 (ABC)"
COR,2023-04-24,19:47:01,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,Amerisourcebergen reported 5% EPS growth,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Stock Joins Elite Group Of Top Performers -- IBD
COR,2023-04-24,19:48:13,7D85A9,AmerisourceBergen Corp.,99,0.4,earnings,up,Amerisourcebergen reported 5% EPS growth,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Stock Joins Elite Group Of Top Performers -- IBD
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.70,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.70-Adj EPS $11.90 >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Adj EPS $3.50,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Adj EPS $3.50 >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 2Q Rev $63.5B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Rev $63.5B >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,2Q EPS $2.13 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q EPS $2.13 >ABC
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 Second Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $63.5 billion for the Second Quarter, a 9.9 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.70 to $11.90,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 second quarter ended March 31, 2023, revenue increased 9.9 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: our full year financial outlook,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,-0.24,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue declined 0.2 percent,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the second quarter of fiscal 2023,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.34,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, net interest expense of $64.1 million increased 21.2 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2023 was $176.0 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -2-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 2.62,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:00,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.87,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 2Q Net $435.4M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 2Q Net $435.4M >ABC
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,assets,,"AmerisourceBergen Corp.: Total assets $58,766,183 $ 56,560,616",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Second -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Second Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $63.5 billion for the Second Quarter, a 9.9 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Second Quarter GAAP Diluted EPS of $2.13,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.70 to $11.90,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 second quarter ended March 31, 2023, revenue increased 9.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: our full year financial outlook,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.24,revenues,down,AmerisourceBergen Corp.: International Healthcare Solutions revenue declined 0.2 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,AmerisourceBergen Corp.: Adjusted Operating Expenses: In the second quarter of fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, revenue was $63.5 billion, up 9.9 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Second Quarter Results
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.34,equity-actions,up,"AmerisourceBergen Corp.: In the second quarter of fiscal 2023, net interest expense of $64.1 million increased 21.2 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the second quarter of fiscal 2023 was $176.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.15 $ 2.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.61,earnings,positive,AmerisourceBergen Corp.: Gross profit 3.87,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,98,0.0,assets,,"AmerisourceBergen Corp.: Total assets $58,766,183 $ 56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted net income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-05-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-05-02,10:30:53,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,up,Amerisourcebergen Sees FY23 Adjusted EPS Up 8%-10%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY23 Adjusted EPS Up 8%-10% Constant Currency >ABC
COR,2023-05-02,10:31:24,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen Now Sees FY23 Revenue Growth 6%-8%,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Now Sees FY23 Revenue Growth 6%-8%; Had Seen 5%-7% >ABC
COR,2023-05-02,10:34:00,7D85A9,AmerisourceBergen Corp.,100,-0.36,earnings,down,Amerisourcebergen Q2 EPS $2.13 vs. $2.59 a year ago,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen Q2 EPS $2.13 vs. $2.59 a year ago
COR,2023-05-02,10:35:01,7D85A9,AmerisourceBergen Corp.,100,0.46,earnings,above-expectations,Amerisourcebergen Q2 adj. EPS $3.50; FactSet consensus $3.30,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen Q2 adj. EPS $3.50; FactSet consensus $3.30
COR,2023-05-02,10:35:01,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,above-expectations,Amerisourcebergen Q2 revenue $63.457 bln vs. $57.719 bln a year ago; FactSet consensus $60.458 bln,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen Q2 revenue $63.457 bln vs. $57.719 bln a year ago; FactSet consensus $60.458 bln
COR,2023-05-02,10:36:01,7D85A9,AmerisourceBergen Corp.,100,0.48,revenues,up,Amerisourcebergen now sees FY23 revenue up 6% to 8%,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen now sees FY23 revenue up 6% to 8% vs. prior guidance of up 5% to 7%
COR,2023-05-02,10:37:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen now sees FY23 adj. EPS of $11.70 to $11.90,FULL-ARTICLE,MarketWatch,MW AmerisourceBergen now sees FY23 adj. EPS of $11.70 to $11.90 vs. prior range of $11.50 to $11.75
COR,2023-05-02,10:56:21,7D85A9,AmerisourceBergen Corp.,100,0.7,earnings,up,Amerisourcebergen Boosts Earnings Outlook for 2023,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Earnings Outlook for 2023
COR,2023-05-02,10:56:21,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,Amerisourcebergen said it also expects revenue to grow 6% to 8%,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Boosts Earnings Outlook for 2023
COR,2023-05-03,11:13:03,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2023-05-03,11:13:03,7D85A9,AmerisourceBergen Corp.,100,0.4,price-targets,upgrade,Amerisourcebergen Price Target Raised to $174.00/Share From $170.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $174.00/Share From $170.00 by Mizuho
COR,2023-05-03,14:32:04,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by TD,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by TD Cowen
COR,2023-05-03,14:32:04,7D85A9,AmerisourceBergen Corp.,100,0.68,price-targets,upgrade,Amerisourcebergen Price Target Raised to $187.00/Share From $174.00 by TD,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $187.00/Share From $174.00 by TD Cowen
COR,2023-05-03,18:27:05,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by Citigroup
COR,2023-05-03,18:27:05,7D85A9,AmerisourceBergen Corp.,100,0.6,price-targets,upgrade,Amerisourcebergen Price Target Raised to $195.00/Share From $185.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $195.00/Share From $185.00 by Citigroup
COR,2023-05-09,15:18:34,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-05-10,20:04:15,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-05-11,13:04:02,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,Discovery Partners with AmerisourceBergen for,PRESS-RELEASE,PR Newswire,Patient Discovery Partners with AmerisourceBergen for Cancer Care Equity
COR,2023-05-12,02:13:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds
COR,2023-05-12,02:13:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds
COR,2023-05-12,02:16:07,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen for $694M in Initial Proceeds >WBA
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance >ABC
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.59,equity-actions,,Amerisourcebergen Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-12,02:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-05-15,21:11:36,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Llc Reports 16.5% Stake in AmerisourceBergen Corp.,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Holdings LLC Reports 16.5% Stake in AmerisourceBergen Corp.
COR,2023-05-15,21:19:51,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 292,792 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 292,792 Of AmerisourceBergen Corp >ABC"
COR,2023-05-17,16:00:32,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Campbell Registers 7,500 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 7,500 Of AmerisourceBergen Corp >ABC"
COR,2023-05-19,20:03:52,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Campbell Sells 7,500 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 7,500 Of AmerisourceBergen Corp >ABC"
COR,2023-05-19,20:12:40,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 12,545 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 12,545 Of AmerisourceBergen Corp >ABC"
COR,2023-05-26,12:16:46,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by UBS
COR,2023-05-26,12:16:46,7D85A9,AmerisourceBergen Corp.,100,0.7,price-targets,upgrade,Amerisourcebergen Price Target Raised to $184.00/Share From $170.00 by UBS,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $184.00/Share From $170.00 by UBS
COR,2023-06-07,15:18:58,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Buy by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Buy by B of A Securities
COR,2023-06-07,15:18:58,7D85A9,AmerisourceBergen Corp.,100,0.42,price-targets,upgrade,Amerisourcebergen Price Target Raised to $200.00/Share From $195.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $200.00/Share From $195.00 by B of A Securities
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Announce Completion Of Acquisition Of OneOncology >ABC,NEWS-FLASH,Dow Jones Newswires,TPG And AmerisourceBergen Announce Completion Of Acquisition Of OneOncology >ABC
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Announce Completion of Acquisition of OneOncology,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.57,acquisitions-mergers,completed,Amerisourcebergen Announce Completion of Acquisition of OneOncology,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-09,12:18:00,7D85A9,AmerisourceBergen Corp.,100,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology
COR,2023-06-13,14:12:33,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-06-14,20:15:18,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-06-20,11:52:56,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 275,984 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 275,984 Of AmerisourceBergen Corp >ABC"
COR,2023-06-22,18:45:26,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Vp Clark Registers 27,542 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 27,542 Of AmerisourceBergen Corp >ABC"
COR,2023-06-23,20:08:30,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Vp Clark Sells 27,542 Of AmerisourceBergen Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 27,542 Of AmerisourceBergen Corp >ABC"
COR,2023-06-29,20:30:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release
COR,2023-06-29,20:34:00,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2023 Earnings Release
COR,2023-07-03,20:08:22,7D85A9,AmerisourceBergen Corp.,100,0.52,insider-trading,,Vp Donato Acquires 898 Of AmerisourceBergen Corp >ABC,TABULAR-MATERIAL,Dow Jones Newswires,VP Donato Acquires 898 Of AmerisourceBergen Corp >ABC
COR,2023-07-11,11:48:55,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Neutral by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Neutral by Mizuho
COR,2023-07-11,11:48:55,7D85A9,AmerisourceBergen Corp.,100,0.78,price-targets,upgrade,Amerisourcebergen Price Target Raised to $192.00/Share From $174.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $192.00/Share From $174.00 by Mizuho
COR,2023-07-11,14:12:30,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-07-12,20:16:41,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Sees FY Adj EPS $11.85,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Sees FY Adj EPS $11.85-Adj EPS $11.95 >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Adj EPS $2.92,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Adj EPS $2.92 >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,3Q EPS $2.35 >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q EPS $2.35 >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen 3Q Rev $66.9B >ABC,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Rev $66.9B >ABC
COR,2023-08-02,10:30:00,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,Amerisourcebergen 3Q Net $479.6M,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen 3Q Net $479.6M >ABC
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Third Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $66.9 billion for the Third Quarter, an 11.5 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $2.35,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,Amerisourcebergen will change its name to,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.85 to $11.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 third quarter ended June 30, 2023, revenue increased 11.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,unchanged,AmerisourceBergen Corp.: Revenue $66.9B $66.9B,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.16,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, net interest expense of $57.9 million increased 9.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2023 was $187.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.44,products-services,cut,AmerisourceBergen Corp.: to reduce prices for our products and services;,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -3-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.37 $ 1.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.38,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,assets,,"AmerisourceBergen Corp.: Total assets $61,177,196 $ 56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -7-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -8-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,97,0.0,revenues,,"AmerisourceBergen Corp.: For the third quarter of fiscal 2023, (i) revenue of $66.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,97,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Reports Fiscal -9-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,Amerisourcebergen Reports Fiscal 2023 Third Quarter Results,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue of $66.9 billion for the Third Quarter, an 11.5 Percent Increase",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Third Quarter GAAP Diluted EPS of $2.35,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Diluted EPS Guidance Range Raised to $11.85 to $11.95,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"Amerisourcebergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 third quarter ended June 30, 2023, revenue increased 11.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,unchanged,AmerisourceBergen Corp.: Revenue $66.9B $66.9B,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,-0.16,equity-actions,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, net interest expense of $57.9 million increased 9.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: Revenue: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.0,earnings,,AmerisourceBergen Corp.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.41,revenues,up,"AmerisourceBergen Corp.: In the third quarter of fiscal 2023, revenue was $66.9 billion, up 11.5 percent",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,100,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third Quarter Results
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,revenues,,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Segment operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.6,earnings,positive,AmerisourceBergen Corp.: Segment operating income in the third quarter of fiscal 2023 was $187.1 million,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,Amerisourcebergen will change its name to,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: Revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.65,revenues,up,AmerisourceBergen Corp.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,investor-relations,,AmerisourceBergen Corp.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -2-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,-0.44,products-services,cut,AmerisourceBergen Corp.: to reduce prices for our products and services;,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -3-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,equity-actions,,AmerisourceBergen Corp.: Operating expenses,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Earnings per share: Basic $ 2.37 $ 1.95,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -4-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,92,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.38,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -5-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Gross profit 3.47,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.47,equity-actions,,AmerisourceBergen Corp.: Restructuring,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -6-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,earnings,,AmerisourceBergen Corp.: Operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -7-
COR,2023-08-02,10:30:01,7D85A9,AmerisourceBergen Corp.,95,0.0,assets,,"AmerisourceBergen Corp.: Total assets $61,177,196 $ 56,560,616",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -7-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.61,earnings,positive,AmerisourceBergen Corp.: Adjusted gross profit,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted operating income,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,0.0,earnings,,AmerisourceBergen Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,99,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -8-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,98,0.0,revenues,,"AmerisourceBergen Corp.: For the third quarter of fiscal 2023, (i) revenue of $66.9 billion",PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -9-
COR,2023-08-02,10:30:02,7D85A9,AmerisourceBergen Corp.,98,-0.56,earnings,suspended,AmerisourceBergen Corp.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,AmerisourceBergen Reports Fiscal 2023 Third -9-
COR,2023-08-02,10:32:45,7D85A9,AmerisourceBergen Corp.,100,0.0,revenues,,Amerisourcebergen Now Sees FY23 Revenue Up at Least 8,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Now Sees FY23 Revenue Up at Least 8%; Had Seen Up 6%-8% >ABC
COR,2023-08-03,13:43:31,7D85A9,AmerisourceBergen Corp.,100,0.0,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Equal-Weight by Morgan Stanley
COR,2023-08-03,13:43:31,7D85A9,AmerisourceBergen Corp.,100,0.7,price-targets,upgrade,Amerisourcebergen Price Target Raised to $190.00/Share From $176.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $190.00/Share From $176.00 by Morgan Stanley
COR,2023-08-03,20:33:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10.5 million shares of common stock of the Company,PRESS-RELEASE,Business Wire,AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase
COR,2023-08-03,20:33:00,7D85A9,AmerisourceBergen Corp.,99,0.59,equity-actions,,AmerisourceBergen Corp.: offering of 10.5 million shares of common stock of the Company,PRESS-RELEASE,Dow Jones Newswires,Press Release: AmerisourceBergen Announces Registered Public Offering of Common Shares and Common Share Repurchase
COR,2023-08-03,22:48:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Business Wire,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds
COR,2023-08-03,22:48:00,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.85 Billion of Initial Proceeds
COR,2023-08-03,22:48:47,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen Corp,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of AmerisourceBergen Corp for $1.85B of Initial Proceeds
COR,2023-08-03,22:57:37,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells About $1.6B of AmerisourceBergen Shares,NEWS-FLASH,Dow Jones Newswires,"Walgreens Boots Alliance Sells About $1.6B of AmerisourceBergen Shares Through a Registered Public Offering, Also Enters a Concurrent Shr Repurchase Agreement for About $250M"
COR,2023-08-03,23:17:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance sells shares of AmerisourceBergen,FULL-ARTICLE,MarketWatch,MW Walgreens Boots Alliance sells shares of AmerisourceBergen for $1.85 billion
COR,2023-08-03,23:17:01,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shares Of AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Walgreens Boots Alliance Sells Shares Of AmerisourceBergen For $1.85 Billion -- MarketWatch
COR,2023-08-07,15:10:46,7D85A9,AmerisourceBergen Corp.,100,0.34,analyst-ratings,neutral,Amerisourcebergen Is Maintained at Outperform by TD Cowen,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Is Maintained at Outperform by TD Cowen
COR,2023-08-07,15:10:46,7D85A9,AmerisourceBergen Corp.,100,0.56,price-targets,upgrade,Amerisourcebergen Price Target Raised to $215.00/Share From $205.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Price Target Raised to $215.00/Share From $205.00 by TD Cowen
COR,2023-08-07,21:50:05,7D85A9,AmerisourceBergen Corp.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Sells 1,320,858 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Sells 1,320,858 Of AmerisourceBergen Corp >ABC"
COR,2023-08-08,18:57:32,7D85A9,AmerisourceBergen Corp.,100,-0.48,insider-trading,,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-08-09,20:09:27,7D85A9,AmerisourceBergen Corp.,100,-0.49,insider-trading,,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 10,499 Of AmerisourceBergen Corp >ABC"
COR,2023-08-19,07:13:37,7D85A9,AmerisourceBergen Corp.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2023 (ABC)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2023 (ABC)"
COR,2023-08-28,13:00:01,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Signs Agreement with AmerisourceBergen,PRESS-RELEASE,Business Wire,Tivic Health Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers
COR,2023-08-28,13:00:29,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Signs Agreement With AmerisourceBergen,NEWS-FLASH,Dow Jones Newswires,Tivic Health Signs Agreement With AmerisourceBergen for Retail Pharmacy Customers
COR,2023-08-28,13:00:40,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Signs Agreement with AmerisourceBergen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Tivic Health Signs Agreement with AmerisourceBergen for Retail Pharmacy Customers
COR,2023-08-28,13:16:47,7D85A9,AmerisourceBergen Corp.,100,0.39,products-services,,Tivic Health Systems Signs Marketplace Agreement With AmerisourceBergen,FULL-ARTICLE,Dow Jones Newswires,Tivic Health Systems Signs Marketplace Agreement With AmerisourceBergen
COR,2023-08-30,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,"Press Release: AmerisourceBergen becomes Cencora, in alignment with the company's growing global footprint and central role in pharmaceutical access and care"
COR,2023-08-30,11:30:00,7D85A9,AmerisourceBergen Corp.,99,0.49,partnerships,,AmerisourceBergen Corp.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,"AmerisourceBergen becomes Cencora, in alignment with the company's growing global footprint and central role in pharmaceutical access and care"
COR,2023-08-30,11:58:11,7D85A9,AmerisourceBergen Corp.,100,0.0,equity-actions,,Amerisourcebergen Changes Name to,FULL-ARTICLE,Dow Jones Newswires,AmerisourceBergen Changes Name to Cencora
COR,2023-09-21,16:12:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Donato Registers 3,386 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,386 Of Cencora Inc >COR"
COR,2023-09-22,20:04:32,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Donato Sells 3,386 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,386 Of Cencora Inc >COR"
COR,2023-09-25,15:39:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Coo Mauch Registers 20,197 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"COO Mauch Registers 20,197 Of Cencora Inc >COR"
COR,2023-09-25,16:09:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 20,971 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 20,971 Of Cencora Inc >COR"
COR,2023-09-27,20:08:05,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 20,971 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 20,971 Of Cencora Inc >COR"
COR,2023-09-27,20:10:11,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Coo Mauch Sells 20,197 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Sells 20,197 Of Cencora Inc >COR"
COR,2023-10-02,20:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,"Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release"
COR,2023-10-02,20:41:33,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Cencora, Formerly AmerisourceBergen, Announces Date and Time for Fourth Quarter Fiscal 2023 Earnings Release"
COR,2023-10-10,14:45:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 25,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 25,000 Of Cencora Inc >COR"
COR,2023-10-10,17:06:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Clark Registers 10,695 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Clark Registers 10,695 Of Cencora Inc >COR"
COR,2023-10-11,20:20:19,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Clark Sells 10,695 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Sells 10,695 Of Cencora Inc >COR"
COR,2023-10-11,20:21:46,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 25,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 25,000 Of Cencora Inc >COR"
COR,2023-10-17,12:03:10,7D85A9,Cencora Inc.,100,0.49,partnerships,,Mirakl Partners with Cencora to Power,PRESS-RELEASE,DJ Global Press Release Wire,Mirakl Partners with Cencora to Power New Marketplace Solution
COR,2023-10-25,23:52:27,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,DJ Global Press Release Wire,Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
COR,2023-10-25,23:52:27,7D85A9,Cencora Inc.,100,0.39,products-services,,"Epigenetics, announced today it has entered into an agreement with Cencora",PRESS-RELEASE,DJ Global Press Release Wire,Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Net $350.6M,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Net $350.6M >COR
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 4Q Rev $68.92B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Rev $68.92B >COR
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,4Q EPS $1.72 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q EPS $1.72 >COR
COR,2023-11-02,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 4Q Adj EPS $2.86,NEWS-FLASH,Dow Jones Newswires,Cencora 4Q Adj EPS $2.86 >COR
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $68.9 Billion for the Fourth Quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $1.72,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent to $262.2 billion for the fiscal year,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2023 GAAP Diluted EPS of $8.53,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today reported that in its fiscal year 2023 fourth quarter ended September 30, 2023, revenue increased 12.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, adjusted diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, diluted EPS",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,-0.3,equity-actions,up,"Cencora Inc.: In the fiscal 2023 fourth quarter, net interest expense of $60.9 million increased 18.3 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.02,earnings,,Cencora Inc.: Adjusted operating income increased 4.0 percent to $3.3 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2023 Summary Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.2,equity-actions,up,Cencora Inc.: Operating expenses increased 11.6 percent,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, GAAP diluted EPS was $8.53",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent from last fiscal year to $262.2 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 7.3 percent to $9.0 billion,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, adjusted diluted EPS was $11.99",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.51,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -2-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 1.74 $ 1.42,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -3-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit 3.27,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 8.62 $ 8.15,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -4-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,94,0.0,earnings,,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -5-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,94,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -5-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.48,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -6-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -6-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $62,558,746 $56,560,616",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -6-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -7-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -7-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2023, (i) revenue of $68.9 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -8-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2023, (i) revenue of $262.2 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -8-
COR,2023-11-02,10:30:07,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2023 Fourth Quarter and -8-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Fourth Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: Revenue of $68.9 Billion for the Fourth Quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fourth Quarter GAAP Diluted EPS of $1.72,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent to $262.2 billion for the fiscal year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Fiscal Year 2023 GAAP Diluted EPS of $8.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen Corporation, today reported that in its fiscal year 2023 fourth quarter ended September 30, 2023, revenue increased 12.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, adjusted diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,"Cencora Inc.: For fiscal year 2023, diluted EPS",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,-0.3,equity-actions,up,"Cencora Inc.: In the fiscal 2023 fourth quarter, net interest expense of $60.9 million increased 18.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue: No adjustments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the fourth quarter of fiscal 2023, revenue was $68.9 billion, up 12.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth Quarter and Year End Results
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.02,earnings,,Cencora Inc.: Adjusted operating income increased 4.0 percent to $3.3 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Fiscal Year 2023 Summary Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.2,equity-actions,up,Cencora Inc.: Operating expenses increased 11.6 percent,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, GAAP diluted EPS was $8.53",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Summary Fiscal Year GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.41,revenues,up,Cencora Inc.: Revenue increased 9.9 percent from last fiscal year to $262.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora Inc.: Adjusted gross profit increased 7.3 percent to $9.0 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.61,earnings,positive,"Cencora Inc.: In fiscal year 2023, adjusted diluted EPS was $11.99",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.65,revenues,down,Cencora Inc.: Adjusted operating income margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: The quarterly dividend of $0.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -2-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 1.74 $ 1.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -3-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit 3.27,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 8.62 $ 8.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,96,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -4-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,94,0.0,earnings,,Cencora Inc.: Gross profit 3.25,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -5-
COR,2023-11-02,10:31:20,7D85A9,Cencora Inc.,94,0.47,equity-actions,,Cencora Inc.: Restructuring,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -5-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -6-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -6-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,97,0.0,assets,,"Cencora Inc.: Total assets $62,558,746 $56,560,616",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -6-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -7-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -7-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the fourth quarter of fiscal 2023, (i) revenue of $68.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -8-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For fiscal 2023, (i) revenue of $262.2 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -8-
COR,2023-11-02,10:31:21,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2023 Fourth -8-
COR,2023-11-02,10:34:09,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees FY24 Revenue Growth of 7% to 10 %,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Revenue Growth of 7% to 10 % >COR
COR,2023-11-02,10:34:36,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY24 Adj EPS $12.70,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY24 Adj EPS $12.70-Adj EPS $13 >COR
COR,2023-11-03,14:39:41,7D85A9,Cencora Inc.,99,0.4,earnings,up,Cencora's fiscal fourth-quarter adjusted EPS rose 10% to $2.86,FULL-ARTICLE,Dow Jones Newswires,"Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand -- IBD"
COR,2023-11-03,14:39:41,7D85A9,Cencora Inc.,99,0.48,revenues,up,Cencora sees revenue up 7% to 10%,FULL-ARTICLE,Dow Jones Newswires,"Cardinal Health, Cencora Break Out With Assist From GLP-1 Demand -- IBD"
COR,2023-11-09,23:49:00,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Walgreens Boots Alliance Sells Shares of Cencora, Inc.",PRESS-RELEASE,Business Wire,"Walgreens Boots Alliance Sells Shares of Cencora, Inc. for $674 Million of Initial Proceeds"
COR,2023-11-09,23:49:01,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Walgreens Boots Alliance Sells Shares of Cencora, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Walgreens Boots Alliance Sells Shares of Cencora, Inc. for $674 Million of Initial Proceeds"
COR,2023-11-09,23:50:26,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,Walgreens Boots Alliance Sells Shrs of Cencora,NEWS-FLASH,Dow Jones Newswires,Walgreens Boots Alliance Sells Shrs of Cencora for $674M of Initial Proceeds
COR,2023-11-09,23:58:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-09,23:58:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-09,23:58:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance >COR
COR,2023-11-09,23:58:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-09,23:58:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2023-11-10,00:24:22,7D85A9,Cencora Inc.,96,0.49,partnerships,,"Cencora,"" a partner with Walgreens since",FULL-ARTICLE,Dow Jones Newswires,Walgreens Sells Shares Of Drug Distributor Cencora -- MarketWatch
COR,2023-11-10,00:24:22,7D85A9,Cencora Inc.,96,0.49,partnerships,,"Cencora,"" a partner with Walgreens since",FULL-ARTICLE,MarketWatch,MW Walgreens sells shares of drug distributor Cencora
COR,2023-11-13,20:12:37,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Donato Registers 3,387 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,387 Of Cencora Inc >COR"
COR,2023-11-13,21:38:15,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 7,582 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 7,582 Of Cencora Inc >COR"
COR,2023-11-13,21:39:02,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 1,889 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 1,889 Of Cencora Inc >COR"
COR,2023-11-13,21:41:28,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Clark Acquires 8,033 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 8,033 Of Cencora Inc >COR"
COR,2023-11-13,21:42:32,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 16,183 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 16,183 Of Cencora Inc >COR"
COR,2023-11-13,21:45:24,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 59,675 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 59,675 Of Cencora Inc >COR"
COR,2023-11-13,21:48:48,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Donato Acquires 5,325 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 5,325 Of Cencora Inc >COR"
COR,2023-11-13,21:48:57,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 1,751 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 1,751 Of Cencora Inc >COR"
COR,2023-11-13,21:50:01,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Coo Mauch Acquires 20,055 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Acquires 20,055 Of Cencora Inc >COR"
COR,2023-11-14,12:52:20,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 1,279,590 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 1,279,590 Of Cencora Inc >COR"
COR,2023-11-14,16:54:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 25,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 25,000 Of Cencora Inc >COR"
COR,2023-11-14,21:59:11,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Donato Acquires 1,244 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Acquires 1,244 Of Cencora Inc >COR"
COR,2023-11-14,22:11:24,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 3,778 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 3,778 Of Cencora Inc >COR"
COR,2023-11-14,22:22:25,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Clark Acquires 1,831 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Clark Acquires 1,831 Of Cencora Inc >COR"
COR,2023-11-14,22:25:32,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Campbell Acquires 1,322 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Acquires 1,322 Of Cencora Inc >COR"
COR,2023-11-14,23:38:40,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Battaglia Acquires 2,499 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Acquires 2,499 Of Cencora Inc >COR"
COR,2023-11-15,01:44:25,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Coo Mauch Acquires 4,357 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"COO Mauch Acquires 4,357 Of Cencora Inc >COR"
COR,2023-11-15,02:01:01,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Chmn Collis Acquires 13,931 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Acquires 13,931 Of Cencora Inc >COR"
COR,2023-11-15,02:04:13,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Vp Krikorian Acquires 1,393 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Acquires 1,393 Of Cencora Inc >COR"
COR,2023-11-15,23:11:42,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Donato Sells 3,387 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,387 Of Cencora Inc >COR"
COR,2023-11-15,23:14:47,7D85A9,Cencora Inc.,100,0.52,insider-trading,,"Cfo Cleary Jr Acquires 12,440 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Cleary Jr Acquires 12,440 Of Cencora Inc >COR"
COR,2023-11-15,23:15:19,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 25,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 25,000 Of Cencora Inc >COR"
COR,2023-11-16,16:18:35,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 14,747 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 14,747 Of Cencora Inc >COR"
COR,2023-11-17,21:25:12,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 14,747 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 14,747 Of Cencora Inc >COR"
COR,2023-11-19,08:37:27,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 3Q 2023 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 3Q 2023 (COR)"
COR,2023-11-22,14:00:07,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corporation, Enter into Distribution Agreement",PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:07,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We are honored to partner with Cencora to,PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:23,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corporation, Enter into Distribution Agreement",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:23,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We are honored to partner with Cencora to,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:00:30,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corp, Enter Into Distribution Agreement",NEWS-FLASH,Dow Jones Newswires,"Sapphiros and Cencora, Formerly AmerisourceBergen Corp, Enter Into Distribution Agreement"
COR,2023-11-22,14:01:11,7D85A9,Cencora Inc.,100,0.39,products-services,,"Amerisourcebergen Corporation, Enter into Distribution Agreement",PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-11-22,14:01:11,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We are honored to partner with Cencora to,PRESS-RELEASE,PR Newswire,"Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement"
COR,2023-12-01,17:12:43,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 2,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 2,000 Of Cencora Inc >COR"
COR,2023-12-04,21:07:36,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 2,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 2,000 Of Cencora Inc >COR"
COR,2023-12-12,15:12:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 25,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 25,000 Of Cencora Inc >COR"
COR,2023-12-13,21:11:41,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 25,000 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 25,000 Of Cencora Inc >COR"
COR,2023-12-13,21:15:42,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 42,885 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 42,885 Of Cencora Inc >COR"
COR,2023-12-13,21:25:08,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 5,162 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 5,162 Of Cencora Inc >COR"
COR,2023-12-14,12:51:50,7D85A9,Cencora Inc.,100,0.01,analyst-ratings,neutral,Cencora Initiated at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Initiated at Equal-Weight by Wells Fargo
COR,2023-12-14,12:51:51,7D85A9,Cencora Inc.,100,0.0,price-targets,set,Cencora Price Target Announced at $213.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Announced at $213.00/Share by Wells Fargo
COR,2023-12-14,22:22:11,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora's Long-Term IDR at 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Affirms Cencora's Long-Term IDR at 'A-'; Upgrades Short-Term IDR to 'F1'; Outlook Stable
COR,2023-12-14,22:22:11,7D85A9,Cencora Inc.,100,0.09,credit-ratings,affirmation,Fitch Affirms Cencora's Long-Term IDR at 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term IDR at 'A-'; Upgrades Short-Term IDR to 'F1'; Outlook Stable
COR,2023-12-14,22:22:11,7D85A9,Cencora Inc.,100,0.44,credit,reduction,Cencora reduced its debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term IDR at 'A-'; Upgrades Short-Term IDR to 'F1'; Outlook Stable
COR,2023-12-14,22:22:21,7D85A9,Cencora Inc.,100,0.0,credit-ratings,affirmation,Fitch Affirms Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term -2-
COR,2023-12-14,22:22:31,7D85A9,Cencora Inc.,100,0.0,credit-ratings,affirmation,Fitch Affirms Cencora,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Affirms Cencora's Long-Term -3-
COR,2023-12-15,21:25:11,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 5,162 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 5,162 Of Cencora Inc >COR"
COR,2023-12-15,21:25:37,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 42,885 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 42,885 Of Cencora Inc >COR"
COR,2023-12-15,22:16:18,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 168 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 168 Of Cencora Inc >COR
COR,2023-12-15,22:18:12,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Coo Mauch Acquires 487 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,COO Mauch Acquires 487 Of Cencora Inc >COR
COR,2023-12-15,22:21:02,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Clark Acquires 137 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Clark Acquires 137 Of Cencora Inc >COR
COR,2023-12-15,22:23:15,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Cfo Cleary Jr Acquires 307 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,CFO Cleary Jr Acquires 307 Of Cencora Inc >COR
COR,2023-12-18,21:11:24,7D85A9,Cencora Inc.,100,0.0,insider-trading,,"Chmn Collis Gifts 3,600 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Gifts 3,600 Of Cencora Inc >COR"
COR,2023-12-19,13:30:01,7D85A9,Cencora Inc.,100,0.44,products-services,,World Courier to Expand Storage Capacity,PRESS-RELEASE,Business Wire,World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
COR,2023-12-19,13:30:01,7D85A9,Cencora Inc.,100,0.36,assets,upgrade,Cencora Inc.: will expand World Courier's capacity to store,PRESS-RELEASE,Business Wire,World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
COR,2023-12-19,13:30:01,7D85A9,Cencora Inc.,100,0.52,products-services,,World Courier recently launched a Container,PRESS-RELEASE,Business Wire,World Courier to Expand Storage Capacity and Cold Chain Capabilities With Three New Transport Stations in the United States
COR,2023-12-21,18:18:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Donato Registers 3,400 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Donato Registers 3,400 Of Cencora Inc >COR"
COR,2023-12-26,21:01:13,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Donato Sells 3,400 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Donato Sells 3,400 Of Cencora Inc >COR"
COR,2022-01-06,17:55:00,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition of CoreSite Realty Corporation,PRESS-RELEASE,Business Wire,CoreSite Announces New Senior Leadership Team
COR,2022-01-06,17:55:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition of CoreSite Realty Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces New Senior Leadership Team
COR,2022-01-20,17:13:00,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,Coresite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud,PRESS-RELEASE,Business Wire,CoreSite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud Exchange(R)
COR,2022-01-20,17:13:01,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,Coresite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud Exchange(R)
COR,2022-01-20,21:15:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,"On December 28, 2021, American Tower completed the acquisition of CoreSite",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Tax Reporting Information for 2021 Distributions
COR,2022-01-20,21:15:02,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,"On December 28, 2021, American Tower completed the acquisition of CoreSite",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Tax Reporting Information for 2021 Distributions
COR,2022-01-06,17:55:00,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition of CoreSite Realty Corporation,PRESS-RELEASE,Business Wire,CoreSite Announces New Senior Leadership Team
COR,2022-01-06,17:55:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition of CoreSite Realty Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces New Senior Leadership Team
COR,2022-01-20,17:13:00,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,Coresite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud,PRESS-RELEASE,Business Wire,CoreSite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud Exchange(R)
COR,2022-01-20,17:13:01,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,Coresite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud Exchange(R)
COR,2022-01-20,21:15:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,"On December 28, 2021, American Tower completed the acquisition of CoreSite",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Tax Reporting Information for 2021 Distributions
COR,2022-01-20,21:15:02,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,"On December 28, 2021, American Tower completed the acquisition of CoreSite",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Tax Reporting Information for 2021 Distributions
COR,2022-01-06,17:55:00,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition of CoreSite Realty Corporation,PRESS-RELEASE,Business Wire,CoreSite Announces New Senior Leadership Team
COR,2022-01-06,17:55:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition of CoreSite Realty Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces New Senior Leadership Team
COR,2022-01-20,17:13:00,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,Coresite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud,PRESS-RELEASE,Business Wire,CoreSite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud Exchange(R)
COR,2022-01-20,17:13:01,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,Coresite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud Exchange(R)
COR,2022-01-20,21:15:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,"On December 28, 2021, American Tower completed the acquisition of CoreSite",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Tax Reporting Information for 2021 Distributions
COR,2022-01-20,21:15:02,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,"On December 28, 2021, American Tower completed the acquisition of CoreSite",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Tax Reporting Information for 2021 Distributions
COR,2022-01-06,17:55:00,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition of CoreSite Realty Corporation,PRESS-RELEASE,Business Wire,CoreSite Announces New Senior Leadership Team
COR,2022-01-06,17:55:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,American Tower Completes Acquisition of CoreSite Realty Corporation,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Announces New Senior Leadership Team
COR,2022-01-20,17:13:00,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,Coresite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud,PRESS-RELEASE,Business Wire,CoreSite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud Exchange(R)
COR,2022-01-20,17:13:01,9810C0,CoreSite Realty Corp.,100,0.49,partnerships,,Coresite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud,PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Partners with Zenlayer to Empower Enterprises to Reach Global Markets on CoreSite's Open Cloud Exchange(R)
COR,2022-01-20,21:15:01,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,"On December 28, 2021, American Tower completed the acquisition of CoreSite",PRESS-RELEASE,Business Wire,CoreSite Realty Corporation Announces Tax Reporting Information for 2021 Distributions
COR,2022-01-20,21:15:02,9810C0,CoreSite Realty Corp.,99,0.57,acquisitions-mergers,completed,"On December 28, 2021, American Tower completed the acquisition of CoreSite",PRESS-RELEASE,Dow Jones Newswires,Press Release: CoreSite Realty Corporation Announces Tax Reporting Information for 2021 Distributions
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-04,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-04,13:47:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment of Dr. Dariusz Naziek to Its Board of Directors
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2024-01-22,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-02-13,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-02-13,13:32:51,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-03-20,12:30:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Reports -2-
COR,2024-03-20,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2024-01-11,03:04:09,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,"Camino Minerals Corp.: In addition, David Baker has stepped down as a Director of the Company",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Board and Executive Changes; Significantly Strengthens Management Team to Support Corporate and Project Development
COR,2024-04-11,10:01:31,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The recent success of our step-out drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts 1.34% Cu Over 25m From Surface and 0.79% Cu Over 12.7m in New Areas of Copper Mineralization at Los Chapitos, Peru"
COR,2024-05-29,10:01:16,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence the Inaugural Drilling Program at,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence the Inaugural Drilling Program at Maria Cecilia Porphyry with 0.7% Oxidized Copper Identified at Surface
COR,2024-06-27,12:35:39,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,12:35:42,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Nittetsu and Camino plan to finalize a 50:50 joint venture,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,-0.65,equity-actions,halt,Shares of Camino will remain halted,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-10-07,13:01:35,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-10-07,13:31:36,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile"
COR,2024-10-07,13:51:04,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Camino Minerals Corporation Camino, Nittetsu, Denham Capital Sign Agreement"
COR,2024-10-22,10:00:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Identifies New Copper Satellite Zones
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones -2-
COR,2024-10-28,10:01:16,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
COR,2024-10-28,11:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Provides Exploration Summary in Peru
COR,2024-11-28,13:18:01,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:18:04,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,interest,Camino Minerals Corp.: the Company's proposed joint acquisition,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-01-11,03:04:09,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,"Camino Minerals Corp.: In addition, David Baker has stepped down as a Director of the Company",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Board and Executive Changes; Significantly Strengthens Management Team to Support Corporate and Project Development
COR,2024-04-11,10:01:31,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The recent success of our step-out drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts 1.34% Cu Over 25m From Surface and 0.79% Cu Over 12.7m in New Areas of Copper Mineralization at Los Chapitos, Peru"
COR,2024-05-29,10:01:16,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence the Inaugural Drilling Program at,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence the Inaugural Drilling Program at Maria Cecilia Porphyry with 0.7% Oxidized Copper Identified at Surface
COR,2024-06-27,12:35:39,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,12:35:42,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Nittetsu and Camino plan to finalize a 50:50 joint venture,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,-0.65,equity-actions,halt,Shares of Camino will remain halted,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-10-07,13:01:35,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-10-07,13:31:36,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile"
COR,2024-10-07,13:51:04,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Camino Minerals Corporation Camino, Nittetsu, Denham Capital Sign Agreement"
COR,2024-10-22,10:00:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Identifies New Copper Satellite Zones
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones -2-
COR,2024-10-28,10:01:16,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
COR,2024-10-28,11:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Provides Exploration Summary in Peru
COR,2024-11-28,13:18:01,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:18:04,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,interest,Camino Minerals Corp.: the Company's proposed joint acquisition,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-01-11,03:04:09,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,"Camino Minerals Corp.: In addition, David Baker has stepped down as a Director of the Company",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Board and Executive Changes; Significantly Strengthens Management Team to Support Corporate and Project Development
COR,2024-04-11,10:01:31,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The recent success of our step-out drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts 1.34% Cu Over 25m From Surface and 0.79% Cu Over 12.7m in New Areas of Copper Mineralization at Los Chapitos, Peru"
COR,2024-05-29,10:01:16,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence the Inaugural Drilling Program at,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence the Inaugural Drilling Program at Maria Cecilia Porphyry with 0.7% Oxidized Copper Identified at Surface
COR,2024-06-27,12:35:39,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,12:35:42,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Nittetsu and Camino plan to finalize a 50:50 joint venture,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,-0.65,equity-actions,halt,Shares of Camino will remain halted,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-10-07,13:01:35,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-10-07,13:31:36,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile"
COR,2024-10-07,13:51:04,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Camino Minerals Corporation Camino, Nittetsu, Denham Capital Sign Agreement"
COR,2024-10-22,10:00:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Identifies New Copper Satellite Zones
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones -2-
COR,2024-10-28,10:01:16,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
COR,2024-10-28,11:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Provides Exploration Summary in Peru
COR,2024-11-28,13:18:01,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:18:04,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,interest,Camino Minerals Corp.: the Company's proposed joint acquisition,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-01-11,03:04:09,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,"Camino Minerals Corp.: In addition, David Baker has stepped down as a Director of the Company",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Board and Executive Changes; Significantly Strengthens Management Team to Support Corporate and Project Development
COR,2024-04-11,10:01:31,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The recent success of our step-out drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts 1.34% Cu Over 25m From Surface and 0.79% Cu Over 12.7m in New Areas of Copper Mineralization at Los Chapitos, Peru"
COR,2024-05-29,10:01:16,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence the Inaugural Drilling Program at,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence the Inaugural Drilling Program at Maria Cecilia Porphyry with 0.7% Oxidized Copper Identified at Surface
COR,2024-06-27,12:35:39,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,12:35:42,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Nittetsu and Camino plan to finalize a 50:50 joint venture,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,-0.65,equity-actions,halt,Shares of Camino will remain halted,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-10-07,13:01:35,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-10-07,13:31:36,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile"
COR,2024-10-07,13:51:04,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Camino Minerals Corporation Camino, Nittetsu, Denham Capital Sign Agreement"
COR,2024-10-22,10:00:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Identifies New Copper Satellite Zones
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones -2-
COR,2024-10-28,10:01:16,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
COR,2024-10-28,11:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Provides Exploration Summary in Peru
COR,2024-11-28,13:18:01,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:18:04,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,interest,Camino Minerals Corp.: the Company's proposed joint acquisition,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-01-11,03:04:09,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,"Camino Minerals Corp.: In addition, David Baker has stepped down as a Director of the Company",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Board and Executive Changes; Significantly Strengthens Management Team to Support Corporate and Project Development
COR,2024-04-11,10:01:31,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The recent success of our step-out drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts 1.34% Cu Over 25m From Surface and 0.79% Cu Over 12.7m in New Areas of Copper Mineralization at Los Chapitos, Peru"
COR,2024-05-29,10:01:16,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence the Inaugural Drilling Program at,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence the Inaugural Drilling Program at Maria Cecilia Porphyry with 0.7% Oxidized Copper Identified at Surface
COR,2024-06-27,12:35:39,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,12:35:42,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Nittetsu and Camino plan to finalize a 50:50 joint venture,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,-0.65,equity-actions,halt,Shares of Camino will remain halted,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-10-07,13:01:35,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-10-07,13:31:36,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile"
COR,2024-10-07,13:51:04,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Camino Minerals Corporation Camino, Nittetsu, Denham Capital Sign Agreement"
COR,2024-10-22,10:00:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Identifies New Copper Satellite Zones
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones -2-
COR,2024-10-28,10:01:16,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
COR,2024-10-28,11:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Provides Exploration Summary in Peru
COR,2024-11-28,13:18:01,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:18:04,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,interest,Camino Minerals Corp.: the Company's proposed joint acquisition,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-01-11,03:04:09,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,"Camino Minerals Corp.: In addition, David Baker has stepped down as a Director of the Company",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Board and Executive Changes; Significantly Strengthens Management Team to Support Corporate and Project Development
COR,2024-04-11,10:01:31,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The recent success of our step-out drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts 1.34% Cu Over 25m From Surface and 0.79% Cu Over 12.7m in New Areas of Copper Mineralization at Los Chapitos, Peru"
COR,2024-05-29,10:01:16,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence the Inaugural Drilling Program at,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence the Inaugural Drilling Program at Maria Cecilia Porphyry with 0.7% Oxidized Copper Identified at Surface
COR,2024-06-27,12:35:39,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,12:35:42,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Nittetsu and Camino plan to finalize a 50:50 joint venture,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,-0.65,equity-actions,halt,Shares of Camino will remain halted,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-10-07,13:01:35,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-10-07,13:31:36,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile"
COR,2024-10-07,13:51:04,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Camino Minerals Corporation Camino, Nittetsu, Denham Capital Sign Agreement"
COR,2024-10-22,10:00:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Identifies New Copper Satellite Zones
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones -2-
COR,2024-10-28,10:01:16,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
COR,2024-10-28,11:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Provides Exploration Summary in Peru
COR,2024-11-28,13:18:01,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:18:04,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,interest,Camino Minerals Corp.: the Company's proposed joint acquisition,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-01-11,03:04:09,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,"Camino Minerals Corp.: In addition, David Baker has stepped down as a Director of the Company",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Board and Executive Changes; Significantly Strengthens Management Team to Support Corporate and Project Development
COR,2024-04-11,10:01:31,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The recent success of our step-out drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts 1.34% Cu Over 25m From Surface and 0.79% Cu Over 12.7m in New Areas of Copper Mineralization at Los Chapitos, Peru"
COR,2024-05-29,10:01:16,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence the Inaugural Drilling Program at,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence the Inaugural Drilling Program at Maria Cecilia Porphyry with 0.7% Oxidized Copper Identified at Surface
COR,2024-06-27,12:35:39,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,12:35:42,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Nittetsu and Camino plan to finalize a 50:50 joint venture,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,-0.65,equity-actions,halt,Shares of Camino will remain halted,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-10-07,13:01:35,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-10-07,13:31:36,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile"
COR,2024-10-07,13:51:04,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Camino Minerals Corporation Camino, Nittetsu, Denham Capital Sign Agreement"
COR,2024-10-22,10:00:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Identifies New Copper Satellite Zones
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones -2-
COR,2024-10-28,10:01:16,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
COR,2024-10-28,11:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Provides Exploration Summary in Peru
COR,2024-11-28,13:18:01,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:18:04,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,interest,Camino Minerals Corp.: the Company's proposed joint acquisition,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-01-11,03:04:09,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,"Camino Minerals Corp.: In addition, David Baker has stepped down as a Director of the Company",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Board and Executive Changes; Significantly Strengthens Management Team to Support Corporate and Project Development
COR,2024-04-11,10:01:31,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The recent success of our step-out drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts 1.34% Cu Over 25m From Surface and 0.79% Cu Over 12.7m in New Areas of Copper Mineralization at Los Chapitos, Peru"
COR,2024-05-29,10:01:16,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence the Inaugural Drilling Program at,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence the Inaugural Drilling Program at Maria Cecilia Porphyry with 0.7% Oxidized Copper Identified at Surface
COR,2024-06-27,12:35:39,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,12:35:42,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Nittetsu and Camino plan to finalize a 50:50 joint venture,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,-0.65,equity-actions,halt,Shares of Camino will remain halted,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-10-07,13:01:35,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-10-07,13:31:36,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile"
COR,2024-10-07,13:51:04,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Camino Minerals Corporation Camino, Nittetsu, Denham Capital Sign Agreement"
COR,2024-10-22,10:00:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Identifies New Copper Satellite Zones
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones -2-
COR,2024-10-28,10:01:16,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
COR,2024-10-28,11:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Provides Exploration Summary in Peru
COR,2024-11-28,13:18:01,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:18:04,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,interest,Camino Minerals Corp.: the Company's proposed joint acquisition,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-01-11,03:04:09,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,"Camino Minerals Corp.: In addition, David Baker has stepped down as a Director of the Company",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Board and Executive Changes; Significantly Strengthens Management Team to Support Corporate and Project Development
COR,2024-04-11,10:01:31,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The recent success of our step-out drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts 1.34% Cu Over 25m From Surface and 0.79% Cu Over 12.7m in New Areas of Copper Mineralization at Los Chapitos, Peru"
COR,2024-05-29,10:01:16,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence the Inaugural Drilling Program at,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence the Inaugural Drilling Program at Maria Cecilia Porphyry with 0.7% Oxidized Copper Identified at Surface
COR,2024-06-27,12:35:39,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,12:35:42,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Nittetsu and Camino plan to finalize a 50:50 joint venture,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-06-27,16:46:37,B99302,Camino Minerals Corp.,99,-0.65,equity-actions,halt,Shares of Camino will remain halted,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Secure Exclusive Rights to Negotiate Copper Mine Acquisition in Chile
COR,2024-10-07,13:01:35,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-10-07,13:31:36,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino, Nittetsu and Denham Capital Sign Definitive Agreement for Acquisition of the Puquios Copper Project in Chile"
COR,2024-10-07,13:51:04,B99302,Camino Minerals Corp.,99,0.49,partnerships,,Pleased to expand our collaboration with Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),"Camino Minerals Corporation Camino, Nittetsu, Denham Capital Sign Agreement"
COR,2024-10-22,10:00:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Identifies New Copper Satellite Zones
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones Along Major La Estancia Fault at the Los Chapitos Copper Project in Peru
COR,2024-10-22,10:01:01,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies New Copper Satellite Zones,PRESS-RELEASE,DJ Global Press Release Wire,Camino Identifies New Copper Satellite Zones -2-
COR,2024-10-28,10:01:16,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Provides Exploration Summary for the Maria Cecilia Copper Porphyry Project in Peru
COR,2024-10-28,11:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Provides Exploration Summary in Peru
COR,2024-11-28,13:18:01,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:18:04,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: Canadian Investment Regulatory Organization Trading Halt - COR
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,interest,Camino Minerals Corp.: the Company's proposed joint acquisition,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2024-11-28,13:31:02,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces a Private Placement of up to CAD$2.0 Million
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:05:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:06:54,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Announces 10 to 1 Reverse Stk Split,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Announces 10 to 1 Reverse Stk Split >RSPI
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-05,21:14:10,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-01-08,13:00:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,RespireRx Pharmaceuticals Inc.: Under a License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,equity-actions,,Respirerx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-08,13:32:44,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
COR,2021-02-09,02:30:29,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: We are developing treatment,PRESS-RELEASE,GlobeNewswire,Corrected Headline: RespireRx Pharmaceuticals Up Listed to OTCQB and Ticker Returns to RSPI
COR,2021-06-08,22:20:14,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-06-08,22:20:59,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-04,12:46:40,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.55,acquisitions-mergers,interest,RespireRx Pharmaceuticals Inc.: No offer to buy shares of the Company's common stock in an,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-22,13:46:59,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces CEO's OTC Venture Market Podcast
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-29,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-11-30,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of Book Chapter Describing Novel Analgesic Properties of KRM-II-81
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: While clinical development of,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Publication of Review Article Describing Advances in the Discovery, Development and Commercialization of GABAkines, Including KRM-II-81"
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: In the Phase 2 ADHD clinical trial,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-06,13:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:18:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. to Present at -2-
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,marketing,,Respirerx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.44,products-services,,RespireRx Pharmaceuticals Inc.: Biotech Showcase(TM) is being delivered in a new hybrid format,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,100,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to Present at Upcoming Virtual Life Sciences Investor Conference and Biotech Showcase(TM)
COR,2021-12-14,13:21:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. to -2-
COR,2021-02-03,14:01:06,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies Additional Mineralized Copper and Silver Veins,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Additional Mineralized Copper and Silver Veins at Plata Dorada with Channel Samples Grading up to 5.76% Cu and 1,500 g/t Ag; Increases Mineral Claims at Plata Dorada to 3,800 Ha"
COR,2021-02-22,14:03:34,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The successful 2020 drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino identifies Copper and Gold System at Los Chapitos sampling 1.71% Cu, 1.3 g/t Au and 6.1% Cu, 0.48 g/t Au"
COR,2021-03-30,12:05:46,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - COR
COR,2021-03-30,12:05:47,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - COR
COR,2021-03-30,15:14:53,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The contemplated drill program at Maria Cecilia is supported by more than five,PRESS-RELEASE,DJ Global Press Release Wire,Camino Purchases Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-03-30,16:12:59,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Resumption - COR
COR,2021-03-30,16:13:00,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Resumption - COR
COR,2021-04-29,13:01:20,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corporation to Raise $5M,PRESS-RELEASE,DJ Global Press Release Wire,Camino Minerals Corporation to Raise $5M to Commence Copper Discovery Drilling in Peru
COR,2021-05-03,13:00:50,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Increases Private Placement to $7.5M on Strong Institutional Demand
COR,2021-05-12,13:01:59,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino also identified new areas,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies New Polymetallic Silver Mineralization and New Veins at Plata Dorada with up to 1,565 g/t Ag, 0.67 g/t Au, 1.19% Cu, 32% Zn, and 18.25% Pb; Increases Mineral Claims to 5,500 Hectares"
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Minerals Corp.: we believe have large copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-20,06:00:02,B99302,Camino Minerals Corp.,99,-0.65,earnings,negative,"January 2021, Camino reported a net loss of C$835,296",PRESS-RELEASE,LSE Regulatory News Service (RNS),METAL TIGER PLC: Investment into Camino Minerals Corporation
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.36,marketing,release,Camino to Launch Marketing Campaign Ahead of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino is currently closing the acquisition of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino having completed its recent $7.5 million financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.47,labor-issues,,"Capital, was appointed to the board of directors of Camino",PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-08-10,13:01:27,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its New Lidia Copper & Gold Zone at Los Chapitos Project
COR,2021-09-07,13:01:44,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Discovery Drilling,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Commences Discovery Drilling at the Los Chapitos Copper Project, Peru"
COR,2021-09-20,13:08:20,B99302,Camino Minerals Corp.,99,0.51,exploration,,"Camino Minerals Corp.: Thus, when copper mining",PRESS-RELEASE,DJ Global Press Release Wire,Camino Adopts Environmental and Social Governance Reporting Initiative with Digbee Ltd.
COR,2021-02-03,14:01:06,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies Additional Mineralized Copper and Silver Veins,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Additional Mineralized Copper and Silver Veins at Plata Dorada with Channel Samples Grading up to 5.76% Cu and 1,500 g/t Ag; Increases Mineral Claims at Plata Dorada to 3,800 Ha"
COR,2021-02-22,14:03:34,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The successful 2020 drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino identifies Copper and Gold System at Los Chapitos sampling 1.71% Cu, 1.3 g/t Au and 6.1% Cu, 0.48 g/t Au"
COR,2021-03-30,12:05:46,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - COR
COR,2021-03-30,12:05:47,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - COR
COR,2021-03-30,15:14:53,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The contemplated drill program at Maria Cecilia is supported by more than five,PRESS-RELEASE,DJ Global Press Release Wire,Camino Purchases Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-03-30,16:12:59,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Resumption - COR
COR,2021-03-30,16:13:00,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Resumption - COR
COR,2021-04-29,13:01:20,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corporation to Raise $5M,PRESS-RELEASE,DJ Global Press Release Wire,Camino Minerals Corporation to Raise $5M to Commence Copper Discovery Drilling in Peru
COR,2021-05-03,13:00:50,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Increases Private Placement to $7.5M on Strong Institutional Demand
COR,2021-05-12,13:01:59,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino also identified new areas,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies New Polymetallic Silver Mineralization and New Veins at Plata Dorada with up to 1,565 g/t Ag, 0.67 g/t Au, 1.19% Cu, 32% Zn, and 18.25% Pb; Increases Mineral Claims to 5,500 Hectares"
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Minerals Corp.: we believe have large copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-20,06:00:02,B99302,Camino Minerals Corp.,99,-0.65,earnings,negative,"January 2021, Camino reported a net loss of C$835,296",PRESS-RELEASE,LSE Regulatory News Service (RNS),METAL TIGER PLC: Investment into Camino Minerals Corporation
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.36,marketing,release,Camino to Launch Marketing Campaign Ahead of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino is currently closing the acquisition of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino having completed its recent $7.5 million financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.47,labor-issues,,"Capital, was appointed to the board of directors of Camino",PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-08-10,13:01:27,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its New Lidia Copper & Gold Zone at Los Chapitos Project
COR,2021-09-07,13:01:44,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Discovery Drilling,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Commences Discovery Drilling at the Los Chapitos Copper Project, Peru"
COR,2021-09-20,13:08:20,B99302,Camino Minerals Corp.,99,0.51,exploration,,"Camino Minerals Corp.: Thus, when copper mining",PRESS-RELEASE,DJ Global Press Release Wire,Camino Adopts Environmental and Social Governance Reporting Initiative with Digbee Ltd.
COR,2021-02-03,14:01:06,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies Additional Mineralized Copper and Silver Veins,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Additional Mineralized Copper and Silver Veins at Plata Dorada with Channel Samples Grading up to 5.76% Cu and 1,500 g/t Ag; Increases Mineral Claims at Plata Dorada to 3,800 Ha"
COR,2021-02-22,14:03:34,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The successful 2020 drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino identifies Copper and Gold System at Los Chapitos sampling 1.71% Cu, 1.3 g/t Au and 6.1% Cu, 0.48 g/t Au"
COR,2021-03-30,12:05:46,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - COR
COR,2021-03-30,12:05:47,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - COR
COR,2021-03-30,15:14:53,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The contemplated drill program at Maria Cecilia is supported by more than five,PRESS-RELEASE,DJ Global Press Release Wire,Camino Purchases Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-03-30,16:12:59,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Resumption - COR
COR,2021-03-30,16:13:00,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Resumption - COR
COR,2021-04-29,13:01:20,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corporation to Raise $5M,PRESS-RELEASE,DJ Global Press Release Wire,Camino Minerals Corporation to Raise $5M to Commence Copper Discovery Drilling in Peru
COR,2021-05-03,13:00:50,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Increases Private Placement to $7.5M on Strong Institutional Demand
COR,2021-05-12,13:01:59,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino also identified new areas,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies New Polymetallic Silver Mineralization and New Veins at Plata Dorada with up to 1,565 g/t Ag, 0.67 g/t Au, 1.19% Cu, 32% Zn, and 18.25% Pb; Increases Mineral Claims to 5,500 Hectares"
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Minerals Corp.: we believe have large copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-20,06:00:02,B99302,Camino Minerals Corp.,99,-0.65,earnings,negative,"January 2021, Camino reported a net loss of C$835,296",PRESS-RELEASE,LSE Regulatory News Service (RNS),METAL TIGER PLC: Investment into Camino Minerals Corporation
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.36,marketing,release,Camino to Launch Marketing Campaign Ahead of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino is currently closing the acquisition of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino having completed its recent $7.5 million financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.47,labor-issues,,"Capital, was appointed to the board of directors of Camino",PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-08-10,13:01:27,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its New Lidia Copper & Gold Zone at Los Chapitos Project
COR,2021-09-07,13:01:44,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Discovery Drilling,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Commences Discovery Drilling at the Los Chapitos Copper Project, Peru"
COR,2021-09-20,13:08:20,B99302,Camino Minerals Corp.,99,0.51,exploration,,"Camino Minerals Corp.: Thus, when copper mining",PRESS-RELEASE,DJ Global Press Release Wire,Camino Adopts Environmental and Social Governance Reporting Initiative with Digbee Ltd.
COR,2021-02-03,14:01:06,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies Additional Mineralized Copper and Silver Veins,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Additional Mineralized Copper and Silver Veins at Plata Dorada with Channel Samples Grading up to 5.76% Cu and 1,500 g/t Ag; Increases Mineral Claims at Plata Dorada to 3,800 Ha"
COR,2021-02-22,14:03:34,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The successful 2020 drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino identifies Copper and Gold System at Los Chapitos sampling 1.71% Cu, 1.3 g/t Au and 6.1% Cu, 0.48 g/t Au"
COR,2021-03-30,12:05:46,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - COR
COR,2021-03-30,12:05:47,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - COR
COR,2021-03-30,15:14:53,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The contemplated drill program at Maria Cecilia is supported by more than five,PRESS-RELEASE,DJ Global Press Release Wire,Camino Purchases Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-03-30,16:12:59,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Resumption - COR
COR,2021-03-30,16:13:00,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Resumption - COR
COR,2021-04-29,13:01:20,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corporation to Raise $5M,PRESS-RELEASE,DJ Global Press Release Wire,Camino Minerals Corporation to Raise $5M to Commence Copper Discovery Drilling in Peru
COR,2021-05-03,13:00:50,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Increases Private Placement to $7.5M on Strong Institutional Demand
COR,2021-05-12,13:01:59,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino also identified new areas,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies New Polymetallic Silver Mineralization and New Veins at Plata Dorada with up to 1,565 g/t Ag, 0.67 g/t Au, 1.19% Cu, 32% Zn, and 18.25% Pb; Increases Mineral Claims to 5,500 Hectares"
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Minerals Corp.: we believe have large copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-20,06:00:02,B99302,Camino Minerals Corp.,99,-0.65,earnings,negative,"January 2021, Camino reported a net loss of C$835,296",PRESS-RELEASE,LSE Regulatory News Service (RNS),METAL TIGER PLC: Investment into Camino Minerals Corporation
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.36,marketing,release,Camino to Launch Marketing Campaign Ahead of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino is currently closing the acquisition of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino having completed its recent $7.5 million financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.47,labor-issues,,"Capital, was appointed to the board of directors of Camino",PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-08-10,13:01:27,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its New Lidia Copper & Gold Zone at Los Chapitos Project
COR,2021-09-07,13:01:44,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Discovery Drilling,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Commences Discovery Drilling at the Los Chapitos Copper Project, Peru"
COR,2021-09-20,13:08:20,B99302,Camino Minerals Corp.,99,0.51,exploration,,"Camino Minerals Corp.: Thus, when copper mining",PRESS-RELEASE,DJ Global Press Release Wire,Camino Adopts Environmental and Social Governance Reporting Initiative with Digbee Ltd.
COR,2021-02-03,14:01:06,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies Additional Mineralized Copper and Silver Veins,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Additional Mineralized Copper and Silver Veins at Plata Dorada with Channel Samples Grading up to 5.76% Cu and 1,500 g/t Ag; Increases Mineral Claims at Plata Dorada to 3,800 Ha"
COR,2021-02-22,14:03:34,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The successful 2020 drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino identifies Copper and Gold System at Los Chapitos sampling 1.71% Cu, 1.3 g/t Au and 6.1% Cu, 0.48 g/t Au"
COR,2021-03-30,12:05:46,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - COR
COR,2021-03-30,12:05:47,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - COR
COR,2021-03-30,15:14:53,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The contemplated drill program at Maria Cecilia is supported by more than five,PRESS-RELEASE,DJ Global Press Release Wire,Camino Purchases Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-03-30,16:12:59,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Resumption - COR
COR,2021-03-30,16:13:00,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Resumption - COR
COR,2021-04-29,13:01:20,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corporation to Raise $5M,PRESS-RELEASE,DJ Global Press Release Wire,Camino Minerals Corporation to Raise $5M to Commence Copper Discovery Drilling in Peru
COR,2021-05-03,13:00:50,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Increases Private Placement to $7.5M on Strong Institutional Demand
COR,2021-05-12,13:01:59,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino also identified new areas,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies New Polymetallic Silver Mineralization and New Veins at Plata Dorada with up to 1,565 g/t Ag, 0.67 g/t Au, 1.19% Cu, 32% Zn, and 18.25% Pb; Increases Mineral Claims to 5,500 Hectares"
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Minerals Corp.: we believe have large copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-20,06:00:02,B99302,Camino Minerals Corp.,99,-0.65,earnings,negative,"January 2021, Camino reported a net loss of C$835,296",PRESS-RELEASE,LSE Regulatory News Service (RNS),METAL TIGER PLC: Investment into Camino Minerals Corporation
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.36,marketing,release,Camino to Launch Marketing Campaign Ahead of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino is currently closing the acquisition of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino having completed its recent $7.5 million financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.47,labor-issues,,"Capital, was appointed to the board of directors of Camino",PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-08-10,13:01:27,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its New Lidia Copper & Gold Zone at Los Chapitos Project
COR,2021-09-07,13:01:44,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Discovery Drilling,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Commences Discovery Drilling at the Los Chapitos Copper Project, Peru"
COR,2021-09-20,13:08:20,B99302,Camino Minerals Corp.,99,0.51,exploration,,"Camino Minerals Corp.: Thus, when copper mining",PRESS-RELEASE,DJ Global Press Release Wire,Camino Adopts Environmental and Social Governance Reporting Initiative with Digbee Ltd.
COR,2021-02-03,14:01:06,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies Additional Mineralized Copper and Silver Veins,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Additional Mineralized Copper and Silver Veins at Plata Dorada with Channel Samples Grading up to 5.76% Cu and 1,500 g/t Ag; Increases Mineral Claims at Plata Dorada to 3,800 Ha"
COR,2021-02-22,14:03:34,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The successful 2020 drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino identifies Copper and Gold System at Los Chapitos sampling 1.71% Cu, 1.3 g/t Au and 6.1% Cu, 0.48 g/t Au"
COR,2021-03-30,12:05:46,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - COR
COR,2021-03-30,12:05:47,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - COR
COR,2021-03-30,15:14:53,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The contemplated drill program at Maria Cecilia is supported by more than five,PRESS-RELEASE,DJ Global Press Release Wire,Camino Purchases Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-03-30,16:12:59,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Resumption - COR
COR,2021-03-30,16:13:00,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Resumption - COR
COR,2021-04-29,13:01:20,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corporation to Raise $5M,PRESS-RELEASE,DJ Global Press Release Wire,Camino Minerals Corporation to Raise $5M to Commence Copper Discovery Drilling in Peru
COR,2021-05-03,13:00:50,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Increases Private Placement to $7.5M on Strong Institutional Demand
COR,2021-05-12,13:01:59,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino also identified new areas,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies New Polymetallic Silver Mineralization and New Veins at Plata Dorada with up to 1,565 g/t Ag, 0.67 g/t Au, 1.19% Cu, 32% Zn, and 18.25% Pb; Increases Mineral Claims to 5,500 Hectares"
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Minerals Corp.: we believe have large copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-20,06:00:02,B99302,Camino Minerals Corp.,99,-0.65,earnings,negative,"January 2021, Camino reported a net loss of C$835,296",PRESS-RELEASE,LSE Regulatory News Service (RNS),METAL TIGER PLC: Investment into Camino Minerals Corporation
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.36,marketing,release,Camino to Launch Marketing Campaign Ahead of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino is currently closing the acquisition of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino having completed its recent $7.5 million financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.47,labor-issues,,"Capital, was appointed to the board of directors of Camino",PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-08-10,13:01:27,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its New Lidia Copper & Gold Zone at Los Chapitos Project
COR,2021-09-07,13:01:44,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Discovery Drilling,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Commences Discovery Drilling at the Los Chapitos Copper Project, Peru"
COR,2021-09-20,13:08:20,B99302,Camino Minerals Corp.,99,0.51,exploration,,"Camino Minerals Corp.: Thus, when copper mining",PRESS-RELEASE,DJ Global Press Release Wire,Camino Adopts Environmental and Social Governance Reporting Initiative with Digbee Ltd.
COR,2021-02-03,14:01:06,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies Additional Mineralized Copper and Silver Veins,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Additional Mineralized Copper and Silver Veins at Plata Dorada with Channel Samples Grading up to 5.76% Cu and 1,500 g/t Ag; Increases Mineral Claims at Plata Dorada to 3,800 Ha"
COR,2021-02-22,14:03:34,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The successful 2020 drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino identifies Copper and Gold System at Los Chapitos sampling 1.71% Cu, 1.3 g/t Au and 6.1% Cu, 0.48 g/t Au"
COR,2021-03-30,12:05:46,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - COR
COR,2021-03-30,12:05:47,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - COR
COR,2021-03-30,15:14:53,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The contemplated drill program at Maria Cecilia is supported by more than five,PRESS-RELEASE,DJ Global Press Release Wire,Camino Purchases Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-03-30,16:12:59,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Resumption - COR
COR,2021-03-30,16:13:00,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Resumption - COR
COR,2021-04-29,13:01:20,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corporation to Raise $5M,PRESS-RELEASE,DJ Global Press Release Wire,Camino Minerals Corporation to Raise $5M to Commence Copper Discovery Drilling in Peru
COR,2021-05-03,13:00:50,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Increases Private Placement to $7.5M on Strong Institutional Demand
COR,2021-05-12,13:01:59,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino also identified new areas,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies New Polymetallic Silver Mineralization and New Veins at Plata Dorada with up to 1,565 g/t Ag, 0.67 g/t Au, 1.19% Cu, 32% Zn, and 18.25% Pb; Increases Mineral Claims to 5,500 Hectares"
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Minerals Corp.: we believe have large copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-20,06:00:02,B99302,Camino Minerals Corp.,99,-0.65,earnings,negative,"January 2021, Camino reported a net loss of C$835,296",PRESS-RELEASE,LSE Regulatory News Service (RNS),METAL TIGER PLC: Investment into Camino Minerals Corporation
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.36,marketing,release,Camino to Launch Marketing Campaign Ahead of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino is currently closing the acquisition of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino having completed its recent $7.5 million financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.47,labor-issues,,"Capital, was appointed to the board of directors of Camino",PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-08-10,13:01:27,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its New Lidia Copper & Gold Zone at Los Chapitos Project
COR,2021-09-07,13:01:44,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Discovery Drilling,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Commences Discovery Drilling at the Los Chapitos Copper Project, Peru"
COR,2021-09-20,13:08:20,B99302,Camino Minerals Corp.,99,0.51,exploration,,"Camino Minerals Corp.: Thus, when copper mining",PRESS-RELEASE,DJ Global Press Release Wire,Camino Adopts Environmental and Social Governance Reporting Initiative with Digbee Ltd.
COR,2021-02-03,14:01:06,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies Additional Mineralized Copper and Silver Veins,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Additional Mineralized Copper and Silver Veins at Plata Dorada with Channel Samples Grading up to 5.76% Cu and 1,500 g/t Ag; Increases Mineral Claims at Plata Dorada to 3,800 Ha"
COR,2021-02-22,14:03:34,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The successful 2020 drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino identifies Copper and Gold System at Los Chapitos sampling 1.71% Cu, 1.3 g/t Au and 6.1% Cu, 0.48 g/t Au"
COR,2021-03-30,12:05:46,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - COR
COR,2021-03-30,12:05:47,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - COR
COR,2021-03-30,15:14:53,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The contemplated drill program at Maria Cecilia is supported by more than five,PRESS-RELEASE,DJ Global Press Release Wire,Camino Purchases Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-03-30,16:12:59,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Resumption - COR
COR,2021-03-30,16:13:00,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Resumption - COR
COR,2021-04-29,13:01:20,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corporation to Raise $5M,PRESS-RELEASE,DJ Global Press Release Wire,Camino Minerals Corporation to Raise $5M to Commence Copper Discovery Drilling in Peru
COR,2021-05-03,13:00:50,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Increases Private Placement to $7.5M on Strong Institutional Demand
COR,2021-05-12,13:01:59,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino also identified new areas,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies New Polymetallic Silver Mineralization and New Veins at Plata Dorada with up to 1,565 g/t Ag, 0.67 g/t Au, 1.19% Cu, 32% Zn, and 18.25% Pb; Increases Mineral Claims to 5,500 Hectares"
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Minerals Corp.: we believe have large copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-20,06:00:02,B99302,Camino Minerals Corp.,99,-0.65,earnings,negative,"January 2021, Camino reported a net loss of C$835,296",PRESS-RELEASE,LSE Regulatory News Service (RNS),METAL TIGER PLC: Investment into Camino Minerals Corporation
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.36,marketing,release,Camino to Launch Marketing Campaign Ahead of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino is currently closing the acquisition of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino having completed its recent $7.5 million financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.47,labor-issues,,"Capital, was appointed to the board of directors of Camino",PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-08-10,13:01:27,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its New Lidia Copper & Gold Zone at Los Chapitos Project
COR,2021-09-07,13:01:44,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Discovery Drilling,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Commences Discovery Drilling at the Los Chapitos Copper Project, Peru"
COR,2021-09-20,13:08:20,B99302,Camino Minerals Corp.,99,0.51,exploration,,"Camino Minerals Corp.: Thus, when copper mining",PRESS-RELEASE,DJ Global Press Release Wire,Camino Adopts Environmental and Social Governance Reporting Initiative with Digbee Ltd.
COR,2021-02-03,14:01:06,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Identifies Additional Mineralized Copper and Silver Veins,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Additional Mineralized Copper and Silver Veins at Plata Dorada with Channel Samples Grading up to 5.76% Cu and 1,500 g/t Ag; Increases Mineral Claims at Plata Dorada to 3,800 Ha"
COR,2021-02-22,14:03:34,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The successful 2020 drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino identifies Copper and Gold System at Los Chapitos sampling 1.71% Cu, 1.3 g/t Au and 6.1% Cu, 0.48 g/t Au"
COR,2021-03-30,12:05:46,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Halt - COR
COR,2021-03-30,12:05:47,B99302,Camino Minerals Corp.,100,-0.65,equity-actions,halt,Iiroc Trading Halt - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Halt - COR
COR,2021-03-30,15:14:53,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The contemplated drill program at Maria Cecilia is supported by more than five,PRESS-RELEASE,DJ Global Press Release Wire,Camino Purchases Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-03-30,16:12:59,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Canadian News Wire,IIROC Trading Resumption - COR
COR,2021-03-30,16:13:00,B99302,Camino Minerals Corp.,100,0.48,equity-actions,resumed,Iiroc Trading Resumption - COR,PRESS-RELEASE,Dow Jones Newswires,Press Release: IIROC Trading Resumption - COR
COR,2021-04-29,13:01:20,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corporation to Raise $5M,PRESS-RELEASE,DJ Global Press Release Wire,Camino Minerals Corporation to Raise $5M to Commence Copper Discovery Drilling in Peru
COR,2021-05-03,13:00:50,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Increases Private Placement to $7.5M on Strong Institutional Demand
COR,2021-05-12,13:01:59,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino also identified new areas,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies New Polymetallic Silver Mineralization and New Veins at Plata Dorada with up to 1,565 g/t Ag, 0.67 g/t Au, 1.19% Cu, 32% Zn, and 18.25% Pb; Increases Mineral Claims to 5,500 Hectares"
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-19,13:00:58,B99302,Camino Minerals Corp.,100,0.61,exploration,,Camino Minerals Corp.: we believe have large copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Private Placement of $7.5M
COR,2021-05-20,06:00:02,B99302,Camino Minerals Corp.,99,-0.65,earnings,negative,"January 2021, Camino reported a net loss of C$835,296",PRESS-RELEASE,LSE Regulatory News Service (RNS),METAL TIGER PLC: Investment into Camino Minerals Corporation
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.36,marketing,release,Camino to Launch Marketing Campaign Ahead of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-06-17,13:02:18,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino is currently closing the acquisition of,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Launch Marketing Campaign Ahead of Planned Exploration and Corporate Development Initiatives
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.57,acquisitions-mergers,completed,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino having completed its recent $7.5 million financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-07-14,13:04:39,B99302,Camino Minerals Corp.,100,0.47,labor-issues,,"Capital, was appointed to the board of directors of Camino",PRESS-RELEASE,DJ Global Press Release Wire,Camino Closes Acquisition of Maria Cecilia Porphyry Complex in Peru as Part of Investment Collaboration with Denham Capital
COR,2021-08-10,13:01:27,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its New Lidia Copper & Gold Zone at Los Chapitos Project
COR,2021-09-07,13:01:44,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Discovery Drilling,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Commences Discovery Drilling at the Los Chapitos Copper Project, Peru"
COR,2021-09-20,13:08:20,B99302,Camino Minerals Corp.,99,0.51,exploration,,"Camino Minerals Corp.: Thus, when copper mining",PRESS-RELEASE,DJ Global Press Release Wire,Camino Adopts Environmental and Social Governance Reporting Initiative with Digbee Ltd.
COR,2021-04-19,19:23:24,D18D2B,Corio N.V.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corio N.V.,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corio N.V.
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,Respirerx is developing dronabinol,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of a Manuscript Describing Its Newest Neuromodulator for Pharmacoresistant Epilepsy and Chronic Pain
COR,2022-01-24,12:06:13,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:00:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.57,products-services,granted,RespireRx Pharmaceuticals Inc.: Since the FDA approval of brexanolone (Zulresso(R),PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
COR,2022-03-16,12:05:11,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Patent -2-
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,products-services,complete,RespireRx Pharmaceuticals Inc.: we have successfully completed two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,"Press Release: RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol"
COR,2022-03-23,12:00:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:00:05,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-16,12:01:12,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-17,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Recent -2-
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa is an Invited Speaker at the 5th International Cannabinoid-Derived Pharmaceuticals Summit
COR,2022-05-24,12:00:07,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Sleep Review has discussed the RespireRx Dronabinol Obstructive Sleep Apnea (OSA) Program in its June 13, 2022 Edition"
COR,2022-08-08,12:00:03,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that Dr. -2-
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces that Dr. Arnold Lippa Is an Invited Speaker at the 5th Meridian Drug Discovery Summit
COR,2022-11-07,13:46:10,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,"RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company's CFO is presenting at the Investor Summit Q4"
COR,2022-11-10,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces that -2-
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry into Letter of Intent with Australian Headquartered CRO for Dronabinol Development for Obstructive Sleep Apnea
COR,2022-11-17,13:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces Entry -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Enters a -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-12-05,13:36:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DGAP News,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:01:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-09-07,13:03:22,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: Site Map of 2022 Drilling Campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts Satellite High-Grade Copper with 55.5m at 0.93% Cu from Surface, including 7.5m of 2.58% Cu at Los Chapitos, Peru"
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.46,equity-actions,,Camino Minerals Corp.: Approximately US $28 million has been invested,PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.57,acquisitions-mergers,completed,"In July 2021, Camino completed the acquisition of Minera Maria Cecilia Ltd. with Denham Capital affiliate",PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DGAP News,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:01:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-09-07,13:03:22,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: Site Map of 2022 Drilling Campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts Satellite High-Grade Copper with 55.5m at 0.93% Cu from Surface, including 7.5m of 2.58% Cu at Los Chapitos, Peru"
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.46,equity-actions,,Camino Minerals Corp.: Approximately US $28 million has been invested,PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.57,acquisitions-mergers,completed,"In July 2021, Camino completed the acquisition of Minera Maria Cecilia Ltd. with Denham Capital affiliate",PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DGAP News,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:01:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-09-07,13:03:22,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: Site Map of 2022 Drilling Campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts Satellite High-Grade Copper with 55.5m at 0.93% Cu from Surface, including 7.5m of 2.58% Cu at Los Chapitos, Peru"
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.46,equity-actions,,Camino Minerals Corp.: Approximately US $28 million has been invested,PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.57,acquisitions-mergers,completed,"In July 2021, Camino completed the acquisition of Minera Maria Cecilia Ltd. with Denham Capital affiliate",PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DGAP News,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:01:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-09-07,13:03:22,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: Site Map of 2022 Drilling Campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts Satellite High-Grade Copper with 55.5m at 0.93% Cu from Surface, including 7.5m of 2.58% Cu at Los Chapitos, Peru"
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.46,equity-actions,,Camino Minerals Corp.: Approximately US $28 million has been invested,PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.57,acquisitions-mergers,completed,"In July 2021, Camino completed the acquisition of Minera Maria Cecilia Ltd. with Denham Capital affiliate",PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DGAP News,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:01:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-09-07,13:03:22,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: Site Map of 2022 Drilling Campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts Satellite High-Grade Copper with 55.5m at 0.93% Cu from Surface, including 7.5m of 2.58% Cu at Los Chapitos, Peru"
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.46,equity-actions,,Camino Minerals Corp.: Approximately US $28 million has been invested,PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.57,acquisitions-mergers,completed,"In July 2021, Camino completed the acquisition of Minera Maria Cecilia Ltd. with Denham Capital affiliate",PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DGAP News,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:01:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-09-07,13:03:22,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: Site Map of 2022 Drilling Campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts Satellite High-Grade Copper with 55.5m at 0.93% Cu from Surface, including 7.5m of 2.58% Cu at Los Chapitos, Peru"
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.46,equity-actions,,Camino Minerals Corp.: Approximately US $28 million has been invested,PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.57,acquisitions-mergers,completed,"In July 2021, Camino completed the acquisition of Minera Maria Cecilia Ltd. with Denham Capital affiliate",PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DGAP News,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:01:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-09-07,13:03:22,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: Site Map of 2022 Drilling Campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts Satellite High-Grade Copper with 55.5m at 0.93% Cu from Surface, including 7.5m of 2.58% Cu at Los Chapitos, Peru"
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.46,equity-actions,,Camino Minerals Corp.: Approximately US $28 million has been invested,PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.57,acquisitions-mergers,completed,"In July 2021, Camino completed the acquisition of Minera Maria Cecilia Ltd. with Denham Capital affiliate",PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DGAP News,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:01:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-09-07,13:03:22,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: Site Map of 2022 Drilling Campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts Satellite High-Grade Copper with 55.5m at 0.93% Cu from Surface, including 7.5m of 2.58% Cu at Los Chapitos, Peru"
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.46,equity-actions,,Camino Minerals Corp.: Approximately US $28 million has been invested,PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.57,acquisitions-mergers,completed,"In July 2021, Camino completed the acquisition of Minera Maria Cecilia Ltd. with Denham Capital affiliate",PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DGAP News,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:00:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,Dow Jones Newswires,PRESS RELEASE: Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-07-06,13:01:18,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The copper discovery,PRESS-RELEASE,DJ Global Press Release Wire,Camino Intercepts 31 metres of 1.23% Copper and 7.95 g/t Silver in New Discovery at the Los Chapitos Copper Project
COR,2022-09-07,13:03:22,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: Site Map of 2022 Drilling Campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Intercepts Satellite High-Grade Copper with 55.5m at 0.93% Cu from Surface, including 7.5m of 2.58% Cu at Los Chapitos, Peru"
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.46,equity-actions,,Camino Minerals Corp.: Approximately US $28 million has been invested,PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2022-09-12,13:01:30,B99302,Camino Minerals Corp.,99,0.57,acquisitions-mergers,completed,"In July 2021, Camino completed the acquisition of Minera Maria Cecilia Ltd. with Denham Capital affiliate",PRESS-RELEASE,DJ Global Press Release Wire,Camino Granted Drilling Permit in Central Area of the Maria Cecilia Copper Gold Porphyry Complex in Peru
COR,2021-01-04,07:00:13,E7050B,IDE Group Holdings PLC,99,-0.44,products-services,cut,Ide to reduce the cost of services,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Contract Win
COR,2021-02-01,07:00:17,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,Ide expects to report revenue of GBP23.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2021-02-01,07:44:46,E7050B,IDE Group Holdings PLC,93,-0.68,revenues,down,Ide Group Holdings PLC said Monday that it expects to report a lower revenue,FULL-ARTICLE,Dow Jones Newswires,"IDE Group 2020's Revenue, Adjusted Ebitda Decline"
COR,2021-02-15,07:00:14,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC Resignation of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Resignation of Director
COR,2021-04-20,06:00:17,E7050B,IDE Group Holdings PLC,99,0.53,labor-issues,,IDE Group Holdings PLC: Directorate Change,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Directorate Change
COR,2021-04-20,08:17:36,E7050B,IDE Group Holdings PLC,100,0.53,labor-issues,,Ide Group Appoints David Templeman as Chief Financial Officer,FULL-ARTICLE,Dow Jones Newswires,IDE Group Appoints David Templeman as Chief Financial Officer
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Audited Results for the Year Ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.3,revenues,down,IDE Group Holdings PLC: While revenues declined in 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Losses on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.53,labor-issues,,IDE Group Holdings PLC: We appointed a new Managing Director of,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.51,products-services,,IDE Group Holdings PLC: we win significant long-term contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.52,products-services,,IDE Group Holdings PLC: We are delivering IT services into,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: we have seen gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The net loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.3,revenues,down,"IDE Group Holdings PLC: The Group reported total revenues for the year to 31 December 2020 of GBP24.1 million, down from GBP28.2 million in 2019",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: We invested in operating system,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.48,products-services,,IDE Group Holdings PLC: Exit of UK,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,"IDE Group Holdings PLC: During the year, the restructuring",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -4-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.62,earnings,negative,IDE Group Holdings PLC: Total loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,90,0.46,equity-actions,,IDE Group Holdings PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,90,0.0,assets,,IDE Group Holdings PLC: Trademarks 5 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,93,0.0,revenues,,IDE Group Holdings PLC: Project revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -8-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,0.61,earnings,positive,IDE Group Holdings PLC: 1.23 Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,-0.68,revenues,down,IDE Group Holdings PLC: Revenue from contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Profit/(loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.68,revenues,down,IDE Group Holdings PLC: Revenue from contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 4,532",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.0,equity-actions,,IDE Group Holdings PLC: Restructuring and reorganisation costs in the year ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.0,equity-actions,,IDE Group Holdings PLC: Other exceptional costs in the year ended 31 December 2019,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.0,earnings,,IDE Group Holdings PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Statutory basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.0,equity-actions,,IDE Group Holdings PLC: The depreciation charge for the year of GBP2.6million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,94,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -15-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,97,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,97,0.0,assets,,IDE Group Holdings PLC: 2020 2019 Assets GBP000 GBP000,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The charge for the year ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2021-07-22,08:17:35,E7050B,IDE Group Holdings PLC,100,-0.65,earnings,down,IDE Group Holdings PLC: the company reported a widened pretax loss for 2020,FULL-ARTICLE,Dow Jones Newswires,IDE Group Shares Fall on Widened Pretax Loss for 2020
COR,2021-07-30,15:41:10,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of AGM
COR,2021-08-12,06:00:31,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC Resignation of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Resignation of Director
COR,2021-08-12,07:58:04,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC said Thursday that Chief Financial Officer David Templeman has resigned,FULL-ARTICLE,Dow Jones Newswires,IDE Group CFO Resigns After Less Than Four Months
COR,2021-08-23,11:20:02,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM
COR,2021-09-28,10:44:59,E7050B,IDE Group Holdings PLC,98,-0.44,assets,sale,IDE Group Holdings PLC: Potential sale of subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Potential Sale of Subsidiary
COR,2021-09-28,10:44:59,E7050B,IDE Group Holdings PLC,98,0.0,earnings,,IDE Group Holdings PLC: The Company will release its interim results for the 6 months ended 30 June 2021 on 30 September 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Potential Sale of Subsidiary
COR,2021-09-28,10:50:19,E7050B,IDE Group Holdings PLC,100,-0.42,assets,,"Ide Group in Discussions to Sell Subsidiary for GBP250,000",FULL-ARTICLE,Dow Jones Newswires,"IDE Group in Discussions to Sell Subsidiary for GBP250,000"
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue* of GBP7.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.44,assets,sale,IDE Group Holdings PLC: Sale of subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Results for the six months to 30 June 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit for the six months,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,"IDE Group Holdings PLC: In addition, the costs include GBP0.1 million",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.57,labor-issues,,"IDE Group Holdings PLC: In August, the Company announced the resignation of its Chief Financial Officer",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,90,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation (1,505",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -2-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -2-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,559",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation 2,018",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,557",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.0,earnings,,"IDE Group Holdings PLC: Loss before taxation (1,384",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,07:37:05,E7050B,IDE Group Holdings PLC,100,0.62,earnings,up,IDE Group Holdings PLC: the company reported a narrowed pretax loss for the first,FULL-ARTICLE,Dow Jones Newswires,IDE Group Shares Rise on 1H Narrowed Pretax Loss
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,99,0.55,acquisitions-mergers,,"Ide Group Connect acquired Nimoveri Limited, an IT managed services business.",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Sale of IDE Group Connect and Nimoveri Limited
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco acquires IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.55,acquisitions-mergers,,"Ide acquired Nimoveri Limited, an IT managed services business",PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group -2-
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,NEWS-FLASH,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco acquires IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.55,acquisitions-mergers,,"Ide acquired Nimoveri Limited, an IT managed services business",FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group -2-
COR,2021-01-04,07:00:13,E7050B,IDE Group Holdings PLC,99,-0.44,products-services,cut,Ide to reduce the cost of services,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Contract Win
COR,2021-02-01,07:00:17,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,Ide expects to report revenue of GBP23.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2021-02-01,07:44:46,E7050B,IDE Group Holdings PLC,93,-0.68,revenues,down,Ide Group Holdings PLC said Monday that it expects to report a lower revenue,FULL-ARTICLE,Dow Jones Newswires,"IDE Group 2020's Revenue, Adjusted Ebitda Decline"
COR,2021-02-15,07:00:14,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC Resignation of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Resignation of Director
COR,2021-04-20,06:00:17,E7050B,IDE Group Holdings PLC,99,0.53,labor-issues,,IDE Group Holdings PLC: Directorate Change,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Directorate Change
COR,2021-04-20,08:17:36,E7050B,IDE Group Holdings PLC,100,0.53,labor-issues,,Ide Group Appoints David Templeman as Chief Financial Officer,FULL-ARTICLE,Dow Jones Newswires,IDE Group Appoints David Templeman as Chief Financial Officer
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Audited Results for the Year Ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.3,revenues,down,IDE Group Holdings PLC: While revenues declined in 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Losses on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.53,labor-issues,,IDE Group Holdings PLC: We appointed a new Managing Director of,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.51,products-services,,IDE Group Holdings PLC: we win significant long-term contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.52,products-services,,IDE Group Holdings PLC: We are delivering IT services into,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: we have seen gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The net loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.3,revenues,down,"IDE Group Holdings PLC: The Group reported total revenues for the year to 31 December 2020 of GBP24.1 million, down from GBP28.2 million in 2019",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: We invested in operating system,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.48,products-services,,IDE Group Holdings PLC: Exit of UK,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,"IDE Group Holdings PLC: During the year, the restructuring",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -4-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.62,earnings,negative,IDE Group Holdings PLC: Total loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,90,0.46,equity-actions,,IDE Group Holdings PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,90,0.0,assets,,IDE Group Holdings PLC: Trademarks 5 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,93,0.0,revenues,,IDE Group Holdings PLC: Project revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -8-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,0.61,earnings,positive,IDE Group Holdings PLC: 1.23 Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,-0.68,revenues,down,IDE Group Holdings PLC: Revenue from contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Profit/(loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.68,revenues,down,IDE Group Holdings PLC: Revenue from contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 4,532",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.0,equity-actions,,IDE Group Holdings PLC: Restructuring and reorganisation costs in the year ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.0,equity-actions,,IDE Group Holdings PLC: Other exceptional costs in the year ended 31 December 2019,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.0,earnings,,IDE Group Holdings PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Statutory basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.0,equity-actions,,IDE Group Holdings PLC: The depreciation charge for the year of GBP2.6million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,94,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -15-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,97,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,97,0.0,assets,,IDE Group Holdings PLC: 2020 2019 Assets GBP000 GBP000,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The charge for the year ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2021-07-22,08:17:35,E7050B,IDE Group Holdings PLC,100,-0.65,earnings,down,IDE Group Holdings PLC: the company reported a widened pretax loss for 2020,FULL-ARTICLE,Dow Jones Newswires,IDE Group Shares Fall on Widened Pretax Loss for 2020
COR,2021-07-30,15:41:10,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of AGM
COR,2021-08-12,06:00:31,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC Resignation of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Resignation of Director
COR,2021-08-12,07:58:04,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC said Thursday that Chief Financial Officer David Templeman has resigned,FULL-ARTICLE,Dow Jones Newswires,IDE Group CFO Resigns After Less Than Four Months
COR,2021-08-23,11:20:02,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM
COR,2021-09-28,10:44:59,E7050B,IDE Group Holdings PLC,98,-0.44,assets,sale,IDE Group Holdings PLC: Potential sale of subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Potential Sale of Subsidiary
COR,2021-09-28,10:44:59,E7050B,IDE Group Holdings PLC,98,0.0,earnings,,IDE Group Holdings PLC: The Company will release its interim results for the 6 months ended 30 June 2021 on 30 September 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Potential Sale of Subsidiary
COR,2021-09-28,10:50:19,E7050B,IDE Group Holdings PLC,100,-0.42,assets,,"Ide Group in Discussions to Sell Subsidiary for GBP250,000",FULL-ARTICLE,Dow Jones Newswires,"IDE Group in Discussions to Sell Subsidiary for GBP250,000"
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue* of GBP7.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.44,assets,sale,IDE Group Holdings PLC: Sale of subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Results for the six months to 30 June 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit for the six months,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,"IDE Group Holdings PLC: In addition, the costs include GBP0.1 million",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.57,labor-issues,,"IDE Group Holdings PLC: In August, the Company announced the resignation of its Chief Financial Officer",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,90,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation (1,505",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -2-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -2-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,559",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation 2,018",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,557",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.0,earnings,,"IDE Group Holdings PLC: Loss before taxation (1,384",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,07:37:05,E7050B,IDE Group Holdings PLC,100,0.62,earnings,up,IDE Group Holdings PLC: the company reported a narrowed pretax loss for the first,FULL-ARTICLE,Dow Jones Newswires,IDE Group Shares Rise on 1H Narrowed Pretax Loss
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,99,0.55,acquisitions-mergers,,"Ide Group Connect acquired Nimoveri Limited, an IT managed services business.",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Sale of IDE Group Connect and Nimoveri Limited
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco acquires IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.55,acquisitions-mergers,,"Ide acquired Nimoveri Limited, an IT managed services business",PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group -2-
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,NEWS-FLASH,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco acquires IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.55,acquisitions-mergers,,"Ide acquired Nimoveri Limited, an IT managed services business",FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group -2-
COR,2021-01-04,07:00:13,E7050B,IDE Group Holdings PLC,99,-0.44,products-services,cut,Ide to reduce the cost of services,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Contract Win
COR,2021-02-01,07:00:17,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,Ide expects to report revenue of GBP23.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2021-02-01,07:44:46,E7050B,IDE Group Holdings PLC,93,-0.68,revenues,down,Ide Group Holdings PLC said Monday that it expects to report a lower revenue,FULL-ARTICLE,Dow Jones Newswires,"IDE Group 2020's Revenue, Adjusted Ebitda Decline"
COR,2021-02-15,07:00:14,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC Resignation of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Resignation of Director
COR,2021-04-20,06:00:17,E7050B,IDE Group Holdings PLC,99,0.53,labor-issues,,IDE Group Holdings PLC: Directorate Change,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Directorate Change
COR,2021-04-20,08:17:36,E7050B,IDE Group Holdings PLC,100,0.53,labor-issues,,Ide Group Appoints David Templeman as Chief Financial Officer,FULL-ARTICLE,Dow Jones Newswires,IDE Group Appoints David Templeman as Chief Financial Officer
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Audited Results for the Year Ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.3,revenues,down,IDE Group Holdings PLC: While revenues declined in 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Losses on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.53,labor-issues,,IDE Group Holdings PLC: We appointed a new Managing Director of,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.51,products-services,,IDE Group Holdings PLC: we win significant long-term contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.52,products-services,,IDE Group Holdings PLC: We are delivering IT services into,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: we have seen gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The net loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.3,revenues,down,"IDE Group Holdings PLC: The Group reported total revenues for the year to 31 December 2020 of GBP24.1 million, down from GBP28.2 million in 2019",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: We invested in operating system,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.48,products-services,,IDE Group Holdings PLC: Exit of UK,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,"IDE Group Holdings PLC: During the year, the restructuring",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -4-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.62,earnings,negative,IDE Group Holdings PLC: Total loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,90,0.46,equity-actions,,IDE Group Holdings PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,90,0.0,assets,,IDE Group Holdings PLC: Trademarks 5 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,93,0.0,revenues,,IDE Group Holdings PLC: Project revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -8-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,0.61,earnings,positive,IDE Group Holdings PLC: 1.23 Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,-0.68,revenues,down,IDE Group Holdings PLC: Revenue from contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Profit/(loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.68,revenues,down,IDE Group Holdings PLC: Revenue from contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 4,532",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.0,equity-actions,,IDE Group Holdings PLC: Restructuring and reorganisation costs in the year ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.0,equity-actions,,IDE Group Holdings PLC: Other exceptional costs in the year ended 31 December 2019,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.0,earnings,,IDE Group Holdings PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Statutory basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.0,equity-actions,,IDE Group Holdings PLC: The depreciation charge for the year of GBP2.6million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,94,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -15-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,97,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,97,0.0,assets,,IDE Group Holdings PLC: 2020 2019 Assets GBP000 GBP000,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The charge for the year ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2021-07-22,08:17:35,E7050B,IDE Group Holdings PLC,100,-0.65,earnings,down,IDE Group Holdings PLC: the company reported a widened pretax loss for 2020,FULL-ARTICLE,Dow Jones Newswires,IDE Group Shares Fall on Widened Pretax Loss for 2020
COR,2021-07-30,15:41:10,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of AGM
COR,2021-08-12,06:00:31,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC Resignation of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Resignation of Director
COR,2021-08-12,07:58:04,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC said Thursday that Chief Financial Officer David Templeman has resigned,FULL-ARTICLE,Dow Jones Newswires,IDE Group CFO Resigns After Less Than Four Months
COR,2021-08-23,11:20:02,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM
COR,2021-09-28,10:44:59,E7050B,IDE Group Holdings PLC,98,-0.44,assets,sale,IDE Group Holdings PLC: Potential sale of subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Potential Sale of Subsidiary
COR,2021-09-28,10:44:59,E7050B,IDE Group Holdings PLC,98,0.0,earnings,,IDE Group Holdings PLC: The Company will release its interim results for the 6 months ended 30 June 2021 on 30 September 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Potential Sale of Subsidiary
COR,2021-09-28,10:50:19,E7050B,IDE Group Holdings PLC,100,-0.42,assets,,"Ide Group in Discussions to Sell Subsidiary for GBP250,000",FULL-ARTICLE,Dow Jones Newswires,"IDE Group in Discussions to Sell Subsidiary for GBP250,000"
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue* of GBP7.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.44,assets,sale,IDE Group Holdings PLC: Sale of subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Results for the six months to 30 June 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit for the six months,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,"IDE Group Holdings PLC: In addition, the costs include GBP0.1 million",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.57,labor-issues,,"IDE Group Holdings PLC: In August, the Company announced the resignation of its Chief Financial Officer",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,90,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation (1,505",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -2-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -2-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,559",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation 2,018",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,557",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.0,earnings,,"IDE Group Holdings PLC: Loss before taxation (1,384",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,07:37:05,E7050B,IDE Group Holdings PLC,100,0.62,earnings,up,IDE Group Holdings PLC: the company reported a narrowed pretax loss for the first,FULL-ARTICLE,Dow Jones Newswires,IDE Group Shares Rise on 1H Narrowed Pretax Loss
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,99,0.55,acquisitions-mergers,,"Ide Group Connect acquired Nimoveri Limited, an IT managed services business.",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Sale of IDE Group Connect and Nimoveri Limited
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco acquires IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.55,acquisitions-mergers,,"Ide acquired Nimoveri Limited, an IT managed services business",PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group -2-
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,NEWS-FLASH,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco acquires IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.55,acquisitions-mergers,,"Ide acquired Nimoveri Limited, an IT managed services business",FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group -2-
COR,2021-01-04,07:00:13,E7050B,IDE Group Holdings PLC,99,-0.44,products-services,cut,Ide to reduce the cost of services,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Contract Win
COR,2021-02-01,07:00:17,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,Ide expects to report revenue of GBP23.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2021-02-01,07:44:46,E7050B,IDE Group Holdings PLC,93,-0.68,revenues,down,Ide Group Holdings PLC said Monday that it expects to report a lower revenue,FULL-ARTICLE,Dow Jones Newswires,"IDE Group 2020's Revenue, Adjusted Ebitda Decline"
COR,2021-02-15,07:00:14,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC Resignation of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Resignation of Director
COR,2021-04-20,06:00:17,E7050B,IDE Group Holdings PLC,99,0.53,labor-issues,,IDE Group Holdings PLC: Directorate Change,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Directorate Change
COR,2021-04-20,08:17:36,E7050B,IDE Group Holdings PLC,100,0.53,labor-issues,,Ide Group Appoints David Templeman as Chief Financial Officer,FULL-ARTICLE,Dow Jones Newswires,IDE Group Appoints David Templeman as Chief Financial Officer
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Audited Results for the Year Ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.3,revenues,down,IDE Group Holdings PLC: While revenues declined in 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Losses on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.53,labor-issues,,IDE Group Holdings PLC: We appointed a new Managing Director of,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.51,products-services,,IDE Group Holdings PLC: we win significant long-term contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.52,products-services,,IDE Group Holdings PLC: We are delivering IT services into,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: we have seen gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The net loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.3,revenues,down,"IDE Group Holdings PLC: The Group reported total revenues for the year to 31 December 2020 of GBP24.1 million, down from GBP28.2 million in 2019",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: We invested in operating system,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,-0.48,products-services,,IDE Group Holdings PLC: Exit of UK,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,"IDE Group Holdings PLC: During the year, the restructuring",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -4-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.62,earnings,negative,IDE Group Holdings PLC: Total loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,90,0.46,equity-actions,,IDE Group Holdings PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,90,0.0,assets,,IDE Group Holdings PLC: Trademarks 5 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,93,0.0,revenues,,IDE Group Holdings PLC: Project revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -8-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,0.61,earnings,positive,IDE Group Holdings PLC: 1.23 Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,-0.68,revenues,down,IDE Group Holdings PLC: Revenue from contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,96,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -9-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Profit/(loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.68,revenues,down,IDE Group Holdings PLC: Revenue from contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 4,532",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -10-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.0,equity-actions,,IDE Group Holdings PLC: Restructuring and reorganisation costs in the year ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,95,0.0,equity-actions,,IDE Group Holdings PLC: Other exceptional costs in the year ended 31 December 2019,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.0,earnings,,IDE Group Holdings PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,-0.65,earnings,negative,IDE Group Holdings PLC: Statutory basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,92,0.0,equity-actions,,IDE Group Holdings PLC: The depreciation charge for the year of GBP2.6million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,94,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -15-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,97,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,97,0.0,assets,,IDE Group Holdings PLC: 2020 2019 Assets GBP000 GBP000,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2021-07-22,06:00:16,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The charge for the year ended 31 December 2020,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2021-07-22,08:17:35,E7050B,IDE Group Holdings PLC,100,-0.65,earnings,down,IDE Group Holdings PLC: the company reported a widened pretax loss for 2020,FULL-ARTICLE,Dow Jones Newswires,IDE Group Shares Fall on Widened Pretax Loss for 2020
COR,2021-07-30,15:41:10,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of AGM
COR,2021-08-12,06:00:31,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC Resignation of Director,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Resignation of Director
COR,2021-08-12,07:58:04,E7050B,IDE Group Holdings PLC,100,-0.57,labor-issues,,Ide Group Holdings PLC said Thursday that Chief Financial Officer David Templeman has resigned,FULL-ARTICLE,Dow Jones Newswires,IDE Group CFO Resigns After Less Than Four Months
COR,2021-08-23,11:20:02,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM
COR,2021-09-28,10:44:59,E7050B,IDE Group Holdings PLC,98,-0.44,assets,sale,IDE Group Holdings PLC: Potential sale of subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Potential Sale of Subsidiary
COR,2021-09-28,10:44:59,E7050B,IDE Group Holdings PLC,98,0.0,earnings,,IDE Group Holdings PLC: The Company will release its interim results for the 6 months ended 30 June 2021 on 30 September 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Potential Sale of Subsidiary
COR,2021-09-28,10:50:19,E7050B,IDE Group Holdings PLC,100,-0.42,assets,,"Ide Group in Discussions to Sell Subsidiary for GBP250,000",FULL-ARTICLE,Dow Jones Newswires,"IDE Group in Discussions to Sell Subsidiary for GBP250,000"
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue* of GBP7.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.44,assets,sale,IDE Group Holdings PLC: Sale of subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Results for the six months to 30 June 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit for the six months,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,"IDE Group Holdings PLC: In addition, the costs include GBP0.1 million",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.57,labor-issues,,"IDE Group Holdings PLC: In August, the Company announced the resignation of its Chief Financial Officer",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,99,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,90,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation (1,505",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -2-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -2-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,559",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation 2,018",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,96,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -4-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,557",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,0.0,earnings,,"IDE Group Holdings PLC: Loss before taxation (1,384",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,06:00:08,E7050B,IDE Group Holdings PLC,95,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Half-year Report -5-
COR,2021-09-30,07:37:05,E7050B,IDE Group Holdings PLC,100,0.62,earnings,up,IDE Group Holdings PLC: the company reported a narrowed pretax loss for the first,FULL-ARTICLE,Dow Jones Newswires,IDE Group Shares Rise on 1H Narrowed Pretax Loss
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,99,0.55,acquisitions-mergers,,"Ide Group Connect acquired Nimoveri Limited, an IT managed services business.",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Sale of IDE Group Connect and Nimoveri Limited
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco acquires IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.55,acquisitions-mergers,,"Ide acquired Nimoveri Limited, an IT managed services business",PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:13,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cloudcoco Group PLC Acquisition of IDE Group -2-
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,NEWS-FLASH,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco acquires IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.55,acquisitions-mergers,,"Ide acquired Nimoveri Limited, an IT managed services business",FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group Connect and Nimoveri
COR,2021-10-20,06:00:14,E7050B,IDE Group Holdings PLC,100,0.65,acquisitions-mergers,,Cloudcoco Group PLC Acquisition of IDE Group,FULL-ARTICLE,Dow Jones Newswires,Cloudcoco Group PLC Acquisition of IDE Group -2-
COR,2022-02-21,17:23:52,D18D2B,Corio N.V.,100,0.0,credit-ratings,action,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corio N.V.,NEWS-FLASH,Dow Jones Newswires,Moody's Announces Completion Of A Periodic Review Of Ratings Of Corio N.V.
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
COR,2023-01-12,13:32:53,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: The License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd Amendment to its License Agreement with the University of Illinois
COR,2023-01-23,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the 2nd -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,ResolutionRx Ltd and RespireRx Pharmaceuticals -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx -2-
COR,2023-03-01,13:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-01,13:32:06,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: ResolutionRx Ltd and RespireRx Pharmaceuticals Inc. Announce ResolutionRx's Entry into a Services Agreement with iNGENu CRO Pty Ltd
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces the -2-
COR,2023-03-28,12:31:36,B47A12,RespireRx Pharmaceuticals Inc.,100,0.47,labor-issues,,Respirerx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Names Joseph Siegelbaum to Bd of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.47,labor-issues,,RespireRx Pharmaceuticals Inc.: our invitation to join our Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,products-services,,RespireRx Pharmaceuticals Inc.: Two Phase 2 clinical trials,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Announces the Appointment Joseph Siegelbaum as an Independent Member of the Board of Directors
COR,2023-03-28,12:34:58,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,Respirerx's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-03,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Discloses Novel -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Establishes -2-
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,100,0.49,partnerships,,Respirerx Pharmaceuticals Inc. Establishes Research Collaboration With University College London,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. Establishes Research Collaboration With University College London to Study the Use of AMPAkines for the Treatment of GRIA Disorders
COR,2023-04-05,12:33:55,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,Dow Jones Newswires,"Press Release: ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,100,0.39,products-services,,"Respirerx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research",PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx Pharmaceuticals Inc., Enters into Letter of Intent with Cantheon Capital for the Financing of Anticipated Research and Development Costs"
COR,2023-05-24,12:30:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,"ResolutionRx Ltd, a Subsidiary of RespireRx -2-"
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. and ResolutionRx -2-
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:50:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.39,products-services,,RespireRx Pharmaceuticals Inc.: License Agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company
COR,2023-08-09,12:54:38,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. and -2-
COR,2023-10-12,12:45:00,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc.'s -2-
COR,2023-10-12,12:45:01,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc.'s Subsidiary -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,FULL-ARTICLE,Dow Jones Newswires,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2023-12-11,13:30:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,GlobeNewswire,RespireRx Pharmaceuticals Inc. Announces -2-
COR,2023-12-11,13:32:39,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,RespireRx Pharmaceuticals Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended December,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. -2-
COR,2022-01-27,06:59:54,E7050B,IDE Group Holdings PLC,99,0.65,revenues,up,IDE Group Holdings PLC: Revenue growth in 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2022-01-27,06:59:54,E7050B,IDE Group Holdings PLC,99,0.76,revenues,up,"IDE Group Holdings PLC: We expect double digit revenue growth in 2022, of which 85%",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2022-01-27,08:58:05,E7050B,IDE Group Holdings PLC,100,0.72,revenues,up,Ide Group Expects Double-Digit Rev Growth in 2022,FULL-ARTICLE,Dow Jones Newswires,IDE Group Expects Double-Digit Rev Growth in 2022; Shares Soar
COR,2022-01-27,08:58:05,E7050B,IDE Group Holdings PLC,100,0.41,revenues,up,Ide said revenue grew 20%,FULL-ARTICLE,Dow Jones Newswires,IDE Group Expects Double-Digit Rev Growth in 2022; Shares Soar
COR,2022-04-19,06:02:00,E7050B,IDE Group Holdings PLC,99,0.0,credit,,IDE Group Holdings PLC: December the Company announced a short-term loan of GBP1m,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Related Party Short-Term Loan Update
COR,2022-04-19,08:12:07,E7050B,IDE Group Holdings PLC,100,0.38,credit,,Ide Group in Talks With Lender Over Possible Conversion of Loan,FULL-ARTICLE,Dow Jones Newswires,IDE Group in Talks With Lender Over Possible Conversion of Loan Notes to Equity
COR,2022-04-19,08:27:07,E7050B,IDE Group Holdings PLC,100,0.38,credit,,Ide Group in Talks With Lender Over Possible Conversion of Loan,FULL-ARTICLE,Dow Jones Newswires,IDE Group in Talks With Lender Over Possible Conversion of Loan Notes to Equity
COR,2022-08-31,17:05:45,E7050B,IDE Group Holdings PLC,100,-0.6,earnings,delayed,Ide Delays Release of 2021 Results,FULL-ARTICLE,Dow Jones Newswires,IDE Delays Release of 2021 Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Audited Results for the Year Ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,Ide invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.61,earnings,up,IDE Group Holdings PLC: Adjusted EBITDA increased to GBP3.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Losses on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.44,revenues,up,IDE Group Holdings PLC: Revenue increased by 25.4% to GBP14.5 million for the full year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.39,products-services,,IDE Group Holdings PLC: Multiyear support contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: we have seen gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.5,labor-issues,,IDE Group Holdings PLC: we have reduced Group headcount by 4%,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The administration costs excluding impairment have reduced by GBP0.7 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: we invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,"IDE Group Holdings PLC: During the year, the restructuring",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.62,acquisitions-mergers,,IDE Group Holdings PLC: The Company also purchased and maintained Directors' and Officers' liability insurance throughout the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.51,labor-issues,,IDE Group Holdings PLC: Sebastian White resigned from the Board,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.47,labor-issues,,IDE Group Holdings PLC: David Templeman joined the Board on 20 April 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.49,labor-issues,,IDE Group Holdings PLC: All Directors are required to retire,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: The full year results,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -8-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 6,271",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Total basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,-0.62,earnings,negative,"IDE Group Holdings PLC: Total loss before tax (3,180",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.46,equity-actions,,IDE Group Holdings PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -14-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,assets,,IDE Group Holdings PLC: Trademarks 5 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -14-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,96,0.0,revenues,,IDE Group Holdings PLC: Project revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -15-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,earnings,,IDE Group Holdings PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,equity-actions,,IDE Group Holdings PLC: Restructuring and reorganisation costs in the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit 834,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.0,equity-actions,,IDE Group Holdings PLC: Staff costs for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,92,0.0,earnings,,IDE Group Holdings PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -18-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,92,0.0,equity-actions,,IDE Group Holdings PLC: The impairment charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -18-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The depreciation charge for the year of GBP0.2 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -19-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,Ide invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -19-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The historical loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -20-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -21-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,93,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -22-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,93,0.0,assets,,IDE Group Holdings PLC: 2021 2020 Assets GBP000 GBP000,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -22-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,96,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -23-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The charge for the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -24-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue of GBP6.7 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,IDE Group Holdings PLC: The restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Results for the six months to 30 June 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Net financial costs were GBP1.4 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation (1,226",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -2-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,90,-0.62,earnings,negative,IDE Group Holdings PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -2-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,559",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -3-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,-0.32,equity-actions,,IDE Group Holdings PLC: the Company to issue New Ordinary Shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,Ide raised approximately GBP10 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,IDE Group Holdings PLC: Following the Capital Reorganisation,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,-0.32,equity-actions,,IDE Group Holdings PLC: the Company to issue New Ordinary Shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General -2-
COR,2022-11-02,13:20:36,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM and GM
COR,2022-11-02,16:11:28,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM and GM
COR,2022-11-03,13:28:59,E7050B,IDE Group Holdings PLC,100,0.22,equity-actions,increase,Ide Group Increases Stake in MXC Capital,FULL-ARTICLE,Dow Jones Newswires,IDE Group Increases Stake in MXC Capital
COR,2022-11-04,15:52:45,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Name Change,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Change of Name
COR,2022-11-04,16:00:55,E7050B,IDE Group Holdings PLC,100,0.0,equity-actions,,Ide Group Changes Name to,FULL-ARTICLE,Dow Jones Newswires,IDE Group Changes Name to Tialis Essential IT
COR,2022-01-27,06:59:54,E7050B,IDE Group Holdings PLC,99,0.65,revenues,up,IDE Group Holdings PLC: Revenue growth in 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2022-01-27,06:59:54,E7050B,IDE Group Holdings PLC,99,0.76,revenues,up,"IDE Group Holdings PLC: We expect double digit revenue growth in 2022, of which 85%",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2022-01-27,08:58:05,E7050B,IDE Group Holdings PLC,100,0.72,revenues,up,Ide Group Expects Double-Digit Rev Growth in 2022,FULL-ARTICLE,Dow Jones Newswires,IDE Group Expects Double-Digit Rev Growth in 2022; Shares Soar
COR,2022-01-27,08:58:05,E7050B,IDE Group Holdings PLC,100,0.41,revenues,up,Ide said revenue grew 20%,FULL-ARTICLE,Dow Jones Newswires,IDE Group Expects Double-Digit Rev Growth in 2022; Shares Soar
COR,2022-04-19,06:02:00,E7050B,IDE Group Holdings PLC,99,0.0,credit,,IDE Group Holdings PLC: December the Company announced a short-term loan of GBP1m,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Related Party Short-Term Loan Update
COR,2022-04-19,08:12:07,E7050B,IDE Group Holdings PLC,100,0.38,credit,,Ide Group in Talks With Lender Over Possible Conversion of Loan,FULL-ARTICLE,Dow Jones Newswires,IDE Group in Talks With Lender Over Possible Conversion of Loan Notes to Equity
COR,2022-04-19,08:27:07,E7050B,IDE Group Holdings PLC,100,0.38,credit,,Ide Group in Talks With Lender Over Possible Conversion of Loan,FULL-ARTICLE,Dow Jones Newswires,IDE Group in Talks With Lender Over Possible Conversion of Loan Notes to Equity
COR,2022-08-31,17:05:45,E7050B,IDE Group Holdings PLC,100,-0.6,earnings,delayed,Ide Delays Release of 2021 Results,FULL-ARTICLE,Dow Jones Newswires,IDE Delays Release of 2021 Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Audited Results for the Year Ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,Ide invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.61,earnings,up,IDE Group Holdings PLC: Adjusted EBITDA increased to GBP3.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Losses on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.44,revenues,up,IDE Group Holdings PLC: Revenue increased by 25.4% to GBP14.5 million for the full year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.39,products-services,,IDE Group Holdings PLC: Multiyear support contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: we have seen gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.5,labor-issues,,IDE Group Holdings PLC: we have reduced Group headcount by 4%,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The administration costs excluding impairment have reduced by GBP0.7 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: we invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,"IDE Group Holdings PLC: During the year, the restructuring",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.62,acquisitions-mergers,,IDE Group Holdings PLC: The Company also purchased and maintained Directors' and Officers' liability insurance throughout the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.51,labor-issues,,IDE Group Holdings PLC: Sebastian White resigned from the Board,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.47,labor-issues,,IDE Group Holdings PLC: David Templeman joined the Board on 20 April 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.49,labor-issues,,IDE Group Holdings PLC: All Directors are required to retire,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: The full year results,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -8-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 6,271",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Total basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,-0.62,earnings,negative,"IDE Group Holdings PLC: Total loss before tax (3,180",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.46,equity-actions,,IDE Group Holdings PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -14-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,assets,,IDE Group Holdings PLC: Trademarks 5 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -14-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,96,0.0,revenues,,IDE Group Holdings PLC: Project revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -15-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,earnings,,IDE Group Holdings PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,equity-actions,,IDE Group Holdings PLC: Restructuring and reorganisation costs in the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit 834,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.0,equity-actions,,IDE Group Holdings PLC: Staff costs for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,92,0.0,earnings,,IDE Group Holdings PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -18-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,92,0.0,equity-actions,,IDE Group Holdings PLC: The impairment charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -18-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The depreciation charge for the year of GBP0.2 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -19-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,Ide invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -19-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The historical loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -20-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -21-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,93,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -22-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,93,0.0,assets,,IDE Group Holdings PLC: 2021 2020 Assets GBP000 GBP000,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -22-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,96,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -23-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The charge for the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -24-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue of GBP6.7 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,IDE Group Holdings PLC: The restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Results for the six months to 30 June 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Net financial costs were GBP1.4 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation (1,226",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -2-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,90,-0.62,earnings,negative,IDE Group Holdings PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -2-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,559",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -3-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,-0.32,equity-actions,,IDE Group Holdings PLC: the Company to issue New Ordinary Shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,Ide raised approximately GBP10 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,IDE Group Holdings PLC: Following the Capital Reorganisation,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,-0.32,equity-actions,,IDE Group Holdings PLC: the Company to issue New Ordinary Shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General -2-
COR,2022-11-02,13:20:36,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM and GM
COR,2022-11-02,16:11:28,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM and GM
COR,2022-11-03,13:28:59,E7050B,IDE Group Holdings PLC,100,0.22,equity-actions,increase,Ide Group Increases Stake in MXC Capital,FULL-ARTICLE,Dow Jones Newswires,IDE Group Increases Stake in MXC Capital
COR,2022-11-04,15:52:45,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Name Change,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Change of Name
COR,2022-11-04,16:00:55,E7050B,IDE Group Holdings PLC,100,0.0,equity-actions,,Ide Group Changes Name to,FULL-ARTICLE,Dow Jones Newswires,IDE Group Changes Name to Tialis Essential IT
COR,2022-01-27,06:59:54,E7050B,IDE Group Holdings PLC,99,0.65,revenues,up,IDE Group Holdings PLC: Revenue growth in 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2022-01-27,06:59:54,E7050B,IDE Group Holdings PLC,99,0.76,revenues,up,"IDE Group Holdings PLC: We expect double digit revenue growth in 2022, of which 85%",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2022-01-27,08:58:05,E7050B,IDE Group Holdings PLC,100,0.72,revenues,up,Ide Group Expects Double-Digit Rev Growth in 2022,FULL-ARTICLE,Dow Jones Newswires,IDE Group Expects Double-Digit Rev Growth in 2022; Shares Soar
COR,2022-01-27,08:58:05,E7050B,IDE Group Holdings PLC,100,0.41,revenues,up,Ide said revenue grew 20%,FULL-ARTICLE,Dow Jones Newswires,IDE Group Expects Double-Digit Rev Growth in 2022; Shares Soar
COR,2022-04-19,06:02:00,E7050B,IDE Group Holdings PLC,99,0.0,credit,,IDE Group Holdings PLC: December the Company announced a short-term loan of GBP1m,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Related Party Short-Term Loan Update
COR,2022-04-19,08:12:07,E7050B,IDE Group Holdings PLC,100,0.38,credit,,Ide Group in Talks With Lender Over Possible Conversion of Loan,FULL-ARTICLE,Dow Jones Newswires,IDE Group in Talks With Lender Over Possible Conversion of Loan Notes to Equity
COR,2022-04-19,08:27:07,E7050B,IDE Group Holdings PLC,100,0.38,credit,,Ide Group in Talks With Lender Over Possible Conversion of Loan,FULL-ARTICLE,Dow Jones Newswires,IDE Group in Talks With Lender Over Possible Conversion of Loan Notes to Equity
COR,2022-08-31,17:05:45,E7050B,IDE Group Holdings PLC,100,-0.6,earnings,delayed,Ide Delays Release of 2021 Results,FULL-ARTICLE,Dow Jones Newswires,IDE Delays Release of 2021 Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Audited Results for the Year Ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,Ide invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.61,earnings,up,IDE Group Holdings PLC: Adjusted EBITDA increased to GBP3.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Losses on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.44,revenues,up,IDE Group Holdings PLC: Revenue increased by 25.4% to GBP14.5 million for the full year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.39,products-services,,IDE Group Holdings PLC: Multiyear support contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: we have seen gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.5,labor-issues,,IDE Group Holdings PLC: we have reduced Group headcount by 4%,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The administration costs excluding impairment have reduced by GBP0.7 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: we invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,"IDE Group Holdings PLC: During the year, the restructuring",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.62,acquisitions-mergers,,IDE Group Holdings PLC: The Company also purchased and maintained Directors' and Officers' liability insurance throughout the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.51,labor-issues,,IDE Group Holdings PLC: Sebastian White resigned from the Board,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.47,labor-issues,,IDE Group Holdings PLC: David Templeman joined the Board on 20 April 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.49,labor-issues,,IDE Group Holdings PLC: All Directors are required to retire,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: The full year results,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -8-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 6,271",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Total basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,-0.62,earnings,negative,"IDE Group Holdings PLC: Total loss before tax (3,180",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.46,equity-actions,,IDE Group Holdings PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -14-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,assets,,IDE Group Holdings PLC: Trademarks 5 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -14-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,96,0.0,revenues,,IDE Group Holdings PLC: Project revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -15-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,earnings,,IDE Group Holdings PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,equity-actions,,IDE Group Holdings PLC: Restructuring and reorganisation costs in the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit 834,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.0,equity-actions,,IDE Group Holdings PLC: Staff costs for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,92,0.0,earnings,,IDE Group Holdings PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -18-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,92,0.0,equity-actions,,IDE Group Holdings PLC: The impairment charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -18-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The depreciation charge for the year of GBP0.2 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -19-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,Ide invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -19-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The historical loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -20-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -21-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,93,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -22-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,93,0.0,assets,,IDE Group Holdings PLC: 2021 2020 Assets GBP000 GBP000,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -22-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,96,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -23-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The charge for the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -24-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue of GBP6.7 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,IDE Group Holdings PLC: The restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Results for the six months to 30 June 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Net financial costs were GBP1.4 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation (1,226",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -2-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,90,-0.62,earnings,negative,IDE Group Holdings PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -2-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,559",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -3-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,-0.32,equity-actions,,IDE Group Holdings PLC: the Company to issue New Ordinary Shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,Ide raised approximately GBP10 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,IDE Group Holdings PLC: Following the Capital Reorganisation,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,-0.32,equity-actions,,IDE Group Holdings PLC: the Company to issue New Ordinary Shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General -2-
COR,2022-11-02,13:20:36,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM and GM
COR,2022-11-02,16:11:28,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM and GM
COR,2022-11-03,13:28:59,E7050B,IDE Group Holdings PLC,100,0.22,equity-actions,increase,Ide Group Increases Stake in MXC Capital,FULL-ARTICLE,Dow Jones Newswires,IDE Group Increases Stake in MXC Capital
COR,2022-11-04,15:52:45,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Name Change,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Change of Name
COR,2022-11-04,16:00:55,E7050B,IDE Group Holdings PLC,100,0.0,equity-actions,,Ide Group Changes Name to,FULL-ARTICLE,Dow Jones Newswires,IDE Group Changes Name to Tialis Essential IT
COR,2022-01-27,06:59:54,E7050B,IDE Group Holdings PLC,99,0.65,revenues,up,IDE Group Holdings PLC: Revenue growth in 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2022-01-27,06:59:54,E7050B,IDE Group Holdings PLC,99,0.76,revenues,up,"IDE Group Holdings PLC: We expect double digit revenue growth in 2022, of which 85%",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Trading Update
COR,2022-01-27,08:58:05,E7050B,IDE Group Holdings PLC,100,0.72,revenues,up,Ide Group Expects Double-Digit Rev Growth in 2022,FULL-ARTICLE,Dow Jones Newswires,IDE Group Expects Double-Digit Rev Growth in 2022; Shares Soar
COR,2022-01-27,08:58:05,E7050B,IDE Group Holdings PLC,100,0.41,revenues,up,Ide said revenue grew 20%,FULL-ARTICLE,Dow Jones Newswires,IDE Group Expects Double-Digit Rev Growth in 2022; Shares Soar
COR,2022-04-19,06:02:00,E7050B,IDE Group Holdings PLC,99,0.0,credit,,IDE Group Holdings PLC: December the Company announced a short-term loan of GBP1m,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Related Party Short-Term Loan Update
COR,2022-04-19,08:12:07,E7050B,IDE Group Holdings PLC,100,0.38,credit,,Ide Group in Talks With Lender Over Possible Conversion of Loan,FULL-ARTICLE,Dow Jones Newswires,IDE Group in Talks With Lender Over Possible Conversion of Loan Notes to Equity
COR,2022-04-19,08:27:07,E7050B,IDE Group Holdings PLC,100,0.38,credit,,Ide Group in Talks With Lender Over Possible Conversion of Loan,FULL-ARTICLE,Dow Jones Newswires,IDE Group in Talks With Lender Over Possible Conversion of Loan Notes to Equity
COR,2022-08-31,17:05:45,E7050B,IDE Group Holdings PLC,100,-0.6,earnings,delayed,Ide Delays Release of 2021 Results,FULL-ARTICLE,Dow Jones Newswires,IDE Delays Release of 2021 Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Audited Results for the Year Ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,Ide invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.61,earnings,up,IDE Group Holdings PLC: Adjusted EBITDA increased to GBP3.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Losses on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.44,revenues,up,IDE Group Holdings PLC: Revenue increased by 25.4% to GBP14.5 million for the full year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.39,products-services,,IDE Group Holdings PLC: Multiyear support contracts,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: we have seen gross profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.5,labor-issues,,IDE Group Holdings PLC: we have reduced Group headcount by 4%,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The administration costs excluding impairment have reduced by GBP0.7 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: we invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -2-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,"IDE Group Holdings PLC: During the year, the restructuring",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -3-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.62,acquisitions-mergers,,IDE Group Holdings PLC: The Company also purchased and maintained Directors' and Officers' liability insurance throughout the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -5-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.51,labor-issues,,IDE Group Holdings PLC: Sebastian White resigned from the Board,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -6-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.47,labor-issues,,IDE Group Holdings PLC: David Templeman joined the Board on 20 April 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.49,labor-issues,,IDE Group Holdings PLC: All Directors are required to retire,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -7-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: The full year results,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -8-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 6,271",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Total basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -11-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,-0.62,earnings,negative,"IDE Group Holdings PLC: Total loss before tax (3,180",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -12-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.46,equity-actions,,IDE Group Holdings PLC: Investments in subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -14-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,assets,,IDE Group Holdings PLC: Trademarks 5 years,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -14-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,96,0.0,revenues,,IDE Group Holdings PLC: Project revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -15-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,earnings,,IDE Group Holdings PLC: Other operating income,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,91,0.0,equity-actions,,IDE Group Holdings PLC: Restructuring and reorganisation costs in the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -16-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit 834,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,-0.63,earnings,negative,IDE Group Holdings PLC: Operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.0,equity-actions,,IDE Group Holdings PLC: Staff costs for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -17-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,92,0.0,earnings,,IDE Group Holdings PLC: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -18-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,92,0.0,equity-actions,,IDE Group Holdings PLC: The impairment charge for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -18-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The depreciation charge for the year of GBP0.2 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -19-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,Ide invested in software,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -19-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: The historical loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -20-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,94,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -21-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,93,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP2.55 million of unsecured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -22-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,93,0.0,assets,,IDE Group Holdings PLC: 2021 2020 Assets GBP000 GBP000,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -22-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,96,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -23-
COR,2022-09-29,09:05:07,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: The charge for the year ended 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Final Results -24-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue of GBP6.7 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,IDE Group Holdings PLC: The restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Results for the six months to 30 June 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Net financial costs were GBP1.4 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.6,earnings,positive,IDE Group Holdings PLC: Operating profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,-0.62,earnings,negative,"IDE Group Holdings PLC: Loss before taxation (1,226",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Loss for the financial year,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -2-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,90,-0.62,earnings,negative,IDE Group Holdings PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -2-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,"IDE Group Holdings PLC: Gross profit 3,559",PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -3-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-09-30,14:47:10,E7050B,IDE Group Holdings PLC,98,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Interim Results -4-
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Notice of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,-0.32,equity-actions,,IDE Group Holdings PLC: the Company to issue New Ordinary Shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,Ide raised approximately GBP10 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,0.47,equity-actions,,IDE Group Holdings PLC: Following the Capital Reorganisation,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General Meeting & General Meeting
COR,2022-10-07,06:00:14,E7050B,IDE Group Holdings PLC,99,-0.32,equity-actions,,IDE Group Holdings PLC: the Company to issue New Ordinary Shares,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Notice of Annual General -2-
COR,2022-11-02,13:20:36,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM and GM
COR,2022-11-02,16:11:28,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: Result of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Result of AGM and GM
COR,2022-11-03,13:28:59,E7050B,IDE Group Holdings PLC,100,0.22,equity-actions,increase,Ide Group Increases Stake in MXC Capital,FULL-ARTICLE,Dow Jones Newswires,IDE Group Increases Stake in MXC Capital
COR,2022-11-04,15:52:45,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Name Change,PRESS-RELEASE,LSE Regulatory News Service (RNS),IDE Group Holdings PLC Change of Name
COR,2022-11-04,16:00:55,E7050B,IDE Group Holdings PLC,100,0.0,equity-actions,,Ide Group Changes Name to,FULL-ARTICLE,Dow Jones Newswires,IDE Group Changes Name to Tialis Essential IT
COR,2023-02-01,11:00:40,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining for the Los Chapitos Copper Project, Peru"
COR,2023-02-08,11:00:37,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The Diana Zone appears stratigraphically related to recently discovered oxidized copper mineralization,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Diana Zone as New Satellite Drilling Target at the Los Chapitos Project, Peru; Surface Channel Samples of 1.05% Copper over 56 meters"
COR,2023-06-14,10:33:53,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:39:38,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,NEWS-FLASH,Dow Jones Newswires,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:49:44,B99302,Camino Minerals Corp.,100,-0.1,equity-actions,decrease,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining,FULL-ARTICLE,Dow Jones Newswires,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining
COR,2023-10-24,10:01:49,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino has made copper discoveries,PRESS-RELEASE,DJ Global Press Release Wire,Camino's Mapping and Geophysics Program Identifies Major Deep-Seated Fault at Los Chapitos Copper Project in Peru
COR,2023-11-23,21:31:21,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at Los Chapitos in December,PRESS-RELEASE,DJ Global Press Release Wire,Nittetsu Mining Approves $1.5 Million Second Option Payment for Camino's Los Chapitos Project; Camino to Commence Drilling at Los Chapitos in December
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.49,equity-actions,,Camino Announces up to CAD$2.0 Million Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,earnings,,Camino Minerals Corp.: Proceeds to,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The second drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-12-11,11:01:35,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Signs Contract to Commence Copper Exploration,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Contract to Commence Copper Exploration Drilling in December at Los Chapitos, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The Los Chapitos drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-02-01,11:00:40,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining for the Los Chapitos Copper Project, Peru"
COR,2023-02-08,11:00:37,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The Diana Zone appears stratigraphically related to recently discovered oxidized copper mineralization,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Diana Zone as New Satellite Drilling Target at the Los Chapitos Project, Peru; Surface Channel Samples of 1.05% Copper over 56 meters"
COR,2023-06-14,10:33:53,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:39:38,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,NEWS-FLASH,Dow Jones Newswires,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:49:44,B99302,Camino Minerals Corp.,100,-0.1,equity-actions,decrease,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining,FULL-ARTICLE,Dow Jones Newswires,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining
COR,2023-10-24,10:01:49,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino has made copper discoveries,PRESS-RELEASE,DJ Global Press Release Wire,Camino's Mapping and Geophysics Program Identifies Major Deep-Seated Fault at Los Chapitos Copper Project in Peru
COR,2023-11-23,21:31:21,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at Los Chapitos in December,PRESS-RELEASE,DJ Global Press Release Wire,Nittetsu Mining Approves $1.5 Million Second Option Payment for Camino's Los Chapitos Project; Camino to Commence Drilling at Los Chapitos in December
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.49,equity-actions,,Camino Announces up to CAD$2.0 Million Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,earnings,,Camino Minerals Corp.: Proceeds to,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The second drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-12-11,11:01:35,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Signs Contract to Commence Copper Exploration,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Contract to Commence Copper Exploration Drilling in December at Los Chapitos, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The Los Chapitos drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-02-01,11:00:40,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining for the Los Chapitos Copper Project, Peru"
COR,2023-02-08,11:00:37,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The Diana Zone appears stratigraphically related to recently discovered oxidized copper mineralization,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Diana Zone as New Satellite Drilling Target at the Los Chapitos Project, Peru; Surface Channel Samples of 1.05% Copper over 56 meters"
COR,2023-06-14,10:33:53,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:39:38,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,NEWS-FLASH,Dow Jones Newswires,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:49:44,B99302,Camino Minerals Corp.,100,-0.1,equity-actions,decrease,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining,FULL-ARTICLE,Dow Jones Newswires,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining
COR,2023-10-24,10:01:49,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino has made copper discoveries,PRESS-RELEASE,DJ Global Press Release Wire,Camino's Mapping and Geophysics Program Identifies Major Deep-Seated Fault at Los Chapitos Copper Project in Peru
COR,2023-11-23,21:31:21,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at Los Chapitos in December,PRESS-RELEASE,DJ Global Press Release Wire,Nittetsu Mining Approves $1.5 Million Second Option Payment for Camino's Los Chapitos Project; Camino to Commence Drilling at Los Chapitos in December
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.49,equity-actions,,Camino Announces up to CAD$2.0 Million Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,earnings,,Camino Minerals Corp.: Proceeds to,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The second drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-12-11,11:01:35,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Signs Contract to Commence Copper Exploration,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Contract to Commence Copper Exploration Drilling in December at Los Chapitos, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The Los Chapitos drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-02-01,11:00:40,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining for the Los Chapitos Copper Project, Peru"
COR,2023-02-08,11:00:37,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The Diana Zone appears stratigraphically related to recently discovered oxidized copper mineralization,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Diana Zone as New Satellite Drilling Target at the Los Chapitos Project, Peru; Surface Channel Samples of 1.05% Copper over 56 meters"
COR,2023-06-14,10:33:53,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:39:38,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,NEWS-FLASH,Dow Jones Newswires,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:49:44,B99302,Camino Minerals Corp.,100,-0.1,equity-actions,decrease,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining,FULL-ARTICLE,Dow Jones Newswires,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining
COR,2023-10-24,10:01:49,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino has made copper discoveries,PRESS-RELEASE,DJ Global Press Release Wire,Camino's Mapping and Geophysics Program Identifies Major Deep-Seated Fault at Los Chapitos Copper Project in Peru
COR,2023-11-23,21:31:21,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at Los Chapitos in December,PRESS-RELEASE,DJ Global Press Release Wire,Nittetsu Mining Approves $1.5 Million Second Option Payment for Camino's Los Chapitos Project; Camino to Commence Drilling at Los Chapitos in December
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.49,equity-actions,,Camino Announces up to CAD$2.0 Million Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,earnings,,Camino Minerals Corp.: Proceeds to,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The second drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-12-11,11:01:35,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Signs Contract to Commence Copper Exploration,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Contract to Commence Copper Exploration Drilling in December at Los Chapitos, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The Los Chapitos drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-02-01,11:00:40,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining for the Los Chapitos Copper Project, Peru"
COR,2023-02-08,11:00:37,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The Diana Zone appears stratigraphically related to recently discovered oxidized copper mineralization,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Diana Zone as New Satellite Drilling Target at the Los Chapitos Project, Peru; Surface Channel Samples of 1.05% Copper over 56 meters"
COR,2023-06-14,10:33:53,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:39:38,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,NEWS-FLASH,Dow Jones Newswires,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:49:44,B99302,Camino Minerals Corp.,100,-0.1,equity-actions,decrease,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining,FULL-ARTICLE,Dow Jones Newswires,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining
COR,2023-10-24,10:01:49,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino has made copper discoveries,PRESS-RELEASE,DJ Global Press Release Wire,Camino's Mapping and Geophysics Program Identifies Major Deep-Seated Fault at Los Chapitos Copper Project in Peru
COR,2023-11-23,21:31:21,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at Los Chapitos in December,PRESS-RELEASE,DJ Global Press Release Wire,Nittetsu Mining Approves $1.5 Million Second Option Payment for Camino's Los Chapitos Project; Camino to Commence Drilling at Los Chapitos in December
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.49,equity-actions,,Camino Announces up to CAD$2.0 Million Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,earnings,,Camino Minerals Corp.: Proceeds to,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The second drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-12-11,11:01:35,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Signs Contract to Commence Copper Exploration,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Contract to Commence Copper Exploration Drilling in December at Los Chapitos, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The Los Chapitos drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-02-01,11:00:40,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining for the Los Chapitos Copper Project, Peru"
COR,2023-02-08,11:00:37,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The Diana Zone appears stratigraphically related to recently discovered oxidized copper mineralization,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Diana Zone as New Satellite Drilling Target at the Los Chapitos Project, Peru; Surface Channel Samples of 1.05% Copper over 56 meters"
COR,2023-06-14,10:33:53,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:39:38,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,NEWS-FLASH,Dow Jones Newswires,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:49:44,B99302,Camino Minerals Corp.,100,-0.1,equity-actions,decrease,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining,FULL-ARTICLE,Dow Jones Newswires,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining
COR,2023-10-24,10:01:49,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino has made copper discoveries,PRESS-RELEASE,DJ Global Press Release Wire,Camino's Mapping and Geophysics Program Identifies Major Deep-Seated Fault at Los Chapitos Copper Project in Peru
COR,2023-11-23,21:31:21,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at Los Chapitos in December,PRESS-RELEASE,DJ Global Press Release Wire,Nittetsu Mining Approves $1.5 Million Second Option Payment for Camino's Los Chapitos Project; Camino to Commence Drilling at Los Chapitos in December
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.49,equity-actions,,Camino Announces up to CAD$2.0 Million Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,earnings,,Camino Minerals Corp.: Proceeds to,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The second drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-12-11,11:01:35,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Signs Contract to Commence Copper Exploration,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Contract to Commence Copper Exploration Drilling in December at Los Chapitos, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The Los Chapitos drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-02-01,11:00:40,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining for the Los Chapitos Copper Project, Peru"
COR,2023-02-08,11:00:37,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The Diana Zone appears stratigraphically related to recently discovered oxidized copper mineralization,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Diana Zone as New Satellite Drilling Target at the Los Chapitos Project, Peru; Surface Channel Samples of 1.05% Copper over 56 meters"
COR,2023-06-14,10:33:53,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:39:38,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,NEWS-FLASH,Dow Jones Newswires,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:49:44,B99302,Camino Minerals Corp.,100,-0.1,equity-actions,decrease,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining,FULL-ARTICLE,Dow Jones Newswires,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining
COR,2023-10-24,10:01:49,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino has made copper discoveries,PRESS-RELEASE,DJ Global Press Release Wire,Camino's Mapping and Geophysics Program Identifies Major Deep-Seated Fault at Los Chapitos Copper Project in Peru
COR,2023-11-23,21:31:21,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at Los Chapitos in December,PRESS-RELEASE,DJ Global Press Release Wire,Nittetsu Mining Approves $1.5 Million Second Option Payment for Camino's Los Chapitos Project; Camino to Commence Drilling at Los Chapitos in December
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.49,equity-actions,,Camino Announces up to CAD$2.0 Million Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,earnings,,Camino Minerals Corp.: Proceeds to,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The second drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-12-11,11:01:35,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Signs Contract to Commence Copper Exploration,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Contract to Commence Copper Exploration Drilling in December at Los Chapitos, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The Los Chapitos drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-02-01,11:00:40,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining for the Los Chapitos Copper Project, Peru"
COR,2023-02-08,11:00:37,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The Diana Zone appears stratigraphically related to recently discovered oxidized copper mineralization,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Diana Zone as New Satellite Drilling Target at the Los Chapitos Project, Peru; Surface Channel Samples of 1.05% Copper over 56 meters"
COR,2023-06-14,10:33:53,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:39:38,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,NEWS-FLASH,Dow Jones Newswires,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:49:44,B99302,Camino Minerals Corp.,100,-0.1,equity-actions,decrease,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining,FULL-ARTICLE,Dow Jones Newswires,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining
COR,2023-10-24,10:01:49,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino has made copper discoveries,PRESS-RELEASE,DJ Global Press Release Wire,Camino's Mapping and Geophysics Program Identifies Major Deep-Seated Fault at Los Chapitos Copper Project in Peru
COR,2023-11-23,21:31:21,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at Los Chapitos in December,PRESS-RELEASE,DJ Global Press Release Wire,Nittetsu Mining Approves $1.5 Million Second Option Payment for Camino's Los Chapitos Project; Camino to Commence Drilling at Los Chapitos in December
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.49,equity-actions,,Camino Announces up to CAD$2.0 Million Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,earnings,,Camino Minerals Corp.: Proceeds to,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The second drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-12-11,11:01:35,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Signs Contract to Commence Copper Exploration,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Contract to Commence Copper Exploration Drilling in December at Los Chapitos, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The Los Chapitos drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-02-01,11:00:40,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Earn-in and Joint Venture Letter of Intent with Nittetsu Mining for the Los Chapitos Copper Project, Peru"
COR,2023-02-08,11:00:37,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino Minerals Corp.: The Diana Zone appears stratigraphically related to recently discovered oxidized copper mineralization,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Identifies Diana Zone as New Satellite Drilling Target at the Los Chapitos Project, Peru; Surface Channel Samples of 1.05% Copper over 56 meters"
COR,2023-06-14,10:33:53,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:39:38,B99302,Camino Minerals Corp.,100,0.39,products-services,,Camino and Japanese Miner Nittetsu Mining Sign Agreement,NEWS-FLASH,Dow Jones Newswires,Camino and Japanese Miner Nittetsu Mining Sign Agreement for Interest in the Los Chapitos Copper Project in Peru
COR,2023-06-14,10:49:44,B99302,Camino Minerals Corp.,100,-0.1,equity-actions,decrease,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining,FULL-ARTICLE,Dow Jones Newswires,Camino Sells Interest in Peru Copper Project to Japan's Nittetsu Mining
COR,2023-10-24,10:01:49,B99302,Camino Minerals Corp.,99,0.61,exploration,,Camino has made copper discoveries,PRESS-RELEASE,DJ Global Press Release Wire,Camino's Mapping and Geophysics Program Identifies Major Deep-Seated Fault at Los Chapitos Copper Project in Peru
COR,2023-11-23,21:31:21,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at Los Chapitos in December,PRESS-RELEASE,DJ Global Press Release Wire,Nittetsu Mining Approves $1.5 Million Second Option Payment for Camino's Los Chapitos Project; Camino to Commence Drilling at Los Chapitos in December
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.49,equity-actions,,Camino Announces up to CAD$2.0 Million Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,earnings,,Camino Minerals Corp.: Proceeds to,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The second drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-11-27,20:36:02,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces up to CAD$2.0 Million Private Placement; Proceeds to be Used to Advance Exploration Drilling at the Maria Cecilia Copper Project in Peru
COR,2023-12-11,11:01:35,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Signs Contract to Commence Copper Exploration,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Signs Contract to Commence Copper Exploration Drilling in December at Los Chapitos, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Closes Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2023-12-20,23:03:58,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: The Los Chapitos drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Closes Private Placement of $2.0M; Funding for Discovery Drilling at the Maria Cecilia Copper Porphyry Complex, Peru"
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,99,-0.65,earnings,negative,Corpus Resources PLC: Results for the Year Ended 31 December 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,99,0.0,equity-actions,,Corpus Resources PLC: the Company changed its name to Corpus Resources Plc.,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,99,0.44,labor-issues,,Corpus Resources PLC: Directors' Remuneration,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -4-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,99,0.57,equity-actions,listing,Corpus Resources PLC: the company's listing on the London Stock Exchange,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -6-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,90,-0.62,earnings,negative,Corpus Resources PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -7-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,90,-0.65,earnings,negative,Corpus Resources PLC: Loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -7-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,90,-0.65,earnings,negative,Corpus Resources PLC: Loss per share - Basic and diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -7-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,99,0.62,acquisitions-mergers,,Corpus Resources PLC: On the 4th of October 2017 it acquired Coos Bay Energy,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -8-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,91,0.62,dividends,up,"Corpus Resources PLC: Interest, dividends, gains",PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -9-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,92,-0.65,earnings,negative,Corpus Resources PLC: Loss for the Year Before,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -10-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,92,-0.62,earnings,negative,Corpus Resources PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -10-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,94,-0.62,earnings,negative,Corpus Resources PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -11-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,94,-0.65,earnings,negative,Corpus Resources PLC: The basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -11-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,94,-0.65,earnings,negative,Corpus Resources PLC: Diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -11-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,94,-0.65,earnings,negative,Corpus Resources PLC: Loss) after,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -11-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,94,0.0,equity-actions,,Corpus Resources PLC: Cost: At the beginning of the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -11-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,94,-0.62,earnings,negative,Corpus Resources PLC: Loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -14-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,99,-0.65,earnings,negative,Corpus Resources PLC: Loss for the year 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -15-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,99,0.46,equity-actions,,Corpus Resources PLC: Investments in Subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -16-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,99,0.53,labor-issues,,Corpus Resources PLC: Key management appointment,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -16-
COR,2025-04-30,15:50:58,4DF24B,Corpus Resources PLC,98,-0.65,earnings,negative,"Corpus Resources PLC: In the year ended 31 December 2024, credit losses",PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Annual Financial Report -17-
COR,2025-06-27,10:42:12,4DF24B,Corpus Resources PLC,97,0.0,investor-relations,,Corpus Resources PLC: Results of Annual General Meeting,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Result of AGM
COR,2025-09-22,06:00:09,4DF24B,Corpus Resources PLC,99,0.32,earnings,,Corpus Resources PLC: Unaudited Half-Year Results for the Six Months Ended 30 June 2025,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Half-Year Results to 30 June 2025
COR,2025-09-22,06:00:09,4DF24B,Corpus Resources PLC,99,0.0,equity-actions,,Corpus Resources PLC: Convertible Foreign Share-based loan currency Share Share Consolidation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Half-Year Results to 30 June 2025
COR,2025-09-22,06:00:09,4DF24B,Corpus Resources PLC,99,-0.32,equity-actions,,Corpus Resources PLC: the Company's called up share capital,PRESS-RELEASE,LSE Regulatory News Service (RNS),Corpus Resources PLC Half-Year Results to 30 June -3-
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.57,acquisitions-mergers,completed,Cencora Completes Acquisition Of Retina Consultants Of America >COR,NEWS-FLASH,Dow Jones Newswires,Cencora Completes Acquisition Of Retina Consultants Of America >COR
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.57,acquisitions-mergers,completed,Cencora Completes Acquisition of Retina Consultants of America,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.15 to $15.45,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora has updated its fiscal year 2025 financial guidance,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: The Company now expects adjusted diluted earnings per share (EPS),PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.57,acquisitions-mergers,completed,Cencora Completes Acquisition of Retina Consultants of America,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.15 to $15.45,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora has updated its fiscal year 2025 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: The Company now expects adjusted diluted earnings per share (EPS),PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:16:42,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises 2025 View To EPS $15.15,NEWS-FLASH,Dow Jones Newswires,Cencora Raises 2025 View To EPS $15.15-EPS $15.45 >COR
COR,2025-01-02,21:17:54,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises 2025 View To Adj EPS $15.15,NEWS-FLASH,Dow Jones Newswires,Correct: Cencora Raises 2025 View To Adj EPS $15.15-EPS $15.45 >COR
COR,2025-01-02,22:00:55,7D85A9,Cencora Inc.,99,0.5,acquisitions-mergers,completed,Cencora Inc.: the Company completed the acquisition and RCA became a subsidiary of the Company,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Asset Acquisition Or Disposition >COR
COR,2025-01-02,22:00:55,7D85A9,Cencora Inc.,99,0.22,acquisitions-mergers,,"Cencora Inc.: The Company acquired an interest in RCA of approximately 85%, with certain RCA",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Asset Acquisition Or Disposition >COR
COR,2025-01-07,21:09:58,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 166 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 166 Of Cencora Inc >COR
COR,2025-01-08,12:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
COR,2025-01-08,12:31:01,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
COR,2025-01-22,21:08:22,7D85A9,Cencora Inc.,99,-0.51,labor-issues,,Cencora Inc.: the Company of their intent to retire as directors,RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2025-01-22,21:11:27,7D85A9,Cencora Inc.,100,-0.43,labor-issues,,Cencora: Richard W. Gochnauer and Kathleen W. Hyle to Retire From Board,RNS-SEC8K,Dow Jones Newswires,Cencora: Richard W. Gochnauer and Kathleen W. Hyle to Retire From Board in March
COR,2025-01-24,16:44:42,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by JP Morgan
COR,2025-01-24,16:44:42,7D85A9,Cencora Inc.,100,0.5,price-targets,upgrade,Cencora Price Target Raised to $301.00/Share From $289.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $301.00/Share From $289.00 by JP Morgan
COR,2025-01-27,12:30:01,7D85A9,Cencora Inc.,100,0.49,partnerships,,Harrow Partners with Cencora to Launch,PRESS-RELEASE,Business Wire,"Harrow Partners with Cencora to Launch ""Harrow Cares"" Program, Making IHEEZO(R) and TRIESENCE(R) More Accessible and Affordable for Retina Specialists and Their Patients"
COR,2025-01-27,12:30:01,7D85A9,Cencora Inc.,100,0.49,partnerships,,Harrow Partners with Cencora to Launch,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Harrow Partners with Cencora to Launch ""Harrow Cares"" Program, Making IHEEZO(R) and TRIESENCE(R) More Accessible and Affordable for Retina Specialists and Their Patients"
COR,2025-01-29,11:52:03,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2025-01-29,11:52:03,7D85A9,Cencora Inc.,100,0.62,price-targets,upgrade,Cencora Price Target Raised to $251.00/Share From $237.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $251.00/Share From $237.00 by Wells Fargo
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Net $488.6M,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Net $488.6M >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 1Q Rev $81.49B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Rev $81.49B >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,1Q EPS $2.50 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q EPS $2.50 >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Adj EPS $3.73,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Adj EPS $3.73 >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $81.5 billion for the First Quarter, a 12.8 Percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.50,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.25 to $15.55,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $81.5B $81.5B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2025,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2025 was $182.1 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.5,acquisitions-mergers,completed,"Cencora completed the acquisition of RCA, a leading management services",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,"On January 2, 2025, Cencora updated its fiscal year 2025 financial guidance",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.52 $ 3.01,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.42,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $ 69,054,314 $ 67,101,667",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2025, (i) revenue of $81.5 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: First Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $81.5 billion for the First Quarter, a 12.8 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.25 to $15.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $81.5B $81.5B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2025 was $182.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.5,acquisitions-mergers,completed,"Cencora completed the acquisition of RCA, a leading management services",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,"On January 2, 2025, Cencora updated its fiscal year 2025 financial guidance",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.52 $ 3.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -4-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -4-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $ 69,054,314 $ 67,101,667",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -4-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -5-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -5-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -5-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -6-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -6-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2025, (i) revenue of $81.5 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -6-
COR,2025-02-05,11:30:54,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY25 Adj EPS $15.25,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY25 Adj EPS $15.25-Adj EPS $15.55 >COR
COR,2025-02-05,11:31:40,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Sees Revenue Growth,NEWS-FLASH,Dow Jones Newswires,Cencora Sees Revenue Growth to Be in the Range of 8%-10 % >COR
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Raises Outlook After 1Q Revenue,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora gave its full-year guidance,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Amerisourcebergen posted a profit of $488.6 million,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora sold more products,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-06,15:40:42,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Evercore ISI Group
COR,2025-02-06,15:40:42,7D85A9,Cencora Inc.,100,0.48,price-targets,upgrade,Cencora Price Target Raised to $280.00/Share From $270.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $280.00/Share From $270.00 by Evercore ISI Group
COR,2025-02-07,01:37:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance >COR
COR,2025-02-07,01:37:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:37:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:37:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:37:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:54:40,7D85A9,Cencora Inc.,100,0.59,equity-actions,approved,Cencora: Agreed to Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora: Agreed to Repurchase Around $50M of Own Shares From Walgreens Boots Alliance >COR
COR,2025-02-10,22:00:40,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 204,491 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2025-02-11,00:38:06,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 1,286,376 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 1,286,376 Of Cencora Inc >COR"
COR,2025-02-21,08:15:29,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2024 (COR)"
COR,2025-02-21,17:21:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 5,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 5,000 Of Cencora Inc >COR"
COR,2025-02-24,22:27:08,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 5,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 5,000 Of Cencora Inc >COR"
COR,2025-02-27,16:27:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-02-28,21:08:23,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-03-03,20:33:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,970 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,970 Of Cencora Inc >COR"
COR,2025-03-04,22:36:01,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,970 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,970 Of Cencora Inc >COR"
COR,2025-03-07,22:48:53,7D85A9,Cencora Inc.,100,0.51,products-services,,Amerisourcebergen Drug Gets $5.6B Pharmaceutical Contract,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Drug Gets $5.6B Pharmaceutical Contract From US Military
COR,2025-03-10,10:31:12,7D85A9,Cencora Inc.,99,0.0,marketing,,"Cencora Inc.: the ""Company"") will be presenting at the Leerink Partners Global Healthcare Conference on Monday, March 10, 2025, at 8:40 a.m. ET",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Regulation FD >COR
COR,2025-03-10,10:33:29,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY25 Adj EPS $15.30,RNS-SEC8K,Dow Jones Newswires,Cencora Sees FY25 Adj EPS $15.30-Adj EPS $15.60 >COR
COR,2025-03-10,10:59:58,7D85A9,Cencora Inc.,94,0.0,earnings,,Amerisourcebergen said adjusted earnings per-share for fiscal 2025,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Adjusted EPS Outlook For FY 2025
COR,2025-03-10,10:59:58,7D85A9,Cencora Inc.,94,0.0,marketing,,Cencora Inc.: the company will present at the Leerink Partners Global Healthcare conference,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Adjusted EPS Outlook For FY 2025
COR,2025-03-10,18:12:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 2,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 2,000 Of Cencora Inc >COR"
COR,2025-03-11,20:09:31,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 2,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 2,000 Of Cencora Inc >COR"
COR,2025-03-14,14:04:34,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2025-03-14,14:04:34,7D85A9,Cencora Inc.,100,0.74,price-targets,upgrade,Cencora Price Target Raised to $274.00/Share From $251.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $274.00/Share From $251.00 by Wells Fargo
COR,2025-03-18,16:09:27,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,970 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,970 Of Cencora Inc >COR"
COR,2025-03-19,20:39:26,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,970 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,970 Of Cencora Inc >COR"
COR,2025-03-24,14:54:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 4,127 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 4,127 Of Cencora Inc >COR"
COR,2025-03-25,14:18:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,578 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,578 Of Cencora Inc >COR"
COR,2025-03-26,20:40:34,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 4,127 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 4,127 Of Cencora Inc >COR"
COR,2025-03-26,20:40:57,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,578 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,578 Of Cencora Inc >COR"
COR,2025-03-28,11:00:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
COR,2025-03-28,11:01:43,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
COR,2025-04-11,12:22:47,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Neutral by B of A Securities
COR,2025-04-11,12:22:47,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $270.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $270.00 by B of A Securities
COR,2025-04-21,13:54:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,969 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,969 Of Cencora Inc >COR"
COR,2025-04-22,13:45:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-04-22,20:07:27,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,969 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,969 Of Cencora Inc >COR"
COR,2025-04-23,20:25:31,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-04-29,14:42:48,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by UBS
COR,2025-04-29,14:42:48,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $335.00/Share From $298.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $335.00/Share From $298.00 by UBS
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Net $717.9M,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Net $717.9M >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 2Q Rev $75.45B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev $75.45B >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,2Q EPS $3.68 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q EPS $3.68 >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Adj EPS $4.42,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Adj EPS $4.42 >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $3.68,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.70 to $15.95,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $75.5B $75.5B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2025,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2025 was $159.3 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.70 $ 2.11,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,95,0.61,earnings,positive,Cencora Inc.: Gross profit 4.06,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -4-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.56,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -5-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,98,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -5-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $71,193,874 $ 67,101,667",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -6-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -6-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2025, (i) revenue of $75.5 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -7-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the six months ended March 31, 2025 (i) revenue of $156.9 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -7-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,95,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -8-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Second Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $3.68,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.70 to $15.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $75.5B $75.5B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2025 was $159.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.70 $ 2.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,95,0.61,earnings,positive,Cencora Inc.: Gross profit 4.06,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -4-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $71,193,874 $ 67,101,667",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -6-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -6-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2025, (i) revenue of $75.5 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -7-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the six months ended March 31, 2025 (i) revenue of $156.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -7-
COR,2025-05-07,10:33:45,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises Its 2025 Adjusted Diluted EPS Guidance,NEWS-FLASH,Dow Jones Newswires,Cencora Raises Its 2025 Adjusted Diluted EPS Guidance >COR
COR,2025-05-07,10:34:29,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Expects 2025 Adj EPS in $15.70 to $15.95,NEWS-FLASH,Dow Jones Newswires,Cencora Expects 2025 Adj EPS in $15.70 to $15.95 Range >COR
COR,2025-05-07,10:35:46,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora 2Q Rev Grew 10%,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev Grew 10% >COR
COR,2025-05-07,10:36:24,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora 2Q Rev Growth,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev Growth Primarily Driven by an 11% Rise in Revenue Within the U.S. Healthcare Solutions >COR
COR,2025-05-07,11:39:14,7D85A9,Cencora Inc.,95,0.7,earnings,up,Cencora raised its 2025 earnings projection,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts View on Weight-Loss Drug Demand as Profit Surges
COR,2025-05-08,12:48:55,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2025-05-08,12:48:56,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $350.00/Share From $314.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $350.00/Share From $314.00 by Baird
COR,2025-05-08,19:22:46,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by Citigroup
COR,2025-05-08,19:22:46,7D85A9,Cencora Inc.,100,0.68,price-targets,upgrade,Cencora Price Target Raised to $355.00/Share From $330.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $355.00/Share From $330.00 by Citigroup
COR,2025-05-14,19:54:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Dir Greenberg Registers 3,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Dir Greenberg Registers 3,000 Of Cencora Inc >COR"
COR,2025-05-15,11:01:59,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+'
COR,2025-05-15,11:01:59,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+'
COR,2025-05-15,11:01:59,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora will increase its revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+'
COR,2025-05-15,12:38:34,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2025-05-15,12:38:34,7D85A9,Cencora Inc.,100,0.44,credit,reduction,Cencora will reduce acquisition-related debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2025-05-15,12:38:34,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2025-05-15,12:38:44,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-' -2-
COR,2025-05-16,20:25:06,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Dir Greenberg Sells 3,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Sells 3,000 Of Cencora Inc >COR"
COR,2025-05-19,13:54:36,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,969 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,969 Of Cencora Inc >COR"
COR,2025-05-19,20:51:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora to Sell EUR500M of 2.875% Senior Notes,RNS-SEC8K,Dow Jones Newswires,Cencora to Sell EUR500M of 2.875% Senior Notes Due 2028 and EUR500M of 3.625% Senior Notes Due 2032
COR,2025-05-20,07:14:47,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2025 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2025 (COR)"
COR,2025-05-20,13:48:41,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,578 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,578 Of Cencora Inc >COR"
COR,2025-05-21,20:01:37,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,578 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,578 Of Cencora Inc >COR"
COR,2025-05-21,20:04:54,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,969 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,969 Of Cencora Inc >COR"
COR,2025-05-28,11:30:00,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Lori J. Ryerkerk to Its Board of Directors,PRESS-RELEASE,Business Wire,Cencora Elects Lori J. Ryerkerk to Its Board of Directors
COR,2025-05-28,11:30:03,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Lori J. Ryerkerk to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Elects Lori J. Ryerkerk to Its Board of Directors
COR,2025-05-28,11:30:17,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Lori J. Ryerkerk to Board,NEWS-FLASH,Dow Jones Newswires,Cencora Elects Lori J. Ryerkerk to Board
COR,2025-05-28,21:03:00,7D85A9,Cencora Inc.,99,-0.51,labor-issues,,Cencora Inc.: the Company of her intent to resign from the Board effective immediately,RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2025-05-29,15:39:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 3,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 3,000 Of Cencora Inc >COR"
COR,2025-06-02,20:09:28,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 3,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 3,000 Of Cencora Inc >COR"
COR,2025-06-03,12:48:37,7D85A9,Cencora Inc.,100,0.94,analyst-ratings,positive,Cencora Raised to Overweight From Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Raised to Overweight From Equal-Weight by Wells Fargo
COR,2025-06-03,12:48:37,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $337.00/Share From $274.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $337.00/Share From $274.00 by Wells Fargo
COR,2025-06-06,20:02:24,7D85A9,Cencora Inc.,99,0.38,credit,,Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2025-06-18,13:54:28,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,969 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,969 Of Cencora Inc >COR"
COR,2025-06-18,17:00:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 4,077 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 4,077 Of Cencora Inc >COR"
COR,2025-06-18,20:42:52,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Dir Greenberg Registers 1,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Dir Greenberg Registers 1,000 Of Cencora Inc >COR"
COR,2025-06-20,20:05:57,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,969 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,969 Of Cencora Inc >COR"
COR,2025-06-20,20:07:42,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 4,077 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 4,077 Of Cencora Inc >COR"
COR,2025-06-24,14:24:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-06-25,20:04:42,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-06-30,15:02:39,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Hold by Jefferies,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Hold by Jefferies
COR,2025-06-30,15:02:39,7D85A9,Cencora Inc.,100,0.74,price-targets,upgrade,Cencora Price Target Raised to $300.00/Share From $275.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $300.00/Share From $275.00 by Jefferies
COR,2025-07-03,11:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release
COR,2025-07-03,11:55:23,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release
COR,2025-07-16,12:58:16,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Morgan Stanley
COR,2025-07-16,12:58:16,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $330.00/Share From $313.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $330.00/Share From $313.00 by Morgan Stanley
COR,2025-07-18,15:48:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,968 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,968 Of Cencora Inc >COR"
COR,2025-07-22,13:48:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,578 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,578 Of Cencora Inc >COR"
COR,2025-07-22,14:01:46,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora Inc.: This partnership with MWI is an important step in expanding access to,PRESS-RELEASE,PR Newswire,Farmina Pet Foods Expands U.S. Veterinary Presence with National Distribution Agreement with MWI Animal Health
COR,2025-07-22,20:24:45,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,968 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,968 Of Cencora Inc >COR"
COR,2025-07-23,20:33:10,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,578 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,578 Of Cencora Inc >COR"
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -5-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $73,956,905 $ 67,101,667",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -7-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Net $687.4M,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Net $687.4M >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 3Q Rev $80.66B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Rev $80.66B >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $80.7 billion for the Third Quarter, an 8.7 percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Third Quarter GAAP Diluted EPS of $3.52,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.85 to $16.00,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora delivered strong financial results in the third fiscal quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $80.7B $80.7B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2025,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,3Q EPS $3.52 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q EPS $3.52 >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: On a constant currency basis, International Healthcare Solutions revenue increased by 8.8 percent in the third quarter of fiscal 2025",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2025 was $156.2 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted EPS,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.55 $ 2.44,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Adj EPS $4.00,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Adj EPS $4.00 >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -4-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.60,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -4-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -5-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.45,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -5-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2025, (i) revenue of $80.7 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -7-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2025 (i) revenue of $237.6 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -7-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -8-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -8-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $80.7 billion for the Third Quarter, an 8.7 percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Third Quarter GAAP Diluted EPS of $3.52,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.85 to $16.00,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora delivered strong financial results in the third fiscal quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $80.7B $80.7B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.41,revenues,up,"Cencora Inc.: On a constant currency basis, International Healthcare Solutions revenue increased by 8.8 percent in the third quarter of fiscal 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2025 was $156.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.55 $ 2.44,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -4-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.45,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -5-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -5-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -6-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $73,956,905 $ 67,101,667",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -6-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -6-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2025, (i) revenue of $80.7 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -7-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2025 (i) revenue of $237.6 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -7-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,95,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -8-
COR,2025-08-06,10:38:11,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises FY25 View To Adj EPS $15.85,NEWS-FLASH,Dow Jones Newswires,Cencora Raises FY25 View To Adj EPS $15.85-Adj EPS $16 >COR
COR,2025-08-06,10:39:16,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees FY25 Rev Up About 9%,NEWS-FLASH,Dow Jones Newswires,"Cencora Sees FY25 Rev Up About 9%, Had Expected Growth of 8%-10%"
COR,2025-08-13,12:50:40,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by Wells Fargo
COR,2025-08-13,12:50:40,7D85A9,Cencora Inc.,100,0.58,price-targets,upgrade,Cencora Price Target Raised to $354.00/Share From $337.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $354.00/Share From $337.00 by Wells Fargo
COR,2025-08-18,15:09:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,968 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,968 Of Cencora Inc >COR"
COR,2025-08-19,13:54:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-08-20,07:15:02,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2025 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2025 (COR)"
COR,2025-08-20,20:07:20,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,968 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,968 Of Cencora Inc >COR"
COR,2025-08-20,20:09:22,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-08-27,20:15:01,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Mark Durcan as Chairman,PRESS-RELEASE,Business Wire,Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
COR,2025-08-27,20:15:04,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Mark Durcan as Chairman,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
COR,2025-08-27,20:21:42,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Mark Durcan as Chmn,NEWS-FLASH,Dow Jones Newswires,Cencora Appoints Mark Durcan as Chmn of Its Bd of Directors
COR,2025-08-27,20:22:03,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Lead Independent Director D. Mark Durcan as Chairman,NEWS-FLASH,Dow Jones Newswires,"Cencora Appoints Lead Independent Director D. Mark Durcan as Chairman, Effective Oct 1 >COR"
COR,2025-09-16,14:39:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 31,350 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 31,350 Of Cencora Inc >COR"
COR,2025-09-18,15:57:24,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 5,097 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 5,097 Of Cencora Inc >COR"
COR,2025-09-18,19:57:11,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 31,350 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 31,350 Of Cencora Inc >COR"
COR,2025-09-22,20:17:35,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 5,097 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 5,097 Of Cencora Inc >COR"
COR,2025-10-01,14:39:25,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 1,886 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 1,886 Of Cencora Inc >COR"
COR,2025-10-03,20:04:15,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 1,886 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 1,886 Of Cencora Inc >COR"
COR,2025-10-06,20:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release
COR,2025-10-06,20:35:40,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release
COR,2025-10-16,13:23:08,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Mizuho
COR,2025-10-16,13:23:08,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $334.00/Share From $316.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $334.00/Share From $316.00 by Mizuho
COR,2025-10-20,13:42:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 5,097 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 5,097 Of Cencora Inc >COR"
COR,2025-10-21,20:34:09,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 5,097 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 5,097 Of Cencora Inc >COR"
COR,2025-10-27,17:09:13,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by UBS
COR,2025-10-27,17:09:13,7D85A9,Cencora Inc.,100,0.72,price-targets,upgrade,Cencora Price Target Raised to $380.00/Share From $350.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $380.00/Share From $350.00 by UBS
COR,2025-10-30,12:15:11,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Mizuho
COR,2025-10-30,12:15:11,7D85A9,Cencora Inc.,100,0.34,price-targets,upgrade,Cencora Price Target Raised to $340.00/Share From $334.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $340.00/Share From $334.00 by Mizuho
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.57,acquisitions-mergers,completed,Cencora Completes Acquisition Of Retina Consultants Of America >COR,NEWS-FLASH,Dow Jones Newswires,Cencora Completes Acquisition Of Retina Consultants Of America >COR
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.57,acquisitions-mergers,completed,Cencora Completes Acquisition of Retina Consultants of America,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.15 to $15.45,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora has updated its fiscal year 2025 financial guidance,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: The Company now expects adjusted diluted earnings per share (EPS),PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.57,acquisitions-mergers,completed,Cencora Completes Acquisition of Retina Consultants of America,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.15 to $15.45,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora has updated its fiscal year 2025 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: The Company now expects adjusted diluted earnings per share (EPS),PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:16:42,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises 2025 View To EPS $15.15,NEWS-FLASH,Dow Jones Newswires,Cencora Raises 2025 View To EPS $15.15-EPS $15.45 >COR
COR,2025-01-02,21:17:54,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises 2025 View To Adj EPS $15.15,NEWS-FLASH,Dow Jones Newswires,Correct: Cencora Raises 2025 View To Adj EPS $15.15-EPS $15.45 >COR
COR,2025-01-02,22:00:55,7D85A9,Cencora Inc.,99,0.5,acquisitions-mergers,completed,Cencora Inc.: the Company completed the acquisition and RCA became a subsidiary of the Company,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Asset Acquisition Or Disposition >COR
COR,2025-01-02,22:00:55,7D85A9,Cencora Inc.,99,0.22,acquisitions-mergers,,"Cencora Inc.: The Company acquired an interest in RCA of approximately 85%, with certain RCA",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Asset Acquisition Or Disposition >COR
COR,2025-01-07,21:09:58,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 166 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 166 Of Cencora Inc >COR
COR,2025-01-08,12:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
COR,2025-01-08,12:31:01,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
COR,2025-01-22,21:08:22,7D85A9,Cencora Inc.,99,-0.51,labor-issues,,Cencora Inc.: the Company of their intent to retire as directors,RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2025-01-22,21:11:27,7D85A9,Cencora Inc.,100,-0.43,labor-issues,,Cencora: Richard W. Gochnauer and Kathleen W. Hyle to Retire From Board,RNS-SEC8K,Dow Jones Newswires,Cencora: Richard W. Gochnauer and Kathleen W. Hyle to Retire From Board in March
COR,2025-01-24,16:44:42,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by JP Morgan
COR,2025-01-24,16:44:42,7D85A9,Cencora Inc.,100,0.5,price-targets,upgrade,Cencora Price Target Raised to $301.00/Share From $289.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $301.00/Share From $289.00 by JP Morgan
COR,2025-01-27,12:30:01,7D85A9,Cencora Inc.,100,0.49,partnerships,,Harrow Partners with Cencora to Launch,PRESS-RELEASE,Business Wire,"Harrow Partners with Cencora to Launch ""Harrow Cares"" Program, Making IHEEZO(R) and TRIESENCE(R) More Accessible and Affordable for Retina Specialists and Their Patients"
COR,2025-01-27,12:30:01,7D85A9,Cencora Inc.,100,0.49,partnerships,,Harrow Partners with Cencora to Launch,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Harrow Partners with Cencora to Launch ""Harrow Cares"" Program, Making IHEEZO(R) and TRIESENCE(R) More Accessible and Affordable for Retina Specialists and Their Patients"
COR,2025-01-29,11:52:03,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2025-01-29,11:52:03,7D85A9,Cencora Inc.,100,0.62,price-targets,upgrade,Cencora Price Target Raised to $251.00/Share From $237.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $251.00/Share From $237.00 by Wells Fargo
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Net $488.6M,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Net $488.6M >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 1Q Rev $81.49B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Rev $81.49B >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,1Q EPS $2.50 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q EPS $2.50 >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Adj EPS $3.73,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Adj EPS $3.73 >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $81.5 billion for the First Quarter, a 12.8 Percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.50,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.25 to $15.55,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $81.5B $81.5B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2025,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2025 was $182.1 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.5,acquisitions-mergers,completed,"Cencora completed the acquisition of RCA, a leading management services",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,"On January 2, 2025, Cencora updated its fiscal year 2025 financial guidance",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.52 $ 3.01,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.42,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $ 69,054,314 $ 67,101,667",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2025, (i) revenue of $81.5 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: First Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $81.5 billion for the First Quarter, a 12.8 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.25 to $15.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $81.5B $81.5B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2025 was $182.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.5,acquisitions-mergers,completed,"Cencora completed the acquisition of RCA, a leading management services",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,"On January 2, 2025, Cencora updated its fiscal year 2025 financial guidance",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.52 $ 3.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -4-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -4-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $ 69,054,314 $ 67,101,667",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -4-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -5-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -5-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -5-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -6-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -6-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2025, (i) revenue of $81.5 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -6-
COR,2025-02-05,11:30:54,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY25 Adj EPS $15.25,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY25 Adj EPS $15.25-Adj EPS $15.55 >COR
COR,2025-02-05,11:31:40,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Sees Revenue Growth,NEWS-FLASH,Dow Jones Newswires,Cencora Sees Revenue Growth to Be in the Range of 8%-10 % >COR
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Raises Outlook After 1Q Revenue,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora gave its full-year guidance,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Amerisourcebergen posted a profit of $488.6 million,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora sold more products,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-06,15:40:42,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Evercore ISI Group
COR,2025-02-06,15:40:42,7D85A9,Cencora Inc.,100,0.48,price-targets,upgrade,Cencora Price Target Raised to $280.00/Share From $270.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $280.00/Share From $270.00 by Evercore ISI Group
COR,2025-02-07,01:37:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance >COR
COR,2025-02-07,01:37:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:37:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:37:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:37:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:54:40,7D85A9,Cencora Inc.,100,0.59,equity-actions,approved,Cencora: Agreed to Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora: Agreed to Repurchase Around $50M of Own Shares From Walgreens Boots Alliance >COR
COR,2025-02-10,22:00:40,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 204,491 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2025-02-11,00:38:06,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 1,286,376 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 1,286,376 Of Cencora Inc >COR"
COR,2025-02-21,08:15:29,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2024 (COR)"
COR,2025-02-21,17:21:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 5,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 5,000 Of Cencora Inc >COR"
COR,2025-02-24,22:27:08,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 5,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 5,000 Of Cencora Inc >COR"
COR,2025-02-27,16:27:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-02-28,21:08:23,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-03-03,20:33:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,970 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,970 Of Cencora Inc >COR"
COR,2025-03-04,22:36:01,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,970 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,970 Of Cencora Inc >COR"
COR,2025-03-07,22:48:53,7D85A9,Cencora Inc.,100,0.51,products-services,,Amerisourcebergen Drug Gets $5.6B Pharmaceutical Contract,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Drug Gets $5.6B Pharmaceutical Contract From US Military
COR,2025-03-10,10:31:12,7D85A9,Cencora Inc.,99,0.0,marketing,,"Cencora Inc.: the ""Company"") will be presenting at the Leerink Partners Global Healthcare Conference on Monday, March 10, 2025, at 8:40 a.m. ET",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Regulation FD >COR
COR,2025-03-10,10:33:29,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY25 Adj EPS $15.30,RNS-SEC8K,Dow Jones Newswires,Cencora Sees FY25 Adj EPS $15.30-Adj EPS $15.60 >COR
COR,2025-03-10,10:59:58,7D85A9,Cencora Inc.,94,0.0,earnings,,Amerisourcebergen said adjusted earnings per-share for fiscal 2025,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Adjusted EPS Outlook For FY 2025
COR,2025-03-10,10:59:58,7D85A9,Cencora Inc.,94,0.0,marketing,,Cencora Inc.: the company will present at the Leerink Partners Global Healthcare conference,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Adjusted EPS Outlook For FY 2025
COR,2025-03-10,18:12:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 2,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 2,000 Of Cencora Inc >COR"
COR,2025-03-11,20:09:31,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 2,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 2,000 Of Cencora Inc >COR"
COR,2025-03-14,14:04:34,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2025-03-14,14:04:34,7D85A9,Cencora Inc.,100,0.74,price-targets,upgrade,Cencora Price Target Raised to $274.00/Share From $251.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $274.00/Share From $251.00 by Wells Fargo
COR,2025-03-18,16:09:27,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,970 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,970 Of Cencora Inc >COR"
COR,2025-03-19,20:39:26,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,970 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,970 Of Cencora Inc >COR"
COR,2025-03-24,14:54:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 4,127 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 4,127 Of Cencora Inc >COR"
COR,2025-03-25,14:18:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,578 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,578 Of Cencora Inc >COR"
COR,2025-03-26,20:40:34,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 4,127 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 4,127 Of Cencora Inc >COR"
COR,2025-03-26,20:40:57,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,578 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,578 Of Cencora Inc >COR"
COR,2025-03-28,11:00:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
COR,2025-03-28,11:01:43,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
COR,2025-04-11,12:22:47,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Neutral by B of A Securities
COR,2025-04-11,12:22:47,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $270.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $270.00 by B of A Securities
COR,2025-04-21,13:54:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,969 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,969 Of Cencora Inc >COR"
COR,2025-04-22,13:45:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-04-22,20:07:27,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,969 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,969 Of Cencora Inc >COR"
COR,2025-04-23,20:25:31,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-04-29,14:42:48,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by UBS
COR,2025-04-29,14:42:48,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $335.00/Share From $298.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $335.00/Share From $298.00 by UBS
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Net $717.9M,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Net $717.9M >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 2Q Rev $75.45B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev $75.45B >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,2Q EPS $3.68 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q EPS $3.68 >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Adj EPS $4.42,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Adj EPS $4.42 >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $3.68,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.70 to $15.95,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $75.5B $75.5B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2025,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2025 was $159.3 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.70 $ 2.11,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,95,0.61,earnings,positive,Cencora Inc.: Gross profit 4.06,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -4-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.56,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -5-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,98,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -5-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $71,193,874 $ 67,101,667",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -6-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -6-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2025, (i) revenue of $75.5 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -7-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the six months ended March 31, 2025 (i) revenue of $156.9 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -7-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,95,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -8-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Second Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $3.68,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.70 to $15.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $75.5B $75.5B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2025 was $159.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.70 $ 2.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,95,0.61,earnings,positive,Cencora Inc.: Gross profit 4.06,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -4-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $71,193,874 $ 67,101,667",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -6-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -6-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2025, (i) revenue of $75.5 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -7-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the six months ended March 31, 2025 (i) revenue of $156.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -7-
COR,2025-05-07,10:33:45,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises Its 2025 Adjusted Diluted EPS Guidance,NEWS-FLASH,Dow Jones Newswires,Cencora Raises Its 2025 Adjusted Diluted EPS Guidance >COR
COR,2025-05-07,10:34:29,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Expects 2025 Adj EPS in $15.70 to $15.95,NEWS-FLASH,Dow Jones Newswires,Cencora Expects 2025 Adj EPS in $15.70 to $15.95 Range >COR
COR,2025-05-07,10:35:46,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora 2Q Rev Grew 10%,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev Grew 10% >COR
COR,2025-05-07,10:36:24,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora 2Q Rev Growth,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev Growth Primarily Driven by an 11% Rise in Revenue Within the U.S. Healthcare Solutions >COR
COR,2025-05-07,11:39:14,7D85A9,Cencora Inc.,95,0.7,earnings,up,Cencora raised its 2025 earnings projection,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts View on Weight-Loss Drug Demand as Profit Surges
COR,2025-05-08,12:48:55,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2025-05-08,12:48:56,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $350.00/Share From $314.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $350.00/Share From $314.00 by Baird
COR,2025-05-08,19:22:46,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by Citigroup
COR,2025-05-08,19:22:46,7D85A9,Cencora Inc.,100,0.68,price-targets,upgrade,Cencora Price Target Raised to $355.00/Share From $330.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $355.00/Share From $330.00 by Citigroup
COR,2025-05-14,19:54:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Dir Greenberg Registers 3,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Dir Greenberg Registers 3,000 Of Cencora Inc >COR"
COR,2025-05-15,11:01:59,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+'
COR,2025-05-15,11:01:59,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+'
COR,2025-05-15,11:01:59,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora will increase its revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+'
COR,2025-05-15,12:38:34,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2025-05-15,12:38:34,7D85A9,Cencora Inc.,100,0.44,credit,reduction,Cencora will reduce acquisition-related debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2025-05-15,12:38:34,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2025-05-15,12:38:44,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-' -2-
COR,2025-05-16,20:25:06,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Dir Greenberg Sells 3,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Sells 3,000 Of Cencora Inc >COR"
COR,2025-05-19,13:54:36,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,969 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,969 Of Cencora Inc >COR"
COR,2025-05-19,20:51:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora to Sell EUR500M of 2.875% Senior Notes,RNS-SEC8K,Dow Jones Newswires,Cencora to Sell EUR500M of 2.875% Senior Notes Due 2028 and EUR500M of 3.625% Senior Notes Due 2032
COR,2025-05-20,07:14:47,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2025 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2025 (COR)"
COR,2025-05-20,13:48:41,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,578 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,578 Of Cencora Inc >COR"
COR,2025-05-21,20:01:37,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,578 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,578 Of Cencora Inc >COR"
COR,2025-05-21,20:04:54,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,969 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,969 Of Cencora Inc >COR"
COR,2025-05-28,11:30:00,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Lori J. Ryerkerk to Its Board of Directors,PRESS-RELEASE,Business Wire,Cencora Elects Lori J. Ryerkerk to Its Board of Directors
COR,2025-05-28,11:30:03,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Lori J. Ryerkerk to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Elects Lori J. Ryerkerk to Its Board of Directors
COR,2025-05-28,11:30:17,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Lori J. Ryerkerk to Board,NEWS-FLASH,Dow Jones Newswires,Cencora Elects Lori J. Ryerkerk to Board
COR,2025-05-28,21:03:00,7D85A9,Cencora Inc.,99,-0.51,labor-issues,,Cencora Inc.: the Company of her intent to resign from the Board effective immediately,RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2025-05-29,15:39:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 3,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 3,000 Of Cencora Inc >COR"
COR,2025-06-02,20:09:28,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 3,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 3,000 Of Cencora Inc >COR"
COR,2025-06-03,12:48:37,7D85A9,Cencora Inc.,100,0.94,analyst-ratings,positive,Cencora Raised to Overweight From Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Raised to Overweight From Equal-Weight by Wells Fargo
COR,2025-06-03,12:48:37,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $337.00/Share From $274.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $337.00/Share From $274.00 by Wells Fargo
COR,2025-06-06,20:02:24,7D85A9,Cencora Inc.,99,0.38,credit,,Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2025-06-18,13:54:28,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,969 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,969 Of Cencora Inc >COR"
COR,2025-06-18,17:00:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 4,077 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 4,077 Of Cencora Inc >COR"
COR,2025-06-18,20:42:52,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Dir Greenberg Registers 1,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Dir Greenberg Registers 1,000 Of Cencora Inc >COR"
COR,2025-06-20,20:05:57,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,969 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,969 Of Cencora Inc >COR"
COR,2025-06-20,20:07:42,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 4,077 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 4,077 Of Cencora Inc >COR"
COR,2025-06-24,14:24:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-06-25,20:04:42,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-06-30,15:02:39,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Hold by Jefferies,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Hold by Jefferies
COR,2025-06-30,15:02:39,7D85A9,Cencora Inc.,100,0.74,price-targets,upgrade,Cencora Price Target Raised to $300.00/Share From $275.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $300.00/Share From $275.00 by Jefferies
COR,2025-07-03,11:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release
COR,2025-07-03,11:55:23,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release
COR,2025-07-16,12:58:16,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Morgan Stanley
COR,2025-07-16,12:58:16,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $330.00/Share From $313.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $330.00/Share From $313.00 by Morgan Stanley
COR,2025-07-18,15:48:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,968 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,968 Of Cencora Inc >COR"
COR,2025-07-22,13:48:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,578 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,578 Of Cencora Inc >COR"
COR,2025-07-22,14:01:46,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora Inc.: This partnership with MWI is an important step in expanding access to,PRESS-RELEASE,PR Newswire,Farmina Pet Foods Expands U.S. Veterinary Presence with National Distribution Agreement with MWI Animal Health
COR,2025-07-22,20:24:45,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,968 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,968 Of Cencora Inc >COR"
COR,2025-07-23,20:33:10,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,578 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,578 Of Cencora Inc >COR"
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -5-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $73,956,905 $ 67,101,667",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -7-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Net $687.4M,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Net $687.4M >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 3Q Rev $80.66B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Rev $80.66B >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $80.7 billion for the Third Quarter, an 8.7 percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Third Quarter GAAP Diluted EPS of $3.52,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.85 to $16.00,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora delivered strong financial results in the third fiscal quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $80.7B $80.7B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2025,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,3Q EPS $3.52 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q EPS $3.52 >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: On a constant currency basis, International Healthcare Solutions revenue increased by 8.8 percent in the third quarter of fiscal 2025",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2025 was $156.2 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted EPS,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.55 $ 2.44,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Adj EPS $4.00,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Adj EPS $4.00 >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -4-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.60,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -4-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -5-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.45,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -5-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2025, (i) revenue of $80.7 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -7-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2025 (i) revenue of $237.6 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -7-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -8-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -8-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $80.7 billion for the Third Quarter, an 8.7 percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Third Quarter GAAP Diluted EPS of $3.52,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.85 to $16.00,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora delivered strong financial results in the third fiscal quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $80.7B $80.7B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.41,revenues,up,"Cencora Inc.: On a constant currency basis, International Healthcare Solutions revenue increased by 8.8 percent in the third quarter of fiscal 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2025 was $156.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.55 $ 2.44,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -4-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.45,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -5-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -5-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -6-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $73,956,905 $ 67,101,667",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -6-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -6-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2025, (i) revenue of $80.7 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -7-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2025 (i) revenue of $237.6 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -7-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,95,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -8-
COR,2025-08-06,10:38:11,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises FY25 View To Adj EPS $15.85,NEWS-FLASH,Dow Jones Newswires,Cencora Raises FY25 View To Adj EPS $15.85-Adj EPS $16 >COR
COR,2025-08-06,10:39:16,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees FY25 Rev Up About 9%,NEWS-FLASH,Dow Jones Newswires,"Cencora Sees FY25 Rev Up About 9%, Had Expected Growth of 8%-10%"
COR,2025-08-13,12:50:40,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by Wells Fargo
COR,2025-08-13,12:50:40,7D85A9,Cencora Inc.,100,0.58,price-targets,upgrade,Cencora Price Target Raised to $354.00/Share From $337.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $354.00/Share From $337.00 by Wells Fargo
COR,2025-08-18,15:09:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,968 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,968 Of Cencora Inc >COR"
COR,2025-08-19,13:54:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-08-20,07:15:02,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2025 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2025 (COR)"
COR,2025-08-20,20:07:20,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,968 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,968 Of Cencora Inc >COR"
COR,2025-08-20,20:09:22,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-08-27,20:15:01,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Mark Durcan as Chairman,PRESS-RELEASE,Business Wire,Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
COR,2025-08-27,20:15:04,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Mark Durcan as Chairman,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
COR,2025-08-27,20:21:42,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Mark Durcan as Chmn,NEWS-FLASH,Dow Jones Newswires,Cencora Appoints Mark Durcan as Chmn of Its Bd of Directors
COR,2025-08-27,20:22:03,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Lead Independent Director D. Mark Durcan as Chairman,NEWS-FLASH,Dow Jones Newswires,"Cencora Appoints Lead Independent Director D. Mark Durcan as Chairman, Effective Oct 1 >COR"
COR,2025-09-16,14:39:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 31,350 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 31,350 Of Cencora Inc >COR"
COR,2025-09-18,15:57:24,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 5,097 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 5,097 Of Cencora Inc >COR"
COR,2025-09-18,19:57:11,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 31,350 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 31,350 Of Cencora Inc >COR"
COR,2025-09-22,20:17:35,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 5,097 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 5,097 Of Cencora Inc >COR"
COR,2025-10-01,14:39:25,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 1,886 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 1,886 Of Cencora Inc >COR"
COR,2025-10-03,20:04:15,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 1,886 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 1,886 Of Cencora Inc >COR"
COR,2025-10-06,20:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release
COR,2025-10-06,20:35:40,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release
COR,2025-10-16,13:23:08,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Mizuho
COR,2025-10-16,13:23:08,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $334.00/Share From $316.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $334.00/Share From $316.00 by Mizuho
COR,2025-10-20,13:42:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 5,097 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 5,097 Of Cencora Inc >COR"
COR,2025-10-21,20:34:09,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 5,097 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 5,097 Of Cencora Inc >COR"
COR,2025-10-27,17:09:13,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by UBS
COR,2025-10-27,17:09:13,7D85A9,Cencora Inc.,100,0.72,price-targets,upgrade,Cencora Price Target Raised to $380.00/Share From $350.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $380.00/Share From $350.00 by UBS
COR,2025-10-30,12:15:11,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Mizuho
COR,2025-10-30,12:15:11,7D85A9,Cencora Inc.,100,0.34,price-targets,upgrade,Cencora Price Target Raised to $340.00/Share From $334.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $340.00/Share From $334.00 by Mizuho
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.57,acquisitions-mergers,completed,Cencora Completes Acquisition Of Retina Consultants Of America >COR,NEWS-FLASH,Dow Jones Newswires,Cencora Completes Acquisition Of Retina Consultants Of America >COR
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.57,acquisitions-mergers,completed,Cencora Completes Acquisition of Retina Consultants of America,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.15 to $15.45,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora has updated its fiscal year 2025 financial guidance,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: The Company now expects adjusted diluted earnings per share (EPS),PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:00,7D85A9,Cencora Inc.,100,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.57,acquisitions-mergers,completed,Cencora Completes Acquisition of Retina Consultants of America,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.15 to $15.45,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora has updated its fiscal year 2025 financial guidance,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: The Company now expects adjusted diluted earnings per share (EPS),PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:15:03,7D85A9,Cencora Inc.,100,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Completes Acquisition of Retina Consultants of America
COR,2025-01-02,21:16:42,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises 2025 View To EPS $15.15,NEWS-FLASH,Dow Jones Newswires,Cencora Raises 2025 View To EPS $15.15-EPS $15.45 >COR
COR,2025-01-02,21:17:54,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises 2025 View To Adj EPS $15.15,NEWS-FLASH,Dow Jones Newswires,Correct: Cencora Raises 2025 View To Adj EPS $15.15-EPS $15.45 >COR
COR,2025-01-02,22:00:55,7D85A9,Cencora Inc.,99,0.5,acquisitions-mergers,completed,Cencora Inc.: the Company completed the acquisition and RCA became a subsidiary of the Company,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Asset Acquisition Or Disposition >COR
COR,2025-01-02,22:00:55,7D85A9,Cencora Inc.,99,0.22,acquisitions-mergers,,"Cencora Inc.: The Company acquired an interest in RCA of approximately 85%, with certain RCA",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Asset Acquisition Or Disposition >COR
COR,2025-01-07,21:09:58,7D85A9,Cencora Inc.,100,0.52,insider-trading,,Vp Krikorian Acquires 166 Of Cencora Inc >COR,TABULAR-MATERIAL,Dow Jones Newswires,VP Krikorian Acquires 166 Of Cencora Inc >COR
COR,2025-01-08,12:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
COR,2025-01-08,12:31:01,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
COR,2025-01-22,21:08:22,7D85A9,Cencora Inc.,99,-0.51,labor-issues,,Cencora Inc.: the Company of their intent to retire as directors,RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2025-01-22,21:11:27,7D85A9,Cencora Inc.,100,-0.43,labor-issues,,Cencora: Richard W. Gochnauer and Kathleen W. Hyle to Retire From Board,RNS-SEC8K,Dow Jones Newswires,Cencora: Richard W. Gochnauer and Kathleen W. Hyle to Retire From Board in March
COR,2025-01-24,16:44:42,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by JP Morgan
COR,2025-01-24,16:44:42,7D85A9,Cencora Inc.,100,0.5,price-targets,upgrade,Cencora Price Target Raised to $301.00/Share From $289.00 by JP Morgan,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $301.00/Share From $289.00 by JP Morgan
COR,2025-01-27,12:30:01,7D85A9,Cencora Inc.,100,0.49,partnerships,,Harrow Partners with Cencora to Launch,PRESS-RELEASE,Business Wire,"Harrow Partners with Cencora to Launch ""Harrow Cares"" Program, Making IHEEZO(R) and TRIESENCE(R) More Accessible and Affordable for Retina Specialists and Their Patients"
COR,2025-01-27,12:30:01,7D85A9,Cencora Inc.,100,0.49,partnerships,,Harrow Partners with Cencora to Launch,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Harrow Partners with Cencora to Launch ""Harrow Cares"" Program, Making IHEEZO(R) and TRIESENCE(R) More Accessible and Affordable for Retina Specialists and Their Patients"
COR,2025-01-29,11:52:03,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2025-01-29,11:52:03,7D85A9,Cencora Inc.,100,0.62,price-targets,upgrade,Cencora Price Target Raised to $251.00/Share From $237.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $251.00/Share From $237.00 by Wells Fargo
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Net $488.6M,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Net $488.6M >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 1Q Rev $81.49B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Rev $81.49B >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,1Q EPS $2.50 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q EPS $2.50 >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 1Q Adj EPS $3.73,NEWS-FLASH,Dow Jones Newswires,Cencora 1Q Adj EPS $3.73 >COR
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $81.5 billion for the First Quarter, a 12.8 Percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.50,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.25 to $15.55,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $81.5B $81.5B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2025,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2025 was $182.1 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.5,acquisitions-mergers,completed,"Cencora completed the acquisition of RCA, a leading management services",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,"On January 2, 2025, Cencora updated its fiscal year 2025 financial guidance",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -2-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.52 $ 3.01,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -3-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.42,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $ 69,054,314 $ 67,101,667",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -4-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -5-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 First Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2025, (i) revenue of $81.5 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 First Quarter Results -6-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: First Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $81.5 billion for the First Quarter, a 12.8 Percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: First Quarter GAAP Diluted EPS of $2.50,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.25 to $15.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $81.5B $81.5B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the first quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the first quarter of fiscal 2025, revenue was $81.5 billion, up 12.8 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First Quarter Results
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.49,equity-actions,up,Cencora Inc.: Interest expense increased,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the first quarter of fiscal 2025 was $182.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.5,acquisitions-mergers,completed,"Cencora completed the acquisition of RCA, a leading management services",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,"On January 2, 2025, Cencora updated its fiscal year 2025 financial guidance",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: Revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -2-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: the Company's Annual Report on Form 10-K for the fiscal year ended September,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 2.52 $ 3.01,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -3-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.42,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -4-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -4-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,96,0.0,assets,,"Cencora Inc.: Total assets $ 69,054,314 $ 67,101,667",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -4-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -5-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -5-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -5-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.67,earnings,down,Cencora Inc.: the gain (loss,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -6-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -6-
COR,2025-02-05,11:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the first quarter of fiscal 2025, (i) revenue of $81.5 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 First -6-
COR,2025-02-05,11:30:54,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY25 Adj EPS $15.25,NEWS-FLASH,Dow Jones Newswires,Cencora Sees FY25 Adj EPS $15.25-Adj EPS $15.55 >COR
COR,2025-02-05,11:31:40,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Sees Revenue Growth,NEWS-FLASH,Dow Jones Newswires,Cencora Sees Revenue Growth to Be in the Range of 8%-10 % >COR
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.72,revenues,up,Cencora Raises Outlook After 1Q Revenue,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora gave its full-year guidance,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Amerisourcebergen posted a profit of $488.6 million,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-05,11:55:00,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora sold more products,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Outlook After 1Q Revenue Climbs
COR,2025-02-06,15:40:42,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Evercore ISI Group
COR,2025-02-06,15:40:42,7D85A9,Cencora Inc.,100,0.48,price-targets,upgrade,Cencora Price Target Raised to $280.00/Share From $270.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $280.00/Share From $270.00 by Evercore ISI Group
COR,2025-02-07,01:37:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance >COR
COR,2025-02-07,01:37:00,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:37:00,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Business Wire,Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:37:03,7D85A9,Cencora Inc.,100,0.59,equity-actions,,Cencora Announces Common Share Repurchase,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:37:03,7D85A9,Cencora Inc.,100,0.49,partnerships,,Cencora Inc.: We partner with pharmaceutical innovators across,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
COR,2025-02-07,01:54:40,7D85A9,Cencora Inc.,100,0.59,equity-actions,approved,Cencora: Agreed to Repurchase,NEWS-FLASH,Dow Jones Newswires,Cencora: Agreed to Repurchase Around $50M of Own Shares From Walgreens Boots Alliance >COR
COR,2025-02-10,22:00:40,7D85A9,Cencora Inc.,99,0.59,equity-actions,,"Cencora Inc.: the Company agreed to repurchase 204,491 shares",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2025-02-11,00:38:06,7D85A9,Cencora Inc.,100,-0.34,equity-actions,decrease,"Holder Walgreens Boots Alliance Inc Sells 1,286,376 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Holder Walgreens Boots Alliance Inc Sells 1,286,376 Of Cencora Inc >COR"
COR,2025-02-21,08:15:29,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 4Q 2024 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 4Q 2024 (COR)"
COR,2025-02-21,17:21:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 5,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 5,000 Of Cencora Inc >COR"
COR,2025-02-24,22:27:08,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 5,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 5,000 Of Cencora Inc >COR"
COR,2025-02-27,16:27:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-02-28,21:08:23,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-03-03,20:33:32,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,970 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,970 Of Cencora Inc >COR"
COR,2025-03-04,22:36:01,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,970 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,970 Of Cencora Inc >COR"
COR,2025-03-07,22:48:53,7D85A9,Cencora Inc.,100,0.51,products-services,,Amerisourcebergen Drug Gets $5.6B Pharmaceutical Contract,NEWS-FLASH,Dow Jones Newswires,AmerisourceBergen Drug Gets $5.6B Pharmaceutical Contract From US Military
COR,2025-03-10,10:31:12,7D85A9,Cencora Inc.,99,0.0,marketing,,"Cencora Inc.: the ""Company"") will be presenting at the Leerink Partners Global Healthcare Conference on Monday, March 10, 2025, at 8:40 a.m. ET",RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Regulation FD >COR
COR,2025-03-10,10:33:29,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Sees FY25 Adj EPS $15.30,RNS-SEC8K,Dow Jones Newswires,Cencora Sees FY25 Adj EPS $15.30-Adj EPS $15.60 >COR
COR,2025-03-10,10:59:58,7D85A9,Cencora Inc.,94,0.0,earnings,,Amerisourcebergen said adjusted earnings per-share for fiscal 2025,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Adjusted EPS Outlook For FY 2025
COR,2025-03-10,10:59:58,7D85A9,Cencora Inc.,94,0.0,marketing,,Cencora Inc.: the company will present at the Leerink Partners Global Healthcare conference,FULL-ARTICLE,Dow Jones Newswires,Cencora Raises Adjusted EPS Outlook For FY 2025
COR,2025-03-10,18:12:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 2,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 2,000 Of Cencora Inc >COR"
COR,2025-03-11,20:09:31,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 2,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 2,000 Of Cencora Inc >COR"
COR,2025-03-14,14:04:34,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Wells Fargo
COR,2025-03-14,14:04:34,7D85A9,Cencora Inc.,100,0.74,price-targets,upgrade,Cencora Price Target Raised to $274.00/Share From $251.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $274.00/Share From $251.00 by Wells Fargo
COR,2025-03-18,16:09:27,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,970 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,970 Of Cencora Inc >COR"
COR,2025-03-19,20:39:26,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,970 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,970 Of Cencora Inc >COR"
COR,2025-03-24,14:54:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 4,127 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 4,127 Of Cencora Inc >COR"
COR,2025-03-25,14:18:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,578 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,578 Of Cencora Inc >COR"
COR,2025-03-26,20:40:34,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 4,127 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 4,127 Of Cencora Inc >COR"
COR,2025-03-26,20:40:57,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,578 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,578 Of Cencora Inc >COR"
COR,2025-03-28,11:00:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
COR,2025-03-28,11:01:43,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release
COR,2025-04-11,12:22:47,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Neutral by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Neutral by B of A Securities
COR,2025-04-11,12:22:47,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $285.00/Share From $270.00 by B of A Securities,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $285.00/Share From $270.00 by B of A Securities
COR,2025-04-21,13:54:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,969 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,969 Of Cencora Inc >COR"
COR,2025-04-22,13:45:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-04-22,20:07:27,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,969 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,969 Of Cencora Inc >COR"
COR,2025-04-23,20:25:31,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-04-29,14:42:48,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by UBS
COR,2025-04-29,14:42:48,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $335.00/Share From $298.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $335.00/Share From $298.00 by UBS
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Net $717.9M,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Net $717.9M >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 2Q Rev $75.45B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev $75.45B >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,2Q EPS $3.68 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q EPS $3.68 >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 2Q Adj EPS $4.42,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Adj EPS $4.42 >COR
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $3.68,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.70 to $15.95,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $75.5B $75.5B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2025,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Second Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2025 was $159.3 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter Results -2-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.70 $ 2.11,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -3-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,95,0.61,earnings,positive,Cencora Inc.: Gross profit 4.06,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -4-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,98,0.61,earnings,positive,Cencora Inc.: Gross profit 3.56,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -5-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,98,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -5-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $71,193,874 $ 67,101,667",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -6-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -6-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2025, (i) revenue of $75.5 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -7-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the six months ended March 31, 2025 (i) revenue of $156.9 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -7-
COR,2025-05-07,10:30:01,7D85A9,Cencora Inc.,95,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Second Quarter -8-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Second Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Second Quarter GAAP Diluted EPS of $3.68,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.70 to $15.95,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 second quarter ended March 31, 2025, revenue increased 10.3 percent year-over-year",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $75.5B $75.5B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the second quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the second quarter of fiscal 2025, revenue was $75.5 billion, up 10.3 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second Quarter Results
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,Cencora Inc.: U.S. Healthcare Solutions revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the second quarter of fiscal 2025 was $159.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: International Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -2-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.70 $ 2.11,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -3-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,95,0.61,earnings,positive,Cencora Inc.: Gross profit 4.06,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -4-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $71,193,874 $ 67,101,667",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -6-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -6-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the second quarter of fiscal 2025, (i) revenue of $75.5 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -7-
COR,2025-05-07,10:30:04,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the six months ended March 31, 2025 (i) revenue of $156.9 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Second -7-
COR,2025-05-07,10:33:45,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises Its 2025 Adjusted Diluted EPS Guidance,NEWS-FLASH,Dow Jones Newswires,Cencora Raises Its 2025 Adjusted Diluted EPS Guidance >COR
COR,2025-05-07,10:34:29,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Expects 2025 Adj EPS in $15.70 to $15.95,NEWS-FLASH,Dow Jones Newswires,Cencora Expects 2025 Adj EPS in $15.70 to $15.95 Range >COR
COR,2025-05-07,10:35:46,7D85A9,Cencora Inc.,100,0.41,revenues,up,Cencora 2Q Rev Grew 10%,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev Grew 10% >COR
COR,2025-05-07,10:36:24,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora 2Q Rev Growth,NEWS-FLASH,Dow Jones Newswires,Cencora 2Q Rev Growth Primarily Driven by an 11% Rise in Revenue Within the U.S. Healthcare Solutions >COR
COR,2025-05-07,11:39:14,7D85A9,Cencora Inc.,95,0.7,earnings,up,Cencora raised its 2025 earnings projection,FULL-ARTICLE,Dow Jones Newswires,Cencora Lifts View on Weight-Loss Drug Demand as Profit Surges
COR,2025-05-08,12:48:55,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Baird
COR,2025-05-08,12:48:56,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $350.00/Share From $314.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $350.00/Share From $314.00 by Baird
COR,2025-05-08,19:22:46,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by Citigroup
COR,2025-05-08,19:22:46,7D85A9,Cencora Inc.,100,0.68,price-targets,upgrade,Cencora Price Target Raised to $355.00/Share From $330.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $355.00/Share From $330.00 by Citigroup
COR,2025-05-14,19:54:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Dir Greenberg Registers 3,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Dir Greenberg Registers 3,000 Of Cencora Inc >COR"
COR,2025-05-15,11:01:59,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+,NEWS-FLASH,Dow Jones Newswires,S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+'
COR,2025-05-15,11:01:59,7D85A9,Cencora Inc.,100,0.06,credit-ratings,set,S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+'
COR,2025-05-15,11:01:59,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora will increase its revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: S&PGR Rates Cencora Inc.'s Senior Unsecured Notes 'BBB+'
COR,2025-05-15,12:38:34,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2025-05-15,12:38:34,7D85A9,Cencora Inc.,100,0.44,credit,reduction,Cencora will reduce acquisition-related debt,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2025-05-15,12:38:34,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,NEWS-FLASH,Dow Jones Newswires,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-'
COR,2025-05-15,12:38:44,7D85A9,Cencora Inc.,100,0.16,credit-ratings,set,Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-,PRESS-RELEASE,Dow Jones Newswires,Press Release: Fitch Rates Cencora's Senior Unsecured Notes Offering 'A-' -2-
COR,2025-05-16,20:25:06,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Dir Greenberg Sells 3,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Greenberg Sells 3,000 Of Cencora Inc >COR"
COR,2025-05-19,13:54:36,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,969 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,969 Of Cencora Inc >COR"
COR,2025-05-19,20:51:03,7D85A9,Cencora Inc.,100,0.0,credit,,Cencora to Sell EUR500M of 2.875% Senior Notes,RNS-SEC8K,Dow Jones Newswires,Cencora to Sell EUR500M of 2.875% Senior Notes Due 2028 and EUR500M of 3.625% Senior Notes Due 2032
COR,2025-05-20,07:14:47,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 1Q 2025 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 1Q 2025 (COR)"
COR,2025-05-20,13:48:41,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,578 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,578 Of Cencora Inc >COR"
COR,2025-05-21,20:01:37,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,578 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,578 Of Cencora Inc >COR"
COR,2025-05-21,20:04:54,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,969 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,969 Of Cencora Inc >COR"
COR,2025-05-28,11:30:00,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Lori J. Ryerkerk to Its Board of Directors,PRESS-RELEASE,Business Wire,Cencora Elects Lori J. Ryerkerk to Its Board of Directors
COR,2025-05-28,11:30:03,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Lori J. Ryerkerk to Its Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Elects Lori J. Ryerkerk to Its Board of Directors
COR,2025-05-28,11:30:17,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Elects Lori J. Ryerkerk to Board,NEWS-FLASH,Dow Jones Newswires,Cencora Elects Lori J. Ryerkerk to Board
COR,2025-05-28,21:03:00,7D85A9,Cencora Inc.,99,-0.51,labor-issues,,Cencora Inc.: the Company of her intent to resign from the Board effective immediately,RNS-SEC8K,Dow Jones Newswires,"Cencora Files 8K - Director, Officer or Compensation Filing >COR"
COR,2025-05-29,15:39:29,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Krikorian Registers 3,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Krikorian Registers 3,000 Of Cencora Inc >COR"
COR,2025-06-02,20:09:28,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Krikorian Sells 3,000 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Krikorian Sells 3,000 Of Cencora Inc >COR"
COR,2025-06-03,12:48:37,7D85A9,Cencora Inc.,100,0.94,analyst-ratings,positive,Cencora Raised to Overweight From Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Raised to Overweight From Equal-Weight by Wells Fargo
COR,2025-06-03,12:48:37,7D85A9,Cencora Inc.,100,0.78,price-targets,upgrade,Cencora Price Target Raised to $337.00/Share From $274.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $337.00/Share From $274.00 by Wells Fargo
COR,2025-06-06,20:02:24,7D85A9,Cencora Inc.,99,0.38,credit,,Innomar Strategies Inc. entered into an Amended and Restated Credit Agreement,RNS-SEC8K,Dow Jones Newswires,Cencora Files 8K - Entry Into Definitive Agreement >COR
COR,2025-06-18,13:54:28,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,969 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,969 Of Cencora Inc >COR"
COR,2025-06-18,17:00:34,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Battaglia Registers 4,077 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Battaglia Registers 4,077 Of Cencora Inc >COR"
COR,2025-06-18,20:42:52,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Dir Greenberg Registers 1,000 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Dir Greenberg Registers 1,000 Of Cencora Inc >COR"
COR,2025-06-20,20:05:57,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,969 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,969 Of Cencora Inc >COR"
COR,2025-06-20,20:07:42,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Battaglia Sells 4,077 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Battaglia Sells 4,077 Of Cencora Inc >COR"
COR,2025-06-24,14:24:30,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-06-25,20:04:42,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-06-30,15:02:39,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Hold by Jefferies,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Hold by Jefferies
COR,2025-06-30,15:02:39,7D85A9,Cencora Inc.,100,0.74,price-targets,upgrade,Cencora Price Target Raised to $300.00/Share From $275.00 by Jefferies,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $300.00/Share From $275.00 by Jefferies
COR,2025-07-03,11:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release
COR,2025-07-03,11:55:23,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release
COR,2025-07-16,12:58:16,7D85A9,Cencora Inc.,100,0.0,analyst-ratings,neutral,Cencora Is Maintained at Equal-Weight by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Equal-Weight by Morgan Stanley
COR,2025-07-16,12:58:16,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $330.00/Share From $313.00 by Morgan Stanley,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $330.00/Share From $313.00 by Morgan Stanley
COR,2025-07-18,15:48:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,968 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,968 Of Cencora Inc >COR"
COR,2025-07-22,13:48:26,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,578 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,578 Of Cencora Inc >COR"
COR,2025-07-22,14:01:46,7D85A9,Cencora Inc.,99,0.49,partnerships,,Cencora Inc.: This partnership with MWI is an important step in expanding access to,PRESS-RELEASE,PR Newswire,Farmina Pet Foods Expands U.S. Veterinary Presence with National Distribution Agreement with MWI Animal Health
COR,2025-07-22,20:24:45,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,968 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,968 Of Cencora Inc >COR"
COR,2025-07-23,20:33:10,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,578 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,578 Of Cencora Inc >COR"
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -5-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,assets,,"Cencora Inc.: Total assets $73,956,905 $ 67,101,667",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -6-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -7-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Net $687.4M,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Net $687.4M >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,,Cencora 3Q Rev $80.66B >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Rev $80.66B >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $80.7 billion for the Third Quarter, an 8.7 percent Increase",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Third Quarter GAAP Diluted EPS of $3.52,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.85 to $16.00,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora delivered strong financial results in the third fiscal quarter,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $80.7B $80.7B,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2025,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,3Q EPS $3.52 >COR,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q EPS $3.52 >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: On a constant currency basis, International Healthcare Solutions revenue increased by 8.8 percent in the third quarter of fiscal 2025",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2025 was $156.2 million,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted diluted EPS,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -2-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.55 $ 2.44,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -3-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora 3Q Adj EPS $4.00,NEWS-FLASH,Dow Jones Newswires,Cencora 3Q Adj EPS $4.00 >COR
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -4-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.60,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -4-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -5-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Gross profit 3.45,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -5-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2025, (i) revenue of $80.7 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -7-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2025 (i) revenue of $237.6 billion",PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -7-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Reports Fiscal 2025 Third Quarter Results,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -8-
COR,2025-08-06,10:30:03,7D85A9,Cencora Inc.,100,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Business Wire,Cencora Reports Fiscal 2025 Third Quarter Results -8-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Third Quarter GAAP Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue of $80.7 billion for the Third Quarter, an 8.7 percent Increase",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Third Quarter GAAP Diluted EPS of $3.52,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Diluted EPS Guidance Range Raised to $15.85 to $16.00,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 third quarter ended June 30, 2025, revenue increased 8.7 percent year-over-year",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora delivered strong financial results in the third fiscal quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,revenues,unchanged,Cencora Inc.: Revenue $80.7B $80.7B,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,equity-actions,,Cencora Inc.: Adjusted Operating Expenses: In the third quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: Revenue: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.0,earnings,,Cencora Inc.: Diluted Earnings Per Share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.41,revenues,up,"Cencora Inc.: In the third quarter of fiscal 2025, revenue was $80.7 billion, up 8.7 percent",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,100,0.61,earnings,positive,Cencora Inc.: Adjusted Gross Profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third Quarter Results
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.41,revenues,up,"Cencora Inc.: On a constant currency basis, International Healthcare Solutions revenue increased by 8.8 percent in the third quarter of fiscal 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Segment operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.6,earnings,positive,Cencora Inc.: Segment operating income in the third quarter of fiscal 2025 was $156.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward-looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.65,revenues,up,Cencora Inc.: U.S. Healthcare Solutions segment revenue growth,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,dividends,,Cencora Inc.: Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss its operating results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -2-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Gross profit (1,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,equity-actions,,Cencora Inc.: Operating expenses,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Earnings per share: Basic $ 3.55 $ 2.44,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -3-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,96,0.61,earnings,positive,Cencora Inc.: Gross profit 3.60,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -4-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,97,0.61,earnings,positive,Cencora Inc.: Gross profit 3.45,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -5-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,97,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -5-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,earnings,,Cencora Inc.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -6-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,assets,,"Cencora Inc.: Total assets $73,956,905 $ 67,101,667",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -6-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.61,earnings,positive,Cencora Inc.: Adjusted gross profit,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -6-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the third quarter of fiscal 2025, (i) revenue of $80.7 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -7-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,99,0.0,revenues,,"Cencora Inc.: For the nine months ended June 30, 2025 (i) revenue of $237.6 billion",PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -7-
COR,2025-08-06,10:30:06,7D85A9,Cencora Inc.,95,-0.56,earnings,suspended,Cencora Inc.: The Company does not provide forward looking guidance on,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Reports Fiscal 2025 Third -8-
COR,2025-08-06,10:38:11,7D85A9,Cencora Inc.,100,0.7,earnings,up,Cencora Raises FY25 View To Adj EPS $15.85,NEWS-FLASH,Dow Jones Newswires,Cencora Raises FY25 View To Adj EPS $15.85-Adj EPS $16 >COR
COR,2025-08-06,10:39:16,7D85A9,Cencora Inc.,100,0.48,revenues,up,Cencora Sees FY25 Rev Up About 9%,NEWS-FLASH,Dow Jones Newswires,"Cencora Sees FY25 Rev Up About 9%, Had Expected Growth of 8%-10%"
COR,2025-08-13,12:50:40,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Overweight by Wells Fargo
COR,2025-08-13,12:50:40,7D85A9,Cencora Inc.,100,0.58,price-targets,upgrade,Cencora Price Target Raised to $354.00/Share From $337.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $354.00/Share From $337.00 by Wells Fargo
COR,2025-08-18,15:09:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 4,968 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 4,968 Of Cencora Inc >COR"
COR,2025-08-19,13:54:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 14,579 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 14,579 Of Cencora Inc >COR"
COR,2025-08-20,07:15:02,7D85A9,Cencora Inc.,100,0.0,investor-relations,,"Amerisourcebergen Corporation, Inst Holders, 2Q 2025 (COR)",RNS-SEC13F,Dow Jones Newswires,"AmerisourceBergen Corporation, Inst Holders, 2Q 2025 (COR)"
COR,2025-08-20,20:07:20,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 4,968 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 4,968 Of Cencora Inc >COR"
COR,2025-08-20,20:09:22,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 14,579 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 14,579 Of Cencora Inc >COR"
COR,2025-08-27,20:15:01,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Mark Durcan as Chairman,PRESS-RELEASE,Business Wire,Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
COR,2025-08-27,20:15:04,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Mark Durcan as Chairman,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Appoints Mark Durcan as Chairman of Its Board of Directors
COR,2025-08-27,20:21:42,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Mark Durcan as Chmn,NEWS-FLASH,Dow Jones Newswires,Cencora Appoints Mark Durcan as Chmn of Its Bd of Directors
COR,2025-08-27,20:22:03,7D85A9,Cencora Inc.,100,0.47,labor-issues,,Cencora Appoints Lead Independent Director D. Mark Durcan as Chairman,NEWS-FLASH,Dow Jones Newswires,"Cencora Appoints Lead Independent Director D. Mark Durcan as Chairman, Effective Oct 1 >COR"
COR,2025-09-16,14:39:31,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Chmn Collis Registers 31,350 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"Chmn Collis Registers 31,350 Of Cencora Inc >COR"
COR,2025-09-18,15:57:24,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 5,097 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 5,097 Of Cencora Inc >COR"
COR,2025-09-18,19:57:11,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Chmn Collis Sells 31,350 Of Cencora Inc >COR",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Collis Sells 31,350 Of Cencora Inc >COR"
COR,2025-09-22,20:17:35,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 5,097 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 5,097 Of Cencora Inc >COR"
COR,2025-10-01,14:39:25,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Vp Campbell Registers 1,886 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"VP Campbell Registers 1,886 Of Cencora Inc >COR"
COR,2025-10-03,20:04:15,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Vp Campbell Sells 1,886 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"VP Campbell Sells 1,886 Of Cencora Inc >COR"
COR,2025-10-06,20:30:00,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Business Wire,Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release
COR,2025-10-06,20:35:40,7D85A9,Cencora Inc.,99,0.0,investor-relations,,Cencora Inc.: The Company will host a conference call to discuss the results at 8:30 a.m. ET,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release
COR,2025-10-16,13:23:08,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Mizuho
COR,2025-10-16,13:23:08,7D85A9,Cencora Inc.,100,0.6,price-targets,upgrade,Cencora Price Target Raised to $334.00/Share From $316.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $334.00/Share From $316.00 by Mizuho
COR,2025-10-20,13:42:33,7D85A9,Cencora Inc.,100,-0.48,insider-trading,,"Ceo Mauch Registers 5,097 Of Cencora Inc >COR",RNS-SEC144,Dow Jones Newswires,"CEO Mauch Registers 5,097 Of Cencora Inc >COR"
COR,2025-10-21,20:34:09,7D85A9,Cencora Inc.,100,-0.49,insider-trading,,"Ceo Mauch Sells 5,097 Of Cencora Inc",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Mauch Sells 5,097 Of Cencora Inc >COR"
COR,2025-10-27,17:09:13,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Buy by UBS
COR,2025-10-27,17:09:13,7D85A9,Cencora Inc.,100,0.72,price-targets,upgrade,Cencora Price Target Raised to $380.00/Share From $350.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $380.00/Share From $350.00 by UBS
COR,2025-10-30,12:15:11,7D85A9,Cencora Inc.,100,0.34,analyst-ratings,neutral,Cencora Is Maintained at Outperform by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Is Maintained at Outperform by Mizuho
COR,2025-10-30,12:15:11,7D85A9,Cencora Inc.,100,0.34,price-targets,upgrade,Cencora Price Target Raised to $340.00/Share From $334.00 by Mizuho,NEWS-FLASH,Dow Jones Newswires,Cencora Price Target Raised to $340.00/Share From $334.00 by Mizuho
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,DJ Global Press Release Wire,RespireRx Pharmaceuticals Inc. CFO and CEO Issue -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -4-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:00:02,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,GlobeNewswire,(PMZN) RespireRx Pharmaceuticals Inc. CFO and CEO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.53,labor-issues,,RespireRx Pharmaceuticals Inc.: Appointment of New Director,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.4,products-services,,RespireRx Pharmaceuticals Inc.: we will receive at least one new grant to support,PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -4-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our Annual Report on Form 10-K for the year ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-02-10,12:06:44,B47A12,RespireRx Pharmaceuticals Inc.,99,0.0,earnings,,"RespireRx Pharmaceuticals Inc.: our quarterly reports on Form 10-Q as of March 31, 2024, June 30",PRESS-RELEASE,Dow Jones Newswires,Press Release: RespireRx Pharmaceuticals Inc. CFO -6-
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.47,equity-actions,,Camino Announces Restructured,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: the Company plans to commence an exploration drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.55,acquisitions-mergers,,Camino Minerals Corp.: the Company's previously announced acquisition of the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-16,11:46:11,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Announces Effective Date of Share Consolidation,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Effective Date of Share Consolidation
COR,2025-01-22,11:14:03,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Copper Discovery Exploration Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of First Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.62,acquisitions-mergers,,"Camino Minerals Corp.: the Company acquired an aggregate of 3,690,475 Common Shares in the First",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-03-17,10:00:01,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Filing of Technical Report
COR,2025-03-17,10:01:34,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
COR,2025-04-17,10:02:13,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
COR,2025-04-17,11:16:48,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino and Nittetsu Complete Acquisition
COR,2025-05-06,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Exploration Results
COR,2025-05-06,10:07:10,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-10-08,10:00:00,B99302,Camino Minerals Corp.,99,0.0,labor-issues,shares-options,"Camino granted stock options to certain directors, officers",PRESS-RELEASE,DJ Global Press Release Wire,Camino Receives Approval for Waste Dump Expansion and Achieves Milestone at the Puquios Copper Project in Chile
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos -2-
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Camino Minerals Corp.: the ""Company"") is pleased to announce that its joint venture with Nittetsu Mining Co., Ltd.",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,,Camino signed a Definitive Agreement to purchase the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.47,equity-actions,,Camino Announces Restructured,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: the Company plans to commence an exploration drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.55,acquisitions-mergers,,Camino Minerals Corp.: the Company's previously announced acquisition of the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-16,11:46:11,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Announces Effective Date of Share Consolidation,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Effective Date of Share Consolidation
COR,2025-01-22,11:14:03,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Copper Discovery Exploration Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of First Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.62,acquisitions-mergers,,"Camino Minerals Corp.: the Company acquired an aggregate of 3,690,475 Common Shares in the First",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-03-17,10:00:01,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Filing of Technical Report
COR,2025-03-17,10:01:34,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
COR,2025-04-17,10:02:13,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
COR,2025-04-17,11:16:48,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino and Nittetsu Complete Acquisition
COR,2025-05-06,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Exploration Results
COR,2025-05-06,10:07:10,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-10-08,10:00:00,B99302,Camino Minerals Corp.,99,0.0,labor-issues,shares-options,"Camino granted stock options to certain directors, officers",PRESS-RELEASE,DJ Global Press Release Wire,Camino Receives Approval for Waste Dump Expansion and Achieves Milestone at the Puquios Copper Project in Chile
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos -2-
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Camino Minerals Corp.: the ""Company"") is pleased to announce that its joint venture with Nittetsu Mining Co., Ltd.",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,,Camino signed a Definitive Agreement to purchase the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.47,equity-actions,,Camino Announces Restructured,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: the Company plans to commence an exploration drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.55,acquisitions-mergers,,Camino Minerals Corp.: the Company's previously announced acquisition of the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-16,11:46:11,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Announces Effective Date of Share Consolidation,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Effective Date of Share Consolidation
COR,2025-01-22,11:14:03,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Copper Discovery Exploration Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of First Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.62,acquisitions-mergers,,"Camino Minerals Corp.: the Company acquired an aggregate of 3,690,475 Common Shares in the First",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-03-17,10:00:01,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Filing of Technical Report
COR,2025-03-17,10:01:34,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
COR,2025-04-17,10:02:13,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
COR,2025-04-17,11:16:48,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino and Nittetsu Complete Acquisition
COR,2025-05-06,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Exploration Results
COR,2025-05-06,10:07:10,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-10-08,10:00:00,B99302,Camino Minerals Corp.,99,0.0,labor-issues,shares-options,"Camino granted stock options to certain directors, officers",PRESS-RELEASE,DJ Global Press Release Wire,Camino Receives Approval for Waste Dump Expansion and Achieves Milestone at the Puquios Copper Project in Chile
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos -2-
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Camino Minerals Corp.: the ""Company"") is pleased to announce that its joint venture with Nittetsu Mining Co., Ltd.",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,,Camino signed a Definitive Agreement to purchase the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.47,equity-actions,,Camino Announces Restructured,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: the Company plans to commence an exploration drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.55,acquisitions-mergers,,Camino Minerals Corp.: the Company's previously announced acquisition of the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-16,11:46:11,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Announces Effective Date of Share Consolidation,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Effective Date of Share Consolidation
COR,2025-01-22,11:14:03,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Copper Discovery Exploration Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of First Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.62,acquisitions-mergers,,"Camino Minerals Corp.: the Company acquired an aggregate of 3,690,475 Common Shares in the First",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-03-17,10:00:01,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Filing of Technical Report
COR,2025-03-17,10:01:34,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
COR,2025-04-17,10:02:13,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
COR,2025-04-17,11:16:48,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino and Nittetsu Complete Acquisition
COR,2025-05-06,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Exploration Results
COR,2025-05-06,10:07:10,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-10-08,10:00:00,B99302,Camino Minerals Corp.,99,0.0,labor-issues,shares-options,"Camino granted stock options to certain directors, officers",PRESS-RELEASE,DJ Global Press Release Wire,Camino Receives Approval for Waste Dump Expansion and Achieves Milestone at the Puquios Copper Project in Chile
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos -2-
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Camino Minerals Corp.: the ""Company"") is pleased to announce that its joint venture with Nittetsu Mining Co., Ltd.",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,,Camino signed a Definitive Agreement to purchase the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.47,equity-actions,,Camino Announces Restructured,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: the Company plans to commence an exploration drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.55,acquisitions-mergers,,Camino Minerals Corp.: the Company's previously announced acquisition of the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-16,11:46:11,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Announces Effective Date of Share Consolidation,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Effective Date of Share Consolidation
COR,2025-01-22,11:14:03,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Copper Discovery Exploration Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of First Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.62,acquisitions-mergers,,"Camino Minerals Corp.: the Company acquired an aggregate of 3,690,475 Common Shares in the First",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-03-17,10:00:01,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Filing of Technical Report
COR,2025-03-17,10:01:34,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
COR,2025-04-17,10:02:13,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
COR,2025-04-17,11:16:48,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino and Nittetsu Complete Acquisition
COR,2025-05-06,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Exploration Results
COR,2025-05-06,10:07:10,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-10-08,10:00:00,B99302,Camino Minerals Corp.,99,0.0,labor-issues,shares-options,"Camino granted stock options to certain directors, officers",PRESS-RELEASE,DJ Global Press Release Wire,Camino Receives Approval for Waste Dump Expansion and Achieves Milestone at the Puquios Copper Project in Chile
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos -2-
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Camino Minerals Corp.: the ""Company"") is pleased to announce that its joint venture with Nittetsu Mining Co., Ltd.",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,,Camino signed a Definitive Agreement to purchase the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.47,equity-actions,,Camino Announces Restructured,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: the Company plans to commence an exploration drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.55,acquisitions-mergers,,Camino Minerals Corp.: the Company's previously announced acquisition of the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-16,11:46:11,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Announces Effective Date of Share Consolidation,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Effective Date of Share Consolidation
COR,2025-01-22,11:14:03,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Copper Discovery Exploration Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of First Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.62,acquisitions-mergers,,"Camino Minerals Corp.: the Company acquired an aggregate of 3,690,475 Common Shares in the First",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-03-17,10:00:01,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Filing of Technical Report
COR,2025-03-17,10:01:34,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
COR,2025-04-17,10:02:13,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
COR,2025-04-17,11:16:48,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino and Nittetsu Complete Acquisition
COR,2025-05-06,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Exploration Results
COR,2025-05-06,10:07:10,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-10-08,10:00:00,B99302,Camino Minerals Corp.,99,0.0,labor-issues,shares-options,"Camino granted stock options to certain directors, officers",PRESS-RELEASE,DJ Global Press Release Wire,Camino Receives Approval for Waste Dump Expansion and Achieves Milestone at the Puquios Copper Project in Chile
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos -2-
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Camino Minerals Corp.: the ""Company"") is pleased to announce that its joint venture with Nittetsu Mining Co., Ltd.",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,,Camino signed a Definitive Agreement to purchase the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.47,equity-actions,,Camino Announces Restructured,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: the Company plans to commence an exploration drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.55,acquisitions-mergers,,Camino Minerals Corp.: the Company's previously announced acquisition of the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-16,11:46:11,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Announces Effective Date of Share Consolidation,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Effective Date of Share Consolidation
COR,2025-01-22,11:14:03,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Copper Discovery Exploration Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of First Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.62,acquisitions-mergers,,"Camino Minerals Corp.: the Company acquired an aggregate of 3,690,475 Common Shares in the First",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-03-17,10:00:01,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Filing of Technical Report
COR,2025-03-17,10:01:34,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
COR,2025-04-17,10:02:13,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
COR,2025-04-17,11:16:48,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino and Nittetsu Complete Acquisition
COR,2025-05-06,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Exploration Results
COR,2025-05-06,10:07:10,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-10-08,10:00:00,B99302,Camino Minerals Corp.,99,0.0,labor-issues,shares-options,"Camino granted stock options to certain directors, officers",PRESS-RELEASE,DJ Global Press Release Wire,Camino Receives Approval for Waste Dump Expansion and Achieves Milestone at the Puquios Copper Project in Chile
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos -2-
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Camino Minerals Corp.: the ""Company"") is pleased to announce that its joint venture with Nittetsu Mining Co., Ltd.",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,,Camino signed a Definitive Agreement to purchase the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.47,equity-actions,,Camino Announces Restructured,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: the Company plans to commence an exploration drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.55,acquisitions-mergers,,Camino Minerals Corp.: the Company's previously announced acquisition of the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-16,11:46:11,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Announces Effective Date of Share Consolidation,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Effective Date of Share Consolidation
COR,2025-01-22,11:14:03,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Copper Discovery Exploration Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of First Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.62,acquisitions-mergers,,"Camino Minerals Corp.: the Company acquired an aggregate of 3,690,475 Common Shares in the First",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-03-17,10:00:01,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Filing of Technical Report
COR,2025-03-17,10:01:34,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
COR,2025-04-17,10:02:13,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
COR,2025-04-17,11:16:48,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino and Nittetsu Complete Acquisition
COR,2025-05-06,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Exploration Results
COR,2025-05-06,10:07:10,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-10-08,10:00:00,B99302,Camino Minerals Corp.,99,0.0,labor-issues,shares-options,"Camino granted stock options to certain directors, officers",PRESS-RELEASE,DJ Global Press Release Wire,Camino Receives Approval for Waste Dump Expansion and Achieves Milestone at the Puquios Copper Project in Chile
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos -2-
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Camino Minerals Corp.: the ""Company"") is pleased to announce that its joint venture with Nittetsu Mining Co., Ltd.",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,,Camino signed a Definitive Agreement to purchase the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.47,equity-actions,,Camino Announces Restructured,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Minerals Corp.: the Company plans to commence an exploration drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-10,11:00:47,B99302,Camino Minerals Corp.,100,0.55,acquisitions-mergers,,Camino Minerals Corp.: the Company's previously announced acquisition of the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Restructured Private Placement of up to C$2.0 Million and Proposed Consolidation
COR,2025-01-16,11:46:11,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Announces Effective Date of Share Consolidation,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Effective Date of Share Consolidation
COR,2025-01-22,11:14:03,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino Commences Copper Discovery Exploration Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino Commences Copper Discovery Exploration Drilling at the Los Chapitos Project in Peru
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of First Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-01-29,11:00:54,B99302,Camino Minerals Corp.,100,0.62,acquisitions-mergers,,"Camino Minerals Corp.: the Company acquired an aggregate of 3,690,475 Common Shares in the First",PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of First Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.4,equity-actions,completed,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-02-05,11:00:57,B99302,Camino Minerals Corp.,100,0.0,equity-actions,,Camino Minerals Corp.: Completion of the Financing,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Closing of Final Tranche of Non-Brokered Private Placement
COR,2025-03-17,10:00:01,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Filing of Technical Report
COR,2025-03-17,10:01:34,B99302,Camino Minerals Corp.,99,0.0,equity-actions,,Camino Minerals Corp.: mining cost of US$2.10,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Filing of Pre-Feasibility Study Technical Report and Provides Update on Previously Announced Acquisition of the Puquios Copper Project
COR,2025-04-17,10:02:13,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Complete Acquisition of Permitted Puquios Copper Project in Chile
COR,2025-04-17,11:16:48,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Nittetsu Mining Co. Ltd.: our collaboration with Camino in Peru, and now in Chile",PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino and Nittetsu Complete Acquisition
COR,2025-05-06,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces Exploration Results
COR,2025-05-06,10:07:10,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: The greenfield drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:01,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,DJ Global Press Release Wire,"Camino Announces High-Grade Copper, with Bornite, Trench Results of 90 Meters at 1.07 % Copper including 4 Meters at 3.05% Copper in New Mirador Zone at Los Chapitos in Peru"
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.53,labor-issues,,Camino Minerals Corp.: Appoints New CFO for,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,0.51,exploration,,Camino Minerals Corp.: A planned drilling campaign,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-07-16,10:00:03,B99302,Camino Minerals Corp.,99,-0.57,labor-issues,,Be stepping down as Chief Financial Officer of Camino,PRESS-RELEASE,LSE Regulatory News Service (RNS),Camino Minerals Corporation Camino Announces High-Grade Copper at Los Chapitos
COR,2025-10-08,10:00:00,B99302,Camino Minerals Corp.,99,0.0,labor-issues,shares-options,"Camino granted stock options to certain directors, officers",PRESS-RELEASE,DJ Global Press Release Wire,Camino Receives Approval for Waste Dump Expansion and Achieves Milestone at the Puquios Copper Project in Chile
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos Copper Project in Peru; Peru's Ministry of Energy and Mines Names Los Chapitos Among Top 15 Priority Exploration Projects
COR,2025-10-15,10:00:01,B99302,Camino Minerals Corp.,100,0.51,exploration,,Camino to Commence Drilling,PRESS-RELEASE,DJ Global Press Release Wire,Camino to Commence Drilling at its Los Chapitos -2-
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.49,partnerships,,"Camino Minerals Corp.: the ""Company"") is pleased to announce that its joint venture with Nittetsu Mining Co., Ltd.",PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-10-30,10:00:02,B99302,Camino Minerals Corp.,99,0.55,acquisitions-mergers,,Camino signed a Definitive Agreement to purchase the construction-ready Puquios copper mine,PRESS-RELEASE,DJ Global Press Release Wire,Camino and Nittetsu Commence Proprietary Leaching Studies for Growth Opportunities at the Puquios Copper Project in Chile
COR,2025-09-08,06:00:17,E7050B,IDE Group Holdings PLC,100,0.47,labor-issues,,Tialis Essential IT PLC Appointment of Independent Non-Executive Directors,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Appointment of Independent Non-Executive Directors
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue of GBP8.8 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit of GBP2.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.62,acquisitions-mergers,,"IDE Group Holdings PLC: Additionally in June 2025, Tialis also acquired MXC",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.51,products-services,increase,IDE Group Holdings PLC: growing market demand for our AI-driven solutions,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.26,credit,,Tialis has completed a debt refinancing,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,credit,,IDE Group Holdings PLC: GBP285k of the loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.47,labor-issues,,IDE Group Holdings PLC: Board Changes,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.57,acquisitions-mergers,completed,IDE Group Holdings PLC: we have successfully completed our first acquisition.,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Exceptional costs amounted to GBP0.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.58,equity-actions,down,Tialis expects exceptional costs to decrease,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Loss per share was 3.58p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: The Group invested GBP0.02 million in fixed assets,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,-0.62,earnings,negative,IDE Group Holdings PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -3-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,90,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -3-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,96,-0.62,earnings,negative,IDE Group Holdings PLC: Total loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -4-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,0.0,revenues,,IDE Group Holdings PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,97,-0.65,earnings,negative,IDE Group Holdings PLC: 13.11) Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -6-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,97,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -6-
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.22,acquisitions-mergers,,IDE Group Holdings PLC: The acquisition of a 50 per cent. investment stake in MXLG represents a strategic opportunity for Tialis and,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.49,partnerships,,IDE Group Holdings PLC: Partnering with established market participants also enables Tialis to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,"IDE Group Holdings PLC: For the year ended 31 December 2024, MXLG reported revenue of GBP28.2m",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: annual general meeting of the Company to be held in 2026,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related -2-
COR,2025-10-07,12:45:20,E7050B,IDE Group Holdings PLC,100,0.57,acquisitions-mergers,completed,Tialis Essential IT PLC Completion of Acquisition of stake in MXLG,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Completion of Acquisition of stake in MXLG
COR,2025-10-13,06:00:18,E7050B,IDE Group Holdings PLC,99,0.22,acquisitions-mergers,,"IDE Group Holdings PLC: the Company, acquired 31,000 ordinary shares of 1p each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Director Dealing
COR,2025-09-08,06:00:17,E7050B,IDE Group Holdings PLC,100,0.47,labor-issues,,Tialis Essential IT PLC Appointment of Independent Non-Executive Directors,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Appointment of Independent Non-Executive Directors
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue of GBP8.8 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit of GBP2.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.62,acquisitions-mergers,,"IDE Group Holdings PLC: Additionally in June 2025, Tialis also acquired MXC",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.51,products-services,increase,IDE Group Holdings PLC: growing market demand for our AI-driven solutions,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.26,credit,,Tialis has completed a debt refinancing,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,credit,,IDE Group Holdings PLC: GBP285k of the loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.47,labor-issues,,IDE Group Holdings PLC: Board Changes,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.57,acquisitions-mergers,completed,IDE Group Holdings PLC: we have successfully completed our first acquisition.,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Exceptional costs amounted to GBP0.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.58,equity-actions,down,Tialis expects exceptional costs to decrease,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Loss per share was 3.58p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: The Group invested GBP0.02 million in fixed assets,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,-0.62,earnings,negative,IDE Group Holdings PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -3-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,90,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -3-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,96,-0.62,earnings,negative,IDE Group Holdings PLC: Total loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -4-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,0.0,revenues,,IDE Group Holdings PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,97,-0.65,earnings,negative,IDE Group Holdings PLC: 13.11) Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -6-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,97,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -6-
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.22,acquisitions-mergers,,IDE Group Holdings PLC: The acquisition of a 50 per cent. investment stake in MXLG represents a strategic opportunity for Tialis and,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.49,partnerships,,IDE Group Holdings PLC: Partnering with established market participants also enables Tialis to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,"IDE Group Holdings PLC: For the year ended 31 December 2024, MXLG reported revenue of GBP28.2m",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: annual general meeting of the Company to be held in 2026,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related -2-
COR,2025-10-07,12:45:20,E7050B,IDE Group Holdings PLC,100,0.57,acquisitions-mergers,completed,Tialis Essential IT PLC Completion of Acquisition of stake in MXLG,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Completion of Acquisition of stake in MXLG
COR,2025-10-13,06:00:18,E7050B,IDE Group Holdings PLC,99,0.22,acquisitions-mergers,,"IDE Group Holdings PLC: the Company, acquired 31,000 ordinary shares of 1p each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Director Dealing
COR,2025-09-08,06:00:17,E7050B,IDE Group Holdings PLC,100,0.47,labor-issues,,Tialis Essential IT PLC Appointment of Independent Non-Executive Directors,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Appointment of Independent Non-Executive Directors
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue of GBP8.8 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit of GBP2.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.62,acquisitions-mergers,,"IDE Group Holdings PLC: Additionally in June 2025, Tialis also acquired MXC",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.51,products-services,increase,IDE Group Holdings PLC: growing market demand for our AI-driven solutions,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.26,credit,,Tialis has completed a debt refinancing,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,credit,,IDE Group Holdings PLC: GBP285k of the loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.47,labor-issues,,IDE Group Holdings PLC: Board Changes,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.57,acquisitions-mergers,completed,IDE Group Holdings PLC: we have successfully completed our first acquisition.,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Exceptional costs amounted to GBP0.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.58,equity-actions,down,Tialis expects exceptional costs to decrease,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Loss per share was 3.58p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: The Group invested GBP0.02 million in fixed assets,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,-0.62,earnings,negative,IDE Group Holdings PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -3-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,90,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -3-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,96,-0.62,earnings,negative,IDE Group Holdings PLC: Total loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -4-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,0.0,revenues,,IDE Group Holdings PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,97,-0.65,earnings,negative,IDE Group Holdings PLC: 13.11) Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -6-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,97,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -6-
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.22,acquisitions-mergers,,IDE Group Holdings PLC: The acquisition of a 50 per cent. investment stake in MXLG represents a strategic opportunity for Tialis and,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.49,partnerships,,IDE Group Holdings PLC: Partnering with established market participants also enables Tialis to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,"IDE Group Holdings PLC: For the year ended 31 December 2024, MXLG reported revenue of GBP28.2m",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: annual general meeting of the Company to be held in 2026,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related -2-
COR,2025-10-07,12:45:20,E7050B,IDE Group Holdings PLC,100,0.57,acquisitions-mergers,completed,Tialis Essential IT PLC Completion of Acquisition of stake in MXLG,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Completion of Acquisition of stake in MXLG
COR,2025-10-13,06:00:18,E7050B,IDE Group Holdings PLC,99,0.22,acquisitions-mergers,,"IDE Group Holdings PLC: the Company, acquired 31,000 ordinary shares of 1p each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Director Dealing
COR,2025-09-08,06:00:17,E7050B,IDE Group Holdings PLC,100,0.47,labor-issues,,Tialis Essential IT PLC Appointment of Independent Non-Executive Directors,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Appointment of Independent Non-Executive Directors
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,IDE Group Holdings PLC: Revenue of GBP8.8 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.61,earnings,positive,IDE Group Holdings PLC: Gross profit of GBP2.6 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.62,acquisitions-mergers,,"IDE Group Holdings PLC: Additionally in June 2025, Tialis also acquired MXC",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.51,products-services,increase,IDE Group Holdings PLC: growing market demand for our AI-driven solutions,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.26,credit,,Tialis has completed a debt refinancing,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,credit,,IDE Group Holdings PLC: GBP285k of the loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.47,labor-issues,,IDE Group Holdings PLC: Board Changes,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.57,acquisitions-mergers,completed,IDE Group Holdings PLC: we have successfully completed our first acquisition.,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,equity-actions,,IDE Group Holdings PLC: Exceptional costs amounted to GBP0.1 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.58,equity-actions,down,Tialis expects exceptional costs to decrease,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Loss per share was 3.58p,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.46,equity-actions,,IDE Group Holdings PLC: The Group invested GBP0.02 million in fixed assets,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,99,-0.62,earnings,negative,IDE Group Holdings PLC: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -2-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,90,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -3-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,90,0.0,earnings,,IDE Group Holdings PLC: Adjusted EBITDA,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -3-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,96,-0.62,earnings,negative,IDE Group Holdings PLC: Total loss before tax,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -4-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,0.0,revenues,,IDE Group Holdings PLC: Total revenue,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,0.47,equity-actions,,IDE Group Holdings PLC: Restructuring,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,91,-0.65,earnings,negative,IDE Group Holdings PLC: Basic and diluted unaudited loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -5-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,97,-0.65,earnings,negative,IDE Group Holdings PLC: 13.11) Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -6-
COR,2025-09-09,06:00:21,E7050B,IDE Group Holdings PLC,97,0.0,credit,,IDE Group Holdings PLC: the Company issued GBP5.3 million of secured loan,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Unaudited Interim Results -6-
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.22,acquisitions-mergers,,IDE Group Holdings PLC: The acquisition of a 50 per cent. investment stake in MXLG represents a strategic opportunity for Tialis and,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.49,partnerships,,IDE Group Holdings PLC: Partnering with established market participants also enables Tialis to,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,revenues,,"IDE Group Holdings PLC: For the year ended 31 December 2024, MXLG reported revenue of GBP28.2m",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related Party Transaction
COR,2025-09-12,06:00:21,E7050B,IDE Group Holdings PLC,99,0.0,investor-relations,,IDE Group Holdings PLC: annual general meeting of the Company to be held in 2026,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Notice of GM and Related -2-
COR,2025-10-07,12:45:20,E7050B,IDE Group Holdings PLC,100,0.57,acquisitions-mergers,completed,Tialis Essential IT PLC Completion of Acquisition of stake in MXLG,PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Completion of Acquisition of stake in MXLG
COR,2025-10-13,06:00:18,E7050B,IDE Group Holdings PLC,99,0.22,acquisitions-mergers,,"IDE Group Holdings PLC: the Company, acquired 31,000 ordinary shares of 1p each in the Company (""Ordinary Shares",PRESS-RELEASE,LSE Regulatory News Service (RNS),Tialis Essential IT PLC Director Dealing
